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THESIS SUMMARY
Cancer is one of the leading causes of death in the UK. The Cancer Reform 
Strategy (2007) highlighted the need for integration of psychological services into 
routine cancer care. Previous research into psychosocial aspects of adjustment is, 
however, inconsistent This thesis opens w ith a background on cancer 
epidemiology and policy; the psychological impact of cancer; and, the 
shortcomings of previous intervention-based research. The Transactional Model is 
introduced as a potential framework for modelling adjustment. The thesis aimed 
to test this model for cancer patients in order to provide evidence to better inform 
the provision of psychological services for cancer patients.
A systematic review summarised the literature exploring the extent to which 
personality, appraisals and emotions were associated w ith psychosocial outcome. 
68 studies were included. A number of small meta-analyses were performed using 
the Hunter and Schmidt method. Findings demonstrated a lack of consistency, and 
a number of research questions still unanswered. A methodological critique was 
provided based on systematic quality assessment.
The empirical study had two purposes: prediction of clinical outcome and 
theory development 160 recently diagnosed colorectal, breast, lung and prostate 
cancer patients were recruited. Measures of personality, appraisal, emotion, 
coping and outcome (anxiety, depression and quality o f life) were collected at 
baseline, three- and six-month follow-up. Analyses demonstrated that the data 
generally fitted the model but adaptations were proposed. Clinically, between 47 
and 74% of variance in psychosocial outcome was explained by these predictor 
variables, w ith cognitive appraisals most predictive of all Transactional Model 
components. Statistical theory testing of cognition-emotion processes did not 
confirm the Transactional Model (Lazarus, 1999). These findings question the 
prescriptive nature of the theory and further testing is suggested, particularly in 
response to chronic stressors.
Guidelines for methodological improvements are provided. The thesis 
concludes w ith  proposals for further research, including suggestions for theory- 
informed interventions.
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CHAPTER 1 
BACKGROUND LITERATURE REVIEW
1.1 CHAPTER OVERVIEW
This chapter will review some of the key theoretical and applied psychology 
literature that underpins the rationale for this thesis. After a brief summary of the 
relevant epidemiological literature (section 1.2) and a review of current cancer 
policy (section 1.3), an overview of psychological issues commonly faced by cancer 
patients will be presented (section 1.4). Together, these will help to delineate the 
need for increased psychological input into the care of cancer patients.
Published psychosocial intervention trials have had varying success and few 
have replicated the promising early effects on survival reported by Spiegel and his 
colleagues (e.g. Speigel, Bloom, Kraemer & Gottheil, 1989). Nonetheless, there is 
evidence that a variety of psychological variables are predictive of many short­
term outcomes including distress and quality of life. Few studies have approached 
empirical investigation of cancer adjustment from a fully theoretical perspective. 
An overview of the relevant intervention literature is presented in section 1.5 
including a summary of some of the methodological problems with these studies.
The second half of the chapter (sections 1.6-1.11) introduces personality and 
stress theory as potentially useful frameworks for understanding adjustment to 
cancer. Although some evidence is published linking a limited number of 
personality traits to outcome, there are many others which have simply not 
featured in previous research. Additionally, though not yet empirically tested in 
entirety, by incorporating cognitive, affective, and behavioural factors, 
underpinned by personality and individual differences, the Transactional Model of 
Stress holds promise for bringing together findings from the many disparate 
studies already conducted in this field. Two primary issues remain. First, in 
clinical application, it is not yet clear which aspects of the Transactional Model 
(Lazarus, 1999) are most predictive of outcome, and therefore which should be 
targeted in future research and clinical intervention. Second, theory-testing of the 
latest version of this model has not been sufficiently comprehensive to justify 
either the complexity of the model or the hypothesised nature of inter-variable 
relationships.
1
Herein lie the multifaceted aims of this thesis:
• To systematically review the literature to date in line w ith this 
theoretical framework
• To explore the u tility  of Transactional Model components in the 
prediction of clinically-relevant psychosocial outcomes in cancer 
patients
• To test the specific nature of Transactional Model w ith regards to 
theoretically hypothesised associations between cognitions and 
emotions.
The chapter concludes w ith a description of how each of these questions w ill 
be approached (section 1.12).
1.2 CANCER INCIDENCE AND EPIDEMIOLOGY
Cancer remains the biggest threat to health in the UK accounting for 26% of 
all deaths (Department of Health, 2007). A disease most prevalent in the elderly 
(Geraci, Birch, Alston, Moran & Eden, 2007), of the 239,000 new diagnoses made in 
2005,26% were patients younger than 60 years o f age (Office of National 
Statistics, 2008). There were 152,491 cancer-related deaths in the UK in 2005, of 
which, 47% resulted from a diagnosis of lung, colorectal, breast or prostate cancer. 
These still remain the most common cancer diagnoses made. Although incidence- 
proportional mortality rates remain higher in men than women, general trends of 
decreasing m ortality for both genders are evident (Cancer Research UK, 2008). 
Despite this, five year survival rates for UK cancer patients remain significantly 
lower than most comparable European healthcare systems where the UK ranks 9th 
out o f 28 for male survival and just 22nd out of 28 for female survival (Department 
of Health, 2007).
1.2.1 Cancer site-specific incidence and epidemiology
In the UK, cancer diagnoses are staged using both cancer-type specific 
systems and generic tumour-node-metastases (TNM) systems. TNM staging 
provides a score from 0-4 for each of the three aspects to give a specific 
categorisation o f the extent o f disease. TNM scores are translated into a more 
generic cancer stages ranging from 0 to IV w ith higher staging indicating worst
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prognosis (at its simplest level, stage IV represents metastatic spread to other 
parts of the body).
1.2.1.1 Breast cancer
Breast cancer is the most commonly diagnosed cancer in the UK and age- 
standardised incidence is higher than in any other country worldwide (McPherson, 
Steel & Dixon, 2000). Twenty percent of diagnoses are made in the under 50 age 
group. Approximately 100 new diagnoses of female breast cancer are made every 
day, but just 300 new diagnosis of male breast cancer are made each year (Cancer 
Research UK, 2008). Fifty-five percent of breast cancer patients are diagnosed at 
Stage 0 (non-invasive lobular or ductal carcinoma in situ) or w ith early stage (1 or 
II) invasive adenocarcinomas (85% ductal, 15% lobular) (Moorman, Jones, 
Millikan, Hall & Newman, 2001). A number of rarer diagnoses also exist, for 
example, Paget's disease and inflammatory breast disease (each diagnosed at 
incidence of 1-2%; Cancer Help UK, 2007). Due perhaps to increased symptom 
awareness and more accurate and available screening, diagnosis rates of stage III 
and IV (advanced) breast cancer have significantly decreased (Cancer Research 
UK, 2008). Most breast cancer patients w ill undergo surgery and many w ill also 
receive radiotherapy and/or hormone therapy. Chemotherapy is less commonly 
used, but can particularly improve survival when combined w ith treatments like 
Herceptin for some patient groups w ith advanced or aggressive breast cancer 
(Cancer Research UK, 2008). Eighty percent o f patients survive beyond five years 
(Office for National Statistics, 2008), however, this varies significantly between 
those diagnosed at early or advanced stage (Miller, Ellis, Sainsbury & Dixon, 1994).
1.2.1.2 Lung cancer
Lung cancer is the most commonly diagnosed type of cancer worldwide, and 
remains second most common (after breast) in the UK (Office of National Statistics, 
2008). Diagnosis is more common in men than women at a ratio of 7:5. The 
majority of diagnoses are of adenocarcinoma or squamous cell carcinoma. An 
additional 15-20% are diagnosed w ith small cell carcinoma which has a poorer 
prognosis (Blows, 2005). Other rare diagnoses include mesothelioma and large 
cell carcinoma (Cancer Help UK, 2007). Once again, cancer staging is based on 
TNM staging; over two thirds of patients are diagnosed at a late stage (Yoder,
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2006) and just 7% survive beyond five years after diagnosis (Cancer Research UK, 
2008). This survival rate drops even further for small cell carcinoma which carries 
a two year survival prognosis of just 2%. Surgical excision of the tumour is the 
only curative treatment available to lung cancer patients but this is suitable for 
fewer than 10% of diagnoses. Most patients w ithout metastatic spread are offered 
combination treatments including surgery, radiotherapy and chemotherapy, which 
can increase five-year survival up to 20% (Cancer Help UK, 2007). Although the 
prognosis following a lung cancer diagnosis remains poor, rates of diagnosis are 
falling, and are expected to continue doing so w ith the recent significant decrease 
in smoking related behaviour (Cancer Research UK, 2008).
1.2.1.3 Colorectal Cancer
Colorectal cancer has a higher incidence in the UK (th ird most common) in 
comparison to many other countries (Boyle & Langman, 2000). Of all UK 
diagnoses, two thirds originate in the colon, and one th ird  in the rectum. Eighty 
three percent of cases are diagnosed in those over 60 years of age (Office of 
National Statistics, 2008). Ninety percent are diagnosed as adenocarcinomas, w ith 
adenomas accounting for the remaining 10%. Staging is made using TNM 
classification system or by using the colorectal-specific Dukes scale (Categories A -  
D where A represents best prognosis and D refers to advanced or metastatic 
cancer) (Midgley & Kerr, 2000). Just 10% of patients are diagnosed at an early 
stage (Dukes A) but those who are have an 85% chance of five-year survival 
(Cancer Research UK, 2008). Thirty percent are diagnosed w ith advanced (Dukes 
D) colorectal cancer (Cancer Help UK, 2007), one of the highest UK rates of 
advanced cancer at the point of diagnosis. Eighty percent of patients w ill be 
offered surgery for colorectal cancer, although this is not always w ith curative 
intent (Cancer Help UK, 2007). Chemotherapy is usually offered for all non­
metastatic cancers of the colon and has been shown to improve five-year survival 
by 6-7%. (Midgley & Kerr, 2000). Radiotherapy is typically used for treatment of 
rectal cancer, but can also be used as a form of palliative therapy and symptom 
control for advanced colon cancer (Cancer Help UK, 2007). Colorectal cancer is the 
second most common cause of cancer-related death in the UK (Office of National 
Statistics, 2007) but this is expected to significantly decrease since the
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introduction of routine screening w ith colonoscopy for the over 60's in 2006 
(Department o f Health, 2005).
1.2.1.4 Prostate cancer
Prostate cancer is the most commonly diagnosed male cancer in the UK 
accounting for 24% of all diagnoses, totalling around 35,000 diagnoses per year 
and a male lifetime risk of 1 in 14 (Office of National Statistics, 2008).
Significantly increased diagnosis rates over the past 20 years have been concluded 
not to represent increasing incidence, but better detection following introduction 
of PSA (Prostate Specific Antigen) testing (Cancer Research UK, 2008). Sixty 
percent of all men diagnosed w ith prostate cancer are over 70 years of age (Cancer 
Research UK, 2008) but evidence shows that between 15 and 30% of all men over 
50 show some symptoms of the disease (Cancer Help UK, 2007). This figure rises 
to 66% in over 75's (Dawson & W hitfield 1996) and continues to rise w ith 
increasing age. Extent of prostate cancer can be indicated in three ways. Whilst 
PSA levels are a good indicator of cancer presence, high levels do not always 
equate w ith worst prognosis (Cancer Help UK, 2007). TNM staging is more 
frequently used, as is the prostate specific Gleason classification. Where TNM 
staging indicates overall extent and spread of illness, Gleason scores are an 
indicator of tumour histology only. Scores range from 0-10, where scores above 
eight indicate the fastest growing tumours (Cancer Help UK, 2007). Very few men 
die from prostate cancer directly (approximately 4%; Cancer Research UK, 2008). 
The most common treatment options are active surveillance (monitoring of those 
who may, at a later date, benefit from curative radical treatment), watchful waiting 
(treating symptoms of those who are unlikely to benefit from radical treatment on 
an ad hoc basis) or hormone therapy, particularly where the illness is diagnosed in 
more elderly patients (Cancer Help UK, 2007; Neal, 2008). Radical therapy 
(radiotherapy or surgery) is also used for localised disease, w ith chemotherapy 
generally only reserved for cases of advanced cancer (Dawson & Whitfield, 1996).
1.2.2 North Wales incidence
Six counties contribute to the geographical area of North Wales (Anglesey, 
Conwy, Denbighshire, Flintshire, Gwynedd and Wrexham) comprising a population 
of approximately 670,000 persons (Welsh Cancer Intelligence and Surveillance
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Unit, 2006). Table 1.1 summarises total incidence, mortality, and survival 
statistics for this region between 1995 and 2000. These statistics are highly 
comparable w ith  the summary data previously discussed for general UK trends, 
but not the improved incidence-related trends observed in many other European 
countries.
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Table 1.1. Incidence, Absolute Survival and Mortality Statistics fo r  breast, prostate, lung and colorectal cancers in North Wales (provided by the Welsh 
Cancer Intelligence and Surveillance Unit).
Total Incidence 
(1995-2004)
1 Year Absolute Survival * 5 Year Absolute Survival * Total Deaths 
(1995-2004)Male Female Male Female
Male Female RelativeSurvival 95% Cl
Relative
Survival 95% Cl
Relative
Survival 95% Cl
Relative
Survival 95% Cl Male Female
Breast 5368 92.0% 90.5,93.3 79.3% 77.1,81.3 1838
Lung 3270 2039 16.3% 14.5,18.3 14.6% 12.4,16.9 4.1% 3.1, 5.1 5.0% 3.7,6.5 2704 1630
Colon 1577 1603 62.9% 58.6,66.8 55.5% 51.1, 59.6 46.2% 41.5, 50.7 37.7% 33.3,42.1 753 894
Rectum 1137 810 70.9% 66.2, 75.2 70.3% 64.5, 75.3 48.1% 42.7,53.3 47.3% 40.9, 53.5 450 347
Prostate 4156 85.5% 83.2, 87.6 72.6% 69.0, 75.8 1300
*  Based on diagnoses made 1995-2000 and followed up until 2005.
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1.3 CANCER GUIDANCE AND POLICY
Increasing incidence, high levels of mortality, and poor comparison in terms 
of survival statistics have ensured that cancer remained at the forefront o f NHS 
policy during the last decade. The NHS Cancer Plan (Department of Health, 2000) 
set cancer as a health services p rio rity  and laid out a number of key aims including 
better co-ordination between primary and secondary care services, increased 
participation in clinical trials, and better end of life care, amongst others. It also 
stated the need for personalised support and individually tailored care for each 
patient, w ith a requirement to address inequalities in care over different social 
groups. The NHS Improvement Plan (Department of Health, 2004) also aimed to 
build upon previous success by increasing the quality and speed of treatment, and 
by proposing much more choice and decision-making responsibility for the 
patient.
Despite a large body of literature stressing the importance of quality of life, 
these latest two documents, in aiming for improvement of service delivery, tend to 
focus on the practicalities o f cancer care and medically based treatments rather 
than psychosocial concerns. An earlier report by the Chief Medical Officers of 
England and Wales (A Policy Framework for Commissioning Cancer Services; 
Department of Health, 1995) gave more recognition to quality of life, and 
psychological support and care of cancer patients claiming survival to be o f "...no 
means the only outcome of importance." (p.27). It also stated the likelihood of 
differing quality o f life following different treatment programmes.
The Cancer Reform Strategy (Department of Health, 2007) builds upon 
earlier strategic documents and aims to illustrate "how by 2012 [English] cancer 
services can and should become among the best in the world." (p. 7). In addition 
to many suggestions regarding the organisation of medical care, the strategy lays 
out a clear role for psychological services in achieving this aim, recognising as it 
does, that support services are "as important as any other aspect o f the ir 
treatment" (p.76). Despite this objective, the practicalities of implementing this 
are not clear; dedicated psychological services are not explicitly included under 
treatment improvements, nor are staff listed in summaries of the expanded cancer 
workforce since 2004 (also in the same report). Four levels of psychological 
input are suggested:
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• Level one: Information and communication issues
• Level two: Problem solving interventions
• Level three: Counselling and theoretically driven interventions
• Level four: Specialist psychological and psychiatric interventions.
Of these, the first two, and possibly even the th ird are suggested to become a key 
component of the role of Clinical Nurse Specialist, thus requiring higher levels of 
training and support for these individuals.
The latest strategic policy in Wales, Designed to Tackle Cancer in Wales 
(Welsh Assembly Government, 2008), falls slightly short of the Cancer Reform 
Strategy by failing to explicitly outline the role of psychological services in ongoing 
cancer care improvement. Aims of the strategy do, however, include surveys of the 
experiences and needs of cancer patients and survivors which seems an obvious 
first step.
1.4 PSYCHOLOGICAL OUTCOMES AND INTERVENTIONS IN CANCER CARE.
1.4.1 Incidence of psychological co-morbidity
A large body of multi-disciplinary literature is available (psychology, liaison 
psychiatry, nursing, social work, clinical oncology and so forth) demonstrating the 
psychological impact of a cancer diagnosis. Indeed, cancer is not unique among the 
chronic and terminal illnesses, w ith worsening physical health significantly 
associated w ith higher risk of developing psychological co-morbidity (G. Smith, 
2003). W ithin oncology, the need to tackle such problems is clear (Ramirez, 1989; 
Pendlebury & Snars, 1996).
Following cancer diagnosis, and throughout treatment, few individuals are 
able to maintain previous levels of psychological health and well-being w ithout at 
least some challenges. However, there are many inconsistencies in the literature 
concerning incidence levels and prognosis of such co-morbidity. In short, the 
process of, and long-term outcomes from, psychological adjustment to cancer are 
unpredictable and unknown.
Distress, a term used w ith in the literature to encompass a broad range of 
negative psychological co-morbidity (Ridner, 2004), is reported to be problematic 
for in excess of 30% of patients (Zabora, Brintzenhofezoc, Curbow, Hooker & 
Piantadosi, 2001; Jacobsen, 2007; Mitchell, Kaar, Coggan & Herdman, 2008). In 
some cases, distress levels are reported as high as 75% (Galway, Black, Cantwell,
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Cardwell, Mills & Donnelly, 2008). As such there is a growing movement w ith in the 
field of psychosocial oncology for distress to be recognised as a sixth ‘vital sign' in 
cancer care, alongside the more traditional physiological assessments of body 
temperature, pulse, blood pressure, respiratory rate, and pain (Bultz & Carlson, 
2006).
Maguire (2000) reports that around one th ird of all patients diagnosed w ith 
cancer w ill develop one or more psychological co-morbidities, such as anxiety or 
depression. Anxiety is perhaps the most common of these (Missiha, Solish & From, 
2003), but incidence rates at diagnosis are variable ranging from 10% (Ratcliffe, 
Dawson & Walker, 1995) to 41% (Glinder & Compas, 1999). Clinical depression 
appears less common, but nevertheless incidence is still considerable ranging from 
as low as 2% (Ratcliffe e t al., 1995) to 34% (Epping-Jordan, Compas, Osoweicki, 
Oppedisano, Gerardt, Primo e t al., 1999; Glinder & Compas, 1999). Such wide 
ranges of reported clinical psychological co-morbidity in cancer patients may be 
reflective of clinical, demographic and psychosocial variation between studies 
investigating such outcomes. There is relatively consistent evidence that post­
diagnosis levels of depression and anxiety are related to both pre-illness 
psychological history and concurrent psychological factors (Robinson, Boshier, 
Dansak & Peterson, 1985). Anxiety and depression are not only common at the 
time of diagnosis: Sukantarat, Greer, Brett & Williamson (2007) claim that cancer 
is one of many illnesses in which patients show evidence of such co-morbidity 
many months—even years—after diagnosis.
Cancer can also have exceptional effects on an individual's quality of life, 
resulting in psychosocial, sexual and physical challenges and dysfunction 
(Fallowfield, 1995; Boini, Brian^on, Guillemin, Galan & Hercberg, 2004). Alhama, 
Extremera, Mesa, Martin, Vizoso & Vico (1996) report that around 50% of newly 
diagnosed patients are dissatisfied w ith their quality o f life, yet a study of breast 
cancer patients by Kessler (2002) suggests that patients reported better quality of 
life than they perceived the general population to have. A review by de Haes & van 
Knippenberg (1983) concluded that there was insufficient evidence to suggest that 
quality of life differences could be fully accounted for by differences in clinical 
presentation and treatment modalities and that, as in the case of anxiety and 
depression, psychological mechanisms are likely to be implicated. Although a
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relatively old review paper, no empirical evidence has yet been published to the 
contrary.
1.4.2 The process of adjustment
In the case of illness, the term adjustment can be used to refer to the process 
of adaptation or return to 'normality' that ensues after a diagnosis. Many studies 
in the field of psychosocial oncology suggest that this process of adjustment 
commences very quickly after diagnosis for both distress (Trask, Paterson, Fardig 
& Smith, 2003; Deshields, Tibbs, Fan, Bayer, Taylor & Fisher, 2005) and quality of 
life outcomes (Felder-Puig, Formann, Mildner, Bretschneider, Bucher, Windhager 
et al., 1998; Chan, Ngan, Li, Yip, Ng, Lee et al., 2001; Yan & Sellick, 2004). However, 
there is also a substantial literature which suggests that adjustment is far more 
complicated and that each different psychosocial outcome may follow different 
adjustment trajectories. Indeed, some studies seem to imply that over the course 
of illness, quality of life and distress are relatively stable (although differing in 
quantity between patient groups), and that it is not until after treatment has 
finished that they begin to improve (Bleiker, van der Ploeg, Ader, van Daal & 
Henriks, 1995; Nordin & Glimelius, 1998; Butow, Coates & Dunn,1999). The linear 
relationship between high quality of life and low distress seem an obvious 
observation to make given the supportive literature, but this is important to note 
(D'Antonio, Long, Zimmerman, Peterman, Petti & Chonkich, 1998).
1.4.3 Psychological interventions to aid adjustment
Given the potential for poor psychological adjustment, and therefore, poorer 
long-term psychological well-being, it is no surprise that the need for psychological 
support for cancer patients is well documented (Spiegel, 1994). Attempts have 
previously been made to introduce psychological interventions to compliment 
physical therapies for cancer patients (e.g. Mermelstein & Holland, 1991; Spiegel, 
Morrow, Classen, Raubertas, Stott, Mudalier etal, 1999; Donelley, Kornblith, 
Fleishman, Zuckerman, Raptis, Hudis, et al., 2000). These have enjoyed varying 
success but few have replicated the promising early Findings of Speigel and 
colleagues that such interventions may directly impact upon survival in cancer 
patients (e.g. Speigel, Bloom, Kraemer & Gottheil, 1989; Richardson, Shelter, Krailo 
& Levine, 1990); whilst both clinical and demographic factors are found to 
contribute to long-term disease-free survival, evidence for the role of psychological
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variables is weak, if present at all (Cassileth, Walsh & Lusk, 1988; Smedslund & 
Ringdal, 2004).
Whilst Walker, Hayes & Eremin (1999) suggest that there is theoretical 
potential for improved survival from psychosocial interventions, the mounting 
criticism, predominately from Coyne and his colleagues, suggests otherwise. In 
the first of two commentary articles in response to publications of 
psychotherapeutic interventions, Palmer and Coyne (2004) suggest that 
methodological weaknesses are often apparent; namely sampling weaknesses and 
unclear justification for the intervention components. More so, they go on to 
suggest that in published reviews of interventions, publication biases and 
inappropriate comparison analyses between included studies falls below 
appropriate standards and so not even these conclusions can be trusted. In the 
second commentary (Coyne, Hanisch & Palmer, 2007) and two further review 
articles (Lepore & Coyne, 2006; Coyne, Stefanek & Palmer, 2007), the overall 
conclusion is that the lack of evidence to date is sufficient to abandon all claims of 
survival effects from psychological interventions, in favour of more subtle 
hypothesis testing of intervention effects on behavioural aspects of illness; 
experiences of and coping with side effects of treatment, treatment adherence, and 
follow-up care delivery, for example (Coyne, Hanisch e ta l, 2007).
Whilst Coyne et a/'s methodological critique is sound and has been echoed 
elsewhere in the literature (e.g. Edwards, Hulbert-Williams & Neal, 2008), their 
conclusion that interventions should not be aimed at survival, or indeed the many 
other important psychosocial outcomes, seems premature. Indeed, putting 
survival outcomes aside, there is evidence that intervention may have beneficial 
impacts upon psychosocial outcomes such as anxiety, depression, distress, 
perceived pain, information needs and so forth (Fallowfield, Ratcliffe, Jenkins & 
Saul, 2001).
Two recently published Cochrane reviews of psychological interventions 
within oncology samples further question the findings of individual studies; the 
first (Edwards etal, 2008) explored of the impact of two types of psychological 
intervention (Cognitive Behavioural Therapy and Supportive-Expressive Group 
Therapy) on a variety of outcomes within metastatic breast cancer patients and 
the other (Akechi, Okuyama, Onishi, Morita, & Furukawa, 2008) focuses
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specifically on psychotherapeutic interventions targeted at depression but in a 
range of palliative diagnoses. Edwards et al. (2008) concluded that whilst 
interventions can improve short-term psychological comorbidity, the small corpus 
of established literature offers little in terms of conclusive evidence for benefits on 
long term psychological or physical outcome. Akechi et al. (2008) conducted 
numerous meta-analyses which demonstrate that where effects on anxiety were 
non-significant, some ameliorating effect on depression was observed.
Whilst these two reviews focus upon those with metastatic illness, the 
findings are not just limited to these patient populations and similar findings are 
reported for those with less advanced illness (Trijsburg, can Knippenburg & 
Rijpna,1992; Jacobsen & Hann, 1998; Uitterhoeve, Vernooy, Litiens, Potting, 
Bensing & deMulder, 2004; Owen, Klapow, Hicken &Tucker, 2001; Schofield,
Carey, Bonevski & Sanson-Fisher, 2006). As yet, no up-to-date systematic reviews 
of the effects of intervention for early cancer diagnosis has been published, 
although one is currently underway for quality of life outcomes (Galway et al., 
2008). Given the ongoing debate on the efficacy of psychosocial intervention, the 
scope for a similar review for interventions aimed at psychological outcomes in 
patients with early stage diagnosis patients is clear. Despite the, albeit 
controversial, evidence from intervention studies for improvements in distress 
and quality of life, the practicality and cost-effectiveness of offering these to all 
patients is questioned given the reported benefits (Owen etal., 2001; Rehse & 
Pukrop, 2003). Bloom (2007,2008) promotes the view that whilst intervention 
research has failed to establish a clear benefit for recurrence or survival, the 
shorter-term psychological benefits could result from an indirect effect of 
increased social support, a conclusion also drawn earlier by Llewelyn, Murray, 
Johnston, Johnston, Preece and Dewar (1999).
Other indirect benefits of psychosocial interventions have been reported, 
including the fostering of an environment conducive to emotional expression 
(Shrock, Palmer & Taylor, 1999), and the enhancement of psychophysiological 
immune functioning (Compass & Leuken, 2002). This latter finding has also been 
supported by growing research into the effects of mindfulness-based psychological 
therapies. Although it is perhaps too early to make any substantive claims from 
such research regarding disease progression and survival, promising results, both
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in terms of short-term distress levels and psycho-neuroimmunological functioning, 
have been published (Mackenzie, Carlson & Speca, 2005).
Coyne etal.'s (2007) conclusion that the trialling of interventions should be 
tailored entirely to medical and behavioural outcome is neither universally 
accepted nor promoted in this thesis. What is clear, however, is that should 
psychological intervention ever be intended to impact upon clinical oncology in a 
significant way, more methodologically sound, theoretically based empirical 
research is needed (Ross, Boesen, Dalton & Johansen, 2002; Schofield etal., 2006). 
Furthermore, the methodology of the non-intervention based psychosocial 
oncology literature is also questionable and may well account for the inconsistency 
of findings. The use of randomised controlled trials and longitudinal designs over 
cross sectional surveys is becoming more important as a marker of good quality 
research (Yardley & Moss-Morris, 2007) and yet this remains a critical problem in 
psychosocial oncology. Furthermore, the effects of clinical variables and within 
sample bio-medical differences (Andersen, 1992; Edwards et at, 2008) need to be 
considered with more methodological rigour.
Particular attention is also due to the many reviews (e.g. Cull,1990;
Andersen, 1994) which suggest that the greatest weakness in the field arises from 
a lack of sound theoretical rationale (this critique of the literature is not new 
within health and clinical psychology; see Marteau & Johnston, 1987 for an early 
commentary on the potential of health psychology theory application). Basing 
future research on established and validated theory may improve the credibility of 
the findings.
It has long been suggested that research with a multidimensional focus is 
required (Baltrusch & Waltz, 1985). Rather than continued study of behavioural 
processes, a focus on the additional effects of individual differences, cognitive 
processes and emotional (or affective) reactions on patient outcome should be 
investigated as these may act to facilitate or impede psychosocial interventions 
(Folkman & Greer, 2000; Compas & Lueken, 2002). One attempt to model these 
complex variable interactions was proposed by Brennan (2001) in his Social- 
Cognitive Theory of adjustment. This process model of adjustment encompasses a 
broader range of psychosocial components primarily centred around the notion 
that distress results when the diagnosis (and its sequalae) require greatest re-
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organisation of the patient's mental map (Brennan & Moynihan, 2004), a term 
used to refer to individual cognitive schema and experience of the world. 
Interventions encompassing such components (e.g. self-efficacy, self-regulation 
and outcome expectancies) have previously been reported to be efficacious in 
improving psychosocial outcome (Graves, 2003). However, the model requires 
further development and empirical support; specifically, its research and multi­
disciplinary application beyond clinical psychology services is unclear.
Whilst Brennan's model is rooted in clinical psychology, the discipline of 
health psychology may offer useful alternatives. Self-Regulation Theory—based 
upon the work of Leventhal and his colleagues (e.g. Leventhal, Leventhal & 
Schaefer, 1989) and Carver & Scheier (e.g. Carver & Scheier, 1999)—has to date 
dominated research into cognitive aspects of illness adjustment, both within 
cancer and other illness groups. Self-regulation theory was in part developed from 
more generic stress and coping theory (Schroevers, Kraaij & Garnefski, 2008) in 
order to expand such theories to encompass goal-related cognitions. However, 
even this popular model has weaknesses, primarily that the longitudinal aspect of 
how the different components of self-regulation change over time and interact is 
under-developed and un-clear (Marks, Murray, Evans, Willig, Woodall & Sykes, 
2005). As an alternative approach, recently expanded socio-cognitive- 
motivational models of stress (i.e. Lazarus's Transactional Model) may be 
considered well positioned to provide a theoretically developed and empirically 
supported model which could (but haven't yet in their fullness) be applied to 
oncology. The remainder of this chapter will focus on reviewing this theory and 
some of the relevant research.
1.5 THE TRANSACTIONAL MODEL OF STRESS
Psychologists define stress as a fundamentally subjective transactional 
process involving appraisal of the potential stressor (the circumstance initiating 
the stress reaction) and perceived resources (the individual's ability to cope with, 
and deal with the stressor) (Lazarus & Folkman, 1987). Individual differences in 
response to similar stressors reflect cognitive appraisal variations (Lazarus, 1984). 
It is these variations in event and resource appraisal that make some individuals 
particularly vulnerable to stress. Appraisal occurs at both conscious and
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unconscious levels and is influenced by situational, temporal, and personal factors. 
For example, an individual receiving a diagnosis may appraise it as a threat (e.g. to 
future goals), as a challenge (to overcome) or as a loss (e.g. loss of role). In turn 
these appraisals will vary depending upon the diagnosis made, the past experience 
of the patient, and even the age of the patient
Coping represents the cognitive and behavioural efforts made by an 
individual to make the situation more manageable and less demanding or 
threatening, or what a person will do or think in order to meet the perceived 
challenge. Although numerous dichotomies of coping have been proposed within 
the literature—for example Folkman and Lazarus's (1988) Problem versus 
Emotion focussed coping, or Carver's Adaptive versus Maladaptive coping 
(1997)—it is perhaps the process and flexibility of the constructs which should be 
of importance, rather than the specific label assigned, which may (as in Carver's 
case) be misleading: a strategy perceived by one to be adaptive, may be perceived 
by another, or indeed that same person in a different situation, to be maladaptive. 
What is generally accepted within the coping literature is that coping is complex, 
flexible, dynamic, and more crucially, primarily dependent on cognitive appraisals. 
Furthermore, within a given stressful situation, individuals will often report using 
many different types of coping approach to handle the different demands 
associated with that stressor (Lazarus, 1993).
There is a significant body of empirical evidence concluding that coping is 
linked with event outcome. However, it has recently been suggested that it may be 
individual differences in the cognitive appraisals and affective processes which lie 
behind the coping effort that have most predictive value (Schneider, 2008). 
Lazarus's revised stress theory (1993,1999), the Transactional Model, proposes 
that under threat of potential stress, the individual will not only appraise the 
situation/event, but will also make an assessment or appraisal of how one will 
cope with stressor and how the stressful experience will interfere with attainment 
of one's personal goals. It was also in these latter developments of the theory that 
appraisals were split into macro and micro components (see table 1.2). Lazarus 
refers to this former group as the core-relational themes, a summary perception of 
harms or benefits from the situation. Within a given situation, a specific core- 
relational theme is referred to as a relational meaning, and each is paired with one
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of 12 core emotions (Smith & Ellsworth, 1985; Lazarus, 1999). It is interesting to 
note that where ten of these pairings are unique, there are two independent 
emotions (sadness and resignation) which, according to the literature, can result 
from the same core-relational theme (loss/helplessness). It is differing 
combinations of the individual appraisal components which produce varying 
perceptions of relational meaning (at the micro processing level). At this point, 
appraisal theory had moved away from a simple assessment of harm, loss and 
challenge, to a more complex interaction of motivational (relevance of the 
situation and how congruent this is to one's goals), situational (locus of 
accountability and coping expectations), and future-oriented (expected length of 
disruption due to the stressor and perceived long-term impact) appraisals 
(Lazarus, 1993).
Although the one-to-one relationships between emotions and relational 
meaning are well documented, the unique appraisal component contributions to 
each core-relational theme are less clear. For six so-called 'hot' cognitions (which 
underlie the emotions of anger, guilt, fear/anxiety, sadness, hope/challenge, and 
happiness), the entire process (an emotion-specific cognition model) is fully 
proposed. The remainder (these haven't yet been assigned a grouped sub-title 
within the literature), are less defined and a description of which appraisal 
components are (or aren't) involved has not been established. Indeed, there are 
some emotions, for example regret, for which even the unique relational meaning 
is not fixed due to the neutrality of the emotional state to which they are 
associated (Smith, 2006). Table 1.2 summarises which components are implicated 
for each emotional reaction according to the latest academic opinion (Smith and 
Lazarus, 1993; Lazarus, 1999; Smith, 2006).
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Table 1.2. Hypothesised relationships between Transactional Model components.
Emotion Core-Relational Theme Appraisal Components
The 'Hot'Cognitions
Anger Other-blame Motivational relevance 
Motivational incongruence 
Other accountability
Guilt Self-blame Motivational relevance 
Self accountability
Fear/Anxiety Danger/threat Motivational relevance
Motivational incongruence
Low Emotion focussed coping potential
Sadness Loss/ helplessness Motivational relevance 
Motivational incongruence 
Low Problem focussed coping potential 
Low Future expectancy
Hope/Challenge Optimism Motivational relevance 
Motivational incongruence 
Problem focussed coping potential
Happiness Success Motivational congruence
Other Cognition
Surprise Unexpectedness Not specified
Resignation Loss/helplessness Not specified
Tranquility Lack of concern Not specified
Shame/Humiliation Self consciousness Not specified
Interest Relevance Not specified
Boredom Irrelevance Not specified
Relief Threat removal
Frustration Not specified Not specified
Self-Directed Anger Not specified Not specified
Regret Not specified Not specified
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Over the course of the late 1980s and 1990s, the order of the linear process 
between components in this model changed numerous times. Some papers (e.g. 
Lazarus, 1991) placed both emotion and coping as concurrent outcomes from the 
appraisal process while others placed emotion before coping (e.g. Lazarus, 1999). 
In his 1999 text, Lazarus also comments that coping can even shape emotion, 
presumably by changing situational appraisals. Despite such inconsistencies, 
assessment of the interdependent role of each component—appraisal, emotion, 
and coping—has been concluded as imperative to best outcome prediction 
(Folkman, Lazarus, Dunkel-Schetter, DeLongis & Gruen, 1986; Lazarus, 1999; 
Storbeck & Clore, 2007). Figure 1.1 presents a diagrammatic summary of the 
model encompassing feedback loops between outcome and re-appraisal, and 
between coping and re-appraisal, to emphasise the ongoing and cyclical nature of 
the stress process.
Stressor OutcomeCoping
Appraisal
Relational
Meaning
Figure 1.1. The Transactional Model o f stress (adapted from Lazarus, 1999).
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1.6 EMPIRICAL EVIDENCE FOR THE TRANSACTIONAL MODEL
Only a few published studies test the full complexity of the Transactional 
Model in sample of physically ill individuals (though there are some, for example 
Lowe, Vedhara, Bennet, Brookes, Gale, Munnoch etal. 2003; Bennet, Lowe & 
Honey, 2003). The majority of empirical support comes from laboratory-based, 
experimental studies by Lazarus and colleagues (Lazarus, 1993) and their 
published theoretically-based hypotheses, position papers, and textbooks. A 
distinction must be drawn here between the two categorisations of stress often 
made in health psychology; that between chronic stressors (high impact, ongoing 
stressors) and acute stressors (low impact, short lived stressors). In summarising 
previous methodological approachs to this subject, Lazarus (1999) suggests that 
most experimental studies have focussed primarily on short-term acute stressors 
(e.g. exam stress), vicarious stressors (e.g. responses to viewing stressful 
situations on film), or retrospective reflections on heterogenous stressors within 
the same sample (e.g. requiring participants to respond based on a recent stressful 
event of their choice). Few, if any, have successfully tested the Transactional 
Model within the context of chronic stressors (e.g. diagnosis of a life-threatening 
illness). Whilst the effect on the individual of each stressor type is thought to be 
quantitative rather than qualitative—in other words, that the same psychological 
and psycho-biological process may result, but at differing levels, with the potential 
for resultant outcomes to differ in both quantity and time-extent (Lazarus,
1999)—it is imperative that future empirical tests of this model focus on the 
homogenous experience of chronic stressors in addition to the lesser impacting 
acute stressors.
1.7 APPRAISAL, EMOTIONS, COPING AND ADJUSTMENT TO CANCER
Cancer diagnosis could theoretically operate at many levels of Lazarus's 
model (Jenkins & Paragament, 1988). For example, illness adjustment and 
outcome rely not only on personal coping, but also on personal appraisal and 
external intervention (e.g. treatment) which can pose a challenge to personal 
control of the situation. Additionally, illness frequently has major emotional 
implications and often challenges personal goals (Brennan, 2001). And yet, 
research testing specific components of the model in the adjustment process is
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sparse. Chapter Two of this thesis will provide a systematic review of such 
evidence, however, an overview of some of the key research in psychosocial 
oncology is provided here to form the rationale for this research thesis.
1.7.1 Appraisals
In terms of cognitive appraisal, a variety of components have been studied, 
though few repeatedly enough to form sound conclusions. Costanzo, Lutgendorf, 
Bradley, Rose and Anderson (2005) found that strong internal attributions were 
associated with greater distress, as did Faller, Schilling and Lang (1995) and Gotay 
(1995). Where Jenkins and Paragament (1988) found only moderate predictive 
ability for appraisals on outcome, other studies report that primary appraisals 
relate to outcome more strongly than do secondary appraisals (Burgess and Haaga,
1998). In-keeping with the Transactional Model, Krietler, Chaitchik, Kreitler, 
Rapoport and Algor (1996) report findings which highlight the importance of 
motivation-related cognitions (assessment of how much impact the stressor will 
have on the achievement of current goals and activities) in adjustment to cancer, a 
factor virtually absent from current empirical literature and models of cancer- 
specific adjustment.
1.7.2 Coping
Research relating coping to illness outcome is abundant compared with 
research into cognitions or affective responses. The majority of these papers 
however, demonstrate such relationships with only modest effect sizes (Felton & 
Revenson, 1984; de Ridder & Schreurs, 1996). Regardless of strength of effect, 
most replicate the transactional and fluid nature of coping demonstrated in the 
general health psychology literature (Gammon, 1993). For long-term illness 
adjustment, it is a general principle that escape or avoidant coping, excess denial, 
or emotion-focussed coping tend to be more strongly associated with higher 
distress than do active or problem-focussed coping (Zabalegui, 1999; McCaul, 
Sandgren, King, O'Donnell, Branstetter & Foreman, 1999). The latter should, 
according to Cohen (2002), be the focus of psychosocial interventions within this 
patient group. However, as defined earlier, coping responses are subjective and 
should not always be exclusively considered in this simplistic way. Some authors, 
for example, have compared coping responses between patient sub-groups
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implying that these may be indirectly responsible for cultural, age, and gender 
differences in adjustment and outcome (e.g. Culver, Arena, Antoni & Carver, 2002). 
Furthermore, religious-specific coping is becoming an area of increasing research 
interest with preliminary results seeming to show some benefits (with regard to 
psychosocial outcome) for those using religious coping and reporting deeper 
spirituality (Gall, de Renart & Boonstra, 2000; Nairn & Merluzzi, 2003; Gall, 2004).
1.7.3 Emotions
Varying levels of experienced emotion—sadness, fear, or hope, for example— 
have also been reported to influence psychosocial outcome in cancer patients 
(Grassi & Molinari, 1988; Watson, Greer, Rowden, Gorman, Robertson, Bliss et al, 
1991; Longman, Braden & Mischel, 1999). Although published data on a wide 
range of specific emotional components is infrequent with most papers tending to 
focus on more generic affective disorders such as anxiety, depression or distress as 
primary outcome measures.
The concept of emotional control has been researched more often within 
cancer samples, primarily using Watson and Greer's Courtauld Emotional Control 
Scale (CECS; 1983) which assesses the extent to which an individual supresses to 
their anger, anxiety and depressive emotions. Numerous studies have 
demonstrated how in cancer patients, higher emotional repression correlates with 
anxiety (Pettingale, Watson & Greer, 1984), and more general adjustment (Classen, 
Koopman, Angell & Speigel, 1996; Sanderman & Ranchor, 1997; and Denollet,
1999).
1.7.4 The Mental Adjustment to Cancer Scale
Much of the work of Watson, Greer and their various colleagues since the 
early 1980s has focussed on processes involved with cancer adjustment. This 
resulted in the creation of the Mental Adjustment to Cancer (MAC) Scale (Watson, 
Greer, Young, Inayat, Burgess, & Robertson, 1988). With a somewhat ambiguous 
title, the measure was originally created to assess coping strategies in people with 
cancer. However, there are features of this scale which not only relate to the 
construct of coping. When viewed in the context of stress models, the scale also 
seems to assess (whether purposely or not is unclear) cognitive appraisal and 
emotions. As such the scale seems suited to the development of social-cognitive-
22
motivational models of adjustment, if perhaps still requiring of further 
modification and clarification. Of the four main factor components of this scale, 
three are repeatedly found to be correlated with psychosocial outcome: 
helplessness/hopelessness (e.g. Greer, 1991), fatalism (e.g. Watson etal., 1991; 
Kugaya, Akechi, Okamura, Mikami & Uchitomi,1999) and fighting spirit (Classen et 
al., 1996; Gilbar, Or-Han & Plivazky, 2005; Watson, Homewood, Haviland & Bliss, 
2005). Additionally, the role of hopelessness/helplessness has been shown to be 
implicated in disease-free survival (Watson, etal. 2005) but the wider impact of 
fighting spirit on such physical outcomes remains unclear (Coyne et al., 2007). 
Nevertheless, Greer (2008) continues to promote the use of cognitive-behavioural 
therapy to enhance fighting spirit to reduced the risk of recurrence and improve 
survival chances.
In a relatively recent review, Ranchor & Sanderman (2006) further add to the 
confusion as to what is measured by the Mental Adjustment to Cancer Scale by 
referring to the concept of fighting spirit as a personality variable, going on to 
suggest that there is potential for research to explore how Five-Factor models of 
personality relate to this charcteristic. The Mental Adjustment to Cancer Scale, 
and particularly the notion of fighting spirit will be addressed at numerous points 
during this thesis. However, a discussion of the role of personality in cancer 
adjustment follows.
1.8 PERSONALITY THEORY
Carver & Scheier (2000) define personality as "a dynamic organization, 
inside the person, of psychophysical systems that create the person's characteristic 
patterns of behaviour, thoughts, and feelings" (p.5). The overlap here with the 
Transactional Model is clear and numerous researchers including Lazarus and 
Folkman (1987) and O'Brien and DeLongis (1996) make a sound case for the 
hypothesis that person-related variables (e.g. locus of control) may act as causal 
antecedents to stress appraisals, emotions, and coping (the thoughts, feelings, and 
behaviours referred to by Carver & Scheier). Lazarus further clarified his position 
on this issue by writing that:
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"...psychology has long been ambivalent about individual 
differences, opting for the view that its scientific task is to 
note invariances and develop general laws. Variations 
around such laws are apt to be considered errors of 
measurement, though they must be understood if 
reasonably accurate prediction is to be possible." (1993, p.3)
Related more explicitly to illness, Eysenck (1991; 1993) claimed personality and 
individual differences to be as equally important as the stressor and coping 
responses in determining final stress outcomes.
Personality is generally considered to consist of two distinct parts. 'State' 
attributes are those which are changeable: unstable and situation specific (e.g. Self- 
Efficacy). In addition, exists the concept of'trait' personality characteristic—a 
label first coined by Cattell to replace the previously used term 'predisposition' 
(Pervin & )ohn, 2001)—of which there are many different academic perspectives, 
including the psychoanalytic, behaviourist, and cognitive perspectives, for 
example. The dispositional perspective has become one of the most commonly 
researched and holds that individuals display long-term consistency and 
continuity in their cognitive and behavioural actions (Carver & Scheier, 2000).
One popular model from this perspective is the Five-Factor Model (Costa &
McCrae, 1992). This proposes that personality consists of five independent 
factors; extroversion, agreeableness, conscientiousness, neuroticism, and 
openness (note that other theorists within the dispositional perspective also 
propose five-factor models, the factor content of which being relatively equivalent, 
but with different labels attributed to each component. Out of all, Costa &
McCrae's is perhaps the best known, and most cited in empirical research in health 
related fields).
1.9 PERSONALITY AND ADJUSTMENT TO CANCER
A substantive proportion of the literature relating personality to health and 
illness has a very different focus to the proposal here outlined, in that personality 
was researched as a risk factor for onset of illness (Suls & Rittenhouse, 1990): the 
disease-prone personality (Friedman, 1990). However, the current focus is in the 
role that personality may play in prediction of illness outcome (Levy & Heiden, 
1990; Levenson & Bemis, 1991; Vollrath, 2006).
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No conclusive evidence is yet published for an association between 
personality and clinical outcomes such as cancer recurrence or survival (Canada, 
Fawzy and Fawzy, 2005; Nakaya, Tsubono, Nishino, Hosokawa, Fukudo, Shibuya, et 
al, 2005; Ranchor & Sanderman, 2006); these outcomes are assumed to be 
primarily biologically driven (Richardson, Zarnegar, Bisno & Levine, 1990). There 
is, however, some evidence for the influence of personality on some psychosocial 
outcomes, including for example, quality of life (Boini et al, 2004; Llewellyn, 
McGurk & Weinman, 2005), anxiety (Skarstein, Aass, Fossa, Skovlund, & Dahl, 
2000; Montazeri, Jarvandi, Haghighat, Vahdani, Sajadian & Ebrahimi etal, 2001), 
and depression (White and Macleod, 2003). The process by which personality may 
influence these outcomes lacks substantive empirical support (Goldberg & Cullen, 
1985); what evidence there is focuses almost exclusively on neuroticism, 
optimism, self-efficacy and locus of control.
Neuroticism in particular has been found to influence distress levels 
throughout, and after treatment (Millar, Purushotham, McLatchie, George &
Murray, 2005). Temoshock (1987) and Sanderman and Ranchor (1997) also 
report strong evidence for a role of both neuroticism and introversion in illness 
adjustment when measured within the taxonomy of the so-called cancer-prone 
Type C personality; a factor construction of personality variables also 
characterised by a tendency to suppress emotion, and to respond to stress with 
depressive or hopeless reactions, which is associated with not only adjustment, 
but also (tentatively) with cancer onset (Temoshock, 1987; Friedman, 1990; 
Eysenck, 1994).
The boundaries of what constitutes situational specific 'state' attributes are 
unclear and often overlap with concepts of health cognitions. Nonetheless, a 
review by Denollet (1999) suggests that there is clear evidence to support the 
inclusion of both state and trait measures in psychosocial oncology research. In 
making this statement, Denollet is drawing on the large body of literature which 
demonstrates outcome moderating effects of self-efficacy (Lev, 1997; Kreitler,
Peleg & Ehrenfeld, 2007); health related locus of control (Andrykowski & Brady
1994); and, optimism (Carver, Pozo, Harris, Noriega, Scheier, Robinson et al, 1993; 
Allison, Guichard, & Laurent, 2000; Carver, Smith, Antoni, Petronic, Weiss &
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Derhagopian, 2005) in addition to trait-related findings. Some caveats to this are 
necessary.
Regarding control, distinction is often drawn between generic control, often 
referred to as Locus of Control, and situation-specific control, such as self-efficacy 
(Lyons & Chamberlain, 2008). Although support for the role of self-efficacy is 
virtually unanimous, findings related to generic, and even health-specific, locus of 
control are less consistent (Osoweicki & Compass, 1998). In those studies that 
have found significant effects, it is suggested that these could act by indirect 
mechansims of promoting health behaviours (Newsom, Knapp & Schulz, 1996), or 
by fostering a fighting spirit attitude (Watson, Greer, Pruyn & Van den Borne, 
1990). The inconsistency in these results has been suggested, among other 
reasons, to be primarily a by-product of methodological differences, particularly in 
how the concept is operationalised and measured in research (DeBoer, Ryckman, 
Pruyn & Van den Borne, 1999).
The concept of optimism—a tendency to always expect positive outcomes 
(Pitts & Phillips, 1998)—also requires expansion. Although here listed as a state 
variable, there are some (e.g. Carver etal., 1993) whose measures claim to assess 
dispositional optimism, a more longitudinally stable, trait-like form of optimism. 
Pessimism is usually defined as a diametric opposite state to optimism. Whilst 
both have been found to influence illness outcome, there is ongoing debate about 
whether the two constructs exist at opposite ends of the same continuum, or 
indeed, whether they are separate factors requiring different measurement tools 
(Marshall, Wortman, Kusulas, Hervig & Vickers, 1992; Carver et at, 1994). It is, of 
course, feasible for individuals to have unrealistically optimistic beliefs. Whilst 
such unrealistic beliefs are not found to compromise psychological well-being 
(Taylor & Brown, 1994), Spiegel (2001) claims that within cancer samples, 
optimism is only beneficial if the future that is optimistically referred to is 
realistically achievable.
1.10 INTEGRATING PERSONALITY AND THE TRANSACTIONAL MODEL 
INTO CANCER ADJUSTMENT THEORY
Within the context of the Transactional Model, it was previously thought that 
the personality-outcome relationship operated via a mediating effect of coping,
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and there is a good deal of supportive literature for this hypothesis (David & Suls, 
1999; Aarstad, Aarstad, Bru & Olofsson, 2005; Semmer 2006). A recent review by 
Petticrew, Bell and Hunter (2002), however, concluded that coping may not be 
significant as an influencing factor over physical illness outcomes for cancer 
patients. These findings are in contradiction to the basic Transactional Model and 
thus further work is required to clarify the process by which the many factors 
interact to predict outcome.
There is limited empirical evidence explaining how personality may influence 
cognitive appraisals of a health threat A recent study by Tong, Bishop, Enkelmann, 
Why, Diong, Ang et al. (2006), provided evidence that within non-clinical samples 
personality traits according to the Five Factor theory can explain variability in 
appraisals and emotions. Research also demonstrates that personality can affect 
symptom perception, illness self report, and outcome expectancies (Scheier & 
Carver, 1985; Deary & Frier, 1995; Millar et al., 2005). It seems, therefore, a 
reasonable assumption that these same effects could extend to cognitive appraisals 
in line with the Transactional Model.
In their recent meta-analysis, Franks and Roesch (2006) reported that 
coping is clearly related to appraisal: threat appraisal associated with problem- 
focused coping; harm/loss appraisal with avoidance coping; and, challenge 
appraisal with problem-focused and approach coping. In light of this, it is possible 
that it is not coping directly, but the appraisals themselves which form the coping 
response, which acts as the primary link between personality and illness outcome.
1.11 SUMMARY AND THESIS RATIONALE
When considered as a whole, the individual studies contained in this 
overview may lead to a better understanding of how the Transactional Model can 
be applied to the study of cancer outcomes. Although many features are covered 
in other cancer specific adjustment models (particularly Brennan's Social- 
Cognitive Theory, 2001), many lack the in-depth motivation-related appraisals of 
Lazarus's later theory. Empirical findings demonstrate that both personality and 
each component of the Transactional Model are implicated in outcome prediction 
and some studies seem to show that the mechanism by which personality affects 
outcome may not be direct but rather through the effects of coping. This was not,
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however, supported by Petticrew et al.'s (2002) review. Far less research has 
considered the possible role of cognition as the mediating variable, but the high 
correlation between cognition and coping may go some way to explaining the mis­
placed assumption that coping acts as a moderator. Therefore personality- 
cognition-outcome relationships are worthy of further research attention. If these 
are confirmed, a refined theory of adjustment may be possible which will enable 
development of both an improved understanding of the adjustment process and 
clinically applicable systems by which those most at risk of psychological distress 
or quality of life difficulties can be highlighted and treated at earlier illness stages.
1.12 THESIS QUESTIONS
In applying health psychology theory to cancer adjustment, this thesis has 
three aims: to systematically review the literature to date according to this 
theoretical framework; to explore the clinical applicability of the model in a 
pragmatic, empirical way; and to test the micro-level theoretical assumptions 
inherent in the Transactional Model.
The first of these aims has two important components: a review of findings, 
and a review of methodology. Therefore, a systematic review and meta-analysis 
will be performed on the psychosocial oncology literature to answer the following 
two questions.
Question 1: What evidence is there currently in the literature demonstrating 
associations between personality, cognitive appraisal, emotion, and 
psychosocial outcome for cancer patients?
Question 2: Since early reviews, has research methodology in this field 
improved? If not, what further steps need to be taken?
This review will address the need to consider findings within a fully theoretical 
context and improve on previous reviews which instead either focus on just part of 
the model or else stick to the method of a traditional non-systematic review 
without statistical meta-analysis. The review will summarise relevant findings of 
individual studies in a coherent way in order to understand the full application of
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the model and identify potential gaps in the literature which could stimulate future 
research endeavour. Additionally, each study will be rigorously quality assessed 
and the overall methodological approach critiqued. This will allow analysis of the 
overall validity of previous claims that the literature has poor methodological 
quality, and whether this can be justifiably cited as a reason for inconsistent 
findings. Second, and perhaps more important, previous methodological reviews 
have merely claimed that methodology needs to be improved. By taking such a 
rigorous approach to quality assessment, this review will move one step further by 
specifying methodological problems and providing guidelines for precisely how 
quality can be improved in future studies.
A pragmatic approach will be taken to clinical application of this model to 
meet the second aim. An empirical study will follow the adjustment of newly 
diagnosed cancer patients and analyses will be conducted to attempt to identify 
which potentially modifiable variables are most predictive of short-term 
psychosocial outcomes. The purpose is not to thoroughly test the transactional 
model, nor is it to attempt to change components included in the model, but to 
explore correlation between components within it and clinically relevant 
psychosocial outcomes. This data can then be used to inform future empirical 
investigation (including theory-led interventions), and to demonstrate the extent 
to which such variables may prove indicative and predictive in clinical settings.
Question 3: What are the most important predictors of psychosocial 
outcome in newly diagnosed cancer patients, and leading from this, at what 
time point (baseline or three month follow-up) are these most predictive of 
longitudinal (three or six month) follow up?
Studies into psychological aspects of breast and prostate cancer in this field are 
numerous and this is reflected by the improved prognosis and availability of 
psychosocial support for these patient groups seen in recent years (Department of 
Health, 2007). However, a recent meta-analysis of psychosocial interventions has 
been highly critical of research in the field for over reliance on studies based solely 
on breast cancer samples (Rehse & Pukrop, 2003). Cancer patients are not a 
homogenous group in terms of either physiology and psychology and each type of
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cancer presents particular challenges, varying levels of threat and different 
stressors to each individual patient
Although there have been similar medical advances across all cancer 
diagnostic sites, expansion of research attention into these areas is vital. The field 
needs to establish if knowledge about breast and prostate disease is generalisable 
to other cancers and to gain understanding of site-specific problems, and how 
these impact upon each patient's individual psychosocial needs. In particular, the 
collective research focus must widen to also include, for example, colorectal cancer 
where incidence remains high, but wide variability in outcome and adjustment is 
observed, and lung cancer where the psychosocial wellbeing through the course of 
illness, and survival expectancy, remain poor.
The proposed study will recruit a sample of patients with cancer of various 
types, collecting both self-report data (psychosocial predictor and outcome 
variables), and secondary care clinical and histology data to attempt to control for 
such differences in the underlying physiological nature of the illness. This theory- 
driven study will test the rationale introduced within this chapter that adjustment 
could potentially be modelled using personality and stress theory. In keeping with 
methodological recommendations, this will be a longitudinal study. Patients will 
be recruited soon after diagnosis and followed up at three and six month time 
points. The theory in which this research is based lays emphasis on the 
transactional nature of appraisal over time, therefore, an ability to explore 
temporal changes in these variable relationships is paramount to provide the most 
informative evidence (Somerfield & Curbow 1992).
Clinically oriented findings will improve understanding of the psychological 
processes occurring following cancer diagnosis which could have important 
implications for non-medicine based treatments. And by using a sound theoretical 
basis, it should be evident how, and to what extent, clinical factors, personality, 
cognition and emotions interact to enable prediction of short-term psychosocial 
outcome.
The final aim, that of theory testing, directly matches the fourth thesis 
question. Using baseline data from the empirical study (see question three), 
theory testing will focus on the relationships between cognitive and affective 
components of the Transactional Model.
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Question 4: Are the hypothesised associations between cognitive appraisals, 
core-relational themes, and emotions in Lazarus's Transactional Model 
supported in a sample of newly diagnosed cancer patients.
As previously outlined, this model has potential to explain the process of 
adjustment to cancer diagnosis. However, the theoretical basis of this model needs 
empirical development; namely, the complex associations between cognition and 
emotion variables needs testing in a homogenous sample of participants 
undergoing chronic, high impact stress. This will be used to evaluate the wider 
validity of findings reported from previous lab-based investigations, and those of 
heterogenous samples undergoing acute stress. Furthermore, these tests will 
expand beyond the ‘hot' cognitions (to which most previous empirical 
investigations have been limited), to test the full range of affective outcomes 
outlined by Lazarus in the latest version (1999) of the theory.
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Q W EIER Z
PERSONALITY. COGNITIONS AND EMOTIONS AS CORRELATES OF ANXIETY. 
DEPRESSION AND QUALITY OF LIFE: A SYSTEMATIC REVIEW OF THE CANCER
LITERATURE,
2.1 CHAPTER OVERVIEW
Following the narrative theoretical review in Chapter One, this chapter 
presents a systematic review of a more focussed area of the literature. Few 
systematic reviews have been conducted in psychosocial oncology, and at present, 
no up to date review exists examining the application of the Transactional Model 
to adjustment in cancer patients. This theory encompasses a wide range of 
different psychological components (cognitions, emotions, and personality as an 
overall influencing factor). Whilst no studies have been conducted within the 
entire theoretical framework, many studies are expected to have relevance to one 
or other part of the theory. The review is important, therefore, not only to 
synthesise findings, but to attempt to contextualise each of these studies within a 
larger theoretical framework. The need for this type of review became apparent 
early on as scoping searches revealed a vast literature to be synthesised. This 
study was, therefore, planned in addition to a generic background review, to 
feature as a prominent part of the thesis as equally important as the later empirical 
work.
Three primary questions were asked of the data:
1) What is the association between personality and illness 
cognitions and emotions following cancer diagnosis?
2) What is the association between personality on psychosocial 
outcome for cancer patients?
3) What is the association between illness cognitions and emotions 
on psychosocial outcome for cancer patients?
Many studies highlighted in the review do not always use explicitly 
equivalent terminology, for example, illness appraisals and illness perceptions are 
both accepted terms for illness-related cognitions. Therefore, it was necessary to 
group different variables together such that the review could discuss findings in a 
more coherent way. Grouping of these studies was mainly theory-led, but also had
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to be guided by the individual hypotheses being tested in each study. In line with 
theory, groupings used included personality (either state or trait), health control 
beliefs, illness cognitions (appraisals), emotional reaction to illness, and coping. 
Although the predictive effects of coping were not a primary focus of this review, 
data on this construct were essential in order to assess the full model. Therefore, 
coping studies were included if they related to interactions between any of the 
other predictor variables and an outcome variable.
Psychosocial outcome variables were categorised as either psychological 
comorbidity (anxiety, depression) or quality of life. A protocol amendment was 
made during data extraction to also include well-being and general distress as two 
separate but closely related outcome measures. For a number of reasons, 
primarily the lack of specifically relevant literature, question one (the association 
betweem personality on cognitions) was removed from the review after literature 
searches had been completed. The reasons and implications for this are discussed 
more fully in section 2.5.7. Therefore, although the methods section of this chapter 
will include reference to this research question, extraction and analysis were not 
conducted.
The review protocol was written in accordance with standard guidelines 
produced by the NHS Centre for Reviews and Dissemination (NHS CRD: Khan, Reit, 
Glanville, Sowden & Kleinjnen, 2001) and the Cochrane Collaboration (Higgins & 
Green, 2005), in addition to several methodological papers (e.g. Rosenthal, 1995; 
Egger, Smith & Altman, 2001; Papworth & Milne, 2001; and, Rosenthal & DiMatteo, 
2001). Additionally, the protocol, and in particular the search strategy, were peer 
reviewed by the Cardiff University Support Unit for Reviews of Evidence (SURE).
As recommended, and as a further check against bias and subjectivity, two 
reviewers worked independently at all stages of inclusion and quality assessment. 
For this purpose, Helen Dudley, a psychology graduate with some research 
experience in psychosocial oncology, was employed on a casual basis. Throughout 
this review Miss Dudley will be referred to as reviewer one and the candidate as 
reviewer two.
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2.2 BACKGROUND 
2.2.1 Systematic reviewing
Traditional non-systematic reviews, although informative, are subjective and 
often prone to error and bias, both in selection of included studies and in data 
extraction (Egger et al., 2001). A systematic review, on the other hand, aims to 
take an objective, scientific approach to make the process and, therefore, 
conclusions, transparent and replicable (Egger et al., 2001). Not only can the 
process of non-systematic reviewing be prone to study selection bias, but also, 
descriptive summaries may not always make adjustments for within study bias; 
systematic reviews and meta analyses are better placed to take these biases into 
consideration when synthesising results (Petticrew & Gilbody, 2004).
2.2.2 Meta-analysis of effect sizes
The most complex and reliable method of data synthesis is a statistical meta­
analysis. Meta-analysis combines the results of a number of related studies in 
order to "...impose order on chaos..." (Rosenthal & DiMatteo, 2001, p.80) and 
provide a weighted overall mean effect size (r ) .  To avoid giving too much weight 
to small studies, study effect sizes are usually weighted by sample size in order 
that more adequately powered studies are given higher influence in determining 
the mean effect size than their similar under-powered equivalents (Field, 2001). 
Meta-analysis also attempts to overcome the limits of the size or scope of smaller 
studies by combining their findings together (Berman & Parker, 2002) for greater 
applicability. Despite superiority to the non-systematic review, Overton (1998) 
cautions against over-stating the findings of a systematic review; it is not an exact 
science. Despite aims of objectivity, each stage of the systematic review process is 
prone to the effects of subjective bias (albeit less than in an non-systematic 
review), for example in selection of relevant papers and thoroughness of data 
extraction. Furthermore, the size and significance of the findings will be different 
depending on the type of meta-analysis model selected (to be further explained 
later in this section).
The term 'effect-size' is sometimes misunderstood to mean only the 
calculation of a standardized mean difference between groups or condition in an 
experimental design. In fact, the term includes any measure of the magnitude of
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relationship between two variables, for example, correlation coefficients, 
proportions, odds ratios, and so forth (Glass, 2000; Field, 2001; Field, 2003a).
Type of effect size presented often differs, not only between study, but also 
between model of meta-analysis selected.
Meta-analysis assumes that the data are both substantially homogenous (in 
terms of sample, population and design) and follow a normal distribution (Egger et 
al, 2001). Although it is ideal to perform meta-analysis by using individual 
participant data from each study, this is rarely feasible and most statistical 
procedures allow for calculation of mean effect sizes from more commonly 
published summary statistics (Egger etai, 2001).
Within the meta-analysis methodology literature, it is often suggested that 
study designs should be ordered hierarchically, based primarily on the level of 
experimental control and manipulation researchers inherently have in the design. 
Randomised controlled trials (RCTs) are considered the best choice of design at 
the upper end of the hierarchy and observational studies and surveys at the lower 
end. There is some argument (see Egger etai, 2001) that meta-analysis should 
only be conducted on high quality studies. However, particularly within health and 
clinical psychological research where many research questions cannot be 
addressed using experimental designs, meta analysis of observational or 
prognostic (non-experimental) studies is becoming commonplace (Egger,
Schneider & Smith, 1998; Stroup, Berlin, Morton, Olkin, Williamson, Ronnie et al, 
2005).
Meta-analysis of studies at the lower end of the evidence hierarchy remains 
highly controversial and problematic (Berman & Parker, 2002). Altman (2001) 
and Egger et a l (2001) list a number of potential hazards including: greater 
potential for publication bias; variation in designs, measures, and methods of data 
handling; inadequate methodological and outcome variable reporting; biased 
inclusion criteria; inappropriate timing of outcome data collection; retrospective 
data collection; and, last but not least, a lack of recognised quality assessment tools 
(see section 2.6.2).
Glasziou, Vandenbroucke and Chalmers (2004) provide a useful review of the 
application of design hierarchies concluding that their oversimplification leads to 
misconceptions and misuse rather than benefit. They further propose that the
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current conceptualizations of such hierarchies should not be used without further 
development, or alternatively that they be abandoned altogether. In a further 
methodological paper, Gene Glass (the founder of the modern concept of meta­
analysis) remains committed to his original intention for meta-analysis; that it 
should "...deal with all studies, good bad and indifferent, and that their results are 
only properly understood in the context of each other, not after having been 
censored by some a priori set of prejudices." (Glass, 2000, p.10). The most suitable 
design for answering the questions relevant to this review is that of correlation 
design; explorations of association between two observed variables. Thus, this 
review predominantly identifies survey based research studies.
Two dominant models of meta-analysis exist: fixed effect and random effect 
models (Field, 2001). A third model (mixed or conditionally-random effects) has 
been proposed, however, this is rarely used in preference of a more clearly defined 
fixed or random approach (Hedges & Vivea, 1998). Fixed effect statistical models 
assume homogeneity of effects across the studies being combined (assumed 
constancy of (unknown) effect sizes), that is, the true effect size has a common true 
value. In the summary effect sizes, therefore, only the variance of particular 
studies are taken into account (Hedges & Vivea, 1998). Random effect models, 
however, assume that all effect sizes are variable to some extent and that those 
being analysed are a sample of many possible effect sizes true to the population. 
This model, therefore, is often favoured where levels of between study 
heterogeneity are expected to be high; although they sometimes give more weight 
to smaller samples, they calculate error according to, not only within-study 
variance, but also between-study variance (Hedges & Vivea, 1998; Egger et al, 
2001).
Hedges and Vivea (1998) state that choice between fixed or random effects 
models should not be based on study homogeneity (or lack of) alone; the proposed 
inference of the analysis is perhaps more important. To clarify, where the aim of a 
meta-analysis is to make conclusions limited only to its specific constituent studies 
only (conditional inferences), fixed effect methods are more than adequate. 
However, where the aim is to make inferences from the analysis which explicitly 
attempt to generalise to wider populations, random effects models should be used 
(Hedges & Vivea, 1998; Field 2001).
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Hunter and Schmidt (2000) further point out that fixed effect models are 
substantially more likely to result in Type I error bias: wrongly rejecting the null 
hypothesis in favour of deeming an association significant Furthermore, due to 
the calculation of narrower confidence intervals, they imply much greater degrees 
of precision than should be inferred given meta-analytical calculations.
Three main methods are proposed to compute meta-analyses. Whereas both 
the Hedges and Vivea (1998) and Rosenthal and colleagues approaches calculate 
the mean effect sizes via transformation of study effect sizes into a standard 
normalised value (Cohen's d] prior to study weighting, Hunter and Schmidt (also 
cited in Field, 2001) propose calculation of weighted mean effect sizes without 
prior data transformation. Proponents of transformation methods claim that such 
transformations (based on Fisher’s transformation) are essential to eliminate 
within study bias occuring as a function of higher correlation coefficients (Field 
2001). However, Hunter and Schmidt propose that in reality, the actual 
transformation eliminates comparatively little bias to justify the extra error that 
further data manipulation may introduce (cited in Field, 2001). Hedges's and 
Rosenthal's meta-analytic methodologies can be used in either fixed or random 
effect models as they claim that choice of model will be dependent on the purpose 
of meta-analysis and type of data relationships being synthesised. Conversely, 
Hunter and Schmidt propose only a random effects model in order to ensure that 
findings obtained using their method are always grounded in population 
generalisability principles.
Controversy exists about which method of meta-analysis should be used. In 
essence, both Hedges's and Rosenthal's methodologies are very similar and high 
convergence is reported between the results of the two (Johnson, Mullen & Salas,
1995). The method of Hunter and Schmidt is very different and findings can often 
be substantially different So much so, according to Johnson et al., (1995), that it 
violates conventional statistical frameworks and should be used with great 
caution. Schmidt and Hunter (1999) replied to this criticism by stating that in their 
calculations, Johnson etal. had used incorrect calculations of the standard error 
estimate of the mean effect size; when this was corrected for, the findings were 
comparable to both Hedges's and Rosenthal's. Field (2001) also reanalysed the
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Johnson etal.'s (1995) methodological review and highlighted further criticisms of 
this paper.
In his own comparison of the methods, Field (2001) stated two important 
considerations. First, with regard to effect size calculations, he found that where 
studies were homogenous, Hedges's and Rosenthal’s methods tended to 
overestimate the mean effect size. Conversely, the Hunter and Schmidt method 
tended to underestimate the effect size, and although this bias increased with 
larger mean effect sizes (particularly above r=.5), the bias was less severe than 
either Hedges's or Rosenthal’s overestimation effect. Second, regarding the mean 
effect size significance estimates, Hedges's method best controlled for Type I error 
and the Hunter and Schmidt method was judged to be too liberal, claiming 
significance for far too many null results.
Field's more recent paper (2005) further compares the two methods and 
raises two additional important issues. First, he explored the interaction between 
inaccuracy in estimation of the mean effect size and the study effect sizes. Results 
showed that where effect sizes are above r=.30 and standard deviations are large 
(above .16) no difference was found between either Hedges's or Hunter and 
Schmidts method. However, with effect sizes lower than r=.30, Hedges's method 
resulted in far more inaccuracy of mean effect size calculation. Second, confidence 
interval estimates were reported to be far more accurate using Hedges's method. 
Neither Hedges’s, Rosenthal's or the Hunter and Schmidt method were found to 
adequately predict the confidence intervals when only a small number of studies 
were meta-analysed.
2.2.3 Advanced and alternative meta-analytical techniques.
In addition to statistical weighted mean effect sizes, meta-analyses often 
present more sophisticated inferential statistics. Funnel plots are a way of 
identifying bias; where a normal distribution is not observed, the results of the 
meta-analysis must be treated with caution as they may be indicative of 
publication bias. Homogeneity analysis tests the assumption that all effect sizes 
are estimating the same population mean. This is calculated using variance 
estimates based on both the raw data (weighted mean) and inferred population 
variance estimates. Using sensitivity analysis, one can assess the robustness of the 
overall findings by conducting smaller meta-analyses comparing sub-groups of the
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studies based between different study features, for example, study designs or 
between high versus low quality studies (Egger et al., 2001).
To conduct these advanced statistics on a meta analysis based on few studies 
is of little practical and scientific value; the utility of graphical or statistical 
demonstrations of between study similarity are meaningless, for example, when 
only two or three studies are being compared. Similarly, to attempt to break down 
a meta-analysis into smaller analyses which are then compared is simply 
impossible when few studies are being meta-analysed in the first place.
Rosenthal's fail safe n statistic can be calculated to give an indication of how 
many studies with a negative result (i.e. one in which the direction of relationship 
is opposite to the weighted mean, or which are found to be non-significant) would 
be required to negate any overall effect size and to increase the p value beyond the 
alpha level (cited in Egger etal., 2001). Where the fail safe n is high, one can have 
much more confidence in the findings of the meta-analysis than if the n was low. 
Once again, to attempt calculation of a fail safe n, when the original number of 
studies entered in a meta-analysis is low has little meaning; statistics are simply 
not necessary. It seems logically apparent that when weighted mean effect sizes 
are based on just two or three studies, even where sample sizes are large, that 
confidence in the findings should be low and that the introduction of just one small 
piece of empirical research could significantly change the significant, or even 
directional effect of the result.
Where the number of studies to be entered into a meta-analysis is low, a 
descriptive, or qualitative, data synthesis is recommended (Papworth & Milne, 
2001). The minimum number of studies required before meta-analytical 
techniques become of dubious scientific validity is open to controversy. Rosenthal 
(1995) claims that although the techniques can be applied on as few as two 
individual studies, the results are very unstable and should be treated with 
caution. Papworth and Milne (2001) claim that within the social sciences, 
statistical meta-analysis is not suitable where "...approximately under 50..." 
studies are to be synthesised (p. 195). A comparative study of Hedges's, and the 
Hunter and Schmidt's method, demonstrated that the most accurate estimates of 
population means effect size are yielded using the Hunter and Schmidt method 
(Field, 2001), but that below a minimum of 20 studies, neither method can be
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relied upon as estimates of population variances become more biased and 
inaccurate. Field (20036) stated that in meta-analysis of less than 15 studies, the 
probability of encountering a Type I error is substantially increased.
Systematic reviews employing qualitative data synthesis are still encouraged 
to follow all of the stringent guidelines for study location, relevance screening, and 
extraction of data. According to Egger etal. (1998), systematic reviews of 
observational research are one particular occasion where advanced meta- 
analytical statistical procedures may be difficult to achieve both practically (due to 
data limitations and between study heterogeneity) and mathematically (the 
formulae are often found to simply not work with small data sets). Further, where 
such analysis is reported, they can produce misleading or overly generous 
conclusions. Whilst efforts should be made to make systematic reviews of 
observational studies as objective as possible, the meta-analysis should form only 
a small part of data synthesis with a substantial qualitative synthesis component 
being essential.
2.3 AIMS & OBJECTIVES
The original aim of this review was to systematically review published 
empirical research investigating associations between Transactional Model 
components (personality, cognitions and emotions) and psycho-social outcome 
(quality of life, anxiety and depression) in cancer patients. After searches had been 
completed, a review of the literature pertaining to personality was dropped from 
the review aims: this is further explained in section 2.5.7.
There were two main objectives. First, to provide a precis of the current 
literature: how this question has previously been addressed and the results to 
date. Second, assessment of the methodological quality of each individual study to 
enable a summary methodological critique of the literature.
It was predicted that the published evidence relevant to this review would be 
highly heterogenous. General trends were hypothesised between more positive 
personality domains (e.g. optimism, self efficacy as opposed to neuroticism, for 
example), positive cognitions (fighting spirit, challenge, optimistic treatment 
expectancies, and so forth), positive emotional reactions (e.g. hope as opposed to
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anger), and better adjustment (lower anxiety and depression and higher quality of 
life) following cancer diagnosis.
The overall purpose was to summarise the findings of research to date in a 
coherent way to inform the direction of, and hypothesis setting for, future 
research, including the empirical work that follows in the remainder of this thesis.
2.4 METHOD
2.4.1 Identification of studies
2.4.1.1 Search string development
Although some organisations, such as the Cochrane Collaboration and NHS 
CRD, have developed some common search strings (for example, for identifying 
health economic evaluations or RCTs), given the vast scope of the literature 
potentially relevant to this review, none fitted the wide searching requirements. 
Instead, review-specific searches were developed based on content keywords, 
rather than methodological search terms.
Four search strings were developed: Cancer; Personality and Illness Beliefs; 
Appraisal and Emotions; and Psychosocial Outcome (Table 2.1). Inclusion of terms 
into each search string was determined by both theory (based on personality 
theory and the Transactional Model) and the overall thesis aims. For example, 
although a plethora of different personality terms exist, and indeed were to be 
included in the review, the primary model of trait personality was the Five Factor 
theory. Therefore, although search strings included general personality terms, 
additional terms specific to this model were also included. Similarly, for cognitive 
appraisals and emotions, although general terms were included, terms highly 
specific to the Smith and Lazarus's Appraisal Components and Emotion Themes 
Questionnaires (1993) were also included.
Systematic review searches require careful consideration to ensure that the 
balance between sensitivity or recall, the chance of finding the majority of relevant 
literature, is maximised without loosing feasible levels of specificity or precision, 
making the search unfeasibly large and unfocussed. The crucial factor here is that 
too specific searching can often result in low sensitivity.
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Table 2.1. Terms used in the development o f search strings.
Cancer Personality /  Illness Beliefs Appraisal and Emotion Outcome
Oncology Personality Appraisal Quality of life
Neoplasm Neuroticism Attribution Mental adjustment
Cancer Pessimism Emotion Emotional adjustment
Carcinoma Optimism Shame Life change
Tumour Life Orientation Test Humiliation Life Satisfaction
Sarcoma Hope Interest Anxiety
Malignant Positivism Surprise Depression
Adenocarcinoma Generalised Self-efficacy Boredom Well being
Metastatic Five Factor Inventory Detachment Fatalism
Lymphoma Big Five Tranquillity Hopelessness
Myeloma Individual differences Relief Helplessness
Leukaemia Personality theory Anger Fighting spirit
Teratoma Extroversion Frustration Cognitive avoidance
Seminoma Introversion Resignation Anxious preoccupation
Teratocarcinoma Openness Guilt HADS
Melanoma Agreeableness Fear FACT Inventory
Adenoma Conscientiousness Sadness MAC Inventory
Choriocarcinoma NEO Inventory Hope MiniMAC
Glioma Helplessness Challenge
Astrocytoma Hoplessness Happiness
Blastoma Expectations Coping
(non-) Hodkins Cognitive style Core relational themes
Craniopharyngioma Internal/external Relational meaning
Ependymoma Locus of Control Emotion theme
Esthesioneuroblastoma Transactional
Fibrosarcoma Lazarus
Lymphangioma
Porocarcinoma
Oliogodendroglioma
Osteosarcoma
Nephroblastoma
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Early scoping searches highlighted that this literature was vast and that there 
was little consistency between use of theoretical definitions (see also section 
3.6.3). Therefore, in order to minimise the number of studies which may 
otherwise have been missed by a specific and focused search, a high frequency of 
search terms were used. Sensitivity was thereby maximised, albeit by increasing 
the total recall rate and reducing search precision. Programming commands and 
Boolean operators were then applied to each term, and translated for each 
database, to enable accurate searching of different spellings or truncations of 
terms.
Once terms were established, each was translated into an appropriate 
Subject Heading (for the psychologically based databases) or a MeSH Heading (a 
thesaurus based hierarchy developed by the National Library of Medicine used for 
the medically oriented databases) (Higgins & Green, 2005). Essentially, Subject 
Headings and MeSH Headings are equivalent; they are general terms or keywords 
used to describe each piece of published research held in a database, organised 
into a theoretical hierarchy of terms with links to 'narrower' (related, but more 
focused), terms. To demonstrate this complex organisation priniciple, figure 2.1 
shows a hierarchy for both PsychlNFO and MEDLINE when searching for the 
concept of personality.
By identifying and 'exploding' key terms, researchers are able to quickly and 
accurately identify any piece of research held on the database whose subject 
heading fits into any term in the hierarchy at, or below the level of the specific 
term entered. This search method further enables high sensitivity searching and is 
encouraged by both Cochrane guidance and the NHSCRD.
Search strings were then combined into three combinations, one for each of the 
questions described in this chapter overview:
• 'Cancer' and 'Personality' and 'Appraisals and Emotions'
• 'Cancer' and 'Personality' and 'Outcome'
• 'Cancer' and 'Appraisals and Emotions' and 'Outcome'.
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PsychlNFO MEDLINE
Personality 4816 Psychiatry
v* Used For Behaviour & behavioural mechanisms 0
Character < -*• Adapation, Psychological 24595
Disposition Attitude 8672
Temperament Behaviour 4792
v* Narrower Terms V * . Child rearing 863
Inadequate personality 2 *-► Defense mechanisms 1849
Personality traits [+nt] 8243 Emotions 9226
Psychoanalytic 132 Human characteristics 164
personality factors
Related terms Human development 758
Cognitive Style (♦nt) 1677 Mental competency 2950
v -fr Coronary prone behaviour 218 Motivation 13642
Egocentrism 175 Neurobehavioral manifestations 127
V * . Emotional adjustment 3217 Personality 4891
[♦nt]
v * Emotional states [♦nt] 6829 Assertiveness 373
Five factor personality 
model
919 Authoritarianism 349
*-► Gender identity [+nt] 1784 V * Character 415
Human nature 861 V * Creativeness 1465
Individual differences 5076 Dependency
(psychology)
427
Lifestyle [♦nt] 1431 «-► Empathy 4494
»-► Person environment fit 397 W Individuality 2779
Personality change 389 Intelligence 4381
V * . Personality correlates 846 W Leadership 10236
Personality development 
[♦nt]
1794 Machiavellianism 122
Personality disorders 
[♦nt]
2583 Negativism 490
v * . Personality processes 
[♦nt]
393 Personality 
development [+nt]
2644
Personality theory [+nt] 1438 Temperament 1461
Predisposition 515 Psychology,
Social
899
»-► Psychodynamics 3003 Behaviour discipline and activities 0
Self actualization 274 Mental disorders 29783
Self concept [♦nt] 7893 Psychological phenomena and 0
processes
*-► Self evaluation 1494 Biological Sciences
V * Self monitoring 
(personality)
145
V * Self perception 3459
w Somatotypes 32
Teacher personality 50
Note: In PsychlNFO, personality is the highest term in its appropriate Subject Heading Tree, however, 
in MEDLINE, personality appears as a narrower term under a higher MeSH Heading. Numbers refer 
to the number of article links for each term. [+nt] indicates that specific terms have hierarchical trees 
of their own which, if  exploded, would all be included.
Figure 2.1. Search term hierarchies in PsychlNFO and MEDLINE.
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2.4.1.2 Search strategy
As the subject of psychosocial oncology is multi-disciplinary, a wide range of 
electronic databases were used in literature searching spanning the fields of 
medicine, psychology, nursing and complementary health. The chosen databases 
represent international literature searching, including searching of the grey 
literature:
• Allied & Complementary Medicine Database (AMED)
• British Nursing Index (BNI)
• Cochrane Central Register of Controlled Trials (CENTRAL)
• Cochrane Database of Systematic Reviews
• Cumulative Index to Nursing and Allied Health Literature (CINAHL)
• Database of Abstracts of Review of Effects (DARE)
EMBASE
• Health Management Information Consortium (HMIC)
• Health Technology Assessment Database (HTA)
MEDLINE
• PsychlNFO
• Social Science Citation Index (SSCI)
• System of Information on Grey Literature in Europe (SIGLE) 
Systematic reviews often include searches of health service research
registers (for example, the National Research Register or the Current Science 
Register of Controlled Trials); hand searching of conference abstracts from 
relevant professional societies; and/or, an email request to the key researchers 
within the field. Egger et al. (2001), for example, claim that only 50% of 
conference abstracts, and even fewer dissertations (around 30%), are ever 
published, therefore, searches purely limited to the published literature may miss 
relevant data. Typically though, unpublished studies are lower in methodological 
quality; inclusion, therefore, carries potential to introduce methodological bias 
into the review. The observation that publication of negative results is often much 
harder to achieve (therefore potentially biasing the direction of mean effect sizes 
in a statistical meta-analysis) further confuses matters on this issue.
Searching for non-published data can dramatically increase the length of time 
required to complete a review and is not always feasible. Whilst it is
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acknowledged that to include searching of non-published works could have 
introduced extra information, due to the ongoing debate regarding their suitability, 
and for practical reasons relating to the time allocation for this part of the thesis, 
literature searching for this review focused on published literature only.
2.4.2 Inclusion criteria
A priori specified inclusion criteria are important to ensure that no bias 
occurs when deciding upon which studies are relevant to the review to the 
question. Five categories of inclusion criteria were used.
2.4.2.1 Study Population
The review was concerned with patients who had been diagnosed with 
cancer. Inclusion encompassed any cancer site, and where applicable, different 
cancer sites were planned to be synthesised separately. Those which also 
recruited patients with recurrent cancer were excluded unless the primary cancer 
sub-samples were analysed separately: appraisals of a primary or recurrent 
diagnosis will be very different due the clinical variations of the diagnoses. 
Advanced (terminal/palliative) cancers were included, but comparisons and data 
synthesis between studies recruiting early and advanced cancer patients are to be 
treated with caution. Any ethnic group or gender samples were included, 
however, child cancer samples were excluded: there is some evidence that 
personality does not stabilise until adulthood (Pervin & John, 2001), therefore, 
with personality being a key feature of the review, to include children may have 
skewed the results. Mixed illness samples (i.e. those recruiting generally unwell 
patients rather than, specifically, cancer patients) were excluded unless sub­
samples with cancer were analysed separately from other illnesses.
One of the key premises for this thesis was that cancer adjustment changes 
over time, and that psychological responses to early phases of illness are perhaps 
the most important indicators of longer term adjustment. A number of studies 
were found in which recruited samples demonstrated not only a wide range of 
time between diagnosis and recruitment into the study, but also with mean time 
periods since diagnosis of a great many years, after which treatment will have 
ceased and adjustment could generally be said to have stabilised.
46
A period of five years from diagnosis is considered a critical juncture for 
cancer patients; at this point, chance of continued survival for illness-free patients 
significantly increases. Only studies which reported an average time between 
diagnosis and recruitment of five years or less were to be included in this review.
2.4.2.2 Study Design
Any type of published empirical research was included. This included any 
experimental (e.g. RCT, Intervention study etc.) or non-experimental (e.g. Survey) 
design study. Excluded records comprised commentary articles and narrative 
reviews, as these are primarily subjective pieces; systematic reviews, although 
these were noted for the purposes of writing the narrative thesis review (chapter 
one); conference abstracts; and, dissertations, although these were the subject of a 
further search (See section 3.5.3 for details). Qualitative research was also 
included; the importance of the integration of such data into systematic reviews 
has been cited elsewhere (see Dixon-Woods, Agarwal, Jones, Young & Sutton,
2005; Dixon-Woods, Bonas, Booth, Jones, Miller, Sutton etal., 2006; and Jack,
2006). No studies adopting qualitative methodology were found to be directly 
relevant to the research question and the review, therefore, focuses exclusively on 
quantitative studies.
From early scoping searches, it was expected that most included studies 
would be non-experimental in design as these are the most applicable for the 
review question. It was also entirely feasible that some survey data may have been 
collected as part of larger psychosocial interventions or RCTs within a cancer 
population, and so such experimental designs were potentially important to 
include.
2.4.23 Language of publication
Although it is acknowledged that psychosocial oncology research is 
conducted internationally (this is evidenced, for example, by prominence of the 
International Psycho Oncology Society), only those studies published in the English 
language were included in this review. Due to variations in access to translation 
services, foreign language papers were excluded. Full international expansion of 
this inclusion criterion would have required translation of data at all stages of the 
review (relevance screening, inclusion assessment, quality assessment, and data 
extraction) and this was not feasible.
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2.4.2.4 Variable measurement
For inclusion, studies had to measure at least one of the pre-defined 
predictor variables, in addition to at least one of the pre-defined outcome 
variables. Predictor variables included any personality measure; health control 
belief; cognitive appraisal or attribution measure; or, a measure of emotional 
reaction following illness. Outcome variables included any measure of anxiety, 
depression, or quality of life.
All measures were limited to those which are self-reported: any studies 
which reported on these variables using other-report (e.g. researcher observation, 
medical team or carer reported) were excluded as this review was concerned with 
patients directly, not subjective, proxy, reports of their behaviour.
2.5 LITERATURE SEARCHING
2.5.1 Study Location
Electronic searches were carried out between December 2005 and the end of 
February 2006. To the candidate’s knowledge, no studies have since been 
published in the major journals in the field that would invalidate the results 
published, although an updated systematic search at a future time-point would be 
beneficial.
2.5.2 Deduplication of records
Electronic results from the searches were exported into EndNote referencing 
software. As anticipated, the searches yielded a high output, however, there was 
some overlap between each of the search strings. Once in EndNote, references 
were de-duplicated both using automatic EndNote functions, and also by manual 
methods (automatic de-duplication was found to be quite unreliable, perhaps as a 
result of the large number of records contained in each database, therefore, 
databases were sorted (by author, then by title), and visually searched for 
duplicates). This minimised multiple referencing of the same study between 
databases leaving a total of 59,395 individual references remaining. In later stages 
of the review procedure, further duplicates were highlighted; the flow chart of 
inclusion (figures 2.2 and 2.3) indicates at what stage these extra duplicates were 
removed.
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2.5.3 Relevance screening and inclusion assessment
Titles and abstracts of each study were assessed by two independent 
reviewers for relevance to the review questions. The relevance lists of the two 
reviewers demonstrated around 40% overlap which although surprisingly low, 
can be accounted for by several reasons. These include potential insufficiency of 
training/experience of the reviewers, unclear inclusion criteria, or simply the 
number of search records to be screened. The latter of these is perhaps the most 
likely. Whatever the cause may be, this clearly demonstrates the importance of 
having two reviewers involved at this stage and corroborates with Petticrew and 
Gilbody (2004) who claim that one in every ten references can be missed per 
reviewer in relevance screening (an under-estimate given our data).
Those deemed relevant by one reviewer were discussed and agreement 
made as to the study's relevance. Where agreement could not be made, or any 
doubt regarding relevance remained, a third reviewer (Richard Neal; the main 
thesis supervisor) was asked to resolve the disagreement This occurred very few 
times given the scope of the review. At this point, the three separate lists of 
relevant searches were merged and once again de-duplicated to safeguard against 
duplicate entry from different searches. Figure 2.2 presents a flow chart showing 
the narrowing of the literature through searching, deduplication and relevance 
screening.
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3 Separate Searches
Question 1: Cancer, Personality & Appraisal 
Question 2: Cancer, Personality ft Outcome 
Question 3: Cancer. Appraisal & Outcome
Qu. 1 Ptdupltatton
13, 731 remained
Qy 1. Independent 
Relevance Screening 
Rev 1: 84 identified 
Rev 2: 145 identified
OUHtififl 1
19, 267 Hits
Question 2
21, 852 Hits
Question 3
38, 592 Hits
Qu. 2 DedupHcation 
21, 679 remained
Qu 2, Independent 
Rtkyflncfi Screening
Rev 1: 132 identified 
Rev 2: 110 identified
Qu. 3 Deduplication 
23, 985 remained
Qu 3. Independent 
Relevance Screening
Rev 1: 151 identified 
Rev 2: 141 identified
Combined Relevant Results
(A fter discussion o f those identified by one 
reviewer only, and a fter further de-duplication) 
Question Specific: 316 
Non-question Specific: 53 
Total: 369 Relevant
Figure 2.2. Flow chart presenting the numerical results o f searching, deduplication and 
relevance screening (refer to section 2.5.7 fo r  a note about the inclusion o f question 1).
Three hundred and sixty nine records were identified for full inclusion 
assessment. Of these proposed relevant records, six were later found to be 
duplicates, four were unobtainable, and 117 were excluded; 44 of these exclusions 
were papers written in a language other than English, one was a book chapter, four 
were conference abstracts and 68 were dissertations. As a precaution against loss 
of important data from these dissertations, a further search using first author
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names from each dissertation was conducted using PsychoINFO and MEDLINE 
databases. Relevance from this search was assessed by reviewer two and resulted 
in an additional eight records being identified for full inclusion assessment
The remaining 250 papers were ordered for full article inclusion assessment 
(reviewer two only). Figure 2.3 further demonstrates how these 250 papers were 
further reduced to provide our final included sample of 68 studies.
Of the J69 Relevant Papers
6 Duplicates 
1 Book Chapter 
4 Conference Abstracts 
(no matching publication identified)
4 Unobtainable 
68 Dissertations 
(8 matching papers identified and added) 
44 Foreign Language 
250 Full papes ordered (‘Gets')
Inconclusive Inclusion 
Assessment 
18 Papers
(authors emailed)
Response
6 data not available
Non Response
6 automatic exclusion
Mon SonttcUble
3 authors unknown 
3 emails returned 
(mailbox unknown)
Total: 18 Excluded
Excluded
8 Letters/Commentary Articles 
31 Reviews 
3 Conference Abstracts 
3 Foreign Language 
25 Sampling Issues 
56 Measurement Issues 
33 Not Relevant 
Total: 159 Excluded
Included 
73 Papers
PtflWllCOTQn
68 studies remained
Psvcholoeical Outcome QoL Outcome Both Outcomes
N-36 N« 10 N* 22
Figure 2.3. Flow chart presenting the results o f study inclusion assessment
One hundred and fifty nine records were excluded and the remaining 18 did 
not contain sufficient information for inclusion to be confidently assessed. The 
latter were subject to email requests for further information (see section 2.5.5).
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2.5.4. Description of excluded papers
A high proportion of excluded studies was always expected given the scope 
of the literature search. In inclusion assessment, most papers were excluded 
because of low search specificity; use of key word searches resulted in many 
papers that were of a completely different subject matter and just very loosely 
related. For example, many of the original excluded studies were of a biomedical 
and genetic nature exploring causes, development, and treatment of cancer.
A summary of reasons for exclusion of the 159 papers excluded after full- 
artide assessment is presented in table 2.2.
Table 2.2. Categories, and frequency, o f exclusion fo r  papers obtained fo r fu ll paper 
assessment
Reason N u m b e r  o f  
s tu d ies
Foreign Language Publication 3
Letter/C om m entary Article 8
Review Article 31
Conference Abstracts 3
Sampling Issues
Not Cancer Specific (e.g. Cardiovascular disease patients, f.
rheum atology patients, student samples)
O
included recurrence w ithout separate analysis 12
Mean tim e between diagnosis and recru itm ent greater than 5 7
years (o r not stated and unable to confirm )
/
Inadequate Measurem ent
Not self-report 1
Only m et personality criteria 7
Only m et outcome criteria 38
Only m et appraisal/em otion criteria 4
No outcome measure included 6
Irrelevant to question (e.g. risk/onset prediction, measure 33
creation/validation, screening/treatm ent tria l study)
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2.5.5 Studies with incomplete information to assess inclusion
Eighteen papers did not contain sufficient information to confidently assess 
inclusion, mainly with regards to the time since diagnosis criterion. Summary 
information on these studies is presented in appendix 2.1.
Attempts were made to trace and email corresponding authors to ask for 
clarity regarding inclusion. Three authors were untraceable using world-wide 
web searching; three emails were returned from 'unavailable mailboxes' 
(alternative email addresses could not be found); and, six authors did not respond 
to the email request Of the six who did respond, all confirmed that the required 
data was not available, and therefore, these were also excluded.
2.5.6 Included studies
Seventy-three records were identified for definite inclusion. Of these, there 
were three incidences where the same data was reported in two publications and 
one incidence where the same data was reported in three publications; in these 
cases, the records were merged and considered as the same study (a precaution 
against duplicate study weighting in meta-analysis). Sixty-eight studies thus 
remained. Of these 36 reported on psychological comorbidity outcomes (anxiety, 
depression, or overall distress); 10 reported on quality of life outcomes; and 22 
reported on both quality of life, and psychological comorbidity. Table 2.3 
summarises measures (predictors and outcomes) used and main findings from all 
include studies.
2.5.7 Amendment of review objectives
Despite highlighting a large number of papers in the early stages, question 
one (that of association between personality and appraisal) was removed as a 
study objective at this stage. The objectives were initially reviewed because it was 
felt that the review had become too large to feasibly answer all research questions 
with sufficient clarity and quality. In exploring each question individually it 
became clear that question one was the weakest. There were two primary 
reasons. First, of the three review questions, the least amount of research had 
been conducted on question one and, therefore, it was felt more salient to review 
those that had been the focus of greater research effort. Reviews of this question 
will be important in due course. However, with the heterogeneity observed in this
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field of research, the studies identified were not expected to be similar enough to 
be synthesised in an informative way. Instead, (as with many other excluded 
papers) the studies were used in the narrative review (Chapter One). Second, it 
was expected that in extraction of data relating to the remaining two questions, a 
partial (albeit not strictly systematic) answer to the association between 
personality and appraisal may be possible.
Although this modification to the study objectives did not dramatically 
reduce the literature size (ultimately, only six studies were removed as many of 
the other papers highlighted by this specific search were relevant to other 
research questions), by reducing the scope of the review it made data synthesis 
more straightforward and the findings more comprehensible.
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Table 2.3. Publication details and variables measured fo r  the 68 included studies.
Relevant measures used1
ID Authors Date Title
Personality
Health Belief/ 
Cognition/ 
Emotion
Outcome
Summarised Main Findings
Aarstad, 
Aarstad, 
Heimdal & 
Oloffson
2005 Mood, anxiety and 
sense of humour in 
head and neck 
cancer patients in 
relation to disease 
stage, prognosis and 
quality of life.______
Humour
(SVQ)
Neuroticism
(EPI)
Anxiety
(STA1-S)
Depression
(BDI)
Quality of 
Life (EORTC)
• Higher anxiety/lower depression than controls.
• Some clinical variables predict outcome.
■ Sense of humour at diagnosis predicts QOL and 
depression at six year follow up.
Ahmed, 
Kamal, Zahar 
& Sobhy.
2004 A study of some 
psychological 
variables in 
Egyptian patients 
with cancer bladder.
Trait Anxiety 
(STAI-T) 
Neuroticism 
(EPI)
Extroversion
(EPI)
Psychoticism
(EPQ
Depression ■ Anxiety, depression and neuroticism higher in 
(ZDI) patients than controls.
■ Concurrent anxiety and neuroticism predict 
depression in patients.
Alhama, 
Extremera, 
Mesa, Martin, 
Vizoso & 
Vico.
1996 Quality of life in 
oncological patients. 
A study of 105 
cases.
Locus of Control 
(MHLC)
Quality of ■ Co-morbidity and locus of control were strongly 
Life (GRQLI) associated with QOL
Allison, 2000 A prospective
Guichard & investigation of
Gilain. dispositional
optimism as a 
predictor of health- 
related quality of 
life in head and neck 
cancer patients.
Optimism
(FLOT)
Quality of • Pre- and post- treatment, optimists reported 
Life (EORTC) better QOL
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Table 2.3. Publication details and variables measured fo r the 68 included studies (continued).
ID Authors Date Title Relevant measures used' Summarised Main Findings
5 Andrykowski 1994 Health locus of ■ Locus of Control "Distress • Disease severity and treatment moderate the
& Brady control and (MHLC) (PAIS) relationship between LOC and distress (LOC has
psychological ■ Depression most effect on distress at low levels of perceived
distress in cancer (POMS) severity),
patients: interactive 
effects of context
6 Andrykowski 1996 Psychosocial ' ■ Positive Affect "Depression • Patients reported poorer physical health,
, Curran, adjustment and (PANAS) (POMS/CES- functioning but greater psychosocial adaptation
Studts, quality of life in ■ Negative Affect D) than controls (benign breast problem patients).
Cunningham, women with breast (PANAS) ■ Quality of ■ No differences in distress between patients and
Carpenter, cancer and benign • Personal Change Life (PHQ) controls.
McGrath, breast problems: a
Sloan & controlled
Kenady._______________ c o m p a r i s o n . _________ _________________ _______________________________________
7 Badger, 2004 Depression burden, ■ Negative Affect ■ Well Being ■ Mood at diagnosis is predictive of mood at
Braden, psychological (NAS) (IWB) longitudinal follow-up.
Mishel & adjustment, and ■ Greatest adjustment observed in those reporting
Longman. quality of life in perceived high depression burden in an
women with breast intervention group,
cancer: Patterns
 ____________________over time.______________________________
8 Baider, 2003 Effects of age on ■ Fatalism (MAC) ■ Distress ■ Cross-cultural differences in distress observed.
Andritsch, coping and ■ Hopeless/Helples (PAIS) • Across all subsamples, age and distress were
Uziely, psychological sness (MAC) significantly associated (young women, more
Goldzweig, distress in women ■ Anxious distress).
Ever-Hadani, diagnosed with Preoccupation
Hofman, breast cancer: (MAC)
Krenn& review of literature ■ Fighting Spirit
Samonigg. and analysis of two ■ Thought
different settings. Intrusion/
Avoidance (IES)
56
Table 2.3. Publication details and variables measured fo r the 68 included studies (continued). 
ID Authors Date Title Relevant measures used1 Summarised Main Findings
Bleiker, van 
der Ploeg & 
Ader.
1995 Personality traits of • Rationality
women with breast 
cancer: before and 
after diagnosis.
(SAQ-N) 
Understandin 
g (SAQ-N) 
Optimism 
(SAQ-N) 
Anxiety 
(SAQ-N)
Emotional control
(SAQ-N)
Emotional
expression-in
(SAQ-N)
Emotional
expression-out
(SAQ-N)
Anti-emotionality
(SAQ-N)
Depression ■ Rationality and emotional expression differed 
(SAQ-N) between patients and controls.
• No significant depression differences.
10 Bleiker, 2000 Psychological
Pouwer, van distress two years
der Ploeg, after diagnosis of
Leer & Ader. breast cancer:
frequency and 
prediction.
Rationality
(SAQ-N)
Understandin
g (SAQ-N)
Optimism
(SAQ-N)
Anxiety
(SAQ-N)
Emotional control 
(SAQ-N) 
Emotional 
expression (SAQ- 
N)
Anti-emotionality
(SAQ-N)
Thought intrusion 
(IES)
Thought 
avoidance (IES)
Depression • 16% still distressed, two years after diagnosis.
(SAQ-N) ■ Intrustive thoughts, anxiety and health
complaints were best predictors of two year 
distress levels.
11 Boer, Elving 1998 Psychosocial factors
& Seydel and mental health in
cancer patients: 
opportunities for 
__________________  health promotion.
Self-Efficacy
(GSES)
Quality of 
Life (RAND)
Mental health in cancer survivors is lower than 
general population controls.
Self-efficacy and loneliness were strong 
predictors of mental health.
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Table 2.3. Publication details and variables measured fo r the 68 included studies (continued).
ID Authors Date Title Relevant measures used1 Summarised Main Findings
12 Brown, King, 2000 Patterns over time ■ Isolation (PAC) • Quality of • QOL fluctuates highly over time; mood remained
Butow, Dunn in quality of life, • Minimisation Life stable.
& Coates. coping and (PAC) (LASA/GLQ) ■ Well-being deteriorated over time
psychological ■ Anger (PAC) " Between patient variability accounted for 60%,
adjustment in late ■ Perceived aim of 45%, and 44% of the total variance in effort to
stage melanoma treatment cope, mood and well-being respectively.
patients: An ■ Perceived ability • Perceived treatment aims, minimization, anger,
application of to cope with marital status and better QOL were significant
multilevel models. illness (PACIS) 
■ Coping (COPE)
independent predictors of survival.
Butow, 1999 Psychosocial
Coates & predictors of
Dunn survival in 
metastatic 
melanoma.
13 Carver, Pozo,
Harris,
Noriega,
Scheier,
Robinson,
Ketcham,
Moffat Jr. &
Clark.
1993 How coping 
mediates the effect 
of optimism on 
distress: a study of 
women with early 
stage breast cancer.
Optimism
(LOT)
Coping (COPE) Distress
(POMS)
Optimism was significantly associated with 
distress (prior levels controlled for) at each time 
point
Several coping reactions (esp humour, denial 
and disengagement) are longitudinally 
predictive of lower distress levels.
14 Carver,
Pozo-
Kaderman,
Harris,
Noriega,
Scheier,
Robinson, et
al.
1994 Optimism versus 
pessimism predicts 
the quality of 
women's
adjustment to early 
stage breast cancer.
Optimism
(LOT)
Thought Intrusion 
Life Satisfaction
Distress 
(POMS) 
Quality of sex 
life
Pessimism was significantly predictive of 
longitudinal well-being even when previous 
levels were controlled for.
No effect of pessimism on quality of sex life or 
thought intrusions.
Optimism-pessimism are adequately measured 
using single item scales.
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Table 2.3. Publication details and variables measured fo r the 68 included studies (continued).
ID Authors
15 Carver, 
Harris, 
Lehman, 
Durel, 
Antoni, 
Spencer & 
Pozo- 
Kaderman.
Date Title
2000a How important is 
the perception of 
personal control? 
Studies of early 
stage breast cancer 
patients. Study 1
Relevant measures used1
Cancer 
Expectancy 
Recurrence 
Control Beliefs 
Positive/Negative 
Affect (ABS)
Distress
(POMS)
Summarised Main Findings
Perceived control over remaining cancer free 
was not associated with distress.
Expectancy of remaining cancer free was 
associated with distress levels.
16 Carver, 
Harris, 
Lehman, 
Durel, 
Antoni, 
Spencer & 
Pozo- 
Kaderman.
2000b How important is 
the perception of 
personal control? 
Studies of early 
stage breast cancer 
patients. Study 2
Cancer 
Expectancy 
Recurrence 
control beliefs
Distress
(POMS)
Depression
(CES-D)
17 Cohen, Moor 2000 The association
& Amato between treatment-
specific optimism 
and depressive 
symptomatology in 
patients enrolled in 
a phase I cancer 
clinical trial.
Treatment
Specific
Optimism
Depression ■ Treatment specific optimism was significantly 
(CES-D) associated with fewer depressive symptoms,
Distress lower mood disturbance, and fewer symptoms
(POMS) of distress (after demographic and clinical
variables were controlled for).
■ Clinically depressed patients reported 
significantly lower treatment specific optimism 
at diagnosis.
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Table 2.3. Publication details and variables measured fo r the 68 included studies (continued).
ID Authors Date Title Relevant measures used< Summarised Main Findings
18 Cousson-
Gelie
2000 Breast cancer, 
coping and quality 
of life: A semi- 
prospective study.
• Anxiety 
(STAI-T)
• Perceived Stress 
(PSS)
• Locus of Control 
(CLoCS)
■ Anxiety 
(STAI-S)
• Quality of 
Life (WoC)
■ Coping mediated the relationship between 
health status and QOL
• Self-accusation and perceived stress mediated 
the relationship between trait anxiety and QOL
• Perceived stress mediated the relationship 
between tumour status and QOL
19 De Valck & 
Vinck
1996 Health locus of 
control and quality 
of life in lung cancer 
patients.
■ Locus of Control 
(MHLC)
• Quality of 
Life (DCL)
■ Patients reported higher internally oriented LOC 
beliefs than controls.
• Fluctuations in QOL best explained by 
increasing physical complaints.
■ No significant association between LOC and 
QOL
20 Dropkin 2001 Anxiety, coping 
strategies, and 
coping behaviours 
in patients 
undergoing head 
and neck cancer 
surgery.
■ Anxiety 
(STAI-T)
■ Coping 
(WoC/CBS)
■ Anxiety 
(STAI-S)
■ Self-care was the only significant predictor of 
anxiety.
21 Epping-
Jordan,
Compas,
Osowiecki,
Oppedisano,
Gerhardt,
Primo &
Krag.
1999 Psychological 
adjustment in breast 
cancer: processes of 
emotional distress.
■ Optimism ■ Monitoring
■ Thought Intrusion 
(IES)
■ Thought 
Avoidance (IES)
■ Coping (CSI)
■ Distress 
(SCL)
■ At diagnosis, age and distress relationships were 
mediated by intrusive thoughts. Optimism -  
distress relationships were mediated by coping.
■ At three month follow up, distress was only 
predicted by intrusive thoughts.
■ Six month distress was predicted by optimism 
(mediated by coping).
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Table 2.3. Publication details and variables measured fo r  the 68 included studies (continued).
ID Authors Date Title Relevant measures used' Summarised Mala Findings
22 Evans, 
Thompson, 
Browne, Barr 
& Barton
1993 Factors associated 
with the
psychological well­
being of adults with 
acute leukaemia in 
remission.
• Personality 
(PRF)
■ Coping (CRI) ■ Distress 
(SDS)
■ Well-Being 
(GBI)
• Some differences in well being found to be 
associated with variability across a number of 
personality characteristics (endurance, 
affiliation, cognitive structure, autonomy, and 
nurtu ranee).
23 Faller, 
Bulzebruck, 
Drings & 
Lang.
1999 Coping, distress, and 
survival among 
patients with lung 
cancer.
■ Coping (FQCI) 
• Emotional 
Distress
■ Depression 
(DS)
■ Depressive coping and emotional distress were 
both significant predictors of distress.
24 Gallagher, 
Parle & 
Cairns
2002 Appraisal and 
psychological 
distress six months 
after diagnosis of 
breast cancer.
" Appraisals • Distress 
(GHQ)
• Psychological functioning was significantly 
related to psychiatric history, tumour grade and 
cognitive appraisals (esp. threat and self- 
efficacy).
25 Glinder&
Compas
1999 Self-blame 
attributions in 
women with newly 
diagnosed breast 
cancer: a
prospective study of
psychological
adjustment
■ Self Blame 
(SBI)
■ Coping (CSI) ■ Distress 
(SCL)
• Behavioural self-blame was predictive of 
concurrent distress levels only; 
characterological self-blame was predictive of 
changes in distress over time.
26 Golden- 
Kreutz & 
Andersen
2004 Depressive 
symptoms after 
breast surgery: 
relationships with 
global, cancer- 
related, and life 
event stress.
■ Neuroticism 
(EPI)
■ Perceived Stress 
(PSS)
• Thought Intrusion 
(IES)
■ Thought 
Avoidance (IES)
■ Depression ■ Perceived stress and neuroticism both 
significantly predict depressive symptoms.
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Table 2.3. Publication details and variables measured fo r the 68 included studies (continued).
ID Authors Date Tide Relevant measures used1 Summarised Main Findings
27 Goodwin, 
Ennis, 
Bordeleau, 
Pritchard, 
trudeau, Koo 
& Hood.
28 Grassi & 
Molinari.
2004 Health-related
quality of life and 
psychosocial status 
in breast cancer 
prognosis: analysis 
of multiple 
variables.
Fatalism (MAC) 
Fighting Spirit 
(MAC)
Anxious
Preoccupation
(MAC)
Hopelessness/Hel 
plessness (MAC) 
Emotional Control 
(CECS)__________
Distress 
(POMS/PAIS) 
Quality of 
Life (EORTC)
Psychosocial status and quality of life were not 
associated with medical outcome.
1988 Pattern of emotional 
control and 
psychological 
reactions to breast 
cancer: a 
________ preliminary report
Emotional Control 
(CECS)
Anxiety (IBQ)
Depression
(IBQ)
Some associations between emotional control, 
hostility and psychosocial outcome were found.
29 Green,
Pakenham, 
Headly & 
Gardiner.
2002 Coping and health- 
related quality of 
life in men with 
prostate cancer 
randomly assigned 
to hormonal 
medication or close 
monitoring._______
Self Efficacy Threat appraisal 
Coping (COPE) 
Satisfaction with 
life
Quality of • Patient groups did not differ on measures of
Life (EORTC) distress, life satisfaction, cognitive function,
Depression physical symptoms, or social/role functioning.
(DASS) • Hormonal treatments were associated with
Anxiety poorer psychosexual functioning, but improved
(DASS) physical symptoms.
• Threat appraisals and coping were predictive of 
 _________ longitudinal QOL__________________ ________
30 Hack& 2004 Coping responses
Degner. following breast
cancer diagnosis 
predict 
psychological 
adjustment three 
years later.
Coping (CRI) 
Preference for 
decision making 
Anger Expression 
(AEI)
■ Distress 
(POMS)
Baseline depression and cognitive avoidance 
and minimal use of approach based coping 
strategies were associated with poorer 
adjustment at three years.
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Table 2.3. Publication details and variables measured fo r  the 68 included studies (continued).
ID Authors Date Title Relevant measures used1 Summarised Main Findings
31 Hassanein, 2001 Functional status of » Fatalism (MAC) • Quality of • 25% of patients had anxiety/or depression.
Musgrove & patients with oral ■ Fighting Spirit Life • Poorer functioning was associated with many
Bradbury cancer and its (MAC) (UWQOL/EO clinical and demographic variables.
relation to style of ■ Anxious RTC) " Functionality was also associated with anxiety.
coping, social Preoccupation • Anxiety depression, coping style (support and fighting
support and (MAC) (HADS) spirit were only very weakly associated).
psychological status. • Hopelessness/Hel Depression ■ Anxiety and depression were only weakly
Hassanein, 2005 Psychological plessness (MAC) (HADS) correlated with socio-demographics and
Musgrove & outcome of patients medical variables.
Bradbury. following treatment 
of oral cancer and 
its relation with 
functional status 
and coping 
mechanisms.
• Anxiety and depression were highly correlated 
with cancer specific QOL
• MAC scores were strongly associated with 
psychosocial outcome.
32 Hee, Kim, 2005 Quality of life in ■ Extroversion • Quality of • FACT C is a valid tool for measuring QOL in
Eremenco & colorectal cancer (EPI) Life cancer patients.
Han patients with 
colectomy and the 
validation of the 
functional 
assessment of 
cancer therapy- 
colorectal (FACT-C)
■ Neuroticism 
(EPI)
■ Psychoticism 
(EPI)
(FACT/FLIC) 
■ Distress 
(POMS)
33 Helgeson, 2004 Psychological and 
Snyder & physical adjustment
Seltman to breast cancer
over 4 years: 
identifying distinct 
trajectories of 
change.
Self Esteem 
(RSE)
Illness ambiguity 
(MUIS)
Quality of • Age, self-image, perceived control, and social 
Life (SF-36) resources all distinguished between different 
trajectories of adjustment.
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Table 2.3. Publication details and variables measured fo r the 68 included studies (continued).
ID Authors Date Title Relevant measures used1 Summarised Main Findings
34 Helgeson & 
Lepore
2004 Quality of life 
following prostate 
cancer: the role of 
agency and 
unmitigated agency.
• Agency
■ Self Esteem 
(RSE)
■ Self Esteem 
(GSES)
• Quality of 
Life (SF-36)
• Depression 
(CES-D)
• Agency was associated with indicators of good 
QOL
• Unmitigated agency was associated with 
intrusive thoughts, depressive symptoms and 
poorer mental functioning.
• Role of agency was related to self-efficacy.
35 Iwamitsu, 
Shimoda, 
Abe, Tani, 
Okawa & 
Buck
2005 Anxiety, Emotional 
Suppression, and 
psychological 
distress before and 
after breast cancer 
diagnosis.
■ Emotional Control 
(CECS)
■ Anxiety 
(MAS)
■ Distress 
(POMS)
” Pre surgery anxiety and emotional suppression 
were associated with distress pre- and post- 
surgery.
36 Kessler 2002 Contextual 
variables, emotional 
state, and current 
and expected 
quality of life in 
breast cancer 
survivors.
■ Affects (PANAS) 
• Satisfaction with 
life
■ Quality of 
Life
■ Affect was associated with both life satisfaction 
and QOL
■ Survivors reported greater comparative life 
satisfaction and life satisfaction future 
expectancies.
37 Koopman,
Angell,
Turner-Cobb,
Kreshka,
Donnelly,
McCoy, et al.
2001 Distress, coping and 
social support 
among rural women 
recently diagnosed 
with primary breast 
cancer.
■ Coping
■ Fatalism (MAC)
■ Fighting Spirit 
(MAC)
■ Hopelessness/Hel 
plessness (MAC)
■ Anxious 
Preoccupation 
(MAC)
■ Distress 
(POMS)
■ Distress and hopelessness/helplessness were 
both reported at very high levels.
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Table 2.3. Publication details and variables measured fo r the 68 included studies (continued).
ID Authors Date Title Relevant measures used1 Summarised Main Findings
38 Laubmeier, 2004 The role of ■ Perceived Life • Quality of ■ Spirituality was associated with less distress
Zakowski & spirituality in the Threat Life (FACT) and better QOL regardless of levels of perceived
Bair psychological • Well being life threat
adjustment to (SWBS) ■ Existential, but not religious well being
cancer: a test of the accounted for most variance in QOL
transactional model
of stress and coping.
39 Lehto, 2005 Predictors of quality ■ Coping (WoC) • Distress • Psychosocial factors were the strongest
Ojanen & of life in newly ■ Anger Expression (RSCL) predictors of QOL (when compared with cancer
Kellokrumpu diagnosed ■ Depression and treatment types).
-Lehtinen melanoma and (DEPS) ■ Breast cancer patients received far more social
breast cancer ■ Quality of support than melanoma patients.
patients. Life (EORTC) • Adjuvant treatment may comprimise the 
beneficial role of psychosocial factors that 
enhance QOL
40 Lewis 1982 Experienced
personal control 
and quality of life in 
late-stage cancer 
patients.
Self Esteem 
(RSE)
Purpose in Life 
(PLT)
External Locus of 
Control (HLCS)
Anxiety
(ZAS)
Perceived meaning (but not control) of the 
illness was associated with anxiety and self* 
esteem.
Lewis 1989 Attributions, 
experienced 
meaning, and 
psychosocial well­
being in patients 
with advanced 
cancer.
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Table 2.3. Publication details and variables measured fo r the 68 included studies (continued).
ID Authors Date Tide Relevant measures used' Summarised Main Findings
41 Lloyd, 
Parker, 
Ludlam & 
Maguire
1984 Emotional impact of 
diagnosis and early 
treatment of 
lymphomas.
■ Extroversion 
(EPI)
■ Neuroticism 
(EPI)
■ Psychoticism 
(EPI)
■ Risk of 
psychiatric 
disorder 
(SPI)
■ No age or treatment associations with outcome.
■ Female patients were more likely to meet 
psychiatric disorder criteria.
" Neuroticism was strongly associated with 
dissatisfaction with communication with 
medical staff.
42 Longman, 
Braden & 
Mishel
1999 Side-effects burden, 
psychological 
adjustment, and life 
quality in women 
with breast cancer: 
pattern of 
association over 
time.
• Affect (PANAS) ■ Quality of 
Life (CLQoL)
■ Well-Being 
(IWB)
■ Anxiety 
(SEC)
■ Depression 
(SEC)
• Affect was associated with anxiety and 
depression, but not quality of life.
43 Lowery, 
Jacobsen & 
DuCette
1993 Causal attribution, 
control, and 
adjustment to 
breast cancer.
■ Attributions
• Cancer Control 
(CSC)
■ Thought Intrusion 
/Avoidance(IES)
■ Locus of Control 
(MHLC)
■ Distress 
(PAIS)
■ 'Why me?' attributions, perceived loss of 
control, and higher impact of event scores were 
associated with both poorer adjustment and 
prediction of psychological distress.
44 Malcarne, 
compass, 
Epping- 
Jordan & 
Howell
1995 Cognitive factors in 
adjustment to 
cancer: attributions 
of self-blame and 
perceptions of 
control.
■ Self Blame ■ Personal Control 
Perceptions
■ Distress 
(BSI)
■ Self blame was associated with longitudinal 
distress (four months), but not concurrent 
distress levels.
• Perceptions of control had no direct or 
mediating effects for distress.
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ID Authors Date Title Relevant measures used< Summarised Main Findings
45 Marks, 
Richardson, 
Graham & 
Levine
1986 Role of health locus 
of control beliefs 
and expectations of 
treatment efficacy in 
adjustment to 
cancer
• Illness 
perceptions
• Locus of Control 
(MHLC/I-E Scale)
• Depression 
(ZDS)
" Perceived control mediated the relationship 
between perceptions of disease severity and 
depression.
46 Miller, 
Manne, 
Taylor, 
Keates & 
Dougherty
1996 Psychological 
distress and well­
being in advanced 
cancer: the effects of 
optimism and 
coping.
■ Optimism 
(LOT)
■ Coping (WoC) • Distress 
(MHI)
■ Well-Being 
(MHI)
■ Optimism and coping were both associated with 
adjustment, even after controlling for functional 
status and prior adjustment measures.
■ Optimism was positively associated with well­
being, and negative associated with distress.
47 Morris,
Greer,
pettingale & 
Watson
1981 Patterns of 
expression of anger 
and their 
psychological 
correlates in women 
with breast cancer.
■ Extroversion
■ Neuroticism 
(EPI)
■ Psychoticism 
(EPI)
■ Anxiety (STI)
■ Anger Expression ■ Anxiety 
(STAI-T)
" Anger expression was higher in patients than 
controls.
• Of all personality traits, only neuroticism 
differed between patients (higher) and controls 
(lower neuroticism).
■ No age -  anxiety association.
48 Nakada, 
Nagao, 
Takiguchi, 
Tatsumi & 
Kuriyama
1996 Quality of life and 
anxiety before and 
after lung cancer 
chemotherapy: 
relationship to 
patient's 
personality.
■ Personality 
EGOGRAM
■ Anxiety 
(STAI-T)
■ Anxiety 
(STAI-S)
■ Quality of 
Life (JQLI)
■ Two out of five EGO states were highly 
correlated with QOL scores.
49 Naus, Price & 
Peter
2005 The moderating 
effects of anxiety 
and breast cancer 
locus of control on 
depression.
■ Health Locus of 
Control (MHLC)
■ Depression 
(BDI)
■ Anxiety (BAI)
■ Demonstrated an interactive effect between 
some locus of control scores and anxiety in the 
prediction of depression.
• Suggest that those loci of control assumed to be 
adaptive in the general population may, in fact, 
be maladaptive in early stage cancer survivors.
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ID Authors Date Title Relevant measures used' Summarised Main Findings
50 Nelson,
Friedman,
Baer,
Montague, 
Lane & Smith
1994 Subtypes of 
psychosocial 
adjustment to 
breast cancer.
■ Coping (CRI)
■ Affect (ABS)
• Distress 
(PAIS)
• Anxiety 
(HADS)
■ Depression 
(HADS)
• Of four patient profile clusters, only one 
demonstrated high distress and global 
maladjustment
• The remainder all had normal affect levels, but 
differed on various QOL/functioning subscales.
• Suggests that even non-emotionally distressed 
patients have varying adjustment trajectories 
and may all benefit from intervention.
51 Nordin & 
Glimelius
1998 Reactions to 
gastrointestinal 
cancer-variation in 
mental adjustment 
and emotional well­
being over time in 
patients with 
different prognoses.
• Fatalism (MAC)
• Fighting Spirit 
(MAC)
■ Anxious 
Preoccupation 
(MAC)
■ Hopelessness/hel 
plessness (MAC)
• Anxiety
■ Depression
■ Quality of 
Life
■ Fighting spirit was associated with emotional 
well-being; hopeless/helplessness and anxious 
preoccupation was not
• MAC scores were generally stable over time.
• Marked differences observed between HADS 
clinical/non clinical subsamples.
52 Osowiecki & 
Compas
1998 Psychological 
adjustment to 
cancer: control 
beliefs and coping in 
adult cancer 
patients.
■ Perception of 
Control
■ Coping (CS1)
■ Thought Intrusion 
(IES)
■ Thought 
Avoidance (IES)
■ Anxiety (BSI)
■ Depression 
(BSI)
• Problem focussed coping was associated with 
low anxiety/depression; emotion focussed 
coping with more symptoms.
■ Interactions between PF coping and control 
were predictive of lower anxiety and depression 
at baseline, but not four months later.
53 Osoweicki & 
Compas
1999 A prospective study 
of coping, perceived 
control, and 
psychological 
adaptation to breast 
cancer.
■ Perceptions of 
Control
■ Coping (CSI)
■ Anxiety (SCL)
■ Depression 
(SCL)
■ PF coping associated with lower distress near 
diagnosis.
■ EF disengagement coping associated to distress 
at 6 months controlling for earlier levels.
■ No main effects for perceived control.
■ Interaction between coping and control 
significant at baseline only, not longitudinally.
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Table 2.3. Publication details and variables measured fo r the 68 included studies (continued).
ID Authors Date Title Relevant measures used' Summarised Main Findings
54 Padilla, 
Mishel & 
Grant
1992 Uncertainty, 
appraisal and 
quality of life.
■ Mastery • Illness uncertainty 
(MUIS)
■ Appraisal (AS)
• Coping (WoC)
• Quality of life 
(MQOLS-CA)
• Distress 
(POMS)
• Mood, illness ambiguity, mastery and danger 
focussed appraisal are all key predictors of QOL. 
explaining far more variance than clinical 
factors.
• Coping was not predictive of QOL
55 Perczek, 
Burke, 
Carver, 
Krongrad & 
Terris
2002 Facing a prostate 
cancer diagnosis: 
who is at risk for 
increased distress?
• Optimism 
(LOT)
■ Coping (Brief 
COPE)
• Distress 
(POMS)
• Avoidance was predictive of increased distress; 
optimism, cancer status, and all other coping 
strategies weren’t  
■ Interactions between optimism and coping 
weren't significant predictors either.
56 Ranchor,
Sanderman,
Steptoe,
Wardle,
Miedema &
Ormel
2002 Pre-morbid 
predictors of 
psychological 
adjustment to 
cancer
■ Neuroticism 
(EPI-N)
■ Self Efficacy 
(GSES)
■ Distress 
(GHQ)
■ High neuroticism was associated with high 
distress in short and long term analyses.
■ Higher social support was associated with 
higher distress.
57 Ratcliffe, 
Dawson & 
Walker.
1995 Eysenck personality 
inventory L-Scores 
in patients with 
Hodgkin's disease 
and non-Hodgkin's
■ Lie (EPI) ■ Anxiety 
(HADS)
■ Depression 
(HADS)
• L-Scores (reflecting the cancer prone 
personality) were high at diagnosis and 
associated with risk of death at 5 years.
■ Depression was also an independent 5 year 
survival risk factor.
58 Rondorf- 
Klym & 
Colling
2003 Quality of life after 
radical
prostatectomy.
■ Self-Esteem 
(RSE)
■ Symptom 
appraisals (PCI)
■ Anger Expression 
(AEI)
■ Health Locus of 
Control (MHLC)
■ Depression 
(CES-D)
■ Quality of 
Life (QLS)
■ Perceived support, self-esteem, and health locus 
of control were all significant predictors of QOL.
■ Urinary function appraisal was mediated by 
locus of control.
• Anger suppression and depression were not 
significant predictors of QOL.
59 Schnoll, 
Knowles & 
Harlow.
2002 Correlates of 
adjustment among 
cancer survivors.
■ Optimism 
(LOT)
■ Life Purpose 
(PLT)
■ Coping (COPE)
■ Quality of life 
(PAIS)
• Higher social support, optimism, high perceived 
meaning in life and lower avoidant coping were 
associated with better adjustment
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Table 2.3. Publication details and variables measured fo r the 68 included studies (continued).
ID Authors Date Tide Relevant measures used% Summarised Main Findings
60 Schou 2004 Pessimism as a ■ Optimism ■ Positive ■ Anxiety • Prevalence of emotional morbidity was
Ekeberg, predictor of (LOT) expectations (HADS) significantly higher among pessimists.
Ruland, emotional morbidity • Fatalism (MAC) • Depression • Pessimism was the strongest predictor of one
Sandvik & one year following • Fighting Spirit (HADS) year anxiety and depression.
Karesen. breast cancer (MAC) • Quality of ■ Optimists and pessimists have different coping
surgery. ■ Hopelessness/Hel Life (EORTC) approaches which may interact to predict
plessness (MAC) outcome.
Schou, 2005a The mediating role ■ Anxious Optimism had both a direct and a mediated (via
Ekeberg & of appraisal and Preoccupation fighting spirit and hopeless/helplessness) effect
Ruland. coping in the (MAC) on QOL
relationshp between ■ Treatment ■ Relationships between predictors and outcomes
opdmism- decision making were also mediated by threat appraisals at the
pessimism and ■ Primary time of diagnosis.
quality of life Appraisals (VASA) Compared to general population controls, at
■ Treatment diagnosis patients reported lower emotional,
Schou, 2005b Multiple predictors decision making cognitive and social functioning.
Ekeberg, of health-related ■ Cognitive and social functioning disparity
Sandvik, quality of life in continued until one year post surgery.
Hjermstad & early stage breast ■ Breast conservation surgery a chemotherapy
Ruland. cancer. Data from a were predictive of functioning one year after
year follow-up study surgery.
compared with the ■ Throughout, optimism was associated with
general population. better QOL and fewer symptoms.
61 Stanton, 2000 Emotionally ■ Hope ■ Quality of ■ Emotionally expressive coping was associated
Danoff-Burg, expressive coping ■ Coping (COPE) Life (FACT) with fewer cancer related medical
Cameron, predicts ■ Perceived Health ■ Distress appointments, enhanced health and vigour, and
Bishop, psychological and (POMS) decreased distress at three month (age, coping
Collins, Kirk, physical adjustment and initial levels controlled for).
Sworowski & to breast cancer. • Relationships between emotionally expressive
Twillman coping and QOL were mediated by social
receptivity.
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Table 2.3. Publication details and variables measured fo r the 68 included studies (continued).
ID Authors Date Tide Relevant measures used' Summarised Mala Findings
62 Taylor,
Lamdan,
Siegel,
O'Connor,
Moran,
Lunch &
Hrywna
1999 The role of coping in 
the psychological 
adjustment of 
African American 
women with early- 
stage breast cancer.
■ Thought Intrusion 
(IES)
• Thought 
avoidance (IES)
■ Coping (COPE)
• Distress 
(MHI)
■ Well Being 
(MHI)
■ Quality of 
Life (CARES)
• Avoidant coping was associated with 
psychological distress, particularly in younger 
patients.
63 Timko &
Janoff-
Bulman
1985 Attributions, 
vulnerability, and 
psychological 
adjustment: the case 
of breast cancer.
• Self-Esteem ■ Emotional 
Reactions (EES)
■ Attributions
• Depression 
(BDI)
• Relationships between illness attributions and 
adjustment were mediated by perceived 
vulnerability beliefs.
64 Trunzo & 
Pinto
2003 Social support as a 
mediator of 
optimism and 
distress in breast 
cancer survivors.
■ Optimism 
(LOT)
■ Distress 
(POMS)
■ Affective social support mediated the 
relationship between optimism and distress at 
baseline and 6 month follow up, but not at ly r  
follow up.
■ Confident social support did not mediate the 
optimism-distress relationship at any point
65 Urcuyo, 
Boyers, 
Carver & 
Antoni
2005 Finding benefit in 
breast cancer: 
relations with 
personality, coping, 
and concurrent 
well-being.
■ Optimism 
(LOT)
■ Threat sensitivity 
(BIS/BAS)
■ Illness Concerns 
• Coping (Brief
COPE)
■ Distress
• Depression 
(CES-D)
■ Quality of 
Life
■ Benefit finding was associated with optimism, 
positive reframing, religious coping, and 
emotional distress.
71
Table 2.3. Publication details and variables measured fo r the 68 included studies (continued).
ID Authors Date Tide Relevant measures used1 Summarised Main Findings
66 Watson, 1991 Relationships ■ Emotional Control • Anxiety • Emotional control and fatalism were highly
Greer, between emotional (CECS) (HADS) significantly associated.
Rowden, control, adjustment • Fatalism (MAC) ■ Depression ” Anger control was associated with helplessness.
Gorman, to cancer and ■ Fighting Spirit (HADS) • Psychological morbidity was related to type of
Robertson, depression and (MAC) adjustment reported.
Bliss & anxiety in breast ■ Anxious
Tunmore cancer patients. Preoccupation
(MAC)
■ Hopelessness/hel 
plessness (MAC)
67 Yamaoka, 1998 Health-related ■ Extroversion ■ Quality of • Optimism was a mediator between eating ability
Shigehisa, quality of life varies (EPI) Life (HRQoL) and quality of life, particularly physical and
Ogoshi, with personality ■ Neuroticism social well-being.
Haruyama, types: a comparison (EPI)
Watanabe, among cancer ■ Psychoticism
Hayashi & patients, non-cancer (EPI)
Hayashi patients and healthy 
individuals in a 
Japanese 
population.
• Optimism 
(LOT)
68 Yu, Fielding 2003 The mediating role ■ Extroversion ■ Quality of ■ High extroversion, low neuroticism, and high
& Chan of optimism on 
post-radiation 
quality of life in 
nasopharyngeal 
carcinoma.
(EPI)
■ Neuroticism 
(EPI)
■ Psychoticism 
(EPI)
Life psychoticism were associated with higher QOL
1 Where validated scales are used, abbreviations are shown in brackets. (For full measure titles see appendix 2.2)
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2.6. PROCEDURE OF DATA EXTRACTION, QUALITY ASSESSMENT, & 
SYNTHESIS
2.6.1 Data extraction
Data were extracted from all included studies using standardised forms. 
These were independently piloted by two reviewers on a random selection of five 
papers during protocol development
Study content and results were extracted by reviewer two only; whilst 
duplicate extraction would have been preferable resources were not available to 
enable this extra step of methodological validation. Data extraction included:
Basic Study Information. Authors, date of publication, and an allocated study 
identification code.
Sample. Sample size, gender ratio, age range/mean, cancer site, cancer stage, 
recruitment rate, and follow up attrition.
Methodology. Design, timing of follow up data collection (if appropriate), 
main study research question, and measures used.
Results. Statistics of relevant findings, descriptions of associated results, and 
poignant comments made in the discussion.
Comments. Any additional comments on the study made by the reviewer.
2.6.2 Quality assessment
Study quality significantly varied between design with prognostic, 
epidemiological, or observational designs usually demonstrating most variance 
and often the poorest standards of methodological rigour (Altman, 2001). 
Assessment of quality is important to enable objective assessment of the individual 
contribution of each study to the field as a whole. As such, quality assessment 
data can be used in numerous ways. First, data can be synthesised qualitatively to 
give a methodological critique of a specific field of research; second, as a grouping 
variable for sensitivity analysis; and, third, many reviews will often use low quality 
scores as a basis for study exclusion as their inclusion can often obscure the true 
nature of variable relationships (Altman & Lyman, 1998). Rosenthal (1995) 
warns against use of quality scores as an exclusion variable as scores are prone to 
the bias of the individual(s) who conducted the quality assessment. Rather, 
Rosenthal promotes using the data to investigate the moderating role of study
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quality in the mean effect size (i.e. in sensitivity analysis) or as an alternative study 
weighting variable in meta-analysis.
Despite substantial criticism against doing so, many reviews continue to 
discount non-RCT designs and as such, numerous quality assessment tools 
currently exist for RCTs; the Delphi List (Verhagen, de Vet, de Bie, Kessels, Boers, 
Bouter etal., 1998) and the GRADE approach (Atkins, Briss, Eccles, Flottorp,
Guyatt, Harbour etal., 2005) for example. As an alternative to quality assessment 
scales, the Cochrane Collaboration encourage the use of risk of bias lists which 
promote evaluation based on sub-domains of quality rather than calculation of 
total quality scores (Higgins & Altman, 2008). Like many of the other tools, 
however, this method is biased towards assessment of the RCT and not all aspects 
are relevant to other methodological designs. The increasing number of such tools 
makes it difficult to distinguish between them and select the most suitable 
(Altman, 2001).
Fewer tools exist for use in assessing the quality of qualitative studies. The 
protocol stated that had qualitative studies been included, their quality would be 
assessed using the well-validated Mays and Pope (1996) tool (these criteria will 
not be detailed here as no qualitative studies were ultimately included, however, 
they are readily available: see Mays and Pope, 1996; Kahn et al. 2001).
Converse to the number of experimental design quality assessment tools, 
there are no widely accepted quality criteria for studies of observational or non- 
experimental research. To use experimental quality criteria would be invalid as 
many features are simply not suitable for theses design specific quality indicators. 
Therefore, many review teams create their own, usually citing NHS CRD guidance, 
the Cochrane Handbook and methodological papers (see, for example, Downs & 
Black (1998) and Papworth & Milne, 2001) for their development. This has given 
rise to a number of largely invalidated measures in the literature which are rarely 
used on more than one or two occasions (Altman, 2001).
An alternative approach is proposed by Edwards, Russell and Stott (1998): 
the signal to noise ratio. These authors advocate that to exclude designs lower in 
the evidence hierarchy is inappropriate as such designs are more feasible and 
appropriate to many questions. Edwards et al (1998) propose that in addition to 
quality assessment, the 'noise' component, an assessment should also be made
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about the potential value added by the study, the 'signal' component, to the 
literature. Resultant scores are then presented as a ratio representing study value 
rather than quality perse.
For this review it was necessary to select a method which was relevant to the 
highest number of possible designs, to allow for direct comparisons to be made. 
Whilst the signal to noise method could have been selected, the more 
straightforward and arguably more objective checklist approach was favoured.
As such, the Kmet, Lee and Cook (2004) tool was selected.
Some modification to this quality assessment tool was necessary to meet the 
specific requirements of this review. Based on the assumption that longitudinal 
designs are more informative for explorations of variable association and 
prediction, three items of quality assessment were added relating to such designs. 
Specifically, these items assessed: (1) the suitability of timing between baseline 
and follow-up collection (i.e. long enough for outcomes to have emerged); (2) the 
sufficiency of explanation of sample attrition between baseline and follow up data 
collection; and, (3) whether statistical adjustments were made in the analyses 
based on different lengths of follow-up.
The modified tool used the same scoring instructions recommended by Kmet 
etal. (2004). The standardised form is applied to each study individually and 
assesses the quality, clarity and suitability of the stated aims, hypotheses, design, 
sample, methodology, analysis, reporting of results, and validity of the 
conclusions drawn from the data. Each paper is awarded one of four scores 
(2=yes/good; l=partial; 0=no/poor; X=not applicable) for each of the 19 quality 
criteria. The total (out of 38) is then converted into a percentage indicator of 
quality. Quality assessment was conducted by both reviewer one and reviewer 
two independently and an overall mean score calculated per study. A copy of the 
quality assessment form (including scoring guidelines) is included in appendix 2.3.
Whilst potentially creating some level of confound into data synthesis, 
studies with low quality assessment scores were not excluded (see section 2.2.2). 
This decision was reached based on two observations. First, due to the subjectivity 
inherent in quality assessment checklist, and second, because scoping searches 
had already highlighted that poor quality was an ongoing issue in this field. One of 
the review objectives was to systematically critique methodology in addition to
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synthesising findings. To exclude some studies based on low methodological 
scores would have rendered this objective redundant Whilst total mean scores 
were calculated for each study, domain specific evaluation (as suggested by the 
Cochrane Collaboration) was conducted and in-depth descriptive discussion of 
various aspects of quality are presented in addition to summary scores.
In addition to quality scoring each individual study, Russell, Di Blasi, Lambert 
and Russell (1998) propose a scoring system for systematic reviews themselves.
No systematic reviews are currently available on this topic and as such scoring 
systems were not relevant to data extraction, however, this tool was used in the 
review evaluation (section 2.8.3).
2.6.3 Data synthesis
This review had two objectives. First, to provide a methodological critique of 
the literature to investigate whether claims of poor methodology are valid (for 
example, see Cull, 1990; Altman & Lyman, 1998) and potentially responsible for 
the low impact of research in the field. Second, results were synthesised in order 
to (a) explore if similar studies report corroborative or opposing findings and (b) 
to identify any research gaps to guide future research.
Data were extracted with the aim of conducting numerous small-scale 
statistical meta-analyses; scoping searches previously established that large-scale 
meta-analyses for each outcome were not viable. The method of meta-analysis 
chosen was a random effects model using the Hunter and Schmidt (1999) method. 
A random effects model was selected as the ultimate goal was unconditional 
inference of the findings; generalisability to the population in order to generate 
both research and clinical practice implications. Further, fixed effect models are 
more likely to commit Type I error. As data were presented in a correlation 
coefficient format, it was deemed unnecessary to introduce extra bias into the 
calculation by transformation of these scores; the Hunter and Schmidt method is 
the only one of the three which combines these statistics directly.
Both Hedges's and Rosenthal’s methods are reported to produce over­
estimates of effect sizes and are found to be particularly inaccurate where effect 
sizes fall below r =.3, which they did in many cases in this review. Therefore, the 
comparatively stringent Hunter and Schmidt method was more appropriate. In 
response to claims that it may be poor at accurately detecting true significance, the
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more stringent two-tailed probability test was used; still, given low numbers of 
included studies, reported significance levels should be treated with caution.
Effect sizes were weighted by sample size. Although Rosenthal (1995) 
promotes further weighting of studies by quality score, this was inappropriate due 
to the differences in scores obtained between reviewers, possibly indicative of bias 
in either the scorer or the scoring system (for further detail see section 2.7.2.1).
In preparation for potential meta-analysis, during data extraction and 
synthesis, variables were categorised into either: one of five predictor variable 
groupings, including, personality, health control beliefs, illness 
cognitions/appraisals, emotional reaction to illness and coping; or, into one of five 
outcome variable groupings, including anxiety, depression, distress, quality of life 
and well-being. These groupings were structured around theoretical concepts and 
studies were matched based on an analysis of the content of the specific measures 
used. Care was taken to ensure categorisation was done systematically and 
theoretically rather than basing simply on the title of the selected measure (which 
can often be misleading) or on the stated purpose in each study (which may not 
always be the validated and appropriate use). In most cases this was clear, but for 
others, categorisation was less explicit as usage was found to be inconsistent.
Within this review, the heterogeneity of constructs assessed, and the 
different measures used between studies to assess those constructs was much 
greater than anticipated. Although meta-analysis aims to group similar studies 
this is not always feasible or straightforward; many measures of similar 
psychosocial variables not only have different numbers of factor loadings, but very 
different subscale content For example, within the final number of included 
papers, 17 different measures of quality of life were used. Although more recent 
research seems to be focusing on use of standard measures such as the FACT or 
EORTC, to accurately match subscales from each of these scales is no simple task.
Even more problematic was inconsistency in the application of measures. 
Whilst it is relatively easy to group different measures of the same construct, there 
were a number of occasions where one single measure was used to assess different 
constructs between studies. There are two examples of this. First, the Impact of 
Events Scale was sometimes used as both cognitive predictor variable for 
psychosocial outcome (e.g. a predictor of quality of life), but also as an outcome
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itself (e.g. stress as an outcome). Within the theoretical model adopted for this 
review (where distress and quality of life were the standard outcomes), the IES 
most suitability fits in the cognition category. The result of this is that studies 
which used only the IES as an outcome did not necessarily meet review inclusion 
criteria and were thus excluded.
Even more confusing was application of the Mental Adjustment to Cancer 
(MAC) Scale. Watson et al. (1988) claim that this is a measure of adjustment 
where adjustment is defined as comprising appraisals and their ensuing reactions. 
Many studies, in fact, use this scale not as an adjustment (outcome) measure, but 
as an assessment of coping (particularly where the mediating role of coping is 
being investigated). The reason for this could possibly be the lack of clarity for 
what adjustment actually is, and that the nature of psychological response to 
illness is dynamic: cyclical and not fixed. Schou et al. (2004) also raise this 
problem of definition and when comparing the measure to theoretical literature 
decide that it is best suited to measure 'cognitive coping'. Nelson et al. (1994) 
claim that at least two of the sub-scales, anxious preoccupation and hopelessness/ 
helplessness, should be classed as 'mental attitudes' rather than adjustment 
indicators or coping. Content analysis of the subscales for the purpose of this 
review concluded that the measure was, indeed, more related to cognitive 
processes rather than coping or adjustment Therefore, in this review, the MAC 
was considered a health cognition and appraisal construct
This is an issue, not limited to psychosocial oncology, but to much of health 
psychology. Health psychology is still a young discipline having been 
independently established less than 25 years ago and UK based psychosocial 
oncology was established soon after. Therefore, much of the research has been 
exploratory, leading to many competing theories and multiple assessment tools.
An ideal goal would be for the field to become standardised, and over time, this 
seems likely to happen. However, it is imperative that in preparing new protocols, 
researchers are clear about (1) which theoretical model they are basing their 
research around; (2) how they choose to define different constructs; (3) that 
important (possibly confounding, mediating or moderating) constructs are not 
missed out from their chosen model; and, most importantly (4) that assessment
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tools are carefully selected to validly assess the desired construct within the 
chosen theory.
2.7 RESULTS
Data were synthesised primarily according to the guidance of Egger et al. 
(1998) due to their heterogenous nature. Therefore, the results that follow 
contain a qualitative synthesis of the included studies, a description of why most 
did not fit in with standard requirements for meta-analytic procedures, and a 
number of small meta-analyses which should be treated with caution. Advanced 
statistical procedures (e.g. sensitivity analysis) were not possible due to the 
limited size of the meta-analysis. Additionally, the disproportional number of 
studies in each cancer group meant that synthesis of findings specific to each 
patient group was not possible. Results were synthesised with regard to cancer as 
a group of illnesses, but where differences in site may be important, these are 
highlighted and possible causes for such discrepancy discussed.
Results are presented according to the two objectives. Therefore, the 
methodological critique and results of the quality assessment exercise are 
presented first Appreciation of the methodological issues raised is critical to 
understand the descriptive results which follow thereafter. Results of the 
statistical meta-analysis are presented between the methodological critique and 
the descriptive data synthesis of the main findings from individual studies, into 
which, relevant meta-analytic findings are integrated and discussed.
Due to the number of studies reviewed, it was not possible to discuss 
methodological differences for each study. However, attention is drawn to 
summary information presented in table 2.3 (measures used) and table 2.4 
(clinical descriptors, design features, and summary quality assessment scores). 
The main findings from each study are also presented in table 2.3. Throughout the 
results section, where reference is made to significance of result, this pertains to a 
standardised alpha level of p<.05.
2.7.1 Description of included papers
The clinical, demographic, and design characteristics of the 68 included 
studies are shown in table 2.4. Included papers ranged in date of publication from 
1981 to 2005.
79
Thirty eight of the sixty-eight included studies were carried out in North 
America. Twenty-one were carried out in Europe (of which, four recruited in the 
Netherlands, four in Scandinavia, and six in the United Kingdom); five in Asia; 
three in Australasia; and just one in Africa. The final study was a cross sectional 
analysis comparing Israeli and Austrian cancer patients.
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Tobte 2.4. Summary information on demographic, clinical, design, sampling and quality assessment fo r all included papers
Sample Size Gender
(% )
Age
Quality 
Assessment 
Scores (%)
Study
ID.
Authors Date Country
Cancer Site1 
(Staging at 
diagnosis)
Follow
-up
Timing of 
Recruitment
2.3
Base-
Line4 F/Us M F
Mean
(sd) Range Mean Diff»
Cross Sectional Studies
2 Ahmed 2004 Egypt Bladder 
(Not specified)
n/a Diagnosis 148 n/a 82 18 48.6 63.6 9.1
3 Alhama 1995 Spain Lung (14); Breast 
(31); Colorectal 
(27); Head/Neck
m m ..................
n/a Treatment
105 n/a 55 45 55.6 65.9 4.5
5 Andrykowski 1994 North Leukaemia n/a 21.5 months
America (All) month post
diagnosis
(SD=15.9)
69 n/a 55 45 35.9(8.8) 84.1 4.5
6 Andrykowski 1996 North Breast n/a 28.2 months
America (l-llla, In remission) month post 
diagnosis 
(SD=15.1, R: 
6-57)
80
(81-
86%)
n/a 100 53.9(9.3) 35-79 90.1 0
8 Baider 2003 Austria /  
Israel
Breast
(l-ll. Survivors)
n/a 1 - 5 years 
post
diagnosis
224
(37.3%) n/a
100 30-80 88.6 13.6
11 Boer 1988 Nether­
lands
Gynaecological (11); 
Breast (53); Lung 
(8);
Somach/lntestinai 
(12); Prostate (16) 
(Not Specified)
n/a 2.5 years post 
diagnosis
480 n/a 29 71 60.6(11.8) 20-80 77.3 9.1
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Table 2.4. Summary information on demographic, clinical, design, sampling and quality assessment fo r all included papers (continued).
Study
ID. Authors
Date Country
Cancer Site1 
(Staging at 
diagnosis)
Follow
-up
Timing of 
Recruitment Base-Line4 F/Us M F
Mean
(sd) Range Mean Difl*
16 Carver 2000 North Breast n/a Diagnosis; 3,
b America (Ml) 6, or 12 
month post 
diagnosis
202
(80%)
n/a 100 53.8(12.8) 27-87
22 Evans 1993 Canada Leukaemia n/a 24 months
(Not Specified) post
diagnosis 
(R: 3-91)
40
(71.4%) n/a 21 19 47.0
16-82 75.0 4.5
26 Golden- 2004 North Breast n/a 36.3 days
Kreutz America (N il) post surgery 
(SD=16.89)
210 n/a 100 20-85 86.2 0.4
31 Hassanein 2001 United Oral n/a 23 months
And
Hassanein 2005
Kingdom (All) post
treatment
end
(R: 6months- 
_6yrsJ.................
68
(88.3%) n/a 69 31 58 28-86 87.5
8.3
0.8
35 Iwamitsu 2005 Japan Breast
JNot SpecjfiedJ
n/a Pre-Diagnosis 23 n/a 100 45.5
_I?._6)__
25-72 85.4 4.8
36 Kessler 2002 North Breast n/a 3.5 years post
America (Not Specified) diagnosis 
(SD=3.61, 
R:0.1-19 yrs)
148
(71%) n/a 100
52.4
(11.6) 28-80 74.6 32.6
37 Koopman 2001 North
America
Breast
(O-lll)
n/a 6 months 
post
diagnosis
100 n/a 100 58.6(11.6) 31-82 84.1 22.7
38 Laubmeier 2004 North Prostate (23); n/a 3 months to 5
America Breast (16); Ovarian 
(14); Endrometrial 
(11); Other (36)
(All)
years post 
diagnosis 95(92.3%) n/a 33 67
58.5
(10.8) 27-84 90.9 0
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Table 2.4. Summary information on demographic, clinical, design, sampling and quality assessment fo r all included papers (continued).
Study
ID. Authors Date
Country
Cancer Site1 
(Staging at 
diagnosis)
Follow
-up
Timing of 
Recruitment Base-Line4 F/U5 M F
Mean
(sd) Range
Mea
n Difl*
39 Lehto 2005 Finland Melanoma; Breast 
(All)
n/a 3 - 4 months 
post
diagnosis
175
(83.3%) n/a 21 79 54.5 28-71 81.8 18.2
40 Lewis
And
Lewis
1982
1989
North
America
Lung (23); Breast 
(24); Ovarian (11); 
Lymphatic (9); 
Other (23); 
Unknown Primary 
(10)
JMetastatic)
n/a Treatment 
(2/3rds 
within 1 year 
of treatment) 57 n/a 37 63
54
(13.3) 21-79
72.7
75.0
0
13.7
43 Lowery 1993 North
America
Breast
(All)
n/a 13.9 months 
post
diagnosis
(R:l-60
months^
195 n/a 100 53 81.8 18.2
45 Marks 1986 North
America
Heamatological
m  ....................
n/a Diagnosis 137 n/a 66 34 18-86 79.5 4.5
47 Morris 1981 United
Kingdom
Breast
(Tp-2, No-l Mo)
n/a Pre-Diagnosis 17
(68%) n/a
100 56 82.8 7.2
48 Nakada 1996 Japan Lung
j m ...........................
n/a Diagnosis 50 n/a 58 35-78 65.9 13.6
49 Naus 2005 North
America
Breast
. I I  JO..........................
n/a 4.3 years post 
diagnosis 109 n/a
100
I
i 
1
i 
i
32-79 84.1 4.5
50 Nelson 1994 North
America
Breast
(Not Specified)
n/a 3 years post 
diagnosis 
(R: 1-255 
months) 122(68.6%) n/a 100 52.7 84.1 4.5
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Table 2A. Summary information on demographic, clinical, design, sampling and quality assessment fo r all included papers (continued).
Study
ID. Authors Date Country
Cancer Site1 
(Staging at 
diagnosis)
Follow
-up
Timing of 
Recruitment
24
Base-
Line4 F/Us M F
Mean
(sd) Range Mean DlfP
54 Padilla 1992 North
America
Gynaecological
(All)
n/a 5.1 months 
post
diagnosis 
(SD=3.5, R: 1- 
14 months)
100
(80.6%)
n/a 100
52.9
(15.9) 20-81
90.9 9.1
58 Rondorf- 2003 North Prostate n/a 1 2 -2 4
Klym America (H I) months post
treatment
end
88
(66.6%) n/a 100
66 79.5 31.8
59 Schnoll 2002 North
America
Breast (65);
Prostate (22); Other
n/a 61 months 
post
(13)
(Not Specified, 
Survivors)
diagnosis
(SD=68.7) 109
(100%) n/a 24
76 60.3
( ID
81.8 9.1
62 Taylor 1999 North Breast n/a Sample 1:4
America (All) months post
Sample 2:2.5 ( 6 ^ » )  "/a  100 S  26‘8S 901 91
months
........................................................................................................................................ post_d_iagno_sis_................................................................................................................................
63 Timko 1985 North Breast n/a 8.9 months _
America (NotSpecified) post mc n/a 100 53.4 23-81 86.4 0
...........................................................................................................................................diagnosis ......... ...............................................................................................................
65 Urcoyo 2005 North Breast n/a <1 year post 230 . 53.5 __ 0n. . //, fonnn n/a 100 27-87 90.2 3.2.............................................................America___( ..............................................surgery.................. (80%).................................................. ...........................................................
66 Watson 1991 United Breast n/a l-3 m o p o s t 360 , 55.8 __ __ nc „ n, fn in . focnn n/a 100 25-75 95.4 0Kingdom (0-11) diagnosis (95%) (10.6)
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Table 2.4. Summary information on demographic, clinical, design, sampling and quality assessment fo r all included papers (continued).
Study
ID. Authors Date Country
Cancer Site1 
(Staging at 
diagnosis)
Follow
-up
Timing of 
Recruitment
2J
Base-
Line4 F/Us M F
Mean
(sd) Range Mean
Dirr
6
67 Yamaoka 1998 Japan Stomach 
(Not Specified, 
Survivors]
n/a R: 34d-19.8yr
207 n/a 68 32 57.5 32-831 77.3
18.
2
RCTs
17 Cohen 2001 North
America
Renal; Melanoma 
(Metastatic)
3 week Treatment 46 46(100%J 70
30
54.9
. . m . .
36-76 89.3
21.
4
29 Green
Longitudinal Studies
1 Aarstad
2002
2005
Austra­
lia
Norway
Prostate 
(Not Specified)
Head &Neck
. . m ...........................
6
month 
6 year
Diagnosis
Diagnosis
77
(93.9%)
79
65
(84.4%)
79
(100%J
100
100
69.2
(6.3)
59.9
56-86 84.2
72.5
5.3
16.
5
4 Allison 200 France Upper aero- 
digestive
m ...........................
3,12,
24
month
Diagnosis 101
(99%)
88
(87.1%) 93 7
58.2
(11.6) 84.0 3.6
7 Badger 2004 North
America
Breast
(All)
3,6
month
Diagnosis
169
169
(100%) 100 55.6(12.8) 25-82 74.3 1.3
9 Bleiker 1995 Nether­
lands
Breast
(All)
19.5
month
s
Pre-Illness 25
(78%)
25
(100%) 100
62.5
(10.3)
60.7 0
10 Bleiker 2000 Nether­
lands
Breast
(T14,No3,M0)
18
month
2 mo post
surgery
[SD=0.8]
244
(77%)
170
(69.7%) 100
51.9
(10.5) 29-75 89.3
21.
4
12 Brown
And
Butow
2000
1999
Austra­
lia
Melanoma
(IV)
3,6 ,9 , 
12,15, 
18,21, 
24
month
234 days post
diagnosis
(SD=371) 125
(54%)
44
(35.2%) 60 40
55.0
(14.0)
87.0
Q1 £
4.7
14.
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Table 2.4. Summary information on demographic, clinical, design, sampling and quality assessment fo r all included papers (continued).
Study
ID. Authors Date Country
Cancer Site1 
(Staging at 
diagnosis)
Follow
-up
Timing of 
Recruitment
2JI
Base-
Line4 F/U* M F
Mean
(sd) Range Mean Diff*
13 Carver 1993 North
America
Breast
(l'H)
1, 10 
days. 3. 
6.12  
month
Diagnosis
59 59(100%)
100 58.0(10.8)
33-72 85.0 8.5
14 Carver 1994 North
America
Breast
(I'll]
3.6,12
month
Diagnosis 70 54J77.1% i
100 58.2
.0 .1 :21 .
32-75 85.2 1.1
15 Carver 2000 North
America
Breast
( III)
3.6.12 
month
Diagnosis 147
(85%)
126
(85.6%) 100
55.8 28-78 75.9 20.9
18 Cousson-
Gelie
2000 France Breast
(Early)
3
week. 
2 year
Pre-Diagnosis
75 59(78.7%) 100
48.3
(10) 30-70
69.8 31.9
19 DeValck 1996 Belgium Lung
JNot SpecifiedJ
20
week
Pre-Diagnosis 16 16(100%J 88 12 58 61.9
7.1
20 Dropkin 2001 North
America
Head & Neck 
JNot SpecjfiedJ
4,5,6
day
Diagnosis 75 75(100%J 70 30 61 37-82
69.7 6.1
21 Epping-
Jordan
1999 North
America
Breast
(All)
3,6
month
10.8 days 
post
diagnosis
110 80(72.7%) 100
54.8
(10.3) 85.6 21.2
23 Faller 1999 Germ­
any
Lung
(All)
7-8
year
Diagnosis 
(within 3 
days)
152 103(67.8%) 83 17
59.0
(9.0) 32-84 76.8 25.0
24 Gallagher 2002 Austra­
lia
Breast
(l-lll)
6
month
2 months 
post
diagnosis
195
(71.7%)
195
(100%) 100 57.0 25-90 85.4 13.7
25 Glinder 1999 North
America
Breast
(All)
3,6,12 
month
10.8 day post 
diagnosis
76
(69.1%)
64
(84.2%) 100
54.8
(9.8) 90.8 10.1
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Table 2.4. Summary information on demographic, clinical, design, sampling and quality assessment fo r all included papers (continued).
Study
ID. Authors Date Country
Cancer Site1 
(Staging at 
diagnosis)
Follow
-up
Timing of 
Recruitment
24
Base-
Line4 F/U5 M F
Mean
(sd) Range Mean Difl*
27 Goodwin 2004 North
America
Breast
(T0 3, No i,Mo)
12
month
9.7 weeks 
post
diagnosis: 
0.5-351
378
(95%)
323
(85.4%)
1 0 0
52.0
(9.9)
26-74 87.0 4.7
28 Grassi 1988 Italy Breast 
(TuNoiMo)
1
week,
6
month
Pre-Diagnosis
32
(91.4%)
12
(37.5%) 1 0 0
52.0
(6.4) 29-70
69.2 0
30 Hack 2004 Canada Breast
(HI)
3 year 90.3 days 
post
diagnosis 
(R: 1.5-6 mon 
thsj
70 55(78.%) 1 0 0
55.6
(1 0 .1 )
92.3 15.4
32 Hee 2005 Korea Colorectal
m ...................... .
1.6
month
Diagnosis
98 52(53.1%1 59 41
59.7
_ y .y j
91.3 4.9
33 Helgeson 2004
(a)
North
America
Breast
(N il)
7,13,
19,31,
55
month
Treatment
363
(81.6%)
271
(74.7%) 1 0 0
48.3
(9.8) 27-75 83.2 9.0
34 Helgeson 2004
(b)
North
America
Prostate 
(T13,Nq,Mo)
2 ,8 ,14  
month
47 days post 
treatment 
start (SD=22)
93
(77%)
81
(87.1%) 1 0 0 65 49-80 80.1 13.7
41 Lloyd 1984 United
Kingdom
Lymphoma
i m ........................
6
month
Diagnosis 40
(90.1%)
31
(77.5%1 63 37
43.6
(18.5) 19-77 69.2 38.5
42 Longman 1999 North Breast 3,6 Diagnosis 53
America (All) month (100%)
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Table 2.4. Summary information on demographic, clinical, design, sampling and quality assessment for all included papers (continued).
Cancer Site* Follow Timing of _ Mean
IP ^ Authors Date Country (Staging at -up Recruitment u ne4 ^   ^ fsd) Mean Diff*
*________________________________________ diagnosis)____________________ _______________________________________________________ _ ____ ____________
44 Maicame 1995 North Breast (40); 4 9.75 weeks
America Gynaecological (22); month post
Heamatological diagnosis
(10); Brain (10); (SD=7.34) 98 72 42.5
Lung (6); Testicular (77.7%) (73.5%) (7.5)
& Prostate (4); Skin 
(3); Other (4)
  .....................................................m ...........................................................................................................................................................................................
46 Miller 1996 North Gastrological (77); 2 ,4  10.2 months
America Breast (13); Lung month post
(3); Ovarian (1); diagnosis 121 75 55.4
Unknown Primary (89%) (62.0%) (11.5)
(4)
................................................................. (Metastatic)_.....................................
51 Nordin 1998 Sweden Gastrological 3 ,6 ,12  Within 12
(NotSpecified) month weeks post 139 53 47 66 94.5 3.3
........................................................................ ................................................................. diagnosis...................................^9 .6% )
52 Osoweicki 1998 North Breast (40); 4 10 weeks
America gynaecological (22); month post
Haematological & diagnosis
Lymphoma (8); (SD=5.84)
brain (10); Lung (2); 83 62 41.5
Testicular (6); (75%) (74.7%) 1B BZ (7.5) ^ ' 61 BA1 0
Gastrological (5);
Melanoma (4); other
(3)
(All)
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Table 2.4. Summary information on demographic, clinical, design, sampling and quality assessment for all included papers (continued).
. Cancer Site* Follow Timing of _ Mean
y Authors Date Country (Staging at -up Recruitment . .  F/Us M F . . .  Range Mean DifT*
10________________________ diagnosis)____________ ” Une________________ ^ ________________
53 Osoweicki 1999 North Breast 3 ,6  10.8 days
America (I, II, III) month post
^R-0-43 days) 70  (100%) 100  (10.0) 3 6 8 0  8 9 7  2 4
55 Perczek 2002 North Prostate 2 week Pre-Diagnosis 172 101 __ 66.6  4 ^ 0 7  07-3 n
............................................................ America, _ (Not SpetifjedJ......................................................... (81B.7%]. .  .(58.7%^ _ _U................ (7.5] _ _ , _ _______
56 Ranchor 2002 Nether- Lung (8 ); Breast 2 ,6 ,12  Pre-IHness
lands (16); Prostate (14); month
Gastrological (31); 167 99 71.8
Colorectal (16); (50.3%) (59.3%) (6.5)
Other (14)
........................................................................ m ..............................................................................................................................................................................................
57 Ratdiffe 1995 United Lymphoma 5 year Within 48
Kingdom (All) hours post
diagnosis 56 44 19-73 82.2 28.0
60 Schou 2004 Norway Breast 3,12 12 days post
(I, II, III) month diagnosis
And (R: 2-21d) 96  4 7 1
Schou 2005 195 165 56
(a) (80%) (84.6%) 100  ( 10 .3 ) 2 1 7 8  9 2 7  6 8
And
Schou 2005 90-® 3.0
(b)
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Table 2.4. Summary information on demographic, clinical, design, sampling and quality assessment for all included papers (continued).
Study
ID. Authors Date Country
Cancer Site1 
(Staging at
Follow
-up
Timing of 
Recruitment Base-Line4 F/Us M F
Mean
(sd) Range Mean Dill*diagnosis) 24
61 Stanton 2000 North Breast 3 Within 20
America a  a) month weeks of
treatment
start
122
(83%)
92
(91%) 100
51.56
(10.3)
28-76 91.1 3.6
64 Trunzo 2003 North Breast 3 .6 ,12 247 days post 69
(100%)
57.5
(13.2)America (l-ll, Survivors) month diagnosis(SD=106.6)
69 100 87.5 3.6
68 Yu 2003 China Nasopharyngeal
(All)
4.8
month
20 days post
diagnosis
(SD=48d)
211
(45%)
187
(88.6%) 74 26
49.7
(12.2)
91.0 10.4
Numbers in parentheses refer to percentage of overall sample represented by cancer site sub-sample.
Pre Illness = Before emergence of symptoms; Pre Diagnosis = Pre communication of diagnosis to patient; Diagnosis = between communication of diagnosis 
and treatment start; treatment = receiving active treatment
Numerical values refer to sample means except where otherwise stated. Value in brackets refers to the standard deviation of time where provided.
Sample stated is the number of participants used in analysis (not necessarily the number consenting to participate). Percentage figure reported in 
parentheses refers to the proportion of patients that this sample represents from the original population sampled from (where stated or calculation was 
possible).
Percentage figure reported in parenthesis refers to the proportion of patients analysed at follow up from the originally analysed baseline sample. 
Difference in quality assessment scores (%) between reviewer one and reviewer two.
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2.7.2 Methodological summary and critique of the included studies
2.7.2.1 Quality assessment scores
As discussed in section 2.6.2, quality assessment is an important exercise in 
which distinction can be made between studies, and through which the 
contribution of an individual study to the overall field can be evaluated. 
Concordance between reviewer scores on the modified Kmet etal. (2004) 
assessment tool was lower than expected; only 10 out of the 68 studies were given 
the same quality score by both reviewers. Of the remainder, 11 studies had a 
greater than 20% difference in quality scores. Mean and between-reviewer 
differences in quality scores are presented in table 2.4.
High and low scores approached equivalence between reviewers, but these 
were attributed to different studies. Reviewer one awarded scores ranging from 
50% to 100%: Lloyd et al. (1984) was scored at the lower end and Bleiker et 
a/.(2000), Hack et al. (2004) and Cohen et al. (2001) at the top end of the scale. 
Scores from reviewer two ranged from 54% to 100%. However, the Cousson-Gelie 
(2000) was scored lowest and both Ranchor etal. (2002) and Schou, etal. (2004) 
highest Differences in quality score become of most concern when comparisons 
are made on lowest scoring studies. Although reviewer one awarded just 50% 
quality to the Lloyd (1984) paper, reviewer two awarded this same paper 88%. 
Similarly, whereas reviewer two awarded Cousson-Gelie (2000) 86%, reviewer 
one gave the same paper just 54%. Such differences may be attributed to the level 
of critical evaluation experience of the reviewers; reviewer two being the 
candidate and reviewer one a psychology graduate. Alternatively, these 
differences may indeed reflect a lack of clarity in scoring and interpreting the 
quality criteria. Figure 2.4 shows the distribution of mean quality scores.
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Figure 2.4. Bar chart representation o f mean quality assessment scores (mean o f reviewer 
one and review two scores) fo r included studies.
Mean quality scores were all over 61%. When quality scores are analysed 
separately, reviewer one awarded slightly greater spread of scores (all, however, 
remained above 50%) but w ith  slight positive skew when compared to those 
scores awarded by reviewer two. Means and standard deviations were, however, 
comparable (reviewer one: M=83%, SD=10.5%; reviewer two: M=82%,
SD=11.4%).
Following Cochrane Collaboration guidance (Higgins & Altman, 2008), each 
area of quality w ill be discussed in turn. To ensure clarity references for all 
methodological comparisons are not made. Instead, the general trends and themes 
are discussed and all such detail is provided in previous summary tables and 
where pertinent examples are worth note, these w ill be highlighted.
2.7.2.2 Study designs
Twenty-nine studies used a cross sectional design; 37 employed longitudinal 
designs; and, two presented baseline statistical associations between variables for 
patients recruited into randomised controlled trials (Cohen et al., 2001; Green et 
al, 2002). Of the 37 longitudinal designs, two recruited patients at a pre-symptom
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stage (the sample formed a sub-sample from  larger general population surveys) 
and seven recruited patients between firs t consultation and confirmatory 
diagnosis.
Cross sectional research is not necessarily a design weakness; often it can be 
the most appropria te methodology, and being less complex, is often a far more 
economically efficient way to collect data. However, such designs lack the ability 
for inferences o f causality and prediction to be drawn. W ith in this set of cross 
sectional studies, the same inform ation was found to be repeatedly presented. Up 
to date surveys tended to reproduce findings from earlier studies, w ith few 
methodological improvements. This is despite earlier conclusions that more 
research effort should be concentrated on longitudinal research. Illness 
adjustment is usually considered to be a process and, therefore, w hilst cross 
sectional findings may be inform ative (to in form  o f immediate impact of diagnosis, 
or follow-up psychosocial status, for example), the ir impact is lim ited. Higher 
quality research and subsequent im plem entation into practice is reliant on gaining 
an understanding o f the temporal processes involved and this is simply not 
achievable using single time po int data collection.
One final study is im portant to note. Carver et al. (2000b) recruited a 
number of groups o f breast cancer patients at d iffe ren t illness time-points and 
compared the effect o f tim e since diagnosis. A longitudinal design would have 
been far more appropria te here: not only would this have improved the 
comparable quality, but would also have m inim ised the effects of individual 
differences and confounding variables, thus a llow ing for more sophisticated 
analysis.
2.7.2.3 Timing of recruitment
Longitudinal studies which recruited pre-diagnosis (e.g. deValck & Vinck, 
1996; Perczek et a l,  2002) were considered superior in quality as these gain better 
indications o f baseline scores. Obviously, those w ith in  this category that recruit 
pre-symptom (B le iker et al., 1995; Ranchor et al., 2002) are best as these acheive 
true baseline measurement. Two studies collected baseline data between first 
consultation and com munication o f diagnosis (M orris et al., 1981; Iwamitsu et al. 
2005). Both pre-illness, and pre-diagnosis recru itm ent enable prospective 
investigation of the full impact o f this diagnosis, comparing to pre-morbid
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psychosocial status. Such recru itm ent is obviously not always possible as it 
necessitates recru itm ent o f a large healthy sample and longer term follow up until 
sufficient numbers develop illness. However, the common compromise of 
recruiting post-symptom /  diagnosis and using retrospective self-report is far 
more prone to inaccuracy.
In these studies, a huge range o f between study time periods between 
diagnosis and recru itm ent were reported. W hilst this may not affect some 
research questions, it seems logical when researching illness adjustment to strive 
to recruit patients as close to diagnosis as possible. In particular, this becomes an 
issue when considering event appraisals and attributions; such variables are 
dynamic and as such can change w ith  very slight circumstantial alteration. 
Furthermore, due to the on-going nature o f psychological response to illness, re­
appraisals of an event at a later date have potential to provide very different, and 
sometimes misleading, results.
A related issue is the w ith in  study range of tim e between diagnosis and 
recruitment where large mean tim e differences were apparent between study. In 
other words, recru itm ent inclusion crite ria  were too non-specific for generalisable, 
homogenous samples to be recruited. Andrykowski et al. (1996), for example, 
report a range of tim e between diagnosis and recru itm ent of 6 to 57 months.
Evans etal. (1993) had a range of 87 months; Hassanein e ta l. (2005), a range of up 
to five and half years; Lowery et al. (1993) o f 60 months; Nelson et al. (1994) of 
255 months; and studies by both Kessler (2002) and Yamaoka et al. (1998) had 
ranges of time since diagnosis of 19 years. These samples present results where 
those who have only just recently received a diagnosis are grouped w ith those who 
may have been disease free for up to fifteen or more years. The experiences of 
these patients w ill be very d iffe rent due to changed clinical circumstance (active 
treatment versus remission for example); where time increases, patients w ill have 
had longer to adjust, are un like ly to be receiving active or invasive treatment and 
their uncertainties and fears w ill have, largely, been addressed. Where studies 
compare between groups, this is not an issue, provided that adequate sub-sample 
sizes are achieved for each group. However, when presenting general, all-sample 
correlation data, samples should be re la tive ly homogenous in terms of their 
clinical circumstances. The scientific va lid ity  o f the studies is highly questionable;
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the changing needs and stress demands throughout the illness process create 
anything but a homogenous sample. To recru it a range of patients including 
primary diagnoses, secondary diagnoses, recurrent diagnoses, and survivors 
significantly lim its  the usefulness and theoretical generalisability of these findings.
2.7.2.4 Timing offollow-up
Tim ing of fo llow  up between longitudinal studies was, on the whole, 
standardised. Standardised fo llow  up is im portant in this research field due to the 
rapidity at which these psychosocial variables fluctuate; it is very d ifficu lt to draw 
comparisons between dissim ilar time points in studies. Due to the differences in 
timing of orig inal recruitm ent, when considered as tim e-points through the illness 
process rather than point o f fo llow-up from recruitm ent, much more variability 
emerges. What at firs t may appear to be a vast wealth o f comparable research, 
may in fact, not be so.
2.7.2.5 Sampling issues
Sample sizes ranged from 16 to 480 amongst cross sectional studies. 
Longitudinal study baseline samples ranged from 32 to 278, w ith  follow up 
samples ranging from 12 to 271. Of all included studies, 11 scored an inadequate 
sample size in quality assessment. Of those provid ing sufficient information (39 
out of 68; 57%), response rates appear high; only five studies indicated response 
rates of less than 30% and 17 (44%) reported over 81%. Of more concern though, 
almost half presented unclear or inconsistent in form ation relating to the 
recruitment procedures, response rates, and com pletion rates. An accurate picture 
of true response (and, therefore, the potential generalisability o f the findings) is 
impossible to attain. It is possible that this discrepancy may hide poor recruitment 
strategies or low  response rates.
Five studies recruited specifically male samples; four o f which recruited only 
prostate cancer patients, and one was a head and neck cancer study (Aarstad et al., 
2005) w ith no explanation given for why a male-only sample was recruited.
Twenty nine studies recruited purely female samples and these constitute all of the 
breast cancer research; no studies included in this review recruited male breast 
cancer patients. This is perhaps representative o f the low male to female breast 
cancer diagnosis ratio. However, despite low  incidence, male breast cancer
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research remains an important area of study. The 34 remaining studies recruited 
both males and females although gender ratios differed greatly; the most unequal 
was 82% female biased (Osoweicki & Compas, 1998). The effect of gender 
difference on the findings will be further explored in sections 2.7.3.2 and 2.7.3.4, 
but this issue may be best not considered a cancer site issue rather than a gender 
issue. In other words, gender biases exist because researchers limit inclusion to 
gender exclusive cancer diagnoses.
All of the major cancer diagnoses were represented, although the number of 
studies focusing on breast cancer was disproportional to other cancers (n=43%). 
This is perhaps best explained by both a historical trend for more dedicated 
funding for this type of cancer, and the typical demographics of breast cancer 
patients; typically younger, female, and thus more likely to respond to research 
invitations (Edwards, Roberts, Clarke, DiGuiseppi, Prataap e ta l, 2002). Of those 
recruiting mixed cancer diagnoses, between two and eight different cancers were 
comprised in samples. Two studies did not specify the breakdown of cancer site 
categories and in those that did, varying sub-group sizes were reported. In all, a 
female bias was again evident with higher participation from breast and 
gynaecological cancer patients.
With respect to stage of illness, 21 (30.8%) studies recruited only those 
patients with non-advanced cancer (i.e. without metastases and limited lymph 
node involvement). Five studies (7.4%) recruited only patients with advanced 
cancer and four studies (5.9%) comprised of survivors only (stage of prior illness 
was not specified, but assumed to be relatively non-advanced given the recovery 
observed in these patients). Twenty six studies (38.2%) recruited cancer patients 
at any stage of illness. Typically, these studies were those which reported the 
longest mean times between diagnosis and recruitment into the research. The 
remaining 12 studies (a high 17.6%) did not specify any illness-stage inclusion 
criteria and so are assumed to have included any stage of illness.
2.7.2.6 Data collection
This issue has already been covered in part in section 2.6.3. Aside from the 
issue raised there regarding confusion in construct definition and usage of 
validated measures, two other important points should be noted. First, three 
studies (Aarstad et al, 2005; Bleiker et al, 1995; Bleiker et al, 2000) seem to imply
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that they defined a measure of anxiety and/or depression as a personality variable. 
Second, a large proportion of the longitudinal studies seemed not to repeat all 
measures at all time points meaning that full concurrent, or longitudinal 
relationships are not always obtainable. Such practices are quite commonplace, 
and whilst they are not un-scientific and do have value for the field, in the case of 
very focused review questions such as this, the findings are not always useful.
A number of studies did not use questionnaire data collection methods; 
instead, patients were interviewed using structured or semi-structured schedules. 
It is commonly reported in these studies, that rather than using validated 
measures, researchers use abbreviated, or single-item questions to assess the 
same constructs. To do so can prevent direct comparability with other studies and 
often results in low quality assessment scores; neither the questions, nor 
responses, are clearly defined and categorised, nor corroborated by reliability and 
reproducibility statistics.
2.7.2.7 Control of confounding variables
Inclusion of many different cancer sites has advantages and disadvantages.
On the one hand it is a positive move away from the gender and clinically biased 
research base in breast cancer. Clinical differences (e.g. stage of illness and 
treatment received) between individual cases of cancer lead to different levels of 
morbidity and mortality. It seems sensible to assume, and has been stated in the 
literature, that such differences may be associated with, or influence, variables of 
relevance to this review. Similarly, individual demographic differences (e.g. age or 
gender) are also found to influence psychosocial variables across many types of 
research. In recruitment of samples which may necessitate control of a greater 
number of confounding variables, bigger sample sizes are required and greater 
emphasis should be placed on in-depth testing, and controlling, of the effects of 
differences in sample demographics or clinical variables. Statistical analysis 
should ideally include not only the reporting of descriptive data, but also an 
analysis of how these are related to variables of primary interest. This method 
should be used to assess which variables should be controlled in more complex 
analyses.
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For this review the following information was deemed to be potentially 
important:
Demographic Gender (in mixed gender recruitment)
Age
Education 
Employment Status 
lncome/Socio-Economic Status 
Children/Dependants 
Marital status
Clinical Cancer site (in multi-site recruitment studies)
Cancer stage 
Time since diagnosis 
Treatment received.
Five of the included studies only partially controlled for potential 
confounding clinical and demographic data. Twenty-three did not report on any 
testing of the effects of potential confounders, or confounder controlled analysis.
Of greater concern, particularly when considering only the multi-site studies which 
require even greater control for clinical variables, only 60% of studies appeared to 
fully address this issue.
Further, 27 of all included studies (39.7%) did not contain any information 
beyond a basic descriptive analysis. Because no analysis was mentioned, it is 
unclear whether these variables were not actually analysed, or were analysed, but 
found to be non-significant and thus not presented. Without knowing this 
information, it is not possible to ascertain whether adequate confounding variable 
control has been made during analysis.
Nine papers made general statements that no associations were found 
between background demographic or clinical variables and psychosocial variables 
included in the studies. Although informative to a limited extent, and suitable 
explanation for why multivariate analysis did not include clinical or demographic 
information, these papers lacked detail about which specific background 
information was collected and how possible confounding relationships were 
tested.
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Three papers stated that statistical controls were made for the effects of 
demographic or clinical data, however, no statistical information was reported 
about the significance of direction relationships between variables.
The remaining 35 papers made explicit statements about statistical 
relationships between clinical and/or demographic information and psychosocial 
variables. In some cases it was not clear whether all of the potentially important 
confounding variables were assessed and not reported on, or whether in fact, only 
partial assessment and statistical control of potentially confounding was made. In 
all cases, where significant associations or differences were established, adequate 
controls were made by the authors in subsequent analysis. These specific findings 
are detailed further in section 2.7.3.1 to 2.7.3.4.
2.72*8 Appropriateness of statistical analysis
Further concern was raised by studies which presented unclear hypothesis- 
driven statistical tests and appear to use simply inferential or descriptive statistics 
to compare between clinical or demographic groups (e.g. Andrykowski etal.,
1996; Dropkin, 2001). Additionally, a number simply used multivariate testing, 
without any inferential, univariate or bivariate preliminary tests being reported 
(e.g. Boer et al., 1998; Cohen et al., 2000; Stanton et al., 2000). Although complex 
multivariate tests are considered to be the highest quality statistical analysis due 
to their ability to control for confounding variables and to fully assess variable 
interaction effects, presentation of bivariate statistics is helpful in the 
interpretation of the complex models.
A small number of studies did not present individual correlation effect sizes 
for each bivariate relationship, but rather presented a range of effect sizes (Hee et 
al, 2005; Schou et al, 2004, 2005; Osoweicki & Compas, 1998,1999), without 
specifying where within this range that each particular variable relationship 
associations lies nor the level of significance attributable to each relationship.
2.7.2.9 Transformed outcome scores
A final statistical issue raised by the quality assessment was the alternative 
use of psychological measures either in the form of a dichotomous split, rather 
than continuous scale, or as a composite score.
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From the 68 studies in this review, 15 (22.1%) did not report on the specific 
outcome measured, but combined them into more generalised variables, for 
example the repeated combination of anxiety and depression subscales into 
composite scores of distress. Of the 14 found to score measures in this way, 13 
created composite outcome scores, and one created a composite of mental 
adjustment (based on MAC subscales).
Using composite scores can be convenient; they minimise the number of 
findings reported thus clarifying understanding and their application. However, to 
truly understand complex psychosocial processes, individual subscale analysis is 
also useful, at least to a certain level. For example, there is evidence that anxiety 
and depression have both different predictors, different long-term trajectories of 
change over time, and are reportedly non-overlapping psychological constructs 
(Stavrakaki & Vargo, 1986); such differences are lost by testing only a distress 
composite score.
Where composite scores are required, it is considered good science to 
calculate them using standardised and validated methods. Four studies 
(Osoweicki & Compas, 1998; Epping-Jordan etal., 1999; Glinder & Compas, 1999; 
and Osoweicki & Compas, 1999) created composites using standardised t-score 
normalization methods on the Brief Symptoms Inventory.
Three studies justified their use of a composite score based on a factor 
analysis of their data (Carver et al, 1994; DeValck & Vinck, 1996; and Miller et al, 
1996); on finding that all outcomes loaded onto just one factor, composite scores 
were created. Given that sample sizes for these studies did not rise above 75 
participants, it is not surprising that the results loaded in this way; factor analysis 
was simply not suitable for these small sample sizes and their use of the composite 
outcome measure is questionable. Carver e ta l (1994) based their composite 
scores on highly correlated variables.
The remainder (Andrykowski & Brady, 1994; Carver et al, 2000; Stanton et 
al,2000; Hassanein eta l, 2001; Green etal, 2002; and, Hassanein etal, 2005) are 
to be treated with greatest caution, as within their respective publications, they 
did not clearly specify the justification for, and/or method by which composite 
scores were obtained.
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2.7.3 Synthesis of results
A descriptive overview of data related to clinical and demographic variables 
will be presented first, followed by the results of statistical meta-analysis and in- 
depth discussion of findings related to the importance of the predictor variables 
for each outcome included. Possible moderation or mediation effects presented 
within the included studies are also reviewed.
2,7.3.1 Prevalence and stability: Predictor Variables
Cohen et al. (2001) reported that greater than 80% of their sample were 
optimistic about the effects of treatment on their illness in spite of the fact that 
they had all received diagnoses of metastatic cancer. Lowery etal. (1993) 
reported that only 45% of their participants claimed to feel somewhat or high 
internal control over their illness; 56% reported that other people had highest 
control over their illness. Control beliefs (Osoweicki & Compas 1999) and 
optimism (Miller et al, 1996) were both stable over time (in longitudinal studies) 
supporting trait theories of these constructs.
Emotional expression was significantly higher in breast cancer patients 
compared to RCT control groups (Badger et al., 2004). Morris et al. (1981) report 
that control participants (benign breast problems) were less neurotic and less able 
to control anger expression (CECS-Anger) than breast cancer patients. Bleiker et 
al (2000) state that only 15% and 20% of their sample were above the clinical cut­
offs for thought avoidance and intrusion respectively, and that although these 
caseness figures decreased with time, one fifth of patients were still suffering from 
clinical levels of intrusive thought at two years post diagnosis. Green etal. (2002) 
reported significant decreases in threat appraisals beyond the initial period of 
diagnosis. According to Koopman etal. (2001), 70% reported high levels of 
perceived stress.
2.73.2 Prevalence and stability: Outcome variables
Anxiety was significantly higher in patients than controls in studies by both 
Aarstad etal. (2005: control participants were benign or treated tumours) and 
Ahmed et al. (2004). However, only the former found a significant difference for 
depression. This is not surprising given that matched family members formed the 
control group in the latter study. Reported anxiety caseness ranged from 10%
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(Ratcliffe et al., 1995) to 41% (Glinder & Compass, 1999). Cross-sectionally, mean 
rates of anxiety yielded caseness of 29.8% at baseline, 19.3% at around three 
months post diagnosis, 21% at six months post diagnosis, 16.7% at 12 months, and 
16% at two years post diagnosis, possibly implying an overall trend of decreased 
anxiety over time. However, some between site differences should be noted. 
Diagnosis anxiety was reported to be much lower in non-breast cancer samples 
(comparisons possible only at time shortly after diagnosis and one year follow up). 
It is unclear whether differences are, therefore, related to clinical or gender 
variation. Although the differing clinical characteristics must not be ruled out, a 
gender difference in anxious responses to stress (higher in females) has been 
repeatedly demonstrated in the literature.
A similar trend is also observed for depression above the clinical cut-off. 
Greatest differences were reported at the time of diagnosis, where they ranged 
from 2% (Ratclife et al., 1995) to 34% (Epping-Jordan etal., 1999; Glinder & 
Compass, 1999). Taking a mean across these studies, 25% were potentially within 
the clinical range. However, once again, there were vast site differences; studies of 
breast and gastrointestinal cancer patients report equivalently high rates (<30%), 
however, lymphoma patients scoring much lower (the earlier reported 2% figure). 
Nordin and Glimelius's (1998) sample of gastric cancer patients had a relatively 
even gender split, therefore the between cancer site difference here cannot be 
accounted for by gender; rather, it seems that depression reactions are, at least in 
part, dependant on the site of cancer diagnosis made. Cross sectional mean 
depression levels differed by only 6% between diagnosis and two years follow up 
time points. Interestingly, in studies of breast cancer patients, an increase in 
caseness of depression at six months was reported.
Two studies reported percentage risk of developing a psychiatric disorder at 
or above clinical cut-off levels, rather than focusing specifically on levels of anxiety 
or depression as individual outcome constructs (Lloyd etal., 1984; Gallagher etal.,
2002). In these longitudinal studies, diagnosis risk was reported at 37% (Lloyd et 
qL, 1984: mixed recruitment) to 43% (Gallagher et al., 2002: breast patients), 
decreasing to 26-27%, six months later. An interesting note here, is that although 
breast cancer patients were at significantly worse risk at diagnosis, by six months, 
this was not distinguishable from the mixed cancer sample.
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Considering longitudinal studies only, anxiety and depression were more 
stable than implied by analysing cross sectional time differences (Bleiker etal. 
1995, Nordin & Glimelius, 1998; Brown et al., 2000; Butow et al., 1999). Quality of 
life, on the other hand, was found to fluctuate more (Yu et al., 2003; Hee et al., 
2005), but with a general trend towards improvement (Schou etal. 2004, 2005).
Alhama etal. (1995) reported that during treatment, 50% of patients 
sampled reported dissatisfaction with their quality of life. Strangely, however, 
Kessler (2002) found that patients reported better quality of life than they 
perceived for the general population. Both Hee et al. (2005) and Schou etal. 
(2004/05) reported significant decreases in well-being over time.
2.7.4 The effect of demographic and clinical differences
Due to inherent difference in the aims and hypotheses being tested in 
individual papers, not all studies presented findings relevant to this section. Those 
that did, are summarised in table 2.5. Age is by far the most commonly explored 
demographic variable, however, interesting trends are highlighted for other 
demographic and clinical sample characteristics. Meta-analysis was not conducted 
on this data as this was not the primary focus of this review. As such exact effect 
sizes are not reported the data are presented simply to help contextualise the later 
findings and to provide an overview of the samples recruited into the included 
papers.
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Table 2.5. Significance o f reported associations between demographics, clinical data, and
predictor variables.
Predictor Finding Reported
Age Significant Non-Significant
Optimism Schou et al. (2004) Perczek et al. (2000)
Self-efficacy Ranchor et al. (2002)
Lie Score Ratcliffe et al. (1995)
Neuroticism Morris et al. (1981)
Ranchor etal. (2002)
Thought intrusion Carver et al. (1993) 
Osoweicki & Compass (1998)
Bleiker et al. (2000)
Epping-Jordan etal. (1999)
Thought avoidance Bleiker et al. (2000) Osoweicki & Compas (1998)
Trpafmpnt Pvnprtan
Baider et al. [2003] Epping-Jordan etal. (1999)
1 1 vwllll v II v UAJJCL td 11
Locus of control Marks et al. [1986]
Hope Stanton et al. (2000) Morris etal. (1981)
Mental Adjustment Baider et al. (2003)
Gender
Neuroticism Ranchor et al. (2002)
Self-efficacy Ranchor et al. (2002)
Family Support
Optimism Schou etal. (2004)
Educational Status
Optimism Epping-Jordan etal. (1999) 
Schou etal. (2004)
Thought avoidance Epping-Jordan etal. (1999)
Self-efficacy Ranchor etal. (2002)
Neuroticism Ranchor etal. (2002)
Socio-Economic Status
Locus of Control Marks et al. (1986)
Illness Perceptions Marks etal. (1986)
Disease severity
Though intrusions Carver etal. (1994)
Negative affect Kessler (2002)
Time since diagnosis
Thought intrusion 
Thought avoidance 
Locus of control
Lowery et al. (1993)
Lowery et al. (1993)
Lewis (1982/1989)
Positive affect Kessler (2002)
Self-esteem Lewis (1982/1989)
Purpose in life Lewis (1982/1989)
104
Faller et a l (1999) and Perczek et al. (2000) reported that age had no 
significant impact on any psychosocial variables measured. However, other 
studies report that younger patients were more self-efficacious, more optimistic, 
and scored lower on Eysenck lie-scores. Three papers reported that younger 
patients were significantly more likely to experience intrusive thoughts although 
one paper reported non-significance of effect. Whilst two also found that younger 
patients were significantly more likely to report though avoidance, two did not 
support such hypotheses. Older patients were significantly more likely to have 
negative treatment expectancies and higher beliefs in chance locus of control. 
Contradictory findings were reported for associations between age and hope. 
Measured on the MAC, Baider et a l*s (2003) Austrian sample showed positive 
associations between age and higher fighting spirit, but also, contradictorily, 
increased hopelessness/helplessness and fatalistic acceptance. These findings 
were not replicated in the Israeli comparison sample.
Gender comparisons were far more infrequently reported, presumably due 
to the dominance in the field of single-sex recruitment frameworks; only the 
Ranchor e ta l (2002) paper presented relevant statistics. Family support (being 
married or having children) was found to be associated with higher levels of 
optimism.
Higher educational status was associated with optimism, thought avoidance 
and self-efficacy, but not neuroticism. No specific associations were reported for 
employment status although socio-economic status was negatively associated with 
change and doctor locus of control, and increased perceptions of illness severity.
From a clinical perspective, disease severity and time since diagnosis were 
found to be associated with a range of variables including affect, thought intrusion, 
thought avoidance, and increased personal control beliefs. Where lower self­
esteem and lower purpose in life perceptions were also found to be correlated 
with time since diagnosis, neither reached significance.
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Table 2.6. Significance of reported associations between demographics, clinical data and
outcome variables.
Outcome Finding Reported
Significant Non-Significant
Age
Depression Lehto etal. (2005) 
Baider etal. (2003)
Falleretal. (1991) 
Rondorf-Klym & Colling 
(2003)
Anxiety
Distress
Baider et al. (2003) 
Osoweicki & Compas (1998) 
Stanton etal. (2000)
Carver etal. (1993) 
Epping-Jordan etal. (1999) 
Padilla etal. (1992)
Morris etal. (1981) 
Andrykowski etal. (1996) 
Glinder & Compas (1999) 
Osoweicki & Compas (1999)
Clinical risk 
Functional impairment
Quality of Life
Hassanein et al. (2001) 
Rondorf-Klym & Colling 
(2003}
Schou etal. (2005)
Gallagher et al. (2002)
Alhama et al. (1996) 
Schnoll etal. (2002) 
Lehto etal. (2005)
Well-being Padilla etal. (1992) 
Carver etal. (1994) 
Miller et al. (1996)
Gender
Distress Lehto etal. (2005) 
Ranchor et al. (2002)
Osoweicki & Compas (1998)
Functional impairment Hassanein et al. (2001)
Quality of Life Lehto et al. (2005)
Marital Status 
Quality of Life Schnoll etal. (2002)
Educational Status 
Distress
Quality of Life Glinder & Compas (1999)
Andrykowski & Brady 
(1994)
Padilla etal. (1992)
Alhama etal. (1996) 
Osoweicki & Compas (1998) 
Osoweicki & Compas (1999) 
Schnoll etal. (2002)
Income
Satisfaction with QoL Alhama etal. (1996) 
Schnoll et al. (2002) 
Yu et al. (2003)
Employment status 
Distress Padilla etal. (1992)
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Table 2.6. Significance o f reported associations between demographics, clinical data and
outcome variables (continued).
Outcome Finding Reported
Significant Non-Significant
Cancer Site
Quality of Life Brown etal. (2000)
Sexual Adjustment Schnoll et al. (2002)
Clinical Risk Gallagher etal. (2002)
Satisfaction with QoL
Disease Severity Significant Non-Significant
Clinical Risk Gallagher etal. (2002)
Distress Trunzo & Pinto (2003) Falleretal. (1999)
Glinder & Compas (1998) 
Osoweicki & Compas (1998)
Depression Timko etal. (1985)
Quality of Life Padilla etal. (1992) 
Yu et al. (2003)
Hee etal. (2005)
Time since diagnosis
Distress Lowery et al. (1993) Andrykowski & Brady 
(1984)
Anxiety Lewis (1982/89)
Quality of Life Kessler (2002)
Heeetal. (2002) 
Green etal. (2002)
Schnoll etal. (2002)
Treatment
Distress Carver etal. (1993) 
Hee etal. (2002)
Quality of Life Schou etal. (2004) 
Nakada et al. (1996) 
Padilla etal. (1992}
The effects on outcome were far less consistent Whilst there is general 
consensus that outcomes are worse in younger patients (with the exception of the 
Schou etal. (2005) study) these effects are not always significant. Some gender 
differences were reported which seem to indicate that female patients report not 
only greater distress, but also more functional impairment. In the Ranchor et al 
(2002) study, such effects were consistently significant over time. Those patients 
who were married were also found to report better quality of life.
Whilst educational status was largely non-significantly associated with 
outcome, both employment, and higher family income were significantly
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associated with lower distress and greater satisfaction with current levels of 
quality of life respectively.
Differences in both sexual adjustment and satisfaction with quality of life 
were found between patients with illness at different sites (prostate cancer 
patients were better sexually adjusted than breast cancer patients but breast 
cancer patients were more quality of life satisfied than colorectal cancer patients). 
Quality of life was not found to significantly differ between cancer site, nor was 
clinical psychiatric disorder risk. This latter variable was, however, higher in those 
with more advanced illness. Disease severity was further associated with poorer 
quality of life (in two of three studies), and higher follow-up level (Trunzo & Pinto,
2003) but not concurrent baseline levels of distress. Associations between time 
since diagnosis and distress are contradictory in terms of significance but in both 
studies, longer time was associated with decreased distress. Associations between 
time since diagnosis and quality of life are inconsistent, not only in terms of 
significance, but also direction of effect; where Kessler (2002) and Hee etal.
(2002) found that longer time since diagnosis associated with better quality of life, 
Green etal. (2002) found the opposite direction of effect Few studies reported the 
effects of treatment differences on these outcomes, but those that did reported 
significant effects. The evidence in this review suggests that multiple types of 
treatment, particularly if they involve chemotherapy lead generally to poorer 
outcome.
2.7.5 Meta Analysis
2.7.5.1 Associations between predictors and outcomes
Having discussed the type of study included in this review and some of the 
background demographic and clinical patterns in results, attention will now be 
focussed on discussion of associations between the predictor variables— 
personality, cognitions, and emotions—and the outcome variables—anxiety, 
depression, and quality of life. Two types of results will be discussed. First, the 
results of the statistical meta-analysis are presented; far fewer analyses were 
possible than were expected and so these findings should be treated with caution. 
Second, an in-depth descriptive analysis is presented which not only describes
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those findings included in the meta-analysis, but also the significance and effects of 
those that were not included.
2.7.5.2 Potential for meta-analysis.
Large scale meta analysis of the predictors for anxiety, depression, and 
quality of life was not possible. At first thought to be feasible (despite a vast 
number of different measures being used, a large overlap in underlying constructs 
was measured between studies), during data extraction and synthesis, the extent 
of study heterogeneity became apparent and three primary barriers to large-scale 
meta-analysis were identified: measurement, recruitment and statistics.
It is important that high levels of homogeneity in measurement and samples 
exist between studies to be meta-analysed; they must claim to measure the same 
construct using comparable measures, and only data from similar time-points can 
be meta-analysed between studies. Such requirements were met by very few 
studies within this review.
Similarly, meta-analysis should only be performed on similar statistical 
information, for example, meta-analysis should not be performed on both 
correlation and comparative tests. Additionally, rvalues in correlations cannot be 
meta-analysed together with regression effect sizes; regressions can be separately 
*meta-regressed\ but such procedures were not possible in this review as different 
variables were entered into analysis between various studies. For this reason, 
meta-analysis focussed on correlation data only.
Despite this focussed approach, a larger problem existed: data were not 
presented in all cases where it was expected. Not all studies measuring the same 
predictor-outcome constructs presented usable information. The most likely 
reason for this is related to the high number of differing research questions and 
hypotheses being set; studies accrued masses of data that were not particularly 
relevant to individual research questions, therefore the data were not analysed.
An alternative explanation could be that analyses were conducted, but on the 
finding of null results, the analyses were not published: the Tile drawer' problem, a 
common issue in systematic reviewing (Egger et al., 2001).
Inadequate reporting of statistics ruled a number of other studies out of 
statistical meta-analysis. Three studies reported ranges of effect sizes (Hee et al., 
2005; Schou etal., 2004, 2005; Osoweicki etal., 1998,1999); Osoweicki and
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Compas (1998,1999) converted raw scores into normalised t-scores and 
presented correlations using only these, and not raw data; and, three studies 
(Allison etal., 2000; Iwamitsu etal., 2005; and Schou etal., 2004/05) converted 
raw scores into median split, bivariate scales, thus preventing the use of 
correlation statistics.
Furthermore, the number of studies which presented data in comparison to 
control groups, rather than inter-correlating variables within the cancer sample 
(e.g. Aarstad et al. , 2005; Ahmed et al., 2004; Bleiker, van der Ploeg, & Ader, 1995; 
and Yamaoka et al. 1998), or which used the variables of interest to this review for 
the purposes of mediation testing (e.g. Baider et al. 2003) rather than looking at 
direct associations, further minimised the amount of data that was available for 
meta-analysis. This should not be read to detract from the importance of such 
research questions, but their unsuitability for the current purposes.
A number of small-scale meta-analyses were possible, each comprised of two 
or three studies. These analyses were, as planned, calculated using Hunter and 
Schmidt's method. Due to the small number of studies in each analysis, only basic 
level statistical techniques were performed. As discussed in section 2.2.3, although 
weighted mean effect size calculations, and calculations based on estimations of 
variance from this statistic (e.g. z-scores and their conversion into a probability 
statistic) are feasible, those procedures which involve estimation of population 
variance (e.g. calculation of between study homogeneity of variance and 
confidence intervals for the mean effect size) are prone to error and were, 
therefore, concluded to be inappropriate. Additionally, calculation of fail safe 'n' 
statistics was deemed to be unnecessary given the low number of studies entered 
into each meta-analysis.
2.7.5.3 Meta-analysis procedure.
Meta-analyses were conducted using Field's guidance (2001) whereby 
formulae were programmed into Microsoft Excel. A random sample of calculations 
were further checked using hand calculation (see appendix 2.4 for a breakdown of 
the formulae used, and an example of the hand calculation corroboration exercise). 
To further protect against human error in either the programming or 
interpretation of these results, the meta-analyses were audited by an independent 
statistician.
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In order to calculate p-values, a modulus of each z-score was taken. MiniTab 
statistical software was then used to provide observed significance levels 
according to normal curve distributions. The values were then doubled to account 
for significance according to the more stringent two-tailed hypothesis test 
procedures.
2.7.5.4 Meta-analysis results
Results of the meta-analyses are shown in table 2.7, and will be discussed at 
relevant sections of the following data synthesis. Of the 21 meta-analyses 
calculated, all were significant at the pas 0.05 (or greater) alpha level, except for the 
analysis of Emotional Anxiety and Depression; a p-value of .054 was obtained 
which lies just outside of the standard alpha boundary. The lack of significance is 
probably best explained by the variance amongst the effect sizes which were being 
meta-analysed (n=356, r= 07; n=32, r=.31).
Two notes of caution must be made. First, due to the high number of tests 
conducted, a Bonferroni adjustment is often employed to correct for inflation of 
the alpha (a) level (Field, 2005). Such adjustment essentially involves considering 
a at a much higher or more precise level. There is an argument against using 
Bonferonni adjustment (see Pergner, 1998, for example) as the chance of 
committing a Type 11 error increases instead, however, in this case it was simply 
not necessary; most meta-analyses were significant at p<.001 and so even with 
Bonferonni correction the overall pattern of results did not change. Furthermore, 
as has previously been noted (see section 2.2.2), the Hunter and Schmidt method 
has a poor ability to distinguish between true significance and null results anyway 
and so the primary focus should instead be on the magnitude of effect sizes
Effect size confidence intervals were not calculated as none of the current 
methods of meta-analysis are accurate in estimating these where the number of 
studies in the analysis is small.
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Table 2.7. Study effect sizes and meta-analysis statistics fo r each meta-analysis calculated.
n r______ 7______ S&r_____ SEj______ Z_______P
1) Self-Efficacy & Distress 
Ranchor, 2002 167 -.33
Green, 2002 65 -.01 -.240 .144 .102 -2.365 .018
2) Optimism & Distress
Carver, 2003 54 -.56
Epping-Jordan, 1999 80 -.50 -.526 .021 .014 -38.413 <.001
Miller, 1996 75 -.53
3) Optimism & Well-Being
Miller, 1996 75 .69
Carver, 1993 54 .53
4) Anxious Preoccupation & Anxiety 
Watson, 1991 356 .60
Nordin, 1998 139 .67
5) Hopelessness/Helplessness & Anxiety 
Watson, 1991 356 .44
Nordin, 1998 139 .55
6) Fatalism & Anxiety.
Watson, 1991 356 .23
Nordin, 1998 139 .16
.623 .079 .056 11.163 <.001
.620 .031 .022 27.857 <.001
.471 .049 .035 13.471 <.001
.210 .031 .022 9.456 <.001
7) Fighting Spirit & Anxiety
u aX^ °n'iaan  i* o  11 • • 2 3 Z  0 9 9  0 7 0  - 3 ' 3 1 5  < 0 0 1Nordin, 1998 139 -.39
8) Control of Emotional Anger & Anxiety
Watson, 1991. 356 .04 Q36 o u  Q1() 36Q9 <Q()1
Grassi, 1988 32 -.01
9) Control of Emotional Anxiety & Anxiety
Watson, 1991 356 .13 132 0Q6 0Q4 33.340 <.001
Grassi, 1988 32 .11
10) Control of Emotional Depression & Anxiety
Watson, 1991 356 .11 n 3  Q n  008 14.562 <.001
Grassi, 1988 32 .15
11) Anxious Preoccupation & Depression
Watson, 1991 356 .43 469 063 044 10549 <001
Nordin, 1998 139 .57
12) Hopelessness/Helplessness & Depression
Watson, 1991 356 .40 4?6 m  Q86 5 S46 < 001
Nordin, 1998 139 .67
13) Fatalism & Depression 
Watson, 1991 356 .22 226 oog 0Q6 35.500 <.001
Nordin, 1998 139 .24
14) Fighting Spirit & Depression
Watson, 1991 356 -.29 35? 1Q8 0?6 _4686 006
Nordin, 1998 139 -.53
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Table 2.7. Study effect sizes and meta-analysis statistics for each meta-analysis calculated 
(continued).
n r______ f______ SD,_____ SE^______ Z_______ P_
15) Control of Emotional Anger & Depression
3, ?  %  « < "  ™  ^  < » « >
16) Control of Emotional Anxiety & Depression
Watson, 1991 356 .07 ___ A
Grassi, 1988 32 .31
17) Control of Emotional Depression & Depression 
Watson, 1991 356 .12
Grassi, 1988 32 .32 .136 .055 .390 3.509 <.001
18) Though Intrusion & Distress 
Baider, 1999§ 324  .29
Epping-Jordan,1999 80  .46 .350  .092 .053 6.600 <.001
Osoweicki, 1999  62 .52
19) Thought Avoidance & Distress 
Baider, 19995 3 2 4  .43
Epping-Jordan,1999 80  .20 .402 .097 .056 7.190 <.001
Osoweicki, 1999  62 .52
20) Total Self-Blame & Distress
Glinder, 1999  64  .33 3 J 4  Q15 Q n  2 9 6 7 0  < 0 0 1
Malcame, 1995  72 .30
21)  Fatlism & Total Quality o f Life
Nordin, 1998  139 -.14  J94  05Q Q35 5 515 < 0Q1
Schou, 2005_____________165 -.24____________ _______________________________________
II = Sample Size; r  = Effect Size; r  = Weighted Mean Effect Size [MES]; SDr -  
Standard deviation of the mean; SE- = Standard error of the MES; z = Z- Score; p= 2-tailed 
significance statistic.
i Overall effect sizes were not published, but a weighted mean effect size was 
calculated (and total sample size summated) from the sub-group effect sizes 
reported.
A full discussion of the results of these meta-analyses will be integrated with 
the narrative data synthesis that follows.
2.7.5.5 Associations between personality and outcome
Although personality has received a lot of research attention in psychosocial 
oncology, it was surprising how few studies matched all criteria for inclusion in 
this review. The findings from those that did are synthesised in table 2.8.
Both higher levels of optimism and self-esteem were found to significantly 
correlate with lower levels of anxiety; in the case of the Schou etal. (2004) paper, a 
number of these medium effect sizes remained at follow-up. However, the
113
remaining results reported very low, and non-significant effect sizes. Meta­
analysis of the two studies reporting correlations between Eysenck Lie Score and 
anxiety was not possible due to time of self-report; Morris etal. (1981) report pre­
diagnosis correlations whilst Ratcliffe etal. (1995) report post-diagnosis 
correlations. This methodological difference may go some way to explaining the 
conflicting direction of effect, but this finding should not be heavily weighted due 
to the small effect sizes reported.
Effect sizes for correlations with depression tended to be higher than those 
reported for anxiety and most were reported to be significant; depression 
correlated with low self-esteem, low optimism, lower self-reported humour, and 
higher agency (defined by Aarstad et al. (2005) as an exclusive self-focus). Unlike 
for anxiety, lie scores were not strongly associated. Meta-analysis of the two 
corroborating findings for self-esteem was not possible due to differences in when 
self-reports were made; nine-month as opposed to 12-24 months post diagnosis.
Seven studies reported relevant results on associations between personality 
and distress. Scores of the monitoring personality style (those individuals who are 
constantly attending to stress and threat; Morrison & Bennett, 2006) were not 
associated with distress. However, neuroticism scores were associated with 
distress across both a range of diagnoses and timepoint. Conflicting results were 
found for both the effects of optimism and self-efficacy. In all cases, higher scores 
were associated with lower levels of distress, but effect sizes were much greater 
for optimism. Even though correlations between optimism and distress were 
reported over a number of time-points (and, indeed remained, even when earlier 
levels were statistically controlled for), only baseline scores from each study could 
be meta-analysed (meta-analysis 1). The overall results indicate a highly 
significant (p<.001), large effect size ( r =-.53). A smaller, but still significant 
overall effect size for self-efficacy (meta-analysis 2) was found; r=-.24, p<.05.
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Tabie 2 .8, Sum m ary o f  rep orted  associations betw een perso n ality  and  psychosocial outcom e.
Finding Reported
Significant Non-Significant
Anxiety
Optimism Schou et al. (2004) r=-.36 to .43
Extroversion Morris et al. (1981) r=-.07
Lie Score 
Neuroticism --------------  ---------------------- ..........
---------------- ------ —
Morris etal. (1981) 
Ratcliffe et al. (1995) 
Morris etal. (1981)
r=.10
r=-.01
r=-.07
Psychoticism Morris etal. (1981) r=.10
Trait anxiety Morris etal. (1981) r=-.03
Self-esteem Lewis (1982 /  89) r=-.30
Depression
Lie Score Ratcliffe et al. (1995) r=-.03
Self-esteem Rondorf-Klym & Colling (2003) 
Timko & Janoff-Bulman (1985)
r=-.55
r=-.41
Agency Helgeson & Lepore (2004) r=.49
Optimism Schou etal. (2004) r=-.41 to .51
Humour Aarstad etal. (2005) r=.54
Distress
Monitors Epping-Jordan etal. (2006) r=.15 to 17
Optimism* Carver etal. (1993)
Miller et al. (1996) 
Epping-Jordan etal. (1999)
r=-.56 to -.62 
r= -.50 to -.61 
r= -.40 to -.55
Yu etal. (2003) r=-.4
Neuroticism Ranchoreta/. (2002) r= -.27 to -.33
Self-efficacy* Ranchor et al. (2002) r= -.24 to -.33 Green etal. (2002) r= -.01 to -.11
Clinical Risk 
Neuroticism Lloyd etal. (1984) r=.49
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Table 2 .8  Sum m ary o f  rep orted  associations betw een p ersonality  and  psychosocial outcom e (continued).
Finding Reported
Significant Non-Significant
General Quality of Life 
Optimism Schou et al. (2005) 
Rondorf-Klym et al. (2003)
r=. 29 to .43
Self-esteem r=. 67
Humour Aarstad etal. (2005) r= -.44
Extroversion Yamaoka et al. (2003) r=-.26 to -.29
Neuroticism Yamaoka etal. (2003) r=-.13 to -.24
Psychoticism Yamaoka et al. (2003) r=.18to .27
Physical aspects of Quality of Life 
Optimism Schou etal. (2005) r=.14 to .21
Agency Helgeson & Lepore (2004) r=.02 to .07
Self-efficacy Green et al. (2002) r=(+/-).09 to .05
Mastery Padilla etal. (1992) r=.46
Psycholosocial aspects of Quality of Life
Optimism Schnoll etal. (2002)
Schou etal. (2005)
r=.49
r=.29 to .55
Mastery Padilla etal. (1992) r=.48
Agency Helgeson & Lepore (2004) r=.14
Self-efficacy Green et al. (2002) r=.00 to .21
Humour Aarstad etal. (2005) r=-.44
Well-being
Various traits *** Evans etal. (1993) r=.32 to .52 Evans et al. (1993) r=.09 to .27
Optimism* Carver etal. (1993) 
Miller etal. (1996)
r = .l l  to .72 
r=.58 to .73
* Findings were also meta-analysed: see table 2.7
** Range of correlations presented for different longitudinal comparisons
*** Various range of personality characteristics reported, not congruous with standard trait types; some results were significant, others were not
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Just one study reported correlation between personality and risk scores for 
psychiatric disorder; the high effect size reported by Lloyd etal. (1984) indicates a 
significant association between higher levels of neuroticism and increased scores 
of clinical risk.
Quality of life and a measure of personality were concurrently measured in 
14 studies. On the whole, associations were significant, although they range in 
effect size from the relatively small (agency: Helgeson & Lepore (2004), r=.14) to 
the considerably large (self-esteem: Rondorf-Klym etal.[2003), r=.67).
Comparison of associations between predictors and both general and sub-scales of 
quality of life demonstrate consistency of effect; that higher qualify of life was 
associated higher self-esteem, extroversion, self-efficacy, agency, mastery, 
optimism and lower scores of neuroticism. A few inconsistent findings should be 
noted. First, psychoticism and quality of life appear to be positively correlated; 
second, that humour and quality of life were negatively correlated; and finally, that 
self efficacy correlated significantly with physical quality of life, but non- 
significantly with psychological quality of life, despite both results achieving only 
small effect sizes. Due to the unexpected direction of these effects, findings should 
be treated with caution until empirical replication and explanation become 
available.
Meta-analysis of optimism and well-being correlations (meta-analysis 3) 
yielded the highest of all mean effect sizes ( r =.62, p<.001); these two studies also 
present data longitudinally, and although this could not be meta-analysed, it is 
clear that higher optimism is strongly and consistently correlated with well-being. 
Evans etal. (1993) explored correlations across a range of personality variables on 
the FRF; results indicated a range of effect sizes, only some of which were 
significant
2.7.5.6 Associations between cognitions, emotions and outcome
Many more correlations were reported between cognition or emotion 
variables and outcomes than were for personality variables. Not surprisingly 
perhaps, there was also far more inconsistency in the direction and effect sizes of 
these findings. Table 2.9 presents all relevant information extracted from the 
included papers.
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Anxiety was very strongly correlated with both thought intrusion and 
thought avoidance; confrontative attitudes towards illness also correlated at 
equally high effect sizes, but a self report perception of purpose in life correlated 
far more weakly, albeit still significantly. Where Naus etal. (2005) found 
associations between locus of control and anxiety to be both weak and non­
significant, Lewis (1982 /  89) presents inconsistent findings; using a pre-validated 
measure, significant medium effect sizes were reported, but using a single item 
control measure, non-significance was once again reported.
Two studies reported on associations between MAC components and anxiety; 
large differences in effect sizes were reported, but the majority were significant. 
Exceptions included associations with fatalism, where small effects sizes were 
found to be contradictory but significant, and fighting spirit, where an additional 
study (Hassanein et al., 2005), reported a non-significant result. This latter study 
did, however, assess this correlation at a much later timepoint. Meta-analysis of 
each MAC component revealed significant effects; anxiety associated with higher 
anxious preoccupation (meta-analysis 4 f  =.62), higher hopeless/helplessness 
(meta-analysis 5 f =.47), higher fatalism (meta-analysis 6 r=.21) and lower 
fighting spirit (meta-analysis 7 r =-.23). Nordin et al.'s (2005) follow-up analysis 
reported that where both fighting spirit and fatalism tended to decrease over time, 
the remaining two MAC scales remained stable throughout treatment and 
recovery.
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Table 2.9. Associations betw een cognitions, em otions and  psychosocial outcom e.
Finding Reported
Significant Non-Significant
Thought intrusion Nordin &Glimeius (1998) r=.75
..... -...... ........ -...........-...
Thought avoidance Nordin & Glimeius (1998) r=.56
Locus of Control Lewis (1982/89) r= -.3 Naus et al. (2005J r=.02 to .11
Confrontative attitude Nordin & Glimeius (1998) r= -.71
Purpose in Life Lewis (1982/89) r= -.3
MAC: Anxious Nordin & Glimeius (1998) r=. 67
Preoccupation* Watson et al. (1991) r=.6
MAC: Fatalism* Watson etal. (1991) r=.16 Nordin & Glimeius (1998) r=. 23
MAC: Fighting spirit* Nordin & Glimeius (1998) 
Watson etal. (1991)
r= -.39 
r= -.17
Hassanein etal. (2005) r= -.14
MAC: Nordin & Glimeius (1998) r=.55
Hopeless/helplessness* Watson etal. (1991) r=.44
Negative affect Longman etal. (1999) r=.34 to .46
Positive affect Longman etal. (1999) r= -.05
Anger expression Morris etal. (1981) r=. 02
CECS: Anxiety* Watson etal. (1991) r=.13 Grassi etal. (1988) r= (+/0.02 to .15
CECS: Anger* Watson etal. (1991) r=.4 Grassi etal. (1988) r= -.1 to -.37
CECS: Depression* Watson etal. (1991) r = .l l Grassi etal. (1988) r= (+/-).15 to .45
Depression
Thought intrusion Nordin & Glimeius (1998) 
Bleikeretal. (2000)
r=.60 
r=. 32
Thought avoidance Nordin & Glimeius (1998) r=.53 Bleiker etal. (2000) r=.19
Locus of Control Rondorf-Klym & Colling (2004) 
Naus etal. (2005)
Marks etal. (1986)
r= -.18 
r=.01 to .17 
r= (+/-).05 to.09
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Table 2.9. Associations betw een cognitions, em otions and  psychosocial outcom e (continued).
Finding Reported
Significant Non-Significant
ucptessivn iluiil.j
Perceived Severity Rondorf-Klym & Colling (2004) 
Marks etal. (1986)
r=. 38 
r=.38
Treatment expectancy Marks etal. (1986) r= -.05
Confrontative attitude Nordin & Glimeius (1998) r= -.67
Self-Blame Timko & Janof-Bulman (1985) r= (♦ /-) 05 to .30
MAC: Anxious Nordin & Glimeius (1998) r=. 57
preoccupation* Watson etal. (1991) r=.43
MAC: Fatalism* Watson etal. (1991) r=.22 Nordin & Glimeius (1998) r=.24
MAC: Fighting spirit* Nordin & Glimeius (1998) 
Watson et al. (1991) 
Hassanein etal. (2005)
r= -.53 
r= -.29 
r= -.27
MAC: Nordin & Glimeius (1998) r=. 67
Hopeless/helplessness* Watson etal. (1991) r=.40
Emotional Expression Falleretal. (1991) r=.55
Negative affect Timko & Janoff-Bulman (1985) 
Longman (1999)
r=. 62 
r=.38
CECS: Anxiety* Watson etal. (1991) r=.07 Grassi etal. (1988) r=.04to.31
CECS: Anger* Watson etal. (1991) r=.09 Grassi etal. (1988) r= (+/-) .10 to .42
CECS: Depression* Watson et al. (1991) r=.12 Grassi etal. (1988) r= (+/-) .02 to .66
Distress
Thought intrusion Baider etal. (2003) 
Osoweicki & Compass (1998) 
Epping-Jordan etal. (1999)
r=.09 to .58 
r=. 46
r=.48 to .70
Thought avoidance Baider etal. (2003) 
Osoweicki & Compass (1998)
r= .07 to .4 8 
r=. 52
Epping-Jordan etal. (1999) r=. 20 to .23
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Table 2 .9. Associations betw een cognitions, em otions and  psychosocial outcom e (continued).
Finding Reported 
Significant Nonsignificant
Distress (cont)___________________________________________________________ _______ _____ _______________________ _
Locus of Control Osoweicki & Compas (1999) r= -.07 to .08
_________________________________  _____ ______ Andrykowski etal. [1994) r=.04 to .22
Threat appraisals Green et al. [2003] r=.52to.67
Perceived Severity____________________  _____  Andrykowski etal. (1994} r=.19 _
Self-blame_____________ Glinder & Compass (1999) ____ r=.26 to .53 ____Malcameetal. [1995] _r=.30 to .33_____
MAC: Anxious Baider et al. (2003) r=. 1 to 46
preoccupation  ___      _ _____ _   _ _ ____
MAC: Fatalism__________Baider etal. (2003)____ ___ __r=.15 to .27_____ _  _____________
MAC: Baider etal. (2003) r=.13to.64
Hopeless/helplessness_____________________________________ ___ __ ______________
MAC: Fighting spirit Baider et al. (2003) r= (+/-) .01 to .25
Clinical Risk
Threat appraisal_________ Gallagher etal. (2002)_________ r= -.38________________  ____ _______________ _____________
Confidence in support____ Gallagher et al. (2002)__________r=-.27______________________________________________________
Health care confidence Gallagher et al. (2002) r=.08
General Quality of Life______________________________________________________________________________________________
Thought intrusion_______ Nordin & Glimelius (1998)______ r= -.33______________________________________________________
Thought avoidance______ Nordin & Glimelius (1998)______ r= -.33______________________________________________________
Locus of Control________ Rondoft-Klym & Colling (2005) r=.21____________ DeValck & Vink (1996)__________ r= (+/-) .12 to .34
Minimisation___________Butowetal. (1999)____________ r=.47_______________________________________________________
Treatment perceptions Butow etal. (1999)___________ r=.15_______________________________________________________
Confrontational attitude Nordin & Glimelius (1998)_____ r=.36_______________________________________________________
MAC: Fighting spirit______ Nordin & Glimelius (1998)_____ r=.33_______________________________________________________
MAC: Anxious Nordin & Glimelius (1998) r= -.29
preoccupation________________________________________________________________________________________________
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Table 2 .9. Associations betw een cognitions, em otions a n d  psychosocial outcom e (continued).
Finding Reported
Significant Non-Significant
General Quality of Life (cont)
MAC:
Hopeless/helplessness
Nordin & Glimelius (1998) r= -.42
MAC: Fatalism* 
Anger expression
Schou etal. (2005) 
Butow etal. (1999)
r= -.24 
r= -.48
Nordin & Glimelius (1998) r= -.14
Anger suppression 
Negative affect
_Rondorf-Klym & Colling (2005)
Kessler etal. (2002)
r= -.41 
r= -.66
......... -..................................... -.... -.-.. — .. ........................ .........
Positive affect Kessler etal. (2002) r=.32
Physical Quality of Life
Locus of control DeValck & Vink (1996) r= (+/-).09 to .40
Information perception Padilla etal. (1992) r= -.27
Illness unpredictability Padilla etal. (1992) r= -.28
Illness ambiguity Padilla etal. (1992) r= -.38
Threat appraisal Padilla etal. (1992) 
Green etal. (2002)
r= -.35 
r= -.38 to .50
Challenge appraisal Padilla et al. (1992) 
Symptom aspects of Quality of Life
Threat appraisal Padilla et al. (1992)
r=.30 
r= -.42
Challenge appraisal Padilla etal. (1992) r=.23
Illness unpredictability Padilla etal. (1992) r= -.16
Illness ambiguity Padilla etal. (1992) r= -.40
Illness uncertainty Padilla etal. (1992) r= -.39
Information perception Padilla et al. (1992) 
Emotional aspects of Quality of Life
Confrontational attitude Nordin & Glimelius (1996)
r= -.33 
r= -.67
Challenge appraisal Schou etal. (2005) r=.22 to .24
Thought intrusion Nordin & Glimelius (1996) r=. 64
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Tabim 2 .9 . Associations betw een cognitions, em otions and  psychosocial outcom e (continued).
Finding Reported
Significant Non-Significant
Emotional aspects of Quality of Life (cont)
Though avoidance Nordin & Glimelius (1996) r= -.41
MAC: Fighting spirit Nordin & Glimelius (1996) r=.70
MAC: Anxious Nordin & Glimelius (1996) r= -.55
preoccupation
MAC:
Hopeless/helplessness
Nordin & Glimelius (1996) r= -.47
MAC: Fatalism 
Social aspects of Quality of Life
Threat appraisals Green et al. (2002) 
Psychological aspects of Quality of Life 
Locus of Control
r= -.53 to -.56
Nordin & Glimelius (1996) r = -.07 
DeValck & Vink (1996) r= (+/•) *08 to .15
Threat appraisal Padilla etal. (1992) r= -.54
Challenge appraisal Padilla etal. (1992) r=.48
Illness unpredictability Padilla etal. (1992) r= -.26
Illness ambiguity Padilla etal. (1992) r= -.50
Illness uncertainty Padilla etal. (1992) r= -.48
Information perception Padilla etal. (1992) r= -.42
* Findings were also meta-analysed: see table 2.7
** Range of correlations presented for different longitudinal comparisons
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Both positive and negative affect were found to be significantly correlated 
with anxiety, although the latter to a much reduced extent. Non-significant 
associations between anger expression and anxiety, and inconsistent findings for 
each of the CECS sub-scales were reported. Although both Watson et al. (1991) 
and Grassi et al. (1988) reported similar (small) effect sizes, only the former found 
these to be significant Meta-analysis demonstrated that all were significant but 
minimally correlated; higher suppression of anger, anxious and depressive 
emotions correlated with higher levels of anxiety (Meta-analyses 8-10, ? =.04, r 
=.13, and f =.11 respectively).
Associations between predictor variables and depression were equally 
mixed. Again, thought intrusions were associated with increased depression (effect 
continuing beyond a two-year follow up) but contradictory findings were reported 
for thought avoidance; although these were not viable for meta-analysis, the 
significant findings related, not surprisingly, to much higher effect sizes. No 
significant effects of locus of control were reported and effect sizes for these 
relationships were small and varied over time.
Illness severity perceptions, self-blame attributions, and greater 
confrontative attitude towards illness were all significantly correlated with 
depression. Treatment expectancy did not. Associations between MAC 
components and depression were once again, reported with medium to large effect 
size, and in all but one case to be significant Meta-analysis found that higher 
depression was associated with higher anxious preoccupation, higher 
hopeless/helplessness, increased fatalism, and decreased fighting spirit (meta­
analyses 11-14, r =.47, r =.48, f  =23, and r =-.35 respectively).
Two studies reported associations between negative affect and depression; 
with both reporting medium to large significant effects. These could not be meta- 
analysed due to high variance in the timing of variable measurement Faller et al. 
(1991) further report a high correlation between emotional expression and 
depression. Patterns of association between CECS subscales and depression 
reflect those also found for anxiety; both the Watson et al. (1991) and Grassi et al. 
(1988) studies report very small effect sizes, differing in significance. Meta­
analysis found that Anger suppression ( r=.08) and depression suppression ( r
124
=.14) were highly significant, but the anxiety-suppression mean effect size ( r =.09) 
was marginally insignificant at the p<.05 level.
Associations with distress were also inconsistent. The three studies 
reporting associations between thought intrusion and distress found varying 
levels of, but consistently significant effects; meta analysis (18) found this to be 
highly significant, r =.35. Only two of these studies found associations with 
thought avoidance to be significant; overall meta-analysis (19) concluded a highly 
significant association between higher avoidance and higher distress, r =.40. 
Conversely to depression, perceived severity was found not to be significantly 
associated, as was locus of control (at various time-points). Threat appraisals 
remained significantly and highly associated. Associations between self-blame 
and depression were also meta-analysed (20) finding a highly significant medium 
mean effect size of f  =.31. MAC components were only correlated with distress in 
one study; effect sizes were variable across the many participant subsamples; 
overall, all but fighting spirit were significantly correlated. Gallagher et al. (2002) 
additionally explored associations with clinical risk for psychiatric disorder; both 
higher threat appraisal and lower confidence in family in support significantly 
correlated with higher risk (medium effect sizes), but confidence in health care 
was did not
There was far less replication of findings for associations between cognitions, 
emotions and quality of life. A range of cognition variables including thought 
intrusion, thought avoidance, minimisation, confrontational attitude and treatment 
perceptions were significantly correlated with general quality of life, mostly at 
medium effect sizes. One study reported significant, and one reported non­
significant, associations with locus of control, although due to timing differences, 
these could not be meta-analysed. Three out of four subscales of the MAC were 
found to be significantly correlated (although this is based on just one study), but 
opposing effects were reported for fatalism in other studies. Meta-analysis (21) 
found this to be overall significant, r =-.19, p<.001.
Negative affect was correlated with much higher effect sizes than positive 
affect Strangely, both anger expression and anger suppression were negatively 
correlated with quality of life.
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Padilla et a l (1992) explored associations between six appraisals and 
subscales of quality of life. For psychological and physical subscales, all were 
significantly correlated: all but unpredictability were significant for symptom 
subscales. Locus of control was not significantly correlated with either physical 
nor psychological subscales despite reporting of larger effect sizes for the former. 
Though these studies indicated lack of effect on quality of life, Alhama etal. (2002) 
report that those high in internal control are more satisfied with their current 
quality of life. Higher threat appraisals were significantly correlated with both 
physical and social subscales of quality of life at medium to large effect sizes, with 
effect continuing to various longitudinal follow-ups, but differences in timing 
prevented meta-analysis. In a similar pattern of results, emotional sub-scales of 
quality of life were found to be strongly correlated with lower thought intrusion, 
lower thought avoidance, less confrontation, higher challenge appraisals and three 
of the four MAC subscales (all but fatalism).
2.7.5.7 Inter-correlations between the predictor variables
Although the specific research question pertaining to the associations 
between the two sets of predictor variables was removed from the protocol, some 
relevant associations were highlighted during data extraction. Caution must be 
applied, however, as neither the means by which these data were included, nor 
extracted, were as systematic as the remainder of the review.
Optimism was repeatedly found to be significantly associated with various 
cognition variables in a variety of cancer samples: high perceived control (Carver 
etal, 2000), high treatment expectations, low perceived threat, and challenge 
based appraisals (Schou etal, 2004/05). Neuroticism and self-efficacy beliefs 
were significantly correlated (Ranchor etal, 2002); as were agency and thought 
intrusions (Helgeson & Lepore, 2004); life satisfaction and positive affect (Kessler, 
2002); and, low perceived control and high levels of thought intrusion and 
avoidance (Osoweicki & Compas, 1998)
2.7.5.8 Reported results from multivariate analyses: Moderation and 
mediation effects
Thirty-one studies conducted multivariate tests that were relevant to this 
review. In longitudinal designs, by far the most significant predictor of 
psychosocial outcome is measurement of that same variable at an earlier time
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point (Bleiker et al.,1995; Malcarne et al, 1995; Gallagher et al, 2002; Green et al, 
2002; Badger et al, 2004). In other words, the most highly associated variable for 
quality of life at, say, three months, is quality of life scores at diagnosis. Similarly, 
the most highly correlated variable of follow up distress, is baseline distress level 
(also see Carver et al, 1993; Ranchor et al, 2000; Aarstad et al, 2005). The most 
likely explanation for this effect is that these outcomes are fairly resilient to 
change, particularly where the situation has altered very little; follow-up times in 
these studies were reasonably short and so one might expect that situational 
appraisals and the environment remained relatively constant. Whilst some studies 
find that this strength of association is limited to only outcomes of the same type 
(i.e. functional status is related to earlier functional status, but not psychological 
outcome, and vice versa), this is not substantiated in all research; Hassanein eta l 
(2001,2005), Rondorf-Klym and Colling (2003), and Schou e ta l (2004/05) found 
significant correlation between quality of life and psychological outcomes.
Although stability of the outcome variable is perhaps the most likely 
explanation for this finding, other possibilities must be explored. One much 
discussed theory that might be of relevance is the Hawthorne Effect. The 
Hawthorne Effect occurs when participants' scores on a psychological measure are 
affected by mere completion of that measure, rather than the measure assessing a 
true underlying psychological phenomenon (Chiesa & Hobbs, 2008). For example, 
applied to the current study, it could be that anxiety at baseline is highly correlated 
with anxiety at follow up, not due to stability of anxiety, but because of an 
underlying cognitive bias in response to questionnaires. Individual participants 
may vary in their proneness to the Hawthorne Effect. The methodological 
implication of the Hawthorne Effect is that whilst the measure may not be able to 
identify absolute values of the anxiety (to continue the example), where the focus 
of analysis is on association between variables, the error introduced is minimal 
(O'Sullivan, Orbell, Rakow & Parker, 2004). The use of the Hawthorne Effect as an 
explanatory mechanism is contentious (Adair, 1984) but where self-report 
measures are taken it seems plausible that some error may be introduced. This 
could represent an issue, not only relevant to this review, but to all research using 
participant self-report.
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A related finding reported by numerous researchers (e.g. Miller etal, 1996; 
Schou etal., 2004/05) was that positive predictor variables are more highly 
correlated, and more significantly predictive of positive outcome; conversely, 
negative predictors are more highly correlated with negative outcome. For 
example, bigger effect sizes and more significant prediction are found between 
optimism (+ve) and well being (+ve) than they are for optimism (+ve) and anxiety 
(-ve): neuroticism (-ve) is more predictive (and more strongly associated with) 
levels of distress (-ve) than well-being (+ve). Such associations were not reported 
in all multivariate analyses, but are worthy contenders for an explanation of the 
process by which these variables have effect.
Table 2.10 summarises the main conclusions from those analyses in which 
independent effects of the predictor variables were still evident after controlling 
for potential confounds (e.g. clinical, demographic variables).
Table 2.10. Summary of studies demonstrating significant independent prediction of 
personality, cognitions and emotions.
Predictor Variable Relationship to outcome
Optimism QoL (Ahmed et al., 2004)
Depression (Cohen etal., 2000) 
Distress (Epping-Jordan etal., 1999)
Lie score Anxiety (Ratcliffe etal., 1995)
Neuroticism Distress (Ranchor etal., 2002; Golden-Kreutz & Anderson, 2004)
Appraisals QoL (Brown et al., 2000; Butow et at, 1999)
Self-Efficacy Distress (Helgeson & Lepore, 2004; Gallagher et at, 2002) 
QoL (Helgeson & Lepore, 2004)
Perceived Threat Anxiety (Laubmeier et at, 2004) 
Depression (Laubmeier etal., 2004) 
Distress (Gallagher et at, 2002)
Thought intrusion Distress (Osoweicki & Compass, 1998; Epping-Jordan etal., 1999; 
Hack & Degner, 2004)
Self-blame Distress (Malcarne e ta t, 1995)
Perceived stress QoL (Cousson-Gelie (2000)
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Those retaining significant independent prediction in regression models 
include optimism, lie scores, neuroticism, self-efficacy, self-blame, perceived 
threat, thought intrusion, perceived stress, and some components of cognitive 
appraisal (perceived treatment aims and minimisation). Other variable effects, for 
example agency (Helgeson & Lepore, 2004), were lost when confounding variables 
were controlled for in these analyses. Some, but not all, of these relationships 
were longitudinally predictive: for example, future distress levels were reportedly 
predictable by both earlier levels of thought intrusion (Hack and Degner, 2004) 
and self-blame appraisals (Malcarne et al., 1995).
A small proportion of studies reported findings pertaining to moderation and 
mediation effects resulting from multivariate analyses; table 2.11 summarises 
these results.
Whilst only one study reported a moderation relationship (of optimism on 
both stage of illness and illness cognitions over distress), many more mediation 
relationships were reported. Appraisals, for example, were found to reduce, and 
by a twelve-month follow-up to completely eliminate, the association between 
optimism and quality of life. Epping-Jordan etal. (1999) make an interesting 
observation that where at three month follow up, thought intrusion and avoidance 
act only as mediators between age and optimism, analysis of data three months 
later demonstrates that both of these cognition variables and optimism acted as 
independent predictors for psychosocial outcome. Although Malcarne etal. (1995) 
found no evidence of locus of control mediating the relationship between self­
blame appraisals and distress, a number of other studies reported such mediation 
effects. Far more in fact report mediation effects than reported significant 
bivariate correlations; it is possible that whilst control may not directly predict 
outcome, it may influence the way in which patients cope with their appraisals (i.e. 
it isn't control perse which is important, but an interaction of (a) where control is 
located, (b) whether control is personally desired and (c) how control may help to 
alleviate negative appraisals).
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Table 2.11. Summary of studies demonstrating moderation and mediation effects of 
personality, cognitions and emotions.
Predictor Variable Relationship to outcome
Moderation relationships
Optimism Stage of Illness on distress (Carver et al., 1993) 
Cognitions on distress (Carver et al., 1993)
Mediation relationships
Appraisals Optimism on QoL (Schou et al, 2004/05)
Fatalism Optimism on anxiety (Schou etal, 2004/05) 
Hoplessness/helplessness on depression (Schou et al, 2004/05)
Perceived Stress Symptoms on QoL (Cousson-Gelie, 2000)
Appraisal Trait anxiety on QoL (Cousson-Gelie, 2000)
Control Illness severity on distress (Alhama etal, 1994; Marks etal, 1986) 
Trait anxiety on depression (Naus et al, 2005)
Appraisals on QoL (Rondorf-Klym & Colling, 2003)
Self-efficacy Appraisals on QoL (Rondorf-Klym & Colling, 2003)
Social Support Self-efficacy on distress (Ranchor et al, 2002) 
Perceived health on quality of life (Schnoll et al, 2002) 
Optimim on QoL (Schnoll et al., 2002)
Optimism on distress (Trunzo & Pinto, 2003)
Coping Optimism on distress (Carver et al, 1993)
Optimsm on QoL (Shnoll et al, 2002)
Perceived health on QoL (Schnoll et al, 2002; Cousson-Gelie, 2000) 
Control on distress (Osoweicki & Compas, 1998)
Illness stage and optimism (Epping-Jordan etal, 1999)
Illness stage and distress (Epping-Jordan etal, 1999)
Thought
intrusion/avoidance
Age on optimism (Epping-Jordan et al, 1999)
Not surprisingly given the previous literature, a number of studies reported 
the mediating effects of social support and coping on associations between the 
variables relevant to this review. Last but not least, Osoweicki and Compas (1998) 
report that coping mediates the relationship between locus of control and distress; 
a mismatch (i.e. preference for problem focussed coping and perception of low 
control) results in highest distress levels.
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2.8 DISCUSSION
This is one of few systematic reviews in the field of psychosocial oncology. It 
aimed to assess associations between personality, cognitions, and emotions as 
correlates of anxiety, depression and quality of life outcome variables. As 
expected, heterogeneity between study and a number of quality assessment issues 
prevented large scale meta analysis. However, a number of smaller analyses, and a 
full descriptive data synthesis, including methodological critique were presented.
2.8.1 Summary methodological critique
Methodological quality was good across all studies (mean score >60%) with a 
majority scoring between 81 and 85%. This seems particularly high compared 
with quality scores reported by similar reviews (e.g. Goodwin, Higginson, Edwards, 
Finlay, Cook, Hood etal, 2002) and perhaps highlights a validity weakness in the 
quality assessment method (to be discussed later in section 2.8.3).
A substantial proportion of studies used a cross sectional design; although 
these have provided some interesting baseline Findings, the general consensus 
across the field is toward longitudinal research in order to better assess temporal 
changes in adjustment. Only two studies recruited pre-symptom; where possible 
this should be aimed at in future research to gain a fully prospective insight into 
the impact of diagnosis. Standardised timing of follow-up should also be 
encouraged and researchers should ideally repeat data collection of most 
psychosocial variables under investigation, at each time point; selective 
measurement at different time-points may compromise the full complexity of 
potential analyses (by missing or underestimating the effects of tertiary 
psychological and clinical variables) and their implications.
Perhaps one of the most pertinent issues was regarding the time between 
diagnosis and recruitment into research. As most studies in this review aimed to 
assess the impact of cancer diagnosis, the process of adjustment, or psychosocial 
outcomes; it seems imperative that patients are recruited during early stages of 
illness. The only exception would be cross sectional assessment of outcome, 
although such designs are not recommended due to the added benefit of pre­
outcome (i.e. during treatment) stage longitudinal data collection. This was not 
the case though; not only were times between diagnosis and recruitment variable, 
but within study time ranges of up to 19 years were reported. The findings are,
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therefore, questionable; attention is drawn to the possible effects of confounding 
variables between patients with varying clinical profiles. Additionally, the 
Transactional Model (on which this thesis is based) asserts the dynamic and 
changing nature of psychological responses to stress including feedback loops and 
stressor re-appraisals. The unstable nature of cognition and emotion variables 
highlighted in this review provides evidence for the importance of temporally 
homogenous samples. Furthermore, the effects of post-cancer re-appraisals and 
error in retrospective self-report over these longer periods of time may introduce 
bias into the results of many of the studies.
Substantial sample biases existed; the research field is dominated by breast 
cancer studies, and, therefore, male responses to cancer are highly under­
represented. It is recommended that future research should aim to minimise both 
gender and cancer site biases so that findings can be more readily applied to 
general cancer populations.
Although only 11 out of the total 68 studies were deemed to have an 
inappropriate sample size for the analyses they conducted, very few studies 
explicitly stated sample size calculations with regard to planned analyses. A clearer 
explanation of recruitment strategies are recommended; recruitment and 
response rates are important criteria by which to assess the generalisability of the 
findings. Without such information, findings must always be treated with caution. 
Where reported, response rates are on average high, although the actual range was 
from 37.3% to 100%. Those attaining highest response rates, and those not 
providing such information were judged to provide the vaguest information 
regarding sample recruitment. It is likely that the more conservative estimates are 
reflected in the better quality studies.
Several of the measures used in psychosocial oncology research have been 
purported to measure different underlying psychosocial constructs by different 
researchers. The findings raise concerns about the coherence and definitions of 
some psychosocial constructs and their measurement highlighted in this review.
Choice of statistical analysis was also questionable in a number of papers. Of 
particular note are those studies which present merely descriptive data, or in 
which correlation effect sizes are presented in a 'range' format rather than specific 
bivariate associations. Further, when comparing the vast number of measures
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used with the actual statistics presented in each paper, it became clear that some 
information is simply missing; although it is likely that much of this was due to 
irrelevance to the specific research question (in which case, the ethical 
consequences of measuring data which was not analysed are to be considered), it 
is equally possible that these data were not included due to the finding of null or 
negative results. Publication of these data would have enabled much more in- 
depth meta-analyses and would help to develop more theoretical models of 
adjustment which consider the influence of a great many sources of variable 
changeability.
Findings are often difficult to interpret as some authors chose not to report 
individual outcome findings, but rather merge many outcomes into one variable. 
This is not always helpful when trying to understand the full complexity of the 
results. Numerous authors give neither justification of why, or explanation of how, 
such composite measures were created. Some researchers have used factor 
analysis as the justification, though the failure of a factor structure to emerge in 
their data is unsurprising given the small samples sizes used.
One final important point pertains to the difference between poor science 
and poor reporting of research. Whilst these are interconnected (and in many 
cases inseparable), this highlights an important point regarding publication.
Whilst inappropriately designed and analysed research is essentially the 
responsibility of the authors, much of the critique presented in this review also 
pertains to lack of clarity and insufficient depth in the reporting of such research. 
When information is missing or covered only briefly, it must not necessarily be 
assumed that this is indicative of poor science, but may also be caused (in part at 
least) by submission length restrictions imposed by journal editorial teams.
2.8.2 Summary of main findings
Many significant associations were reported between demographic factors 
and variables of interest in this review. Age was inconsistently associated with 
personality but seemed to be significantly associated with cognitions and 
emotions, with older patients tending to report more positive appraisals, but more 
negative emotional reactions. Although the evidence suggests that younger 
patients tend towards poorer psychological adjustment, significance of these 
effects between study were inconsistent. Female patients were reported to be
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both more neurotic and to report higher distress levels. Higher educational level 
was associated with more positive personality dimensions, but associations with 
outcome were predominantly non-significant.
Reported associations between clinical variables and psychological variables 
were inconsistent; many associations were un-corroborated (or, indeed, opposed) 
by those presented in other studies. No significant correlations were reported 
between personality and clinical variables. Cognitions and emotions were most 
consistently and significantly correlated with psychosocial outcomes. The limited 
evidence seems to suggest that stage of illness, time since diagnosis, and 
treatments received are most pertinent.
Where reported, personality seemed stable (as would be expected), despite 
the major stress and life adjustment that follow a cancer diagnosis. Only 
dispositional optimism is significantly associated with anxiety. Many more 
significant associations were reported between aspects of personality and 
depression; between personality and distress; and, between personality and both 
total, and subscales of, quality of life. The only exceptions were associations 
between mastery and symptom-related quality of life, and between self-efficacy 
and social quality of life. Deeper exploration of subscales of quality of life also 
shows an interesting pattern; personality is more consistently associated with 
psychosocial dimensions, but not physical and illness dimension of quality of life. 
Meta-analysis found the relationship between self-efficacy and distress to be 
overall significant, but with a low effect size. Medium effect sizes were found for 
the meta-analyses between optimism and both well-being and distress.
The evidence for associations between personality variables and cognitions 
seems to imply medium, or highly significant, effect sizes, particularly where 
optimism and neuroticism are concerned. In multivariate analysis, aspects of 
personality remained independent predictors of both distress and quality of life in 
nine separate studies. In seven others, its effect was reported to be mediated by a 
number of tertiary variables including clinical variables, appraisals, coping, social 
support, and locus of control (see section 2.7.5.8).
Emotions were also associated with all psychological outcomes, but not with 
quality of life. Specifically, negative affect was associated with worse psychological 
outcome (and vice versa for positive affect). Both anger suppression and anger
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expression were significantly related to higher levels of both quality of life and 
depression. Meta-analyses between the incongruent findings on the CECS and 
both anxiety and depression yielded small, albeit highly significant, mean effect 
sizes.
Thought intrusion and avoidance were reported to be significant influences 
on levels of anxiety, depression, distress and quality of life. Meta-analysis of 
associations between the Impact of Events Scale and distress yielded highly 
significant, small effect sizes. Illness perceptions and cognitive appraisals 
(including, for example, threat, challenge, perceived severity and so forth) were, on 
the whole significantly associated with both psychological outcome (four studies 
p<.05; two studies p>.05) and quality of life (nine studies p<.05). Self blame was 
significantly associated with both depression and distress: a meta-analysis for the 
latter revealed a small, but highly significant effect size (p<.001) where self blame 
leads to poorer outcome. According to Butow et al. (1999) and Brown et al.
(2000), the importance and reported significance of these cognitive variables is 
that they are not only measures of cognition, but also an indication of positive 
dimensions of personality.
Confrontational attitudes towards illness were found to be significantly 
beneficial for both quality of life and anxiety. Meta-analysis of the sub-components 
of the MAC scale yielded highly significant, small effect sizes between all 
components and both anxiety and depression; where better outcome was 
associated with lower hopelessness/helplessness, lower anxious preoccupation, 
lower fatalistic appraisals, and increased levels of fighting spirit Incongruent 
findings were reported between MAC components and quality of life, but a small 
effect size (p<.001) was found in meta-analysis of the relationship between 
fatalism and quality of life.
Of all cognitions, locus of control appeared to be the most inconsistently 
correlated variable of all with equal evidence for and against significance; the net 
effect seems to be toward no influence on psychological outcome. However, the 
role of control may be more complex than apparent in this review: Carver et al, 
(2000) claim that control perse is not important in terms of correlation or 
prediction of psychosocial outcome, but that best outcome is dependent on high 
concordance between illness expectancies and control beliefs. Andrykowski etal.,
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(1994) also makes similar claims of variable interaction; control has greatest effect 
when illness and treatment perceptions are most negative.
In multivariate analysis, only four studies reported a significant independent 
cognitive predictor of outcome; perceived social support was found to mediate the 
effects of health perception on quality of life, fatalism mediated between 
hopelessness/helplessness and distress, and coping mediated between control and 
distress.
Whereas the predictive validity of personality seemed stable over time, the 
predictive validity and significance of association based on cognitive and 
emotional factors seemed more changeable. Some of the strongest predictors of 
longitudinal adjustment identified in these studies are earlier levels of anxiety, 
depression and quality of life.
Although not specifically analysed in this review, a brief summary must be 
given for coping due its role in the transactional model. Direct associations 
between coping and both psychosocial predictors, and psychosocial outcomes, 
were inconsistently reported both in terms of which strategies were most 
beneficial, at different time points of illness, and in terms of statistical significance. 
Consistency was reported, however, in the mediating role of coping over numerous 
cognitions and appraisals (although cognitions also remain independently 
significant predictors), and numerous personality variables typically at high levels 
of effect size and significance. As such, the findings are clearly concordant with the 
Transactional Model.
A final point about longitudinal analysis. The methodological critique clearly 
stated that longitudinal designs are superior to cross-sectional designs and 
approximately 50% of the included studies, did indeed, collect some follow up 
data. Yet, it will be obvious from this data synthesis that very few longitudinal 
analyses are presented or discussed; data was simply not sufficiently analysed to 
do so within the individual included papers. Longitudinal analysis was largely 
limited to multivariate tests which were not the main focus of this review. 
Correlation analyses were largely limited to cross-sectional data only. The use of 
cross-lagged correlations may be beneficial in future research.
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2.8.3 Review evaluation
The general area of research into which this review fits is vast Whilst many 
related concepts are discussed, and single relevant variables measured, to have 
included every vaguely related psychosocial oncology study would have been 
infeasible on both a practical and an interpretative level. Therefore, a focussed 
question was planned exploring only those which had direct relevance to this 
thesis. Many more important questions have been addressed in psychosocial 
oncology research (e.g. religiosity, sexual adjustment, social support) and are 
equally deserving of systematic review, but beyond the scope of this thesis.
The review was designed to be robust and of high quality by following the 
guidance of both NHSCRD and the Cochrane Collaboration. Positive peer review of 
the protocol reflects the importance of the research and suitability of the approach 
to answering the question. In order to assess whether robustness and quality 
were achieved, Russell et al.’s (1998) quality checklist for systematic reviews was 
applied. Table 2.12 presents the criteria and scores attained.
This scoring exercise highlights two primary weaknesses of the review: 
literature searching and data extraction. The search strings used were highly 
sensitive, perhaps too much so, given the high output from our searches. It is likely 
that this resulted in some studies being omitted from inclusion (this is, in part, 
demonstrated by the lack on concordance between the inclusion lists of the two 
reviewers). However, the fact that a second inclusion assessor was used 
minimised this risk substantially.
i
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Table 2.12. Scoring the quality o f the systematic review.
Criteria Score Comment
1. Specifying the objectives?
Scores: (2) precise (1) vague (0) implicit
2. Searching the literature?
Methods: electronic, handsearching journals, 
reference lists, authors, industry
Scores: (2) 4 *methods (1)2 or 3 (0) 0 or 1
3. Selecting relevant studies?
Scores (2 )2 *  reviewers (1)1 reviewer (0) 
selection implicit
4. Selecting valid studies?
Scores: (2) 2* reviewers (1)1 reviewer (0) 
selection im plicit
5. Extracting the data?
Scores: (2) 2* reviewers (1)1 reviewer (0) 
extraction implicit
6. Synthesising the data?
Methods: rigorous qualitative overview, meta­
analysis rigorous or rejected
Scores: (2) both (1) only one (0) implicit
7. W riting  the report?
Components: table o f included studies, table o f 
excluded studies, discussion o f robustness, 
implications fo r  health care, implications fo r  
research
Score: (2) 4* components (1 )2  or 3 (0) 0 or 1 
Total ___________ _
Due to feasibility issues, 
only electronic searching 
was conducted
Lim ited resources 
available (see main text)
11 (Out o f possible 14)
With regard to searching sources, although a vast range of electronic 
databases were searched (in order to reflect the multi-disciplinary nature of this 
review), this was limited by publication bias. Given the additional time and 
resources necessary to extend the search to also include non-published sources, it 
was not considered feasible to do so for the purpose of this thesis. The final 
inclusion rate as a proportion of search results was low; further searching was 
assumed unlikely to dramatically increase the number of included papers. This 
aspect of the review is undoubtedly a methodological weakness. However, it is 
worth noting that in data synthesis a surprisingly high number of non-significant 
results and a number of methodologically inferior publications are included which
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may indicate against publication bias, to an extent at least A future update of this 
review should consider more extensive searching (including follow-up searching 
of reference lists and key journals), if only to rule out the possibility of any further 
data being available and to be able to make more confidant claims against 
publication bias. Such review replication is not, however, recommended for some 
time: given the heterogeneity of the field, further research needs to be conducted 
before informative and clinically implicative meta-analysis is possible.
Due to resource restrictions, a second reviewer was only available for the 
paper selection phase and quality assessment, not for extraction of data from 
included papers. Whilst single-person data extraction can lead to bias or error, 
compromises were necessary due to limited staffing resources. It was thought that 
of the three areas where multiple reviewers are recommended, this was least 
crucial to the overall quality. In future replications, it would be beneficial to 
ensure that resources are sufficient to fully enable this.
Going beyond Russell etal.’s (1998) criteria, two further points are 
considered important for judging the quality of this review: validity of the quality 
assessment tool used and a cautionary word about the meta-analyses presented.
Independent quality assessment by two reviewers was conducted using a 
pre-validated (but slightly amended) tool applicable to all quantitative research 
designs. Low concordance in scores between quality assessor highlights concern 
that either bias existed in assessment, or in the clarity of scoring guidelines for the 
tool. Although mean quality scores give an indication of overall good 
methodological quality, the descriptive quality critique presented in section 2.7.2 
was more negative on the whole. This discordance between quality score and an 
in-depth descriptive critique indicates possible weakness in the quality 
assessment tool used. Future research should consider the use of alternative 
scoring methods and thorough validation of the Kmet et al. (2005) tool. The 
limited scope of the meta-analysis did not allow for sensitivity analysis based on 
quality scores. Additionally, mean effect size weighting based on quality was not 
appropriate for the meta-analytical methodology used.
Due to between study variability, data synthesis was limited primarily to 
qualitative (non-statistical) data analysis. Many different models of meta-analysis 
were explored and the Hunter and Schmidt, random effects model was selected as
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being most appropriate for the 21 small meta-analyses. Although (on the whole) 
highly significant effect sizes ranging from small to medium levels resulted from 
the statistical analyses, it is important that these findings are considered with 
caution; inference of the implications of findings any more statistically advanced 
than mean effect sizes are of minimal validity.
2.8.4 Recommendations for future research
The findings of this review demonstrate that whilst personality, cognitions 
and emotions are associated with distress and quality of life after cancer diagnosis, 
little directly comparative research has been conducted. More research is clearly 
required. In particular, there is a need for more longitudinal, theory-based 
research of the relationships between all components of the transactional model 
(appraisals, emotional reactions, coping and outcome) to establish which are the 
most influential components. The question of how personality may complement 
or better predict outcome cannot confidently be answered using findings from this 
review. The limited evidence available, however, does seem to imply that 
appraisals are more useful indicators of adjustment. Whilst personality and 
quality of life are associated, correlations with psychological outcomes were more 
variable. Cognitive appraisals and emotions were more consistently associated 
with both psychological and quality of life outcomes. Further theory-based 
research using complex designs is essential though before this claim can be fully 
validated.
Future work must also improve in terms of methodology. First, theoretical 
constructs and the use of various psychological instruments need clarification and 
standardisation. Second, many important issues have been raised regarding 
temporal differences and recruitment into studies which should be considered 
more fully in planning future research. Improvements in sampling and recruitment 
strategies are imperative for optimal confidence in the generalisability of 
individual study findings. Third, more generic cancer research (rather than clinical 
site-specific) controlling for the effects of possible clinically confounding variables 
is required in a move away from the current breast cancer-biased literature.
Finally, a number of statistical limitations were raised. Each of these should be 
carefully considered in the planning of new research protocols in this field.
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2.8.5 Implications for policy making and clinical practice
The findings clearly point to the (varying) importance of individual 
differences, cognitive variables and emotions in adjustment to cancer diagnosis 
(specifically distress and quality of life). This is inkeeping with policy 
recommendations (e.g. the Cancer Reform Strategy, 2007) which call for, amongst 
other targets, better psychosocial support mechanisms, increased personalised 
support, and individually tailored care for the patient.
There is a strong argument for the stability of many personality 
characteristics (there are of course some exceptions, for example optimism) and so 
application of these findings into practice may be limited, however, there could be 
a case for using such information to highlight individuals who may be particularly 
at risk of adjustment difficulties at earlier time points in order refer to specialist 
psychosocial services. Perhaps of more pertinence is the strength of evidence 
found for many of the role of cognitive variables which are infinitely less stable 
than personality, and therefore more likely to be responsive to intervention. 
Although some appraisals are inherent in a cancer diagnosis (e.g. illness 
unpredictability), others are more reflective of individual reactions (e.g. self blame 
and thought intrusion). Therefore, interventions could focus upon both changing 
the way patients appraise their illness, and also the way in which the patient 
responds to, and acts upon these appraisals. There is a clear need to further 
empirically (and rigorously) investigate associations between these variables and 
outcomes to inform intervention research, but the potential contribution of these 
early findings is clear.
The high level of psychological distress reported in these studies is reflective 
of the potentially devastating impact that cancer can have. Although data were 
not available in these studies on how frequently patients had been referred to 
specialist oncology-based psychological support teams, the potential importance of 
such services is clear in both identifying those in distress and in helping patients to 
deal with and alter unhelpful responses to cancer diagnosis.
2.8.6 Concluding summary
Theoretical models of adjustment describe a complex interaction between 
many psychosocial and clinical factors. The implications (both theoretical and 
clinically applied) of studies that fail to address, or report statistical findings
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relating to the full complexity of all psychosocial constructs, is unclear. Biased 
recruitment, occasionally incoherent measurement, missing analysis and a general 
lack of theoretical grounding all contribute to perceptions of poor quality within 
this field of research. However theoretically or clinically interesting study findings 
may be, poor quality studies will not result in improved clinical practice. Many 
researchers in this field are inadvertently limiting both the applicability and 
credibility of research findings in an area so heavily rooted in evidence based 
medicine and influenced by the application of theory to clinical practice.
Considered together though, some interesting findings do emerge. Using improved 
methodology it is possible that such findings may prove crucial to the development 
of successful interventions and clinical support systems for cancer patients.
2.9 INTRODUCTION TO STUDY TWO
Although this systematic review was conducted in parallel to the empirical 
part of this PhD thesis, the conclusions are in keeping with the predictions made 
from early scoping searches. Reflecting methodological improvements, the study 
planned was longitudinal (data collected at diagnosis, three month and six month 
follow up) and aimed to recruit a mixed cancer sample of 160 patients with 
otherwise homogenous clinical disease characteristics. The study was theory- 
based and measured a more coherent set of variables including personality, 
appraisal, emotion, coping, health beliefs and psychosocial outcomes. The results 
of the empirical research build upon the research base synthesised in this review. 
However, through improved methodology it is hoped that the findings may 
contribute more to the field both in terms of theoretical and clinical implication.
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CHAPTER 3 
EMPIRICAL STUDY: METHOD
3.1 CHAPTER OVERVIEW
The following sections of the thesis (Chapters Four to Six) pertain to the 
empirical application of the Transactional Model to explain adjustment in a sample 
of newly diagnosed cancer patients. The current chapter presents information 
about the purpose and aims of the study, the development of the protocol, and a 
detailed description of the method used for data collection.
The study was originally designed as an investigation of associations 
between personality, components of the Transactional Model, and psychosocial 
outcome in newly diagnosed colorectal cancer patients recruited from four Welsh 
NHS Trusts. The target sample size was 156 patients. A number of practical issues 
hindered recruitment into the study. Primarily, a number of procedural delays in 
setting up the study postponed the start of patient recruitment. Furthermore, the 
largest of the Trusts planned to be involved was not, in the end, able to assist with 
recruitment. Without this Trust, recruitment proved far slower than expected and 
achievement of the sample target became infeasible given the time and funding 
restraints of the project.
Consequently, recruitment was temporarily suspended whilst a period of 
study re-design and re-development was carried out and approved by the relevant 
committees. Following this, recruitment was extended to also include breast, 
prostate and lung cancer patients, and focused on three Welsh NHS Trusts.
One hundred and sixty patients were recruited in total. Recruitment rates 
were low (35%), but expectedly so, and comparable to a number of related studies 
(see section 2.7.2.5 of the systematic review for comparison studies). A high 
retention rate of 77% was achieved. The chapter ends with an overview and 
justification of the proposed statistical analyses which are presented in Chapter 4. 
These include both theory testing of the Transactional Model in addition to 
clinically relevant regression analyses to identify the most important predictors of 
psychosocial outcome within this population. Longitudinal analyses included data 
from the 123 patients who completed all three time points of the study.
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3.2 STUDY PURPOSE
3.2.1 Aims
The aim of this study was to investigate personality, cognitive appraisals, 
emotions, and psychosocial adjustment in a cohort of newly diagnosed cancer 
patients. It was designed to address the third and fourth thesis questions (see 
section 1.7). In summary, these questions were:
3) What are the most important predictors of psychosocial outcome in 
newly diagnosed cancer patients, and leading from this, at what time 
point (baseline or three month follow-up) are they most predictive 
of subsequent (three or six month follow-up) outcome?
4) Are the hypothesised associations between cognitive appraisals, 
core-relational themes, and emotions in Lazarus's Transactional 
Model supported in a sample of newly diagnosed cancer patients?
3.2.2 Objectives
1) To identify the most important psychological predictors of anxiety, 
depression and quality of life at three and six month time-points 
after cancer diagnosis.
2) To identify at what time-period (baseline, three or six month follow 
up) predictor variables best predict each of the outcomes at three 
and six month follow-up.
3) To examine whether associated components of the Transactional 
model (cognitive appraisal, core-relational themes, emotion themes, 
and coping) vary equivalently over time.
4) To test the hypothesised associations between specific cognitive 
appraisals, core-relational themes, and emotion themes (i.e. the 
'exclusively' linked components) in relation to cancer diagnosis.
3.2.3 Hypotheses
3.2.3.1 Objective One
Personality differences, and variation in appraisals, emotion, and coping 
are, at both baseline and short term follow-up, expected to contribute to statistical 
models predicting levels of anxiety, depression and quality of life, three and six
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months after diagnosis (Hypothesis one). Health locus of control beliefs are not 
expected to account for any such variance in outcome (Hypothesis two).
3.23,2 Objective Two
Statistical tests are expected to yield varying levels of outcome prediction 
between regression models. Those predicting outcome six months prospectively 
are hypothesised to explain lower total R2 variance explained than those 
predicting outcome three months prospectively (Hypothesis three). Additionally, 
variance explained by three month predictor variables is hypothesised to be higher 
than that explained by baseline variables as this initial period may be too unstable 
and traumatic for accurate predictions to be made (Hypothesis four); although 
quite a general hypothesis given that strength of longitudinal relationship is often 
dependent on the specific nature of the variables in question, this hypothesis is 
based on the findings for similar studies in the field which indicate a more general 
trend toward better prediction over shorter time-periods.
3.2.33 Objective Three
Components of the Transactional Model are hypothesised to fluctuate with 
time (Hypothesis five) and the extent and direction of change between them to be 
equivalent for each theoretically associated component (Hypothesis six).
3.23.4 Objective Four
For the six so-called 'hot' cognitions (see Smith & Lazarus, 1993; Lazarus, 
1991,1999; also refer to section 1.5 for a breakdown of which cognitions this term 
refers to), unique patterns of association are hypothesised between the stated 
specific appraisal, core relational theme and emotion components. (Hypothesis 
seven). These associations are demonstrated in figure 3.1.
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Appraisal Component Core Relational Theme Emotion Theme
^  Optimism
Success
Sadness
Guilt
Anger
Happiness
Fear/
Anxiety
Self-Blame
Other-Blame
Hope/
Challenge
Loss/Harm/ 
Helplessness
Danger/
Threat
Self-
Accountability
Other-
Accountablllty
Future
Expectancy
Motivational
Congruence
Emotion-Focussed 
Coping Potential
Problem Focussed 
Coping Potential
Motivational
Relevance
Fig 3.1. Associations between appraisal components, core-relational themes and emotion 
themes fo r the 'hot ’ cognitions
For a fu rther seven cognitive appraisals, uniquely significant associations are 
hypothesised [by Smith & Lazarus, 1993) between the following core relational 
themes and emotions [Hypothesis eight).
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Core Relational Theme Emotion Theme
Relevance
Irrelevance
Threat Removal
Self consciousness
Lack of Concern
Loss/Helplessness
Unexpectedness
Interest
Relief
Boredom
Surprise
Shame/ Humiliation
Resignation
Tranquility
Figure 3.2. Unique core-relational themes fo r  the emotions o f surprise, resignation, 
tranquility, shame/humiliation, interest, boredom and relief.
Theory testing, therefore, only extends so far as to test these unique 
relationships. An exploratory approach will be taken to identify which unique 
appraisal components will also be associated.
Additionally, for the remaining three emotion themes described in the 
Transactional Model— frustration, self-directed anger, and regret—no appraisal 
components or core-relational themes are proposed in the model. Once again, 
therefore, an exploratory, rather than hypothesis-driven approach will be taken to 
investigate which unique cognitive patterns may precede these emotional 
reactions.
3.3 STUDY DESIGN
3.3.1 Overview
Limited clinical implication and application can be drawn from cross 
sectional designs (see section 2.7.2.2), therefore, a longitudinal cohort study was 
designed. Data were collected from newly diagnosed cancer patients by means of 
questionnaire at three separate time points during treatment Patients were 
recruited from three NHS hospitals in Wales (here after referred to as Centres A, B 
and C).
Most data were quantitative in nature. Predictor variables assessed were 
personality, illness appraisals, emotions, and coping. Outcome variables were 
anxiety, depression and quality of life. Predictor and outcome data were collected 
in a repeated measures design, at each time point. Data were also collected on 
demographic and clinical variables which were identified as possible confounding 
variables; this information was obtained at diagnosis only but with regard to some 
clinical data, included prospective and retrospective elements. Some qualitative 
data were also collected. Content analysis of these data were used to clarify and 
add further meaning and depth to the main quantitative analysis.
3.3.2 Study Development
33.2.1 Funding application and research sponsorship
During the development of the protocol for this research, a successful 
application for small grant funding was made to the North Wales Research 
Committee. A sum of £5000 was awarded for printing costs, data collection costs, 
and conference dissemination (see appendix 3.1). Sponsorship for the study and 
liability cover were provided by Cardiff University (appendices 3.2 and 3.3)
33.2.2 Consultation with clinical teams
Before the study could begin, consultation and negotiation with each clinical 
team was necessary. First, approval from the lead consultant for each cancer team 
was obtained. Second, clinical nurse specialists were approached as these 
individuals were proposed as the key members of the clinical team to be involved 
with recruitment. Provided that both the lead consultant and nurses were willing 
to assist, the research was presented to the remainder of the clinical team at one of 
die weekly multidisciplinary team (MDT) meetings. MDT meetings usually consist
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of administrative staff, representatives from Trust Cancer Services, clinical nurse 
specialists, surgeons, oncologists, radiologists, pathologists and members of the 
palliative care team. Data collection was only possible following full MDT 
approval.
3.3.2.3 Piloting of the questionnaire with service user representatives
A pilot version of the questionnaire was distributed by the local Cancer 
Patient Expert Group Network via the Local Health Board. Ten patients were 
consulted, all of whom had previously been treated for colorectal cancer. Each 
patient was asked to complete the questionnaire and to answer a short survey 
about their experience of participation. A unanimously positive opinion of the 
research was obtained from the five who replied. Four out of the five conveyed 
that they would have been prepared to complete it at the time points which were 
proposed for this study. Two also commented that they would have found 
completing the questionnaire beneficial in order to clarify their thoughts and 
feelings. One commented that the results of the study would be of great value to 
medical staff to increase awareness of patient emotions. No negative feedback was 
received on the questionnaire layout or language used. One commented that the 
questionnaire was definitely too long and that this would be off-putting. It was a 
surprise that more members of the pilot group did not make comments along 
these line. Although the remainder did state that it was a long and at times 
complex questionnaire, the length would not have put them off participating had 
they been approached whilst undergoing treatment. Of course, no comments were 
received from the five pilot group non-responders and it is was possible that this 
sub-group who found the questionnaire too long. Regardless, when compared 
with response rates reported in the systematic review, the 50% response rate at 
this stage appeared reasonable.
33,2.4 Ethics, research governance approval and honorary contracts
Whilst attending MDT meetings and piloting the questionnaire, paperwork 
was completed in order to apply for NHS Ethical Approval (one multi-site 
application made via COREC: The Central Office of Research Ethics Committees) 
and Trust Research Governance (Research and Development /  R&D) approval 
(individual applications for each Trust involved). Copies of approval letters can be
149
L
found in appendices 3.4 to 3.7. Once Ethical and Trust R&D approvals were 
finalised, honorary contract applications were made. Such contracts were 
required from each Trust where patients were to be recruited from, and also 
permitted the use of, and data extraction from, secondary care medical records and 
clinical databases.
33.2.5 Initial recruitment problems
The original intention was to recruit colorectal cancer patients from five NHS 
Hospitals, spread across four NHS Trusts. The most current at the time incidence 
rates of colorectal cancer for each Trust were obtained from the Welsh Cancer 
Intelligence and Surveillance Unit (WISCU; see table 3.1)
Table 3.1. Colorectal cancer incidence in fou r Welsh NHS Trusts, 2002-2003. (Source: 
WISCU, 2004).
Trust IncidenceH O S p iO l
2002 2003 Mean
Trust 1 Centre A 112 133 112.5
Trust 2 Centre B 175 151 163
Trust 3 Centre C 117 135 126
Trust 4 Centre D 132 128 130
Trust 4 Centre E 71 86 78.5
T o ta l 607 613 610
Projected recruitment times were calculated as follows. From the total mean 
incidence across both years, an estimated 25% was deducted to account for those 
diagnoses which were estimated not to match our inclusion criteria (leaving 457.5 
patients). By observing response rates in similar studies identified in our early 
scoping searches, we estimated a recruitment rate of approximately 40%. 
Therefore, it was anticipated that 183 patients were potentially recruitable over 
each year. As the sample size calculations yielded a required sample of 156 
participants (see section 4.5.2), this was calculated to take approximately 10.5 
months of continuous data collection. Recruitment was planned, therefore, to last 
for 11 months.
Initiation of recruitment was staggered and began in Centre A. Recruitment 
was initially slower with both eligibility and response rates being lower than 
expected. Furthermore, an unexpected ten week delay was encountered in gaining 
R&D approval and honorary contracts from the other two Trusts, primarily due to
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long delays in the application of Criminal Records Bureau checks. Such delays are 
actually common and a paper published shortly after this study was approved 
indicates that 150 days is usual for R&D alone (Elwyn, Seagrove, Thorne & Cheung, 
2005). Of greater concern was that even after concerted efforts (emails, 
telephone calls, and in-person meetings) with clinical staff at Trust Four, this site 
was dropped from the study as the clinical teams reported that high levels of 
sickness absence precluded them from committing time to aid with recruitment (a 
constraint of our ethical approval was that recruitment could only be done in 
collaboration with the clinical team due to the practical limitations of honorary 
contracts). This resulted in the loss of Centres D and E: both are in the same NHS 
Trusts which would have potentially referred the highest number of patients into 
the study.
33,2.6 Study re-design
After three months of slow referral from clinical nurse specialists and low 
recruitment into the project, the design was altered. Had these changes not been 
made it would have been unfeasible to complete the project within the time 
limitations of a PhD. Within the first three months of recruitment, only 16 patients 
were assessed as suitable for inclusion, a far lower number than originally 
anticipated. Given that just 31% of these patients returned completed questions, 
projected figures for total recruitment were estimated to be in excess of five years.
Care was taken to ensure that these changes were not detrimental to the 
aims of the PhD or clinical applicability of the study, therefore both theoretical and 
clinical issues were considered. Theoretical advice on these changes was provided 
by the candidate's supervision team, and from further review of the relevant 
literature. A number of academics and NHS based clinicians were consulted, 
including Dr Matthew Makin (Consultant in Palliative Medicine and Clinical Lead 
for Cancer Services), North East Wales NHS Trust), Prof Nick Stuart (Professor of 
Cancer Studies, North West Wales NHS Trust), Dr Simon Gollins (Consultant 
Clinical Oncologist, Conwy and Denbighshire NHS Trust), and Dr Peter Rutherford 
(Caldicott Guardian and Chair of the Local Ethics Committee for the North East 
Wales NHS Trust).
First, the eligibility criteria were altered. Previously, recruitment focussed 
only on colorectal cancer patients. However, the findings were anticipated to be
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equally relevant to all types of cancer patients. To focus on one individual cancer 
site would have made analysis somewhat less complicated, however, obtaining an 
appropriate sample size was a more important issue. Additionally, findings from 
our systematic review demonstrated that conclusions from multi-site studies could 
be equally valuable (in some cases more valuable than single-site studies due to 
increased generalisability), provided that good methodology was employed.
Therefore, new inclusion criteria extended to patients with new diagnoses of 
breast, prostate, and lung cancer, thus representing recruitment of the four most 
commonly diagnosed cancers in the UK (CRUK, 2008). Including other diagnoses 
also had the advantage that comparisons could be drawn between patients with 
different types of illness. Although attrition by mortality was expected to be 
substantially higher in lung cancer (and therefore, far fewer were expected to 
reach the final follow-up) exclusion of this largely understudied patient population 
based on mortality alone could not be justified.
The second change was to the questionnaire itself. In including other 
diagnoses, the titles and wording of the introduction to the questionnaire and 
supplementary materials needed to be changed. The quality of life measure also 
had different subscales for each cancer type resulting in four cancer site-specific 
questionnaires. Finally, in response to feedback regarding the length of the 
questionnaire (particularly from the Ethics Committee and North Wales Research 
Committee), the length of the questionnaire was reduced as follows:
1) The Generalised Self-Efficacy scale (Jerusalem & Schwarzer, 1992) was 
removed. This measures similar health beliefs to the Multidimensional 
Health Locus of Control scale which remained in the study. Although 
the extra information may have had some small theoretical benefit, 
from a clinical perspective, it was not essential as the constructs 
overlapped.
2) The format of presentation of the Appraisal Components Questionnaire 
was also altered. All items were still included, however, instead of 
being answered individually, participants responded to a set of grouped 
statements. This reduced the number of items for participants to 
respond to, and also had the effect of appearing shorter and, therefore, 
less burdensome on the participants. This method has been used
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successfully in many other studies using cancer samples (for example, 
Griner & Smith, 2000; and Bennet, Lowe & Honey, 2003).
3) The originally selected coping measure (Ways of Coping Questionnaire, 
Folkman & Lazarus, 1985) is very lengthy (64 items), and was replaced 
with Carvers’s (1997) Brief COPE (28 items). This alternative scale is 
thoroughly validated for use with cancer patients (see section 4.4.5).
Third, the final follow-up questionnaire was changed from nine months after 
baseline, to six months. As all outcome measures are psychosocial in nature rather 
than, for example, survival or disease progression, there was no concern regarding 
whether or not these outcomes could be measurable, and of clinical relevance, at 
six months. By reducing this time-frame, although losing some depth of data 
regarding longer-term adjustment, the shorter time investment per participant 
enabled a longer initial recruitment window, and increased the chances of more 
patients (i.e. those with lung cancers) surviving to final follow up. Also, the 
systematic review identified that most published longitudinal studies collected 
follow-up data at three and six months. This change rendered the study more 
comparable with these published data.
The final amendment concerned recruitment procedures. Ethical approval 
only allowed for the clinical team to carry out initial patient invitation. Therefore, 
cancer nurse specialists assisted by applying the inclusion/exclusion criteria and 
introducing the study to the patients in person using a standardised study 
description. If patients agreed to be contacted, the nurse specialist filled in a 
referral sheet. On receipt of signed referral sheets, questionnaire packs including 
information sheets, consent forms, and the questionnaire itself were sent to the 
patient via the postal system. The failure of this mode of recruitment was 
reportedly through pressure of work on the part of the nurse specialists. A new 
recruitment method was developed whereby questionnaire packs were 
distributed without prior verbal consent (see section 3.6.1.1 for details). Not only 
did this new method reduce NHS staff time commitment, but also further 
safeguarded against recruitment bias by ensuring that nurses had a more 
standardised route of patient invitation rather than introducing the study on an 
ad-hoc basis.
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All of these changes were re-submitted to, and approved by, all relevant 
Ethics and R&D committees. The remainder of this methodology section 
(Measures and Procedure) relates only to the amended questionnaire and 
procedures.
3.4 MEASURES
The same questionnaire pack was used at each time point. For each, 
questions were anchored to having received a cancer diagnosis rather than specific 
features of the cancer experience (e.g. treatment) in order to gain a more general 
overview of the whole cancer experience rather than a focussed part of it. By 
anchoring all questions to this one stressor, the study was designed to enable 
investigation of not only the predictive value of each variable, but also temporal 
changes through the cancer experience. Although there was some concern about 
measuring cognitive variables (appraisals, core-relational themes) retrospectively 
(delayed event appraisals could be affected by post-hoc reinterpretations or re­
creations of meaning, and similarly, reports of emotions could reflect these 
reinterpretations, rather than the appraisal of the actual event) when anchored to 
recall of a specific event, this has been promoted as valid way of collecting such 
data in this field, especially over numerous time-points (Bennett etal., 2003).
Participants were not asked to provide detailed clinical information; to 
prevent extra patient burden, and to yield more accurate information, these data 
were extracted from clinical records and databases (see section 3.4.3) with their 
consent
3.4.1 Quantitative Measures
The bulk of the questionnaire included validated quantitative measures. The 
measures used are detailed below.
3.4.1.1 Demographic and personal information
The first section assessed basic demographics including age, socio-economic 
status, presence of a significant other, number of dependents, employment status 
and highest educational qualification held (see appendix 3.8). This information 
was intended for use as a basis for conducting comparative analysis as previous 
research has demonstrated some effects of each of these variables on both 
predictor and outcome variables measured (see section 2.7.4). Patients were also
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asked to provide contact details for their General Practitioner (GP) to enable pre­
follow up mortality checks to be made. Further, patients were asked to provide 
brief details of treatments received to date, although some of this information was 
later found to be inconsistent with clinical data, and not always specific or precise 
enough to be used in a constructive manner.
3.4.1.2 Personality measures
Dispositional optimism was assessed using the Life Orientation Test-Revised 
(LOT-R) (Scheier, Carver & Bridges, 1994), the latest version of one of the most 
popular forms of optimism assessment (appendix 3.9). Of the 14 studies 
measuring optimism within the systematic review, ten of these employed either 
the revised version, the original LOT (Scheier & Carver, 1985), or the French 
language validated FLOT (Allison et at, 2003). The scale has also been validated 
into a number of other languages and for other participant groups including 
Chinese, Japanese, and Portugese and an adolescent scale (the YLOT: Ey, Hadley, 
Allen, Palmer, Klosky, Deptula et al, 2005) to name but a few. The LOT-R is 
repeatedly demonstrated to have high internal consistency, good test-retest 
reliability, and adequate levels of validity (see Scheier etal., 1994; Weinman, 
Wright & Johnston, 1995; and Schou eta l, 2005, for example).
Ten items, such as "In uncertain times, I usually expect the best" (including 
four filler items) are assessed using five-point Likert style scales with high total 
scores representing high optimistic beliefs. Although there have been some claims 
that the LOT-R contains two factors—optimism and pessimism (see, for example, 
Robinson-Whelan, Kim, MacCallum & Kiecolt-Glaser, 1997)—an equal number 
support the idea that only optimism is measured by the scale (e.g. Vautier, Rafaste 
&Cariou, 2003). Therefore, in this study, the measure is used as intended by the 
authors. The range of scores ranges from 0 to 24.
Two models of trait personality are most prominent within the health 
psychology literature: Eysenck's EPQ model (Eysenck & Eysenck, 1975) and the 
*Big Five’ model. For the purposes of this study, the latter model was selected.
Most studies in this area of literature have found inconsistent and contradictory 
findings when measuring the EPQ model. There could be three reasons for this: 
the model could be inapplicable or unimportant to illness adjustment, the measure 
could be invalid, or, the model could be too specific in grouping participants on just
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three main personality dimensions. The Five Factor model, conversely, categorises 
personality on five dimensions, a number of which have not yet been explored 
within this specific area of psychosocial oncology research.
In order to assess the Five Factor personality traits of extroversion, 
neuroticism, openness, agreeableness and conscientiousness, the NEO-Five Factor 
Inventory (NEO-FFI) was used (appendix 3.10). This scale was originally 
developed by Costa and McCrae (1992) and has many formats; the NEO-FFI Form S 
was used here, a shorter, revised, self-report version of the original NEO-PI R 
(Costa & McCrae, 1989,1992). The NEO inventory has wide usage, particularly in 
clinical and health psychology, and behavioural medicine (Costa & McCrae, 1992) 
and demonstrates 'excellent psychometric properties’ (O'Brien & Delongis, 1994). 
The inventory manual reports good internal consistency ratings (a in excess of .56 
for individual facet scales); high retest reliabilities (N a=.87, E a=.91,0 a=.86, A 
a=.66, C a=.92), particularly over longer periods of time; and satisfactory levels of 
content, criterion, convergent and discriminate validity (Costa & McCrae, 1992).
Sixty items, for example "I try to perform all the tasks assigned to me 
conscientiously" or "I tend to be cynical and sceptical of others' intentions", are 
assessed on a five-point Likert scale. Total scores can then be obtained for each of 
the five main factors of personality: Neuroticism, Extroversion, Openness, 
Agreeableness, and Conscientiousness. Total scores for each subscale range from 
0 to 48. Normative data mean scores are as follows: Neuroticism = 24.56, 
Extraversion = 30.49, Openness = 27.82, Agreeableness = 30.14, and 
Conscientiousness = 30.71, although variability is demonstrated in the literature 
(eg. Furham & Bramwell, 2006).
3.4.13 Appraisals, core-relational themes, and emotion themes
This next set of questions enabled testing of the Transactional Model.
Although a number of studies claim to assess appraisals (often using un-validated, 
single item scales created for the purposes of their studies), only one measure 
exists which address each of the three factors of the Transactional Model 
(cognitive appraisal, core-relational themes, and emotion themes). It is later 
versions of this measure that have been used to develop later versions of the 
theory. Smith and Lazarus's measure is rarely used in its entirety, with many 
researchers instead choosing to focus on just the appraisals and core-relational
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themes associated with only six emotions; the so called 'hot' cognitions described 
more fully in section 1.5.
Three main versions of this measure exist. The original lists eight single item 
appraisal components, each assessed on a Likert scale ranging from 1-11, which 
can be distinguished as falling into either primary or secondary appraisal; 54 
statements pertaining to thoughts and feelings about the stressor, each assessed 
on a Likert scale ranging from 1 to 9, which are then grouped into 14 core 
relational theme subscales; and 50 statements pertaining to emotional reactions, 
again assessed on a Likert scale ranging from 1 to 9, which are then grouped into 
18 emotion themes. For the six hot cognitions, published figures of internal 
consistency (a) for core-relational themes ranged from .71 to .95, and those for 
their associated emotion themes ranged from .75 to .90.
In a later modification of the scale, Griner and Smith (2000) alter the 
presentation of the measure. The main appraisal components were not changed, 
but reworded to suit the particular stressor in question. Additionally, rather than 
presenting core-relational themes and emotion themes as individual response 
questions, those statements pertaining to each theme were grouped together and 
participants were required to provide just one Likert style response to each 
cluster. A similar approach was later used by Bennett e ta l (2003) however, this 
included an extra eight appraisal questions. Most subscales are equivalent with 
two exceptions; motivational congruence and motivational incongruence were 
merged into one component, and an extra item of situational relevance was added, 
although the authors acknowledge that this related more to what is at stake, rather 
than an appraisal per se. Test-retest reliability is presented in the 2003 paper and 
demonstrates high reliability for all but one appraisal component (congruence) 
and all but two core-relational themes (irrelevance and optimism). Test-retest 
reliability for the emotion themes was reported to be satisfactory (Bennett et al., 
2003).
No study exists in the literature which compares the utility of the three 
versions, therefore a pragmatic approach was taken and the measure was 
presented in the least time-consuming manner for participants which is most 
comparable to that used by Griner and Smith (2000): Appraisal components were 
presented in the eight single-item format, however, slightly reworded to anchor
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the question directly to the cancer event as a stressor (appendix 3.11); and, core 
relational themes (appendix 3.12) and emotion themes (appendix 3.13) were 
presented in the later clustered format.
Whereas previous research has tended to limit use of these questionnaires to 
investigate only the ‘hot' cognitions, this study explored a much fuller range. Only 
two emotions were excluded—affection and sympathy—as these were perceived 
to be irrelevant to the research question. Therefore, all subscales of appraisal 
components were used (Primary Appraisals: Motivational Relevance, Motivational 
Incongruence, Motivational Congruence. Secondary Appraisals: Self- 
Accountability, Other Accountability, Problem-Focussed Coping Potential,
Emotion-Focussed Coping Potential, Future Expectancy); 12 core relational themes 
were assessed (Other-Blame, Self-Blame, Threat, Loss/Helplessness, Effortful 
Optimism, Success, Self-Consciousness, Relevance, Unexpectedness, Irrelevance, 
Lack of Concern and Removal of Threat); and, 15 emotion themes were assessed 
(Surprise, Guilt, Resignation, Tranquility, Frustration, Self-Directed Anger, 
Challenge/Hope, Regret, Sadness, Shame/Humiliation, Interest, Happiness, 
Boredom/Detachment, Anxiety/Fear, Anger and Relief). See section 3.2.3 for 
theoretical and hypothesised associations between the components.
As these scales often result in a large number of variables, the emotion 
variables were grouped into two sub-scales: positive and negative emotions.
Again, this made the study more comparable with the literature presented in the 
systematic review.
3.4.1 A Health control beliefs
Numerous locus of control measures exist which are best compared 
according to the types of scores created. Whereas some of the early, generic locus 
of control scales (see for example, Rotter, 1966) were analysed in terms of a 
continuum representing how internally or externally focused a person's locus was, 
more recent measures tend to further sub-categorise externality into more 
independent dimensions. Rather than using a generic locus of control scale, for 
the purposes of this study a health-oriented scale was selected.
Therefore, the Multi-dimensional Health Locus of Control (MHLC) (Wallston, 
Wallston & DeVellis, 1978) was chosen to assess how the individual perceives the 
influence of various sources of control over their own health (appendix 3.14).
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Anchored towards the illness specifically, questions such as "Whatever 
improvement occurs with my condition is largely a matter of good fortune", are 
comleted using a six-point Likert responses. Total scores for the sub-scales of 
Internal Health Locus of Control (IHLC), Chance Health Locus of Control (CHLC), 
Powerful Others Health Locus of Control (PHLC) Doctor Health Locus of Control 
(DHLC), and General Others Health Locus of Control (OHLC) are obtained, which 
typically demonstrate alpha levels ranging from 0.67 to 0.77 (Wallston, Malcarne, 
Flores, Hansdottir, Smith, & Stein et al, 1999). In effect, DHLC and PHLC are 
further subcategories of OHLC. Into this scale has been added Wallston et al.'s 
(1999) God Locus of Health Control (GLHC) scale. This component adds a further 
six items to the questionnaire, for example "God is directly responsible for my 
condition getting better or worse", and has high internal consistency (0.87 to 0.94) 
over a range of different illnesses (Wallston etal, 1999).
3,4,1.5 Coping
Coping is an important feature of the Transactional Model as it is thought to 
play a mediating role between cognitive stages of the model and outcome. A more 
traditional approach comprising problem versus emotion focused coping (e.g. 
Lazarus & Folkman, 1987) was not adopted for this study. Instead, the Brief COPE 
was chosen (Carver, 1997) (appendix 3.15). Developed from the much longer 
COPE (Carver, Scheier & Weintraub, 1989), this short version scale consists of 28 
items, each assessed on a four-point Likert scale. The scale has good reliability and 
validity data with Cronbach alphas ranging from .50 to .90 (Carver, 1997).
Individual items are grouped into 14 subscales ranging in score from 0 to 6 
(0-3 per item contributing to each subscale): active coping, planning, positive 
refraining, acceptance, humor, religion, using emotional support, using 
instrumental support, self-distraction, denial, venting, substance use, behavioural 
disengagement and self-blame. In accordance with other uses of the Brief COPE, 
individual subscales can then be merged into two further subscales (based on the 
results of previous factor analysis), those of adaptive coping and maladaptive 
coping (score ranges: adaptive, from 0 to 24; maladaptive, from 0 to 18). Please 
refer to section 1.5 for a discussion of these conceptual categorizations of coping.
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3.4.1.6 Current health status
The Short Form 12 General Health Survey (SF-12: Ware, Kosinski & Keller, 
1996) is a widely used measure to assess current health status (appendix 3.16). 
Rather than being a multi-dimensional measure of quality of life, like its 
predecessor, the SF-36 (McHorney, Ware, Raczek, 1993), the SF-12 aims to provide 
a generic measure of health status, and despite its brevity, the same dimensions 
are assessed with similar accuracy (Jenkinson, Layte, Jenkinson, Lawrence, 
Peterson, Paice et a l , 1997). Extensive testing and confirmation of reliability and 
validity have been reported elsewhere (Ware etal., 1996). Twelve items relating 
to health perceptions and functional ability during the previous four weeks are 
assessed using tick box responses. These questions refer to eight-dimensions: 
Physical functioning; Role limitations due to physical problems; Role limitations 
due to emotional problems; Social functioning; Mental health; Energy/Vitality;
Pain; and, General Health Perception. In a rather complex scoring system, scores 
are weighted, totalled, and added to constant values in order to calculate both an 
overall physical health component score, and an overall mental health component 
score.
3.4.1.7 Illness specific cognitions
The Mental Adjustment to Cancer Scale (MAC; Watson, Greer & Bliss, 1989) is 
a very common measure within psychosocial literature. The debate regarding its 
usage has already been covered in section 2.6.3 and the scale remains worthy of 
further independent research studies in order to establish the true content validity 
of the measure. In accordance with the conclusions drawn in the systematic 
review, for the purposes of this study, the scale was included as a measure of 
illness specific cognitive appraisals. In contrast to Smith and Lazarus's appraisal 
components questionnaire which was designed to elucidate appraisals of generic 
stress, the MAC is constructed to directly ask about the cancer experience. Once 
again, rather than using the full measure, the short form version, the MiniMAC 
(appendix 3.17), was used (Watson, Law, dos Santos, & Greer, 1994). The scale has 
been translated into a number of languages, all of which have good psychometric 
properties (e.g. Grassi, Buda, Cavana, Annunziata, Torto & Varetto, 2004).
The scale consists of twenty-nine items, for example "I see my illness as a 
challenge" and "I've had a good life, what's left is a bonus". Each item is assessed
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by four-point Likert style responses to calculate total scores (range of scores for 
each given in parentheses) for five subscales: Helplessness/hopelessness (8 to 32); 
Anxious Preoccupation (8 to 32); Fighting Spirit (4 to 16); Cognitive Avoidance (4 
to 16); and, Fatalism (5 to 20).
3.4.1.8 Quality of life
As concluded in the systematic review, a plethora of quality of life measures 
are available for use; some generic, others cancer-specific. For the purposes of this 
study, a cancer specific measure was deemed to be most clinically informative. Of 
the numerous measures available, two stand out as being the most popular, the 
Functional Assessment of Cancer Therapy (FACT-G: Celia, Tulsky, Gray, Sarafian, 
Linn, Bonomi et al, 1993) and that devised by the European Organisation of 
Research in the Treatment of Cancer (EORTC QLQ-C30: Aaronson, Ahmedzai & 
Bullinger, 1991). Although a recent comparison of the FACT-G and the EORTC 
QLQ-C30 (Rodary, Pezet-Langevin, Garcia-Acosta, Lesimple, Lartholary &
Kaminsky, 2004) claimed the QLQ-C30 to be a slightly more acceptable measure, 
the results also demonstrated that overall patient preference was relatively equal 
to each scale. At the time of proposal the FACT had validated cancer-specific 
component sub-scales for cancer types included in this study, whereas those for 
die EORTC were still in development. Therefore, the FACT was chosen (appendix 
3.18).
The FACT-G consists of 28 items. Questions include, "I am bothered by side 
effects of treatment" and "I am losing hope in the fight against my illness" are 
assessed using five-point Likert style scales. The FACT-G is multi-dimensional, and 
therefore, the total score can also be divided into four sub-scales: Physical well 
being, social/family well being, emotional well being, and functional well being.
For each different cancer site, the appropriate domain 'additional concerns' will be 
added: FACT-C (colorectal), FACT-P (prostate), FACT-B (breast), and FACT-L 
(lung) (appendices 3.19 to 3.22 respecitvely). Alpha levels for the individual scales 
are upwards of .66 in a range of different samples, with a total scale alpha level 
reported at .85 to .91 (Ward, Hahn, Mo, Hernandez, Tulsky & Celia, 2004).
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3.4.1.9 Anxiety and depression
The Hospital Anxiety and Depression Scale (HADS: Zigmond & Snaith, 1983) 
is perhaps the most commonly used measure of assessment of anxiety and 
depression within clinical populations both in primary and secondary care 
(appendix 3.23). Not only does the measure perform well in generic medical 
research but it is specifically successful when used within samples of cancer 
patients (for example, see Nelson etal, 1994; Skarstein etal, 2000; Hassannein et 
al, 2001, 2005). Although the systematic review (Chapter 2) highlighted a number 
of other measures of anxiety and depression, some of which were used more than 
the HADS, in respect to clinical applicability the HADS was deemed better; not only 
is it used more commonly in medical based research than, for example the Profile 
of Mood States (POMS: McNair, Lorr, Droppleman, 1971), but also has guidance for 
standardised and validated clinical cut offs. Cronbach alphas are reported at levels 
up to .76 for the anxiety sub-scale, and .60 for the depression sub-scale (Zigmond 
& Snaith, 1983). The questionnaire is also demonstrated to have good validity 
against psychiatric assessment of these conditions (Bowling, 2001).
The HADS consists of 14 items (7 anxiety, 7 depression) for example, "I feel 
tense or wound up" and "I have lost interest in my appearance". Each item is 
assessed using Likert style response (0 to 3) and total scores calculated ranging 
from 0 to 21. Scores of seven or less are considered to be within the 'normal' 
range; those between eight and ten are considered doubtful, these are those 
individual that show some signs, but not a clear clinical pattern; scores ranging 
from 11 to 21 are considered definite clinical cases (Zigmond & Snaith, 1983).
3.4.2 Qualitative Component
The nature and length of the questionnaire had potential to cause significant 
emotional reactions from the participants. Furthermore, when asking such 
emotive questions in the restrictive ways imposed by Likert scales, there was an 
anticipation that participants may not have a chance to communicate all that they 
wanted to. Therefore, participants were given extra space at the end of the 
questionnaire to make any additional comments which they felt were relevant. 
Patients were invited to make comments with the following instruction:
Please use this space below to make any additional comments that you 
feel are relevant to this study. This may be a more detailed response 
to particular questions (if so, please try to indicate which one), a 
description of how answering the questionnaire made you feel, or 
anything else at all regarding your cancer diagnosis that you may feel 
to be important to this study, and you would like to share with us. If 
nothing else, you may wish to simply record how you are feeling to get 
things off your mind. As with the reminder of the questionnaire, 
anything that you write here will be kept entirely confidential, so 
please do feel able to speak freely about any of your thoughts, feelings, 
and emotions.
This also allowed the participant an opportunity to write about their feelings 
and emotions following questionnaire completion. Acting in part as an emotional 
debriefing session (in absence of the presence of a member of the research team), 
this section was also anticipated to be beneficial to both the patient's psychological 
wellbeing following participation, and to the researchers in analysis of possible 
reasons why certain patterns of answers were given. Furthermore, it was 
expected that some comments would be made regarding more methodological 
issues which were anticipated to be useful for analysis of drop-out from the 
current study, and in planning future research.
Answers to this question were not expected to be sufficiently detailed to 
allow the use of complex interpretative methodologies such as grounded theory 
(Strauss & Corbin, 1990) or interpretative phenomenological analysis (J. Smith, 
2003). A simple content (thematic) analysis was planned.
3.43 Clinical Data
The following clinical data were collected for each participant:
1. Specific cancer cell type
2. Tumour stage at diagnosis
3. Treatment plan at diagnosis
4. Type of referral (Urgent suspected cancer (USC)/Non USC)
5. Date of histological diagnosis
6. Waiting time to treatment
Inclusion of items one, two, three and five was based primarily on the results 
of systematic review (Chapter 3). By including similar data to other studies, 
findings will be comparable with the literature. Additionally, as the review had 
highlighted the possibility that these may act as tertiary variables, attempts to fully 
control for the effects of them was intended. Items four and six were not explored 
within those studies in the review. However, given that the other clinical data may 
have a tertiary effect, then it is reasonable to assume that type of referral made and 
waiting time to treatment may have similar effects.
Due to smaller numbers, for those recruited from Centres B and C, the data 
were provided by the nurse specialists involved with recruitment. For the much 
larger sub-sample of patients recruited from Centre A, data were collected by the 
candidate with assistance from Trust Cancer Services. Using demographic data 
provided in questionnaires, unique patient identification numbers were identified 
using the Trust PAS (Patient Administration Service) Database. From these, staff 
in Cancer Services were able to use the CAN ISC database to extract type of 
diagnosis (4) and treatment delay (6). Cancer Services were able to provide 
researchers with access to MDT meeting minutes from which type of diagnosis (1), 
stage of diagnosis (2) and treatment plan at diagnosis (3) could be extracted.
Finally, the Histology Department in the Trust were able to provide access to the T- 
PATH database from which exact dates of histological diagnosis were extracted.
34.4 Questionnaire design
Questionnaire-based surveys are known to suffer from poor response, 
especially within a population as vulnerable as those with an illness as potentially 
Me threatening as cancer. In order to increase response rate to this study, the 
questionnaire was designed in accordance with findings from a meta-analysis of 
postal survey response rates (Edwards etal., 2002). Thus, questionnaires were 
printed on pale yellow paper; the length was minimised as much as possible 
Without threatening content; letters were personalised and printed on Trust 
headed paper; envelopes were addressed by hand; pre-paid reply envelopes were 
provided for return of questionnaires; reminders were posted four weeks after 
> initial approach, at each time point; demographic items (those easiest to answer) 
f. were presented first; and, the study was introduced to potential participants by 
CNSs (an individual familiar to the patient). Edwards et al. (2002) also list a
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number of other factors which may be influential in improving response rates 
including the giving of incentives, postal by recorded or hand delivery, and making 
contact before delivery of questionnaires. The first two issues were discounted 
from this study for practical financial reasons; regarding the latter factor, pre­
contact was not possible until consent was provided and to have added another 
stage, whilst possibly improving response rate, would have substantially 
lengthened the time taken to recruit the sample, thus reducing the number of 
people that we were able to follow-up within the time constraints of the project.
3.4.5 Psychometric properties
Although the selection of measures used in this study was based in large part 
on the reliability data in the published literature, statistical tests were carried out 
to test the internal consistency of all psychological measures used. Such tests 
allow investigation of anomalies in how these measures performed within the 
current sample. Table 3.2 summarises this data which can be compared with the 
published data in section 3.4.1.
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Table 3.2. Cronbach alpha reliability statistics calculated from  the current data set
Measure (subscale) Reliability
alpha
Life O rientation Test (Revised) .74
NEO-FFI
Neuroticism .81
Extroversion .78
Openness .66
Agreeableness .64
Conscien tiousness .80
Emotion Themes
Negative .83
Positive .70
SF-12 (H ealth  Status)
Mental .55
Physical .70
MHLoC Scale
Internal .73
Chance .72
General Others .63
Doctor .38
Other People .63
God .91
MAC Scale
Hopelessness/helplessness .78
Anxious Preoccupation .90
Fighting Spirit .58
Cognitive Avoidance .72
Fatalism .46
Brief Cope
Active .69
Planning .73
Positive reframing .73
Acceptance .42
Humour .83
Religion .93
Emotional support .72
Instrumental support .73
Self-distraction .55
Denial .70
Venting .54
Behavioural disengagement .56
Self blame .71
Substance use .81
Adaptive .68
Maladaptive .52
I:
FACT-G Quality of life Scale
Physical
Functional
Social
Emotional
.82
.86
.85
.80
FACT Cancer specific quality o f life Subscales
Colorectal
Breast
Lung
Prostate
.02
.45
.35
.31
Hospital Anxiety and Depression Scale 
Depression 
 Anxiety_____________________
.85
.89
Most of these statistics compare favourably with those in the published 
literature and represent sufficient levels of reliability for the current study. LOT 
reliabilities are equivalent and of a good level and NEO-FFI statistics, whilst 
slightly lower than those in the scale manual, are of an acceptable to high level. 
Cronbach alphas for the two emotion theme subscales are high, but as these are 
newly created scales, there are no published comparison statistics. Subscales of 
the MHLC scale were lower than those in the literature, but the God Locus of 
Control scale had reliability equal to the highest published value. The range of 
alpha values found for the Brief COPE were slightly more dispersed than published 
values, however, only one subscale (acceptance) fell below the lowest published 
level. Whilst reliability for the adaptive scale was high, the reliability of the 
maladaptive subscale was disappointingly low.
With regard the SF-12, the mental health component had a low reliability, but 
the physical health component scale was more than adequate. Three out of five 
subscales of the MAC were below published levels, particularly in the case of 
fighting spirit and fatalism.
Reliabilities for the subscales of the FACT-G were much higher than those 
previously reported. Those for the additional concerns were found to be less 
reliable (a all under .45) and, indeed, much lower than published reliability 
statistics for the FACT-B (Brady, Celia, Bonomi, Tulsky, Lloyd, Deasy et al, 1997), 
FACT-L (Celia, Bonomi, Lloyd, Tulsky, Kaplan & Bonomi, 1995) and FACT-P (Esper,
J Mo, Chodak, Sinner, Celia & Pienta, 1997) subscales. The FACT-C (Ward, Hahn, Mo,
i  Hernandez, Tulsky & Celia, 2004) subscale performed especially poortly with a
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Cronbach alpha of just .02, By observing alpha statistics in our data, no particular 
item was responsible for reducing the reliability of these subscales within the 
current data set and, therefore, scale reliability could not be improved. These 
subscales were not used in the analysis; quality of life measures were taken from 
just the FACT-G and it's associated subscales for physical, social, functional, and 
emotional quality of life.
Reliability on both anxiety and depression subscales of the HADS were higher 
than published data.
3.5 PARTICIPANTS
3.5.1 Sample size calculation
Sample size calculations are necessary to ensure that analyses are adequately 
powered. Power refers to the probability that the proposed analyses will correctly 
distinguish between the null and experimental hypotheses (Rossi, 1990). A null 
hypothesis is always one of equilibrium, in other words, that there will be no effect 
found (where effect could be an association, difference, regression coefficient etc.) 
(Field, 2009). Where a null hypothesis is wrongly rejected, or where an effect is 
concluded to exist where it actually doesn't, it is said that a Type I error has been 
committed; a Type II error is one where a significant effect is concluded, where in 
feet, this isn't the case (Rosnow & Rosenthal, 1989; Loftus, 1996). The Greek letter 
a is used to represent the probability of a Type I error occurring and the letter p is 
used to represent the probability of a Type II error occurring. Within psychology, 
standard levels of a=.05 and p=.20 are used. Power calculations are more strongly 
geared to minimisation of a Type II error, therefore, a power level of .80 (1- p) is 
- considered acceptable. (Loftus, 1996). Power is determined by three factors:
I  sample size, effect size, and alpha level (Rossi, 1990). Given that a and p are 
J known entities, estimates of effect sizes from previous research can be used to
hV calculate the required sample size for new research (Wilkinson, 1999). Sample 
I  size calculations are typically based on the analysis requiring highest sample size 
4 pertinent to the primary outcome variables.
In this study, each of the three outcomes (anxiety, depression and quality of 
? ttfe) were given equal weighting in terms of importance but the theory testing 
element was considered secondary to this aim. As regression analyses were
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planned for this question, study sample size calculations were based on the 
minimum number of participants required to sufficiently power multivariate 
linear regressions. It was estimated that fewer than 20 variables would be entered 
into each analysis after prior selection based on correlation data (for more detail, 
see section 3.6.3). External advice on sample size calculations and the proposed 
analyses was sought from both statistical and health psychology experts.
Simultaneous entry of all assessed variables into a regression would be 
impossible due to collinearity and potential loss of power. In two cases (emotions 
and coping), the use of grouped variables were planned; although composite 
scores lose depth of data (as reported in the systematic review), in this case it 
seemed justifiable as neither grouped variable was a primary outcome variable. 
Rather, with regard to coping, instead of using scores from each coping subscale, 
the larger maladaptive and adaptive categories were used (perhaps not an ideal 
scenario (see section 1.5) but a necessary compromise). Similarly, rather than 
considering each emotional reaction, grouped totals of positive and negative 
emotion were used. Initial analysis was proposed to consist of a number of 
correlation analyses between all predictor and outcome variables. Those 
variables found to be significantly related with outcome (at p<.01) were then to be 
altered into regression models (see section 4.5.1.3 for further details of the 
statistical plan). Although minimising the number of variables to be entered into 
regression is not the most statistically ideal method (Cohen 1988, cited in Green 
1991), it is a pragmatic method often used within psychological research 
(Tabachnick & Fidell, 2000). Where data collection from large samples is not 
possible, to enter all possible predictors into regressions, whilst being ideal, would 
be pointless as regression models would become too saturated and would simply 
faiL Therefore, some statistical compromise is necessary whilst continuing to 
address substantial research questions in a meaningful and contributory way.
There is a tradition within the behavioural sciences to use standard 'rules of 
thumb' for estimates of sample sizes required for regression analyses, where 
average ratios of five data cases to one variable are required (see for example,
/  Gravetter & Wallnau, 2000; Maxwell, 2000; Tabachnick & Fidell, 2000). Many 
other rules of thumb have been suggested, some as high as a ratio of 25:1 
(Schmidt, 1971, cited in Green, 1991). Green (1991), however, criticises these
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methods of sample size calculation because they fail to take into account 
anticipated effect sizes. In this same paper, Green provides the reader with a list 
of power analysis calculations for various regression scenarios of differing levels of 
effect size, and various numbers of predictor variables. The calculations are based 
on Cohen's statistical tables and in his paper, Green compares these to standard 
rule of thumb calculations. Green provides an unequivocal argument for superior 
use of power analysis based sample size calculations.
Due to the proposed method of pre-selection of predictor variables, the 
number, and specific nature, of predictor variables relevant to the regressions was 
unknown until analysis began. As an a priori estimation, however, the total 
number were estimated to range between 15-20 variables. Previous research (see 
Chapter two) typically reports some small, but usually medium effect sizes for 
these type of predictor variables and it was not expected that this study would 
differ substantially from this. Therefore, using Cohen's power based calculations 
(1988, cited in Green, 1991, and Field, 2009), it was deduced that to find a medium 
effect size (R2 =0.13), at a power level of .80 (80% chance of detecting an effect 
within the sample if one truly exists), between 138 and 156 participants (for 15 or 
20 predictor variables respectively) would be required. The greater of these 
figures was, therefore set for the target sample size to ensure that the calculation 
remained as flexible and conservative as possible.
By observing participation rates in similar studies (e.g. Lowe etal, 2003; 
Osoweicki & Compass, 1998) it was possible to calculate an estimated response 
rate in the region of 40%. Accordingly, it was deemed necessary to approach in 
excess of 390 patients. Considering that 25% of patients were expected to be 
excluded from the study, the total number of diagnoses needed to achieve this 
sample size was estimated at approximately 520 new cancer diagnoses.
3£.2 Participant inclusion/exclusion criteria
All patients diagnosed with colorectal, breast, prostate or lung cancer from 
three North Wales NHS Hospitals (where clinical teams agreed to collaborate with 
recruitment) were considered for inclusion into the study.
Although any stage of diagnosis was included, any individuals perceived to 
have advanced disease or a very poor life expectancy at diagnosis (i.e. close to
1 *■ 
i
death) were excluded. Exclusion criteria also prevented the following individuals 
from being approached for the study:
• Those who had been diagnosed with cancer, but whom their 
consultant hadn't yet informed, or who don't seem to understand the 
implications of their diagnosis.
• Those diagnosed with recurrent cancer.
• Those who had a poor understanding of the English language.
• Those concurrently suffering from any severe developmental, 
learning, or psychiatric conditions which may have impaired their 
understanding of the questionnaire.
• Any individuals unable to provide consent.
• Any individuals perceived to be at particular vulnerability or distress 
risk through participation (i.e. those perceived by the direct care 
team to have reacted to diagnosis with unusually high distress levels, 
to whom receiving this questionnaire may have a negative impact 
upon their ability to deal with their illness).
• Any individuals diagnosed more than six weeks prior.
Inclusion was determined by the CNS using a standardised inclusion matrix
prior to referral into the study (appendix 3.24). This procedure was conducted in 
the presence of the researcher to minimise selection bias and a reason was 
recorded for each individual excluded from the study. Reasons for patient 
exclusion are discussed in section 3.6.5.
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3.6 PROCEDURE OF RECRUITMENT, DATA COLLECTION AND ANALYSIS
3.6.1 Recruitment of participants
16.1.1 Standardised recruitment procedure
Following the period of project development (see section 3.3.2), and 
obtaining all relevant ethical and Trust approvals, participant recruitment and 
data collection became standardised across each clinical team involved in the 
research.
Initial patient identification. On a fortnightly basis, the researcher met with 
each nurse specialist team and the previous multi-disciplinary team meeting 
patient lists were consulted. These lists are a record of all new cancer diagnoses 
for each cancer site, at each hospital. Participation eligibility was assessed by 
cancer nurse specialists according to the previously outlined inclusion criteria. 
Eligible patients were sent questionnaire packs through the post. This comprised 
an invitation letter (appendix 3.25) introducing the study and research team 
(signed by the nurse specialist, and printed on Trust headed paper), an 
information sheet (appendix 3.26), consent form (appendix 3.27), questionnaire 
pack and a freepost return envelope. All documents sent to participant (with the 
exception of the pre-validated questionnaire pack) were produced bilingually in 
both English and Welsh. Translation of the questionnaire pack was not possible as 
this would have involved a lengthy process of re-validation of the new measures. 
No patient invited to participate would have been disadvantaged by this as a good 
understanding of English was stated as inclusion criteria (see section 3.5.2).
Participants were asked to provide consent and return the completed 
questionnaire (approximately 30 minutes completion time) directly to the 
candidate at the university. Each nurse specialist retained a list of patients who 
had been approached for the study each fortnight. This list was checked against a 
list of participants (and refusers) in order to identify non-responders. After four 
weeks, a further questionnaire pack was posted to non-responders to act as a 
reminder. For all questionnaires returned, a letter of receipt was sent giving 
information about follow up dates (appendix 3.28). At the request of the ethics 
committee, letters were also written to each participants' GP informing them of 
their patient's participation (appendix 3.29). This advance information about
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their patients' participation was also important to expedite later contact with the 
GP to check whether the patients were still alive pre-follow.
A flow chart of the recruitment process with total recruitment figures at each 
stage (table 3.2 presents these figures further broken down by both centre and 
cancer type) is presented in figure 3.3.
NO RESPONSE
RESPONSE
NO RESPONSE
No further contact n»229
n=1603 Month GP Check
OK to contact n»153 Patient deaths n=7 
(Since recruitment)
Reminder sent
Inclusion assessment
Diagnosed n«902
Recruited n*160Refusal to participate n * 73
EXCLUDES n=440INCLUDES n«462
Diagnosis communicated to patient
CONTINUED OVERLEAF
Thankyou letter to patient 
Information letter sent to GP
T1 Questionnaire pack distributed
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OK to contact n«153
T2 Questionnaire pack distributed
NO RESPONSE
RESPONSE
NO RESPONSE
No further contact n«1 2
OK to contact n -147 Patient deaths n« 3 
Between 3 and 6
months (10 Total)
T3 Questionnaire pack distributed
NO RESPONSE
RESPONSE
NO RESPONSE
Thankyou letter to patient
Thankyou letter to patient
Completed n»123
Completed n=138
Refusal to participate n *  3
Refusal to participate n»3
6 Month GP Check n-150  
(All except previous mortalities 
and 72 refusers checked)
Fig. 3.3. A flo w  chart diagram o f the recru itm ent process w ith  to ta l numbers o f patients 
involved at each stage.
Follow-up data collection. Prior to sending follow-up questionnaires letters 
were written to each participant's GP (see appendix 3.30) informing them of 
intention to send a further questionnaire. The letter also requested that if the 
patient had died within the past three months, or was close to death, that they 
inform the research team to avoid any unnecessary upset and distress for families 
of deceased participants caused by receipt of the questionnaire pack (appendix 
4.8). This system worked extremely well and in just two cases, following non­
response from the GP, a follow-up questionnaire was sent to a deceased patient. 
Fortunately, the patient's families were not overtly distressed by this and in each 
case wrote to inform us of the death. Letters of condolence and apology were 
returned by the research team.
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One week prior to the date of the follow-up, a questionnaire was posted to be 
completed and returned using the same procedure as for baseline questionnaires 
such that three and six month follow-up data could be collected. Reminder letters 
were sent two weeks after this if the completed questionnaire was not returned. 
Once each participant had completed their final questionnaire they were sent a 
written debrief sheet with their letter of thanks (appendix 3.31).
Clinical data collection. Each patient was asked to give consent for the 
research team to consult their secondary care medical records in order to retrieve 
accurate data on their clinical condition. All patients provided such consent
3.6.1.2 Clinical teams involved in recruitment
All three centres recruiting patients into the study were similar in that each 
is an NHS funded district general hospital (DGH) providing acute and community 
care in North Wales. North Wales has a largely rural population of 674,498 
people (Office of National Statistics, 2006), and comprises the counties of 
Wrexham, Flintshire, Conwy, Denbighshire, Gwynedd and Anglesey. Centre A is 
the largest of the hospitals and has a total of 697 inpatient beds. Centre B has 684 
acute beds whilst and Centre C has just 468. Within this region, cancer care 
services are currently spread across all three DGHs with surgical, oncology, and 
specialist nurse teams housed in each. Although some treatments are provided in 
each hospital, one (Ysbyty Gian Clwyd) is a specialist cancer centre which takes on 
some treatment of patients from across the entire region. All clinical teams 
(colorectal, breast, lung and prostate) in Centre A participated in recruitment, 
however, recruitment of lung cancer patients was temporarily suspended, for a 
period of four months, whilst the nurse was absent on compassionate leave. A 
short suspension of recruitment of prostate cancer patients also took place; quite 
early on in the project it became apparent that two patients had been sent 
questionnaire packs before receiving a formal diagnosis from the consultant As 
this caused great distress for the patient, their family, and (indirectly) both the 
clinical and research teams, we investigated how this had happened with the 
assistance of the Trust R&D department The first inclusion criterion was that 
patients had to have both received, and seemed to understand, their diagnosis, and 
this had been met. The situation should have been avoidable. It transpired that 
the error was due mainly to communication problems within the clinical team. For
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other cancer sites the nurse specialist was present during a diagnosis consultation 
but this was not the case with the prostate team. The nurse specialist simply 
referred all suitable patients on the multi-disciplinary team meeting list after a 
time delay when one might assume that formal diagnosis had been communicated. 
The ethics committee were informed and consulted with in order to slightly 
modify the recruitment procedure. From this point onwards, before sending 
questionnaire packs to suitable patients, the nurse specialist obtained copies of 
letters which had been sent from the Trust to the patient's GP confirming that 
diagnosis had taken place and that the patient had been fully informed of this. The 
problem did not arise again and thus seemed to have been an isolated incident
In Centre B, only one clinical team participated (Colorectal). The lung cancer 
team did not feel that the study was suitable for their patient group and they felt it 
would cause both too much distress for their patients, and too much additional 
work for their staff. The breast care team were unable to commit their time to the 
study due to a large backlog of work following long term sick absence of one of the 
nurses. Similarly, the prostate nurse took a period of six month sickness leave 
shortly after the project was set up within this trust. On her return, with only a 
few months of recruitment left, it was decided not to pursue recruitment here.
For the colorectal team involved, some problems were experienced regarding 
recruitment, and therefore, in the early stages, recruitment levels were 
comparatively lower. After many discussions with the team, it became clear that 
the nurse specialists felt incredibly uncomfortable trying to recruit patients at this 
early timepoint They perceived their patients to be too vulnerable so soon after 
diagnosis. On confirmation that patients could be approached up to four weeks 
post diagnosis, the nurse specialists began leaving a slightly longer delay before 
approaching patients, which seemed to improve both their attitude towards their 
role in the research, and the actual recruitment rates.
In Centre C, the breast care nurses did not have capacity for any further 
research collaboration due to ongoing commitments. Additionally, we were 
unable to include the prostate team due to a high level of staff turnover amongst 
nurses.
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3.6.2 Participant recruitment rates
Recruitment into this study was challenging. Although this was expected 
given the nature of the both the study and patient group, the conservative sample 
recruitment estimates were still realistic. Recruitment from particular teams was 
especially difficult and many more patients were unsuitable for the study than had 
originally been anticipated. The initial response from patients who had been sent 
a questionnaire pack was 5% lower than estimated: the final response percentage 
was 34.6%. To achieve recruitment in excess of our target sample (156 patients 
were to be initially recruited), therefore, 462 patients were invited compared to 
the estimated figure of 390 study invitations. Perhaps of greatest hindrance to 
recruitment was the number of patients whom nurse specialists excluded from the 
study: patient inclusion rates were estimated at 75%, however, final figures show 
that only 51.2% of all patients were eligible for inclusion. Main reasons given by 
nurse specialists for exclusion are presented in table 3.3. The total number of 
patients diagnosed required therefore increased from an estimated 700 to a much 
higher, 902 diagnoses.
Inclusion rates varied substantially between clinical team (ranging from 
34.7% to 76.0%). It is possible that this could be due to varying impacts of 
different diagnoses (i.e. some diagnoses may be perceived to be more serious, or 
cause greater potential for distress). However, even within cancer type, inclusion 
rates were variable—colorectal cancer inclusion ranged from 34.7% to 62.0% and 
lung cancer inclusion ranged from 38.5% to 61.1%—although clear inclusion 
guidelines were provided, it can be assumed from this variability that inclusion 
decisions may have been subjectively biased by nurses. Recruitment figures 
broken down by both clinical team and cancer type are presented in table 3.4 (a 
simplified version of these, in flow chart format, has already been presented; figure 
33).
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I Tab. 3.3. Reasons given by clinical nurse specialists fo r  patient exclusion.
r Reason Num ber Excluded
Palliative at diagnosis 85
Multiple/other reason 79
Recurrent illness 76
* Advanced illness 60
> IHed before recru itm ent 32
f  Too unwell 26
£  Dementia 17
$  Private patient 15
Too distressed/Vulnerable 11
r Veiy o ld /fra il 11
1 Learning d is a b le d /Illite ra te /n o n  English speaking 9
I Refused tre a tm e n t/e n try  into research 6
Physical co-m orbidity 5
Psychological co-m orb id ity 5
Un-communicated diagnosis 2
Blind 1
! T O T A L  EXCLU DED 440
I
i
The combination of both underestimated rates of inclusion and response, in 
I addition to numerous recruitment problems and temporary suspensions, resulted 
! tea much longer recruitment period than anticipated. Had our original estimates 
been correct, recruitment was expected to take approximately 11 months, 
r Eighteen months were eventually required, thus moving our recruitment end date
it
c from October 2006 to May 2007. Collection of follow-up data was attempted fromI
 ^ ill those initially recruited who hadn't (a) dropped out of the study, (b) died, or (c) 
v were close to death (judged by their GP). Of 147 approached (by December 2007), 
|  123 contributed to this final stage of data collection.
Tab 3.4. Diagnosis, recruitment and follow up statistics.
Centre A Centre B Centre C TotalC'Rectal Breast Lung Prostate C’Rectal C'Rectal Lung
Diagnosed 274 269 72 100 59 50 78 902
Excluded 179 108 28 24 34 19 48 440
% of all diagnoses suitable 34.7% 59.9% 61.1% 76.0% 42.4% 62.0% 38.5% 51.2%
Invited 95 161 44 76 25 31 30 462
Refused 19 20 4 21 1 7 1 73
Non Response 46 72 24 36 15 19 17 229
Total Recruited 30 69 16 19 9 5 12 160
% recruitment (of suitable diagnoses) 31.6% 42.9% 36.4% 25.0% 36.0% 16.1% 40.0% 34.6%
Three month follow up:
Died 0 2 3 0 0 0 2 7
Sent 30 67 13 19 9 5 10 153
Drop out 0 3 0 0 0 0 0 3
Non response 4 0 2 0 2 0 4 12
Response 26 64 11 19 7 5 6 138
% completed 86.6% 95.5% 84.6% 100% 77.7% 100% 60% 90.2%
Six month follow up
Died 1 0 2 0 0 0 0 3
Sent 29 64 11 19 9 5 10 147
Drop out 0 2 0 1 0 0 0 3
Non response 3 5 1 2 2 2 6 21
Response 26 57 10 16 7 3 4 123
% completed 89.7% 89.0% 90.1% 84.2% 77.7% 60.0% 40.0% 83.7%
Summary
Total Invited 95 161 44 76 25 31 30 440
Total Recruited 30 69 16 19 9 5 12 160
Total Died 1 2 5 0 0 0 2 10
Total Drop out 0 5 0 1 0 0 0 6
Total 6 mo responses 26 57 10 16 7 3 4 123
% 6 mo retention 86.6% 82.6% 62.5% 84.2% 77.7% 60.0% 33.3% 76.8%
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3.6.3 Plan of statistical analyses
3.6.3.1 Data input and preparation
All questionnaires were scanned directly into SPSS (v .l l )  databases using 
Teleform software and facilities at the University of Wales, Bangor. Once inputted, 
a random sample (one in every eight datasets) was manually checked against 
paper questionnaires. No errors accountable to Teleform input were detected. 
Clinical data was entered by hand directly into SPSS with 20% double checked for 
accuracy.
Missing data were identified and dealt with using standardised methods 
detailed in scoring and professional manuals for each respective measure. For the 
NEO, missing data was replaced using the neutral response category; for the MAC 
and FACT, mean substitution was used provided that no more than 1 item per 
subscale was missing. For the SF12, no missing data substitution was applied in 
compliance with scoring guidelines (Ware et al, 1996). For the LOT and HADS, no 
missing data guidance is provided and so mean substitution was used, provided 
that no more than 1 item from each subscale was missing. As the COPE and the 
appraisal components and core-relational themes questionnaires were assessed 
using single-item or two-item scales, missing data substitution would have been 
invalid, and was thus not done.
Where necessary, variables were recoded and respective items reverse 
scored. Component sub-totals were then calculated and renamed before the 
databases for each timepoint could be merged to form a single, longitudinal 
dataset
3.6.3.2 Initial data checks
Initially, exploratory statistics were calculated for each variable to ensure 
normality of data, thus defining whether parametric, or non-parametric statistics 
could be used. Most clinical data were approximately normally distributed except 
treatment waiting time; various data transformation (e.g. inverse, logarithmic) did 
not improve the normality of this data, therefore, it was converted into a 
categorical variable with data divided into quintiles (very short wait, short wait, 
medium wait, long wait, very long wait). All personality variables were Normally 
distributed, as were components of locus of control. God Health Locus of Control 
appeared to demonstrate a half distribution only. Following visual analysis of raw
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data and qualitative comments (see section 4.5.3), it was concluded that, in many 
cases, this scale was only completed by non-religious individuals leading to the 
irregular distribution. Therefore, for statistical analyses, this scale was excluded.
The majority of appraisal components, core-relational themes, and emotion 
themes were not normally distributed. This may, in part, be because these were 
single-item psychometric measures. Emotion subtotals (total positive and total 
negative) were normally distributed. Similar transformations were carried out on 
the non-Normally distributed individual coping subscales, but once again, total 
scores (maladaptive and adaptive) represented Normal distributions. Sub-total 
scores on the MiniMAC demonstrated near Normal distributions.
Individual FACT subscales were not normally distributed, however, total 
FACT-G scores were. HADS scores were converted into categorical data using 
recommended clinical cut-off scores (Zigmond & Snaith, 1984). These scores were 
used for descriptive analysis. However, for richness of data, raw HADS data was 
also used in its original format as only a marginal positive skew was evident.
3.6.3.3 Data analysis
Initial descriptive statistics on demographic and clinical variables were 
performed to provide an accurate sample description. Univariate tests were 
conducted between clinical, demographic and psychological variables using a 
variety of tests including t*tests and Analysis of Variance (ANOVA); their non- 
parametric equivalents, Mann-Whitney U tests, and Kruskal-Wallis tests; and, Chi 
squared cross tabulation analyses. Comparative analysis was also performed 
between responders and non-responders, and also those who died during the six 
months of study. Paired-samples statistical tests and ANOVA were also used to 
investigate changes in outcome scores over time in order to gain an accurate 
clinical representation of the sample.
Objectives one and two. Bivariate correlations (Pearson's parametric and 
Spearman's Rho non parametric where relevant) were performed between all 
potential psychological predictor variables (personality and components of the 
Transactional model) and all outcome variables (anxiety, depression and total 
quality of life) to determine which factors were significantly associated. Those 
found to be significantly associated (p<.05) were then entered into a series of 
regression models (one for each outcome variable). Highly inter-correlated
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predictor variables were not selectively excluded from the model; instead, for each 
model multi-collinearity statistics were obtained and will be discussed. Multiple 
regression analyses were employed to test longitudinal predictive relationships: 
time one predictor variables and time two outcomes; time one predictor variables 
and time three outcomes; and, time two predictors and time three outcomes.
Substantial consideration was given to the method of data entry into these 
regression analyses. To recap, the primary purpose of these analyses was not full 
theory testing, but instead a pragmatic approach to identify which potentially 
modifiable variables could potentially contribute to future intervention research 
and clinical application.
Although given due consideration, the use of stepwise regression was 
avoided; due to it's atheorectical, mathematically defined, approach to variable 
inclusion (Osborne, 2000), these techniques are recommended to be primarily 
reserved for analyses aimed at exploratory model building (Field, 2009). There is 
also an argument that stepwise techniques require a much higher sample size to 
variable ratio, therefore, disregarding this method likely improved the overall 
power of the study.
Hierarchical regression was also considered, but there is ongoing debate in 
the literature regarding the specific order in which variables should be entered 
into analysis, particularly where theory is so influentially used in data collection as 
was the case in this study. Tabachnick & Fidell (2007) provide a summary of the 
different standpoints on this issue. The first is that variables should be entered 
based on proximity to the outcome variable; in this case coping would therefore be 
entered first moving backwards through the model. The second is that they should 
be entered based on causality, meaning that in this case, appraisals would be 
entered into the regression first, because the appraisal is formed before the coping 
response in this model. This latter approach reflects the method most closely 
applied in similar studies (Folkman et ai, 1986 and Bennett et ai, 2003, for 
example).
Further confusing this issue is the state of empirical evidence behind the 
Transactional Model; as stated previously, although a well-defined theory, 
evidence for its valid applicability is lacking. Furthermore, there is ongoing 
conflict between which order some components (primarily emotions and coping)
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should appear (see chapter one for further discussion). Choosing to enter 
variables into the regression based entirely on theory was concluded, therefore, to 
be potentially misinformed at this stage of empirical development.
Concurrent entry of all variables at the same time was also avoided; 
Tabachnick and Fidell (2007) further state that where the aim of regression is to 
identify which modifiable predictor variables can best predict a modifiable 
outcome variable, then some distinction should be made between modifiable and 
non-modifiable (e.g. demographic, clinical or control) variables from the outset.
As a best compromise between all of these methods, therefore, a two-block 
multiple hierarchical regression model was used, as suggested in Field (2009). In 
the first block, all non-modifiable and control variables were entered 
(demographics, clinical variables, health status, previous levels of outcome and 
trait personality). The residual level of outcome variable from this block (i.e. the 
proportion of variance not already explained by variables that cannot be changed 
or modified) was entered as the outcome variable for a second regression block 
including those predictor variables which were potentially modifiable (health 
control beliefs, appraisals, emotion, coping etc.). Although there is some ambiguity 
as to what the MAC measures, consensus within the literature implies that 
components of the MAC are modifiable and so these were entered into the second 
block of the regression.
Once again, although some predictor variables were not Normally 
distributed, and additionally, some outcome measures demonstrated skewed 
distributions, analysis of residual outputs demonstrated that hierarchical linear 
regression was an appropriate methodology to use.
Two other forms of regression analysis were considered; first, the use of 
predictor change scores (i.e. changes between T1 and T2 scores rather than single­
point measurement) to predict T3 outcomes, and combinations of both T1 and T2 
variables to predict T3 variables. Neither of these options were considered 
relevant for these specific research questions as previously discussed. Although a 
model requiring predictor variables to be assessed at two time-points may have 
the potential to be more statistically powerful, this would not necessarily infer that 
such a model would be clinically better. Indeed, such forms of multiple-time point 
predictive assessment may be clinically unfeasible as they require more intensive
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psychological monitoring of individual patients over time. Instead, the goal of the 
chosen analysis was to identify individual combinations of variables at discreet 
time-points that would have statistical significance and clinical implementation 
feasibility. In addition to this, changes in predictor variables were furthermore 
considered unnecessary as initial statistical tests demonstrated there was little 
statistical change in these variables over the course of the study.
Objective three. To test whether associated components of the Transactional 
Model vary equivalently over time, correlation analyses were conducted. First, 
change scores were calculated for each variable (between baseline and 6 month 
follow-up). The change scores for associated components were then correlated 
(using Spearman's correlation due to non-normality of the data) in order to 
explore the size and direction of associated change. Bonferroni corrections were 
applied to this data to limit Type I error (Rosnow & Rosenthal, 1989; Perneger, 
1998).
Objective four. In order to investigate theoretical associations between 
appraisal components, core-relational themes, and emotion themes, a series of 
multivariate regression analyses were planned. The concept for these tests was 
based on a modified version of Bennett et ai. 's (2003) testing of the 'hot' 
cognitions. Bennett etal. conducted three step hierarchical regression analyses for 
each emotion whereby theoretically relevant appraisal components were entered 
at step one and theoretically relevant core relational themes were entered at step 
two. As a test of exclusivity of the model, all other appraisals and core relational 
themes were entered using stepwise procedures at step three.
It could be argued that the approach of Bennett et al. is statistically biased as 
initial steps in the regression were 'forced' based on the assumptive theory to be 
tested. That is, the analyses were not data-driven, but restricted by the theory. 
Although the final step does test the exclusivity of each model, this may well be 
biased due to this early 'forced' steps of the regression analysis. A more 
appropriate approach could have used forward stepwise hierarchical regression to 
explore the true relationships provided by the raw data, and then comparing these 
to a further theoretically based regression. This was the approach taken in the 
current study. Of course there are disadvantages to a data-driven approach too, 
primarily that the analyses may become too specific to this particular group of
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participants and so a replication study would find entirely different results. The 
respective advantages of each approach are, therefore, considered in the study 
discussion chapter (Chapter 5).
As with Bennett et al.'s (2003) approach, theory tests involved a series of 
three regressions per emotion. In block one, only those appraisals theoretically 
relevant to that specific emotion were entered. The residual level of emotion was 
used as the dependent variable for block two. In this block, the uniquely paired 
core-relational theme was entered. Again a residual dependent variable was 
calculated. This was then used as the dependent variable for block three in which 
all other appraisals and core-relational themes were entered using a forward 
stepwise approach such that the exclusivity of the theory (blocks one and two 
combined) could be explored. The data driven approach had just one block of 
regression whereby all appraisal components and core-relational themes were 
entered concurrently in a forward stepwise approach. For both stepwise 
regressions, the criterion for entry was p=.05 and the criterion for exclusion was 
p=.10). An example of this method (for anger) is presented in figure 3.4.
Overall theoretical and data-driven models were then compared in two ways. 
First, those variables found to contribute in data driven regressions were 
compared to their theoretical counterparts to see if the data gathered here support 
the Transactional Model. Second, the overall variability in emotion explained was 
compared between theoretical and data driven models in order to explore whether 
the theoretical models, or indeed, the data driven approach explained more 
variance, therefore, most accurately representing variable relationships.
As much of the data were found to be non-Normally distributed, alternative 
methods of regression were considered (e.g. binomial logistic, non-parametric). 
However, hierarchical linear regression was piloted on a small number of models 
as it is considered to be a robust statistical test. The Normality assumption for this 
test is assessed against the residual data rather than raw data. Analysis of 
standardised residuals for each of these linear regressions demonstrated Normal 
distributions. Therefore, the use of this methodology was justified and adopted for 
all models of theory testing.
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Theoretically Driven Model Data Driven Model
Step Three:
Remaining
components
Step One: Motivational relevance
Appraisal Motivational incongruence
components Other accountability
(E n te r)
r
Step Two: (Using step 1 residual DV)
Core-relational
themes Other-blame
(E n te r)
(Using step 1 residual DV)
AC: Motivational congruence 
AC: Self accountability 
AC: Problem focussed coping 
potential 
AC: Emotional focussed 
coping potential 
AC: Future expectancy 
CRT: Lack of concern 
CRT: Effortful optimism 
Self-consciousness, 
Relevance 
Unexpectedness 
Irrelevance 
Lack of concern 
Removal of threat 
Self-blame 
Threat
Loss/helplessness 
Effortful optimism
Success
(stepwise)
AC: Motivational relevance 
AC: Motivational 
incongruence 
AC: Motivational congruence 
AC: Self accountability 
AC: Other accountability 
AC: Problem focussed coping 
potential 
AC: Emotional focussed 
coping potential 
AC: Future expectancy 
CRT: Self-consciousness,
CRT: Relevance 
CRT: Unexpectedness 
CRT: Irrelevance 
CRT: Lack of concern 
CRT: Removal of threat 
CRT: Other-blame 
CRT: Self-blame 
CRT: Threat 
CRT: Loss/helplessness 
CRT: Effortful optimism 
CRT: Success
(Step wise]
(Those variables highlighted in bold indicate variables which made significant 
independent contribution to the model at each step)
Figure 3.4. A com parison o f  theore tica lly  and data driven regressions used in testing o f  the 
Transactional Model f o r  anger em otiona l outcome.
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It should be noted that for this specific objective, a cross-sectional design 
using only baseline data was used. Despite a clear emphasis on longitudinal 
designs being expressed throughout the remainder of this thesis, a cross-sectional 
design was used here for two reasons. First, the purpose was not to statistically 
test clinical outcomes; it was to test a purely theoretical hypothesis. The 
longitudinal design recommendation expressed earlier in the thesis was largely 
made with reference to clinical outcome studies, not for theory testing analyses. 
Furthermore, although some longitudinal association would be expected between 
components of this model, the current literature (e.g. Lazarus, 1999) implies that 
changes in these variables would occur rapidly; therefore the three month time-lag 
between longitudinal data collection in this study was considered inappropriate 
for theory testing, and would likely introduce further difficulties in detecting 
relevant effects.
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CHAPTER 4  
EMPIRICAL INVESTIGATION: RESULTS 
4.1 CHAPTER OVERVIEW
This chapter presents all data analyses. Internal consistency data has been 
reported in the methods chapter (section 3.6.3.2) and so will not be repeated. The 
first two sections (4.2 and 4.3) present exploratory analyses of the sample; clinical 
and descriptive data are summarised and comparative analysis is carried out 
between those who completed all three questionnaires and those who died or 
failed to respond. Prevalence of each of the main outcomes within this sample 
then follows (4.4) before analysis of longitudinal changes and inter-correlation 
between the predictor variables (4.5).
Section 4.6 presents data relevant to thesis question three: this contains 
both bivariate and multivariate analyses to establish which psychological predictor 
variables contribute most to each of the main outcomes beyond that predicted by 
clinical, demographic and control variables. This section concludes with a 
tentative analysis of when these variables might most effectively be assessed in the 
clinical setting.
The following two sections (4.7 and 4.8) present data relevant to the theory 
testing aims of the study. Two approaches are taken. In the first, the longitudinal 
data set was used to explore correlations between change scores on supposedly 
associated cognitive and emotional variables. In the second, cross sectional 
baseline data were used for multivariate analyses testing the uniqueness of the 
theoretical relationships propounded by Lazarus (1999). For the latter tests, 
comparisons are drawn between theory driven and data driven models.
The chapter concludes with a thematic analysis of some of the additional 
comments written by participants at the end of the questionnaire. Data were not 
sufficient to analyse all emergent themes and so a more focussed approach is taken 
in exploring comments made related to participants' reflections on their 
participation in this study.
4.2 DEMOGRAPHIC AND CLINICAL DESCRIPTIONS OF THE SAMPLE
Sixty three males and 97 females were recruited, the majority of whom 
(n=134; 83.8%) were from the North East Wales NHS Trust. The mean sample age
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was 64.24 years, however, male patients were generally older than females (Male: 
M=68.35, SD=8.30, R=49-89; Female: M=61.57, SD=10.09, R=35-80; t(158)=4.45 
pc.Ol). No age differences were found with respect to clinical variables except for 
cancer type (F(3,156)=8.89, p<.01) where pairwise comparisons demonstrated 
most difference between prostate and both breast and lung cancer sub-samples 
(with prostate patients tending to be significantly older).
The majority of participants (n=118; 73.8%) identified having a significant 
other and 17.5% (n=28) identified themselves as having dependents. Ethnicity of 
the sample was 100% white-British. Although this is largely representative of the 
ethnic distribution in North Wales—the most recent census (2001) revealed that 
less than 1.2% of the region come from an ethnic minority grouping (National 
Public Health Service for Wales, 2006)—this does represent some limitation when 
attempting to extrapolate the findings to other populations. A wide range of 
qualification status and current employment status were reported.
Recruitment of equal sub-samples of cancer type was not achieved although a 
comparatively higher proportion of lung patients was recruited (colorectal n=44, 
27.5%; breast rt-69, 43.1%; lung n=28,17.5%; prostate n= 19,11.9%; see Chapter 
2, Table 2.4, for comparisons). Although all patients were approached within six 
weeks of diagnosis, there was considerable variability in time between histological 
diagnosis and recruitment (M=46.12 days, SD=24.81, R=l-116 days). Recruitment 
delay from diagnosis is further explored by cancer type in table 4.1; although 
means are relatively equivalent, higher ranges are demonstrated for colorectal and 
breast sub-samples.
Table 4.1. Differences by cancer g roup  in tim e (days) between h isto log ica l diagnosis and 
consent to partic ipa te .
Mean SD Range
Colorectal 46.67 22.90 1-110
Breast 42.88 23.38 9-111
Lung 49.31 34.87 17-110
Prostate 55.41 23.73 27-116
n.b. A ll p a rtic ipa n ts  were approached w ith in  six weeks o f  diagnosis; the 
rem ainder o f  this delay is pa tien t-de lay in re tu rn ing  questionnaires.
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Referral information was available for 144 of the patients recruited. Whilst 
48 (33.3%) were referred as non-urgent suspected cancers, 87 (60.4%) were 
referred urgently. Three were referred privately (2.1%) and four (2.8%) were of 
an unknown referral type. Twenty four of the 69 breast referrals were made 
through the Breast Test Wales screening service. Urgent referrals were more 
commonly used for the breast and prostate cancer patient sub-samples. This latter 
finding can be explained primarily by the explicit clinical presentation of 
symptoms associated with these cancers.
As would be expected, waiting time to treatment was shorter for urgent 
referrals (1-67 days) compared to non-urgent referrals (3-195 days). As 
demonstrated in table 4.2 these waiting times were typically longer for colorectal 
and prostate cancer patients.
Table 4.2. B reakdown o f  differences in tim e to trea tm en t by cancer sub-sample.
Waiting
Time*
Cancer Sub-Sample Total Sample
Colorectal Breast Lung Prostate
Very Short 21% 11.9% 38.5% 26.3% 18.9%
Short 17.9% 28.4% 10.5% 20.5%
Medium 21.4% 26.9% 7.7% 19.7%
Long 11.1% 25.4% 46.2% 5.3% 21.3%
Very Long 28.6% 7.5% 7.7% 44.0% 19.7%
0 See section 3.5.1.2 fo r  defin itions o f  these categories
Just two patients were referred to specialist cancer psychotherapy services, 
although it is likely that others may have received less formal psychological 
support or non-cancer specific psychological referral.
Although site-specific clinical data were not available for all patients, the 
main findings are summarised in table 4.3.
190
w ~ ~
Table 4.3. Clinical description of participants by cancer sub-type.
Colorectal (total n=44)
Clinical Staging
T N M
Specific histology
Neoadjuvant
Treatment
Surgery' Adjuvant
TO 2.8% NO 66.7% MO 100% Moderately differentiated 51.0% Radio. 35.7% Laparoscopic resection 26.2% Chem. 52.3%
T1 2.8% N1 25.0% In situ 26.8% Chem. 21.4% Hemicolectomy 21.4% Radio. 13.6%
T2 33.3% N2 8.3% Well differentiated 12.2% Abdominal perineal resection 19.0%
T3 58.3% N3 0.0% Differentiated 7.3% Total colectomy 14.9%
T4 2.8% N4 0.0% Poorly differentiated 2.4% Sigmoid colectomy 4.8%
Panprotocolectomy 4.8%
Chem. = Chemotherapy; Radio. = Radiotherapy
Breast (total n=69)
Grade I
Clinical Staging
Grade 11 Grade III Metastatic
Specific histology
Neoadjuvant
Treatment
Surgery Adjuvant
19.6% 51.0% 28.0% 1.4% Invasive ductal 55.0% Chem. 4.3% Local excision 54.2% Chem. 8.7%
Ductal in Situ 21.7% Mastectomy 33.3% Radio. 55.2%
Mixed 11.6% Local excision & mastectomy 10.6% Horm. 34.8%
Invasive lobular 7.2% Microductectomy 1.4% Hercep. 1.4%
Invasive metaplastic 1.4%
Invasive mucinous 1.4% Auxiliary node clearance 68.1%
Paget's disease 1.4%
Chem. = Chemotherapy; Radio. = Radiotherapy; Horm = Homone therapy (Taxmoxifen /  Arimidex/  Letrazole); Hercep. - Herceptin
Lung (total n=28)
T
Clinical Staging 
N M
Specific histology
Neoadjuvant
Treatment
Primary Treatment Adjuvant
TO 10.0% NO 66.0% | M0 90.0% Squamous cell 50.0% Chem. 7.1% Chem. 46.4%
T1 20.0% ! N1 0.0% | M l 10.0% Adenocarcinoma 14.3% Lobectomy 17.9% (Chem. 7.1%)
T2 60.0% 1 N2 10.0% ! Non-small cell carcinoma 14.3% Radiotherapy 17.9%
T3 0.0% N3 30.0% | Small cell mesothelioma 7.1%
T4 10.0% | N4 0.0% !
ii
Carcinoma
Bronchioalveolar carcin. 
Bronchial adenocarcinoma
7.1%
3.6%
3.6%
Chem. = Chemotherapy; Radio. = Radiotherapy
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Table 4.3. Clinical description of participants by cancer sub-type (continued).
Prostate (total n=l 9)
T
Clinical Staging
Gleason PSA
Specific histology Treatm ent
TO 0.0% 1 0.0% <10 66.6% Adenocarcinoma 59.0% Radiotherapy 38.9%
T1 43.8% 2 0.0% 10-19 16.6% Bilateral adenocarinoma 23.6% Hormone therapy 38.9%
T2 37.5% 3 0.0% 20-29 5.6% Invasive adenocarinoma 12.0% Radical therapy 33.3%
T3 18.7% 4 0.0% 30-39 5.6% Prostatic intraepithelial neoplasia 5.6% Surgery 11.1%
T4 0.0% 5 5.6% 40-49 0.0% Active surveillance 11.1%
6 50.0% 50-59 0.0% Biphosphonate (Zometa) 5.6%
7 33.3% 60-69 0.0%
8 5.6% 70-79 5.6%
9 5.6%
Chem. = Chemotherapy; Radio. = Radiotherapy
4.3 SAMPLE ATTRITION
Of the 160 participants, 38 did not contribute to every timepoint of data 
collection. Exploration of possible differences between these groups is important 
to further investigate the generalisability of these findings.
4.3.1 Drop out and non-responders
For the purposes of this comparative analysis, study drop-out and follow up 
non-responders were merged into a single group totalling 28 participants 
(colorectal n=7; breast n=l 1; lung n=7; prostate n=3). Those participants who 
died were excluded from this analysis. These participants were compared with 
the remainder of the sample on all clinical, demographic, predictor variable, and 
outcome variables but few variables were found to show significant differences: 
Those who dropped out were more likely at baseline to report higher self-blame 
appraisals ((7=1314.5, p=<.05) and, higher regret ((7=1172.0, p=<.05) 
shame/humiliation ((7=1239.5, p=<.05) and anger ((7=1082.0, p=<.05) emotions. 
These findings may indicate significantly more negative cognitive and emotional 
reactions to illness within this group.
4.3.2 Deaths
Ten patients (6.3%) died over the course of this study: one colorectal cancer 
patient; two breast cancer patients; and seven lung cancer patients. This 
difference in frequency of death between cancer type was found to be significant 
(^=25.98, p<.01). Although the higher death rate for lung cancer is not surprising, 
the unequal group sizes mean that following analyses should be considered in a 
cautionary manner. As would be expected, those referred urgently were 
significantly more likely to have died in the study than non-urgent referrals 
(jr  = 14.31, p<.01).
Emotional well-being (measured by the FACT) was significantly lower in 
those who died (t=.219, p<.01). Additionally, those who died also scored higher on 
negative emotion (t=1.94, p=.05) and lower on positive emotion (t=-.196, p=.05). 
Significant differences were also found based on relational meaning at diagnosis 
with those who died scoring higher on 'other blame' (7=431.00, p=.02) and 
'loss/helplessness' ((7=376.00, p<.01). Those who died also scored higher on 
hopeless/helplessness (t=2.41, p=.02) as measured using the MAC, and also
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reported less behavioural disengagement ((7=519.00, p=. 03) and more self-blame 
((7-=466.00, p=.02) on the BriefCOPE.
Baseline scores of depression and anxiety were also higher in those who died 
(t=3.266, pc.Ol and t=2.38, p=.02 respectively). No other significant differences 
were found in those that died.
Taken together, these findings may imply a possible relationship between 
negative adjustment (higher negative emotion, increased HADS scores, decreased 
quality of life etc.) and survival. This tentative finding, however, should be treated 
with caution: these effects may be spurious in nature arising as a result of multi­
comparison tests.
4.4 PREVALENCE OF ANXIETY, DEPRESSION AND QUALITY OF LIFE
In order to explore the psychological characteristics of the sample, a number of 
tests were conducted. This section will describe the prevalence of each of the main 
outcome variables—quality of life, anxiety and depression—at each stage of data 
collection. Descriptive statistics for all outcome variables are presented in table 
4.4. Significance levels for stability of each variable are also provided.
Total quality of life is slightly lower at three month follow-up than baseline 
but returns to a higher level by six months. This change was not significant over 
time. Analysis of physical and functional subscales demonstrate a similar pattern 
possibly indicating that the cause of the temporary decrease is physiological in 
nature (three month assessments were typically made during the most intensive 
treatment phase). Over the full six months, a significant decrease in social quality 
of life (Z(106)=-.47, pc.Ol) was observed, however, emotional quality of life 
improved over the course of the study (t(116)=-4.65, pc.Ol). Colorectal, breast, 
and prostate symptom specific subscales improved significantly over time (t(34)=- 
8.19, p<.01; t(48)=-7.05, p<.01; t(ll)= -6 .00 , pc.Ol respectively), with the effect 
clearly most pronounced for the prostate subsample. Whilst there is a temporary 
improvement in lung symptom specific quality of life at three month follow up, this 
then decreases by six months. This is most likely due to the worse prognosis for 
this cancer type. Graphical presentation of these results are shown in figure 4.1.
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Table 4.4. Descriptive statistics (mean, median, standard deviation, standard e rro r and confidence intervals)  fo r  anxiety, depression and qua lity  o f
life a t each tim epoin t o f  data collection. Significance levels represent tests o f  difference between scores a t T1 and T3.
Time 1 Time 2 Time 3 P0
95% Cl's 95% Cl's 95% Cl's
n M Med. SD Lower Upper n M Med. SD Lower Upper n M Med. SD Lower Upper
Quality of life
Total 149 84.63 87.00 14.76 82.24 87.02 134 82.04 85.50 15.93 79.31 84.76 116 86.71 89.00 13.16 84.29 89.13 .76
Physical 155 22.30 24.00 5.31 21.46 23.14 135 20.96 2 2 . 0 0 5.81 19.97 21.95 1 2 0 22.79 24.00 4.47 21.99 23.60 .79
Social 157 24.46 26.00 4.63 23.73 25.20 135 23.18 24.00 5.23 22.29 24.07 118 22.99 24.00 4.51 22.16 23.80 < 0 1
Emotional 153 17.46 18.00 4.94 16.70 18.28 136 18.52 2 0 . 0 0 4.55 17.75 19.29 118 19.50 2 0 . 0 0 368 18.83 20.17 < . 0 1
Functional 155 2 0 . 0 0 2 1 . 0 0 5.99 19.05 20.95 136 19.20 2 0 . 0 0 6.38 18.11 20.28 1 2 0 21.30 2 2 . 0 0 5.14 2 0 . 1 0 21.96 .56
Cancer Site-Specific Quality of Life 
Colorectal 43 13.39 14.00 2.96 12.39 14.21 37 19.35 2 0 . 0 0 4.35 17.78 20.91 35 2 0 . 8 6 2 2 . 0 0 4.74 19.26 22.52 < . 0 1
Breast 6 6 12.49 1 2 . 0 0 5.39 11.16 13.81 64 23.23 25.00 7.09 21.46 25.00 52 24.12 26.50 7.11 22.14 26.10 < . 0 1
Lung 26 15.96 16.00 4.42 14.17 17.75 15 18.72 19.00 5.28 15.80 21.64 1 1 17.09 17.00 4.72 13.92 20.26 .72
Prostate 18 18.46 18.00 4.42 16.26 2 0 . 6 6 19 31.29 33.00 7.46 27.69 34.88 1 2 33.00 34.00 8.25 27.76 38.24 < . 0 1
HADS Scores
Anxiety 158 6.62 6 . 0 0 4.57 5.90 7.34 136 5.78 5.00 4.45 5.02 6.52 1 2 2 5.29 5.00 3.47 4.66 5.90 < . 0 1
Depression 158 3.40 2 . 0 0 3.51 2.84 3.95 136 4.08 3.00 3.65 3.49 4.70 1 2 2 3.41 3.00 3.04 3.96 3.76 . 0 1
*The p-value presented here is the result o f a t-test based (or non-parametric equivalent where relevant) on only the sub-sample who completed all timepoints o f data 
collection and should not be read as a direct test o f comparison between means presented fo r fu ll cross-sectional samples also in the table.
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Qol Subscale
Fig 4.1. Graphical display o f trends over time fo r  a ll QoL subscales (physical, social, 
emotional and functiona l are means from  the fu l l sample: colorectal, breast, lung and 
prostate are means fo r  the ir respective sub-samples) .
As would be expected given that quality of life improved over time, anxiety 
levels significantly decreased over time (Z=-3.49, p=<.01). Depression levels also 
show an overall decrease through the study (Z=-2.45, p=.01) although there was a 
slight non-significant increase in mean score at three month follow up.
To further explore longitudinal changes in anxiety and depression, scores 
were converted categorically according to standardised cut-off scores (Zigmond & 
Snaith, 1983) for normal caseness, borderline caseness, and probable caseness 
(see table 4.5).
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Table 4.5. Number o f participants in each HADS caseness category by time (n=123).
Time One_____
Anxiety Depression
Non-Case 84 1 1 1(68.3%) (90.2%)
Borderline Case 2 1 8(17.1%) (6.5%)
Probable Case 18 4(14.6%) (3.3%)
Missing 2 2
Time Two Time Three
Anxiety Depression Anxiety Depression
87 96 84 99
(73.7%) (82.1%) (75.0%) (88.4%)
17 1 1 2 1 9
(14.4%) (9.4%) (18.8%) (8 .0 %)
14 1 0 7 4
(11.9%) (8.5%) (6 .2 %) (3.6%)
7 8 13 13
For ease of interpretation, these scores are also presented in Figures 4.2 and 
4.3 which display trends of change over time for mean scores of anxiety and 
depression respectively based on baseline caseness categorisation. These figures 
allow a more in-depth analysis of whether different baseline status predicts 
different adjustment patterns over the six months of the study.
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Fig 4.2. Graphical display o f trends over time fo r anxiety (n = ll 0).
Of particular note here are differences between groups. Those originally 
categorised as non-cases, remained that way. Borderline cases show early 
improvement w ith  scores decreasing into the non-case score range by three month 
follow up and stabilising from this point forward, albeit at a higher mean score 
than the original non-cases. Those scoring w ith in  the case range at baseline show
Borderline
continued improvement throughout the study, although the ir mean scores do not 
decrease into the borderline score-range until six month fo llow  up.
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Fig 4.3. Graphical display o f trends over time fo r depression (n= l 10).
There was just a slight increase in depression scores at three month follow 
up for the non-cases, but the ir scores in general remained fa irly stable. Unlike 
anxiety scores, the borderline cases do not show any early improvement; 
remaining stable between baseline and three month fo llow  up, this group do not 
improve un til six month fo llow  up when the ir mean scores fall just w ith in  the top 
end of the non-case score range. Those participants in itia lly  scoring w ith in  the 
clinical caseness range of scores show marked improvement in the first three 
months o f the study w ith  mean scores decreasing by M=3.4, almost enough to 
bring them w ith in  the borderline range. However, between three and six month 
follow up a slight increase in scores is observed again indicating worsening levels 
of depression for this sub-group of participants.
It is im portant to regard these changes over time w ith  caution due to small sample 
sizes in the borderline and case categories, however, they seem to indicate 
different adjustment trajectories depending on in itia l distress levels.
1 9 8
4.5 EXPLORATORY ANALYSIS OF PREDICTOR VARIABLES
Exploratory analysis of the longitudinal changes in, and correlation between, 
each of the psychosocial predictor variables is important to inform and interpret 
later multivariate analyses. Descriptive data for the psychological variables are 
presented in table 4.6.
4.5.1 Longitudinal stability of predictor variables
Standard deviations and ranges for each of the trait personality variables 
indicated a wide spread of scores on each were evident within the sample. As 
would be expected, optimism was found not to be stable over time ( t -2 .72,  pc.Ol) 
but trait personality variables generally were, the only exception being a 
comparison between baseline and later levels of conscientiousness. Similarly, a 
range of scores were reported for health control beliefs. As with personality 
variables, some significant changes over time are reported. General and other 
people subscales of locus of control decreased over time although, in reality, the 
sizes of these differences are minimal.
A much higher level of anxious preoccupation on the MAC was found than for 
any other MAC subscales at baseline. Where the majority of MAC subscales 
remained stable over time, scores on anxious preoccupation were found to 
significantly decrease over time (t= 2.78, pc.Ol).
Surprisingly low scores on appraisals of motivational relevance were 
reported; the appraised importance of the cancer diagnosis seems to be limited 
within this sample. Furthermore, changes on scores of motivational 
(in)congruence indicate that over the course of the study, participants in general 
perceived less incongruence between their cancer and other aspects of their life 
(Z=-5.15, p c .O l). Other-accountability appraisal scores are higher than self­
accountability appraisals. Comparatively higher scores may indicate that 
participants perceived themselves more able to emotionally cope with cancer than 
to practically deal with it. Despite the relatively good clinical prognosis for most of 
this sample, future expectancy scores were low at baseline, and remained this way 
throughout each stage of data collection; participants were not confident of a 
positive outcome.
199
Table 4 5. Descriptive statistics fo r  a ll psychological predictor variables a t each point o f data collection.
Variable CT* 51)
T 1
Min Max CP
T2
SD Mm Max
.. (;T# 7*3
SD Mm Max ...
rsonahtv
Optimism 16.01 5.01 1 . 0 0 24.00 16.49 4.71 3.00 24.00 17.34 4 80 3.00 24.00 ' 0 1
Neuroticism 17.27 7.82 1 . 0 0 38.00 18.53 10.09 0 . 0 0 67.00 15.46 7.66 0 . 0 0 36.00 .30
[{xtroversion 28.92 6.61 13.00 42.00 2 8 . 2 6 7.17 1 1 . 0 0 42.00 28.37 6.48 7.00 42.00 .07
Openness 25.06 5.95 9.00 41.00 25.43 6.27 9.00 40.00 26.24 6.33 8 . 0 0 40.00 .25
Agreeableness 34.47 5.14 19.00 45.00 34.27 5.17 2 2 . 0 0 44.00 34.37 5.08 2 2 . 0 0 46.00 . 2 2
Conscientiousness 36.68 5.97 2 0 . 0 0 48.00 36.48 5.67 18.00 48.00 35.94 5.72 2 1 . 0 0 48.00 <05
Health Locus o f Control
Internal LoC 17.34 5.82 6 . 0 0 35.00 16.38 5.25 6 . 0 0 28.00 16.64 6.17 6 . 0 0 34.00 .14
Chance LoC 21.18 6.35 6 . 0 0 34.00 21.08 7.17 6 . 0 0 36.00 21.27 6.73 7.00 36.00 .39
General Others LoC 28.54 5.03 14.00 36.00 27.13 5.41 1 2 . 0 0 36.00 27.40 5.22 14.00 36.00 < 0 1
Doctor LoC 15.50 2.38 6 . 0 0 18.00 14.82 15.03 2.59 7.00 15.43 2.30 1 0 . 0 0 18.00 .49
Other People LoC 13.04 3.68 3.00 18.00 11.75 1 2 . 1 0 3.94 3.00 11.99 3.86 3.00 18.00 < . 0 1
Mental Adjustment to Cancer
Hopelessness/Helplessness 11.75 3.73 8 . 0 0 26.00 11.60 4.23 8 . 0 0 28.00 11.41 3.80 8 . 0 0 26.00 .79
Anxious Preoccupation 19.75 6.09 8 . 0 0 32.00 18.70 5.61 8 . 0 0 31.00 18.47 5.20 8 . 0 0 32.00 < . 0 1
Fighting Spirit 13.35 2.13 4.00 16.00 12.99 2.38 7.00 16.00 13.20 2.58 5.00 13.00 .89
Fatalism 14.54 2.64 8.75 2 0 . 0 0 14.30 2.85 6 . 0 0 2 0 . 0 0 14.37 2.45 9.00 2 0 . 0 0 .45
Cognitive Avoidance 10.32 2.71 4.00 16.00 1 0 . 1 0 2.81 4.00 16.00 1 0 . 1 2 2 . 6 6 4.00 16.00 .76
Appraisal Components
Motivational Relevance 1.00 / 3.00 1 1 . 0 0 1.00 1.74 5.00 1 1 . 0 0 1.00 1.43 4.00 1 1 . 0 0 .14
Motivational Incongruence 5.00 / 1 . 0 0 1 1 . 0 0 4.50 1.78 1 . 0 0 1 1 . 0 0 4.00 4.37 1 . 0 0 1 1 . 0 0 < . 0 1
Motivational Congruence 8.00 / 1 . 0 0 1 1 . 0 0 8.00 2.42 1 . 0 0 1 1 . 0 0 10.00 2.54 1 . 0 0 1 1 . 0 0 .53
Self-Responsibility 1.00 / 1 . 0 0 1 1 . 0 0 1.00 2.28 1 . 0 0 1 1 . 0 0 1.00 2.23 1 . 0 0 1 1 . 0 0 .78
Other Responsibility 4.50 / 1 . 0 0 1 1 . 0 0 3.00 2 . 1 1 1 . 0 0 1 1 . 0 0 1.00 2 . 2 2 1 . 0 0 1 1 . 0 0 .51
Future Expectancy 2.00 / 1 . 0 0 1 1 . 0 0 2.00 2 . 1 2 2 . 0 0 1 1 . 0 0 2.00 2.25 1 . 0 0 1 1 . 0 0 .46
Problem Focussed Coping Potential 4.00 1 1 . 0 0 1 1 . 0 0 2.95 3.00 1 . 0 0 1 1 . 0 0 4.00 3.09 1 . 0 0 1 1 . 0 0 .15
Emotion Focussed Coping Potential 8.50 / 1 . 0 0 1 1 . 0 0 10.00 1.83 3.00 1 1 . 0 0 9.000 1.92 3.00 1 1 . 0 0 .41
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Table 4 5 Descriptive statistics for all psychological predictor variables at each point of data collection (continued)
Core-Relational Themes
Self Consciousness 6  50 1 . 0 0 BOO 1.00 1 . 2 0 0 . 0 0 BOO 100 1.36 1 . 0 0 9.00 .47
Relevance 1.00 1 . 0 0 9.00 7.00 2.24 1 . 0 0 9.00 7.00 2.25 1 . 0 0 9.00 < 0 1
Unexpectedness 1.00 1 . 0 0 9.00 7.00 2.70 1 . 0 0 9.00 7 00 2.50 1 . 0 0 9.00 .93
Irrelevance 5.50 0 . 0 0 9.00 1.00 1.9S 1 . 0 0 9.00 1.00 2.08 1 . 0 0 9.00 . 0 1
Lack of Concern 1.00 1 . 0 0 9.00 4.00 2.63 1 . 0 0 9.00 5.00 2.82 1 . 0 0 9.00 < 0 1
Removal of Threat 1.00 1 . 0 0 9.00 5.00 2.89 1 . 0 0 9.00 5.00 2.79 1 . 0 0 9.00 < 0 1
Other-Blame 6.50 1 . 0 0 9.00 7.00 1.70 1 . 0 0 8 . 0 0 1.00 1.26 1 . 0 0 7.00 .84
Self-Blame 1.00 1 . 0 0 9.00 1.00 1.45 1 . 0 0 9.00 1.00 1.13 1 . 0 0 8 . 0 0 .92
Threat 3.00 1 . 0 0 9.00 2.00 2.45 1 . 0 0 9.00 2.00 2.25 1 . 0 0 9.00 < . 0 1
Loss/Helplessness 1.00 1 . 0 0 9.00 1.00 1.91 1 . 0 0 9.00 1.00 2.24 1 . 0 0 9.00 . 6 8
Effortful Optimism 6.00 1 . 0 0 9.00 8.00 2 . 2 1 1 . 0 0 9.00 7.00 2.14 1 . 0 0 9.00 .08
Success 1.50 1 . 0 0 9.00 5.00 2.92 1 . 0 0 9.00 6.00 2.59 1 . 0 0 9.00 < . 0 1
Emotion Themes
Surprise 1.00 / 1 . 0 0 9.00 5.00 2.90 1 . 0 0 9.00 6.00 2.77 1 . 0 0 9.00 .71
Guilt 8.00 / 1 . 0 0 9.00 1.00 1.34 1 . 0 0 7.00 1.00 1.59 1 . 0 0 9.00 .80
Resignation 7.00 / 1 . 0 0 9.00 1.00 2 . 0 2 1 . 0 0 9.00 1.00 2.19 1 . 0 0 9.00 .83
Tranquillity 1.00 / 1 . 0 0 9.00 5.00 2.37 1 . 0 0 9.00 5.00 2.28 1 . 0 0 9.00 .54
Frustration 4.00 / 1 . 0 0 9.00 3.00 2 . 6 6 1 . 0 0 9.00 2.00 2.56 1 . 0 0 9.00 .27
Self-Directed Anger 2.00 / 1 . 0 0 9.00 1.00 2 . 2 2 1 . 0 0 9.00 1.00 1.78 1 . 0 0 8 . 0 0 .73
Regret 1.00 / 1 . 0 0 9.00 1.00 1.82 1 . 0 0 9.00 1.00 2 . 0 0 1 . 0 0 9.00 . 8 6
Sadness 3.00 / 0 . 0 0 9.00 3.00 2.63 1 . 0 0 9.00 2.00 2.58 1 . 0 0 9.00 .94
Shame/Humiliation 1.00 / 1 . 0 0 9.00 1.00 1.40 1 . 0 0 9.00 1.00 1.30 1 . 0 0 7.00 .04
Interest 8.00 / 1 . 0 0 9.00 6.00 2.53 1 . 0 0 9.00 6.00 2.63 1 . 0 0 9.00 .90
Happiness 2.00 / 0 . 0 0 9.00 2.00 2.59 1 . 0 0 9.00 2.00 2.54 1 . 0 0 9.00 . 1 2
Boredom/Detachment 11.00 / 1 . 0 0 9.00 1.00 1.24 1 . 0 0 7.00 1.00 1.63 1 . 0 0 9.00 .34
Anger 1.00 / 0 . 0 0 9.00 1.00 2.31 1 . 0 0 9.00 1.00 2.23 1 . 0 0 9.00 .82
Relief 9.50 / 1 . 0 0 9.00 4.00 3.13 1 . 0 0 9.00 5.00 3.14 0 . 0 0 9.00 . 0 1
Hope/Challenge 8.00 / 2 . 0 0 13.49 15.00 3.74 2 . 0 0 18.00 15.00 3.85 2 . 0 0 18.00 .90
Fear/Anxiety 9.00 / 2 . 0 0 18.00 8.00 5.37 2 . 0 0 18.00 8.00 4.94 2 . 0 0 18.00 .13
Total Positive 35.81 10.85 7.00 61.00 36.27 10.46 1 1 . 0 0 71.00 37.54 10.18 15.00 63.00 .09
Total Negative 31.09 15.42 1 1 . 0 0 84.00 30.15 15.32 1 1 . 0 0 71.00 25.50 15.57 1 1 . 0 0 79.00 .73
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Table 4 5 Descriptive statistics fo r a ll psychological predictor variables at each point o f data collection (continued)
Coping
Active Coping 
Planning
Positive Reframing 
Acceptance 
Humour 
Religion
Emotional Support
Instrumental Support
Self-Distraction
Denial
Venting
Substance Use
Behavioural Disengagement
Self-Blame
Total Adaptive Coping 
Total Maladaptive Coping
Health Status 
Physical 
Mental
4.00 / 0 . 0 0 6 . 0 0 4 00 2.97 0 . 0 0 6 . 0 0 4 00 1.77 0 . 0 0 6 . 0 0 . 8 6
100 / 0 . 0 0 6 . 0 0 .100 1.84 0 . 0 0 6 . 0 0 3 00 1.99 0 . 0 0 6 . 0 0 . 2 1
100 / 0 . 0 0 6 . 0 0 3 oo 1.77 0 . 0 0 6 . 0 0 3 00 1.76 0 . 0 0 6 . 0 0 .08
6 .00 / 1 . 0 0 6 . 0 0 6 .00 1.23 0 . 0 0 6  0 0 5 00 1.33 0 . 0 0 6 . 0 0 .97
2.00 / 0 . 0 0 6 . 0 0 2 00 2.03 0 . 0 0 6 . 0 0 2 00 1.91 0 . 0 0 6 . 0 0 .04
0.00 / 0 . 0 0 6 . 0 0 0.00 2.07 0 . 0 0 6 . 0 0 0 00 2.16 0 . 0 0 6 . 0 0 .44
S.00 / 0 . 0 0 6 . 0 0 5.00 1.85 0 . 0 0 6 . 0 0 4.00 1.72 0 . 0 0 6 . 0 0 < 0 1
4.00 / 0 . 0 0 6 . 0 0 3.00 1.81 0 . 0 0 6 . 0 0 3 00 1.85 0 . 0 0 6 . 0 0 .05
4.00 / 0 . 0 0 6 . 0 0 3.00 1.80 0 . 0 0 6 . 0 0 3.00 1.76 0 . 0 0 6 . 0 0 < 0 1
0.00 / 0 . 0 0 6 . 0 0 0.00 1.73 0 . 0 0 6 . 0 0 0 00 1.54 0 . 0 0 6 . 0 0 .43
0.00 / 0 . 0 0 6 . 0 0 1.00 1.45 0 . 0 0 6 . 0 0 0.00 1.33 0 . 0 0 6 . 0 0 .77
0.00 / 0 . 0 0 6 . 0 0 0.00 0.09 0 . 0 0 6 . 0 0 0.00 1.13 0 . 0 0 4.00 .06
0.00 / 0 . 0 0 6 . 0 0 0.00 1.16 0 . 0 0 5.00 0.00 0.99 0 . 0 0 5.00 .93
0.00 / 0 . 0 0 5.00 0.00 1.19 0 . 0 0 6 . 0 0 0 00 0.94 0 . 0 0 5.00 .70
26.25 7.97 0 . 0 0 45.00 25.22 8.08 4.00 46.00 25.58 8.64 2.14 43.00 .09
7.10 4.54 0 . 0 0 24.00 6.74 5.22 0 . 0 0 29.00 6 . 2 2 4.10 0 . 0 0 18.00 .06
42.53 11.55 15.97 62.06 49.60 10.89 17.00 58.94 42.79 10.28 17.60 59.92 .39
49.04 9.89 16.98 63.53 49.60 10.81 15.05 65.08 51.96 8.77 26.56 6 6 . 1 0 .03
these variables were non-norma/ly distributed. Standard deviations are included only fo r  norm ally d istributed data.
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Although a range of scores were reported on the importance of each core- 
relational theme for each participant, analysis of changes over time demonstrated 
significant changes in these cognitions. At baseline, the highest median 
frequencies were for self-consciousness, situational irrelevance, other-blame and 
effortful optimism. At six-month follow-up, however, relevance, unexpectedness, 
lack of concern, threat removal, effortful optimism and success are most frequently 
reported. Whilst those frequently reported at baseline did not significantly 
change, those which were absent but then later became more frequently reported 
represent significant change. Median scores on emotion themes were not found to 
significantly change over time. The most frequently reported emotions were guilt, 
resignation, detachment, fear/anxiety, relief, and hope/challenge reflecting a 
varied emotional response to cancer diagnosis within this sample. Participants 
reported far more use of adaptive coping strategies than maladaptive coping 
strategies, particularly acceptance and seeking emotional support.
Where perceived physical health status was stable, perceived mental health 
status significantly improved over time (t= 2.19, p<.01).
4.5.2 Correlations between predictor variables
A relatively high degree of co-variance would be expected between the 
predictor variables; they are, after all, variations in psychological responses to the 
same stressor. For the current purpose, only predictors at baseline and three- 
month follow-up were used in multivariate analyses. Therefore, correlation 
analysis was conducted between all predictor variables at these timepoints.
Tables 4.7 and 4.8 display the correlation matrices for these variables.
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Table 4.7. Concurrent correlation matrix o f baseline predictor variables (effect size displayed; 0 p<05; 00p<.Ol)
Optimism
Neuroticism
Extroversion
Openness
Agreeableness
Conscientiousness
Internal LoC
Chance LoC
General Others LoC
Doctor LoC
Other People LoC
Hopelessness/Helplessness
Anxious Preoccupation
Fighting Spirit
Cognitive Avoidance
Fatalism
Motivational Relevance
2 3 4 5 6 7
•59" 34" 2 1 " .17* 23" - 1 2
1 . 0 0 -46 " -.24" .33* -35 " 16*
1 0 0 .07 23" 43" -06
1 . 0 0 1 0 05 - . 1 2
1 . 0 0 18* - . 1 1
1 . 0 0 -.30
1.00
Correlation Effect Sixe
8  9 10 11 12 13
-IS 1 0 2 0 * 0 0 •37" -33"
18* -05 - 17* 04 51" 46"
•03 •05 1 1 14 -24" -07
- . 1 0 - . 0 1 06 -05 - 15 - 2 1 "
- 2 1 * -07 03 - 1 1 -24" - 19*
0 0 1 0 19* 0 0 - 1 1 .06
09 14 1 2 1 1 16* .17*
1 . 0 0 .07 - . 0 0 09 24" .15
1 0 0 .73" 90" -.04 .07
1 0 0 34" - 2 1 " -.07
1 . 0 0 08 .14
1 . 0 0 .62"
1.00
Continued overleaf
Table 4.7. Concurrent correlation matrix o f baseline predictor variables (effect stxe displayed; • p<.OS; **p<.Ot)(continued).
18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34
1 Optimism -.01 -.05 -09 - 17* 3 3 - 2 3 - 3 5 - -20* 21* *06 -07 -07 -06 • 2 2 - - 15 - 2 8 - - 3 4 -
2 Neuroticism 12 -.04 .11 .2 6 - -.2 7 - - 18* - 4 2 - 20* 08 08 03 04 08 29** .17* 3 8 - 4 3 -
3 Extroversion .15 .01 -.11 -20* 2 2 - 2 6 - 2 2 - - 15 •03 12 -07 - 11 -07 - 11 -07 - 11 - 18*
4 Openness .12 -.10 .06 04 -08 -02 .04 .01 12 - 2 1 - -00 -02 -02 -08 04 -06 - 14
5 Agreeableness -.00 -.01 - 11 -.20* .02 00 14 -.25 ■05 - 10 •08 00 -09 -.3 3 - -.17* 20* - 20*
6 Conscientiousness .15 -.02 -.10 -.05 .09 .12 13 -.10 -01 14 -40* - 18* - 14 -06 - 14 00 -06
7 Internal LoC -.15 .2 2 - .07 13 -.04 13 -.05 .17* .07 -02 06 10 14 .09 19* 02 .17*
8 Chance LoC .12 -.06 .16 .02 -.09 -.09 -09 10 05 02 .11 12 03 04 -04 06 .13
9 General Others LoC -.04 .01 .08 .11 .09 .05 .01 04 2 7 - 02 -01 19* .18* -.08 - 10 .03 .02
10 Doctor LoC .21* -.14 .13 .60 -.06 14 .07 .10 -.02 .2 2 - 04 08 .09 .17* -.07 -.09 -.05
11 Other People LoC -.067 .12 .3 4 - -.09 .18* .04 .00 1 .06 .2 3 - -01 -.03 .14 -.04 -.07 .07 .03
12 Hopelessness/Helplessness -.03 -.05 -.12 -.01 .18* - .3 5 - -.2 4 - -.4 2 - .2 4 - 10 00 08 -.04 .3 2 - .16* .4 1 - 4 4 -
13 Anxious Preoccupation .70** .08 .5 3 - -.01 .2 4 - - .2 8 - -.2 1 - -.5 0 - .11 2 8 - .2 7 - -.06 - 2 8 - .35** 14 6 4 - .5 6 -
14 Fighting Spirit -.04 4 1 - .14 .07 -.03 .19* .2 8 - .2 2 - - 11 19* .16* .00 -.04 -.03 -.00 -.07 -.08
15 Fatalism .11 OS 3 7 - -.12 .06 -.10 .02 .00 -.07 .14 08 .03 .12 .09 -.02 .02 .05
16 Cognitive Avoidance .05 .2 1 - OS -.13 .05 -.08 -.08 - 10 02 - 13 2 8 - .04 -.04 .12 -.04 .11 .2 2 -
17 Motivational Relevance .5 5 - -.2 2 - -.13 .13 .06 .04 .01 .00 .23* .13 -.13 -.11 -.07 .17* -03 .2 3 - .20*
18 Motivational Incongruence 1.00 -.4 9 - .17* .09 .04 -.06 -.12 .03 .14 .17* -.00 -.07 -.16 .12 -.13 .12 .07
19 Motivational Congruence 1.00 .02 -.12 .07 .12* .07 -.10 -21* -.07 -.01 -.04 .10 -.05 .17* -.13 -.11
20 Self-Responsibility 1.00 .2 5 - -.2 8 - -.11 -.08 2 .6 - -.02 -.09 .03 -.01 .10 .12 .39** .07 .16*
21 Other Responsibility 1.00 -.15 .02 -.11 .01 .15 .03 -.08 .04 .14 .4 7 - .15 .2 8 - .2 4 -
22 Future Expectancy 1.00 .5 1 - .4 9 - -.16* -.08 .11 .03 .12 .3 4 - -.3 8 - -.18* -.36** -.4 3 -
23 PF Coping Potential 1.00 .3 7 - -.13 -.04 -.02 -.01 .01 .2 1 - -.10 .05 -.22** -.29**
24 EF Coping Potential 1.00 -.18* -.12 .01 -.02 .15 .17* -.2 9 - -.09 -.5 3 - -.4 6 -
25 Self Consciousness 1.00 -.02 -.1 .4 5 - .12 .09 .19 .27** .19* .3 4 -
26 Relevance 1.00 -.09 -.02 -.01 -.08 .10 .06 .2 5 - .10
27 Unexpectedness 1.00 .01 .10 .00 .10 -.09 .04 .11
28 Irrelevance 1.00 .3 1 - .3 1 - .09 .2 4 - .03 .13
29 Lack of Concern 1.00 .49** .00 .12 -.19 -.05
30 Removal of Threat 1.00 -.03 .08 -.2 2 - -.09
31 Other-Blame 1.00 .2 7 - .4 7 - .50**
32 Self-Blame 1.00 .13 .3 1 -
33 Threat 1.00 .69**
34 Loss/Helplessness 1.00
Continued overleaf
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Table * 7. Concurrent correlation matrix o f baseline predictor variables (effect sise displayed: * p<OS; **p<.01 J(condnued).
35 36 37 38 39 40
1 Optimism .21** -.05 2 8 " •2 6 " .08 •3 6 "
2 Neuroticism -OS" .00 -4 5 " .50" -03 4 0 "
3 Extroversion .18* 07 11 -09 30 •07
4 Openness .05 - 11 -01 -.17* 19* - 11
5 Agreeableness -.10 -.10 -05 -2 3 " 06 - 14
6 Conscientiousness .14 .02 IS 02 14 -03
7 Internal LoC .15 .09 .17* .22" .21* .24"
8 Chance LoC .13 .18* .11 .05 03 .22"
9 General Others LoC .06 .10 13 -.02 .05 -08
10 Doctor LoC .09 .07 .14 -.05 13 - 14
11 Other People LoC .02 .07 09 .00 -.02 -.02
12 Hopelessness/Helplessness -.14 -.00 -.26" .40" -.11 .32"
13 Anxious Preoccupation .00 -.21* -.30" .66" .06 .56"
14 Fighting Spirit .33" -.02 .25" -.00 .40" .61
15 Fatalism -.08 .07 .00 .98 .00 46
16 Cognitive Avoidance -.04 .03 -.05 .16 .06 3 4 "
17 Motivational Relevance .12 -.00 -.03 .21* .18* .22"
18 Motivational Incongruence .08 -.13 -.15 .12 -.04 .21"
19 Motivational Congruence -.80 .05 .22" -.06 -.01 -.14
20 Self-Responsibility -.03 .09 .07 .16 .08 .13
21 Other Responsibility -.08 .03 -.01 .28" -.10 .18*
22 Future Expectancy .28" .32" .38" -.29" .01 -.22"
23 PF Coping Potential .37" .21* .40" -.07 .12 -.09
24 EF Coping Potential .24" .23" -.07 -.41" .04 -.25"
25 Self Consciousness .06 .11 .09 .20* .02 .07
26 Relevance .17* -.20* .12 .23" .07 .11
27 Unexpectedness .20* .11 .07 .21" .147* .16
28 Irrelevance .12 .13 .31" .03 .02 -.16
29 Lack of Concern .10 .31" .38" -.17* -.07 -.14
30 Removal of Threat .06 .67" -.14 .10 -.01 -.21*
31 Other-Blame -.04 -.00 -.02 .38" -.10 .22"
32 Self-Blame .12 .12 -.23" .32" -.01 .21*
33 Threat -.10 -.23" -.31" .59" .06 .41"
34 Loss/Helplessness -.08 -.07 .36" .57" -.00 .37"
35 Effortful Optimism 1.00 .23" .36" .09 .17* -.06
36 Success 1.00 .38" -.07 .09 -.12
37 Total Positive 1.00 .21* .10 -.25"
38 Total Negative 1.00 .08 .55"
39 Total Adaptive Coping 1.00 .29"
40 Total Maladaptive Coping 1.00
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Table 4.8. Concurrent correlation matrix o f thee month predictor variables (effect size displayed; 0 p<.05; 00p<.Ot)
Optimism
Neuroticism
Extroversion
Openness
Agreeableness
Conscientiousness
Internal LoC
Chance LoC
General Others LoC
Doctor LoC
Other People LoC
Hopelessness/Helplessness
Anxious Preoccupation
Fighting Spirit
Cognitive Avoidance
Fatalism
Motivational Relevance
1.00
Correlation Effect Size
2 3 4 5 6 7 8 9 1 0 1 1 1 2 13 14
-.57- .35** 30- 2 T 24- . 0 0 - 25- - 0 0 07 -05 -49 - -38 - 33-
1.00 -.41- .31- - 2 2 * .27- 1 1 14 - 1 2 - 1 2 -08 54- .47- -.17
1 . 0 0 . 1 2 2 1 * 34- - . 0 1 -09 04 13 -03 •35 - - 16 34-
1 . 0 0 .03 - . 1 2 -07 - 15 •06 - 1 2 - 0 0 •28- -.27- -.07
1 . 0 0 .42- - 14 -03 - . 0 2 1 1 - 1 0 -23 - 0 0 26-
1 . 0 0 - . 0 0 .05 18* 38- - 0 1 -.30- -.04 .32-
1 . 0 0 .04 .19* 1 2 2 0 * - . 0 1 05 19*
1 0 0 .2 1 *
1 . 0 0
1 2
.77-
1 . 0 0
2 2 *
90-
41-
1 . 0 0
.04 
- 23- 
-.30- 
-.13 
1 . 0 0
. 1 0
. 1 0
05
. 1 1
.55*
1 . 0 0
. 0 0
.26-
.29-
.17*
-.33-
.15
1 . 0 0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
Table 4.8. Concurrent correlation matrix o f three month predictor variables (effect size displayed; • p<.OS; **p<.01 J(continued).
18 19 2 0 2 1 2 2 23 24 25 26 27 28 29 30 31
Optimism -.06 .05 - . 0 1 - 13 .26" 26" 37" -.17 •04 -05 -08 16 09 -23"
Neuroticism -.04 .09 .23" .2 0 * -.27" - 2 0 * -46" 13 -03 03 2 1 * - 19* -.2 1 * 17
Extroversion . 1 0 - . 0 2 -.15 - . 1 2 .18* 2 r 24" 04 08 IS -OS - 0 1 .18* 07
Openness .07 - . 0 0 .05 1 2 - . 1 2 -.04 .09 - 15 - 0 2 - 15 -25 " .01 -05 - 1 1
Agreeableness . 1 0 -.07 -.2 0 " -.13 - . 0 0 . 0 2 .04 -.15 05 -05 • 13 -08 -06 - 13
Conscientiousness .05 - . 1 0 -.15 -.15 .13 .09 08 - . 1 1 . 1 0 - 0 2 - 15 - 1 2 -05 -04
Internal LoC -.2 0 * . 1 1 .44" 2 1 * .03 .29" -08 .27" 14 -.05 .06 -08 .13 16
Chance LoC - . 1 1 . 1 1 -.13 - . 0 2 . 0 1 . 0 2 -.04 . 0 1 .2 1 * IS 1 1 .16 . 1 2 .05
General Others LoC .08 . 0 2 -.09 - . 0 2 .18* .06 - . 0 0 -.04 2 2 * 1 1 -.2 1 * . 1 1 .07 -.08
Doctor LoC .2 0 * . 0 1 -.16 - . 1 1 .2 0 * .18* .09 - . 1 0 .27" 16 - 2 2 * .08 16 -.2 1 *
Other People LoC -.03 .07 - . 0 2 .07 . 1 0 -.03 -.04 . 0 2 .16 .07 - 16 1 2 - . 0 2 .04
Hopelessness/Helplessness -.03 . 0 1 .14 .17* -.37" -.32" -.40" .24" -04 .06 15 -.2 0 * -34 " .32"
Anxious Preoccupation .17 -.17 .08 .2 0 * -.28" -.26" -.46" .2 1 * . 1 2 .24" 1 2 -.37" -.2 0 * .19*
Fighting Spirit .07 . 0 2 - . 1 1 - . 1 1 .23" .31" .24" .03 .25" .06 .09 -.09 .13 -.09
Fatalism -.05 .25** -.2 1 * -.06 - . 0 0 . 0 2 .04 .07 .2 0 * . 0 2 - 0 2 .09 -.05 . 0 1
Cognitive Avoidance .05 . 1 0 -.04 . 0 1 - . 0 0 -.07 -.15 . 1 1 -.03 . 0 1 2 0 * -.08 .16 . 0 1
Motivational Relevance .49** -.24" - . 1 1 -.07 .04 .06 -.04 .03 .2 2 * .27" .04 -.13 .08 -.03
Motivational Incongruence 1 . 0 0 -.28" -.27* - . 1 0 - . 0 1 -.11 .05 .07 .15 .25" .08 .03 .03 -.05
Motivational Congruence 1 . 0 0 .06 . 0 0 . 1 1 2 .24" .06 . 1 1 -.05 -.04 .09 .14 .08 -.03
Self-Responsibility 1 . 0 0 .38" -.2 2 " . 0 0 -.27" .24" . 0 0 -.05 .04 -.07 - . 1 0 .18*
Other Responsibility 1 . 0 0 ••Psl -.03 -.29 . 1 2 .05 -.06 -.06 .19* -.13 .2 1 *
Future Expectancy 1 . 0 0 .43" .52" -.15 -.06 .06 -.07 . 1 0 .24" -.32"
PF Coping Potential 1 . 0 0 .45" . 0 2 . 1 0 .05 . 0 1 .07 .2 0 * - . 2 1 1
EF Coping Potential 1 . 0 0 - . 1 2 . 0 1 . 0 2 -.08 .17 .16 -.30"
Self Consciousness 1 . 0 0 . 0 1 .09 .2 1 * . 0 2 .17 .47"
Relevance 1 . 0 0 .19* . 0 2 .08 . 1 1 -.06
Unexpectedness 1 . 0 0 -.05 .08 .15 . 1 2
Irrelevance 1 . 0 0 .15 .04 .16
Lack of Concern 1 . 0 0 ••CM -.08
Removal of Threat 1 . 0 0 .05
Other-Blame 1 . 0 0
Self-Blame
Threat
Loss/Helplessness
Table 4.B. Concurrent correlation matrix o f throe m onth predictor variables (effect else displayed; 0 p*.OS; 00p*.Ol)(continuod).
35 36 37 38 39 40
1 Optimism .29" .17 29" •57 " 16 -.37"
2 Neuroticism -29 " -.24" -29 " 58" - 15 41"
3 Extroversion .2 0 * .2 2 * 32" -.23" 19* -.19*
4 Openness 1 1 .05 .03 30" 1 1 -09
5 Agreeableness -.04 .04 -.07 -.19* 1 1 -.18*
6 Conscientiousness .17 - . 1 1 . 0 2 -.17 .24" -05
7 Internal LoC .08 .17 .29" .07 .26" 24"
8 Chance LoC .09 . 1 0 . 1 0 .13 - 0 0 . 1 0
9 General Others LoC .2 0 * . 1 1 .18* - . 1 1 18* - . 1 2
1 0 Doctor LoC .2 0 * . 1 2 . 1 0 - 15 18* - . 1 2
1 1 Other People LoC .17 .07 .19* -.04 .14 -.09
1 2 Hopelessness/Helplessness -.35" -.30" -.034 .69" -.16 .57"
13 Anxious Preoccupation -.14 -.29" -.17 .63" .15 .50"
14 Fighting Spirit .47" . 1 0 .48" -.2 0 * .47" - . 1 1
15 Fatalism .04 -.04 .28* -.08 .32" -.07
16 Cognitive Avoidance .18* .2 0 * .07 .15 .24" .27"
17 Motivational Relevance .03 . 0 0 .05 .17* . 1 2 .16
18 Motivational Incongruence .04 . 0 0 -.03 .03 - . 1 1 .04
19 Motivational Congruence - . 0 1 .2 0 * .19* -.05 .16 -.05
2 0 Self-Responsibility - . 0 2 .08 . 0 1 .18* .04 .17
2 1 Other Responsibility -.08 - . 0 1 -.15 .25" .03 .19*
2 2 Future Expectancy .28" .25" .33" -.34" . 0 2 -.32"
23 PF Coping Potential .31" .29" .36" -.27" .16 -.2 2 *
24 EF Coping Potential .13 . 1 2 .29" -.51" - . 1 0 -.38"
25 Self Consciousness .04 .18* .09 .28" .04 .15
26 Relevance .26" .14 .24" . 1 0 .32" .17
27 Unexpectedness . 0 2 .14 .24" .24" -.06 . 0 2
28 Irrelevance - . 1 1 - . 0 1 .03 .2 2 * - . 1 1 .15
29 Lack of Concern .04 .31" .24" -.27** -.18* -.28"
30 Removal of Threat .19* .71" .32" -.2 1 * .18* - . 1 0
31 Other-Blame -.06 .03 - . 0 1 .42" - . 0 1 .27"
32 Self-Blame . 0 2 .2 1 * -.05 .26" .06 .28"
33 Threat . 0 1 -.25" -.07 .60" .08 .48"
34 Loss/Helplessness -.25 -.19* - . 2 1 .52" -.07 .39"
35 Effortful Optimism 1 . 0 0 .24" .41" -.27" .39" -.04
36 Success 1 . 0 0 .33" -.2 0 * .13 -.15
37 Total Positive 1 . 0 0 -.23" .17 -.24"
8 Total Negative 1 . 0 0 . 0 2 .55"
39 Total Adaptive Coping 1 . 0 0 .27"
40 Total Maladaptive Coping 1 . 0 0
As expected, inter-correlations between these variables was high with 
approximately 40% of tests demonstrating a significant association across both 
cross-sectional timepoints. Of course, caution is necessary when interpreting these 
results. Due to the vast number of tests, the standard alpha level of p<.05 is not 
suitable; however, a Bonferroni correction to this would minimise the alpha to 
such a great extent that the findings would be meaningless due to the very 
conservative nature of this particularly type of correction (Field, 2009). As this 
section of analysis is oriented on a pragmatic approach to clinical testing, it was 
not considered appropriate to use these results to exclude potentially unnecessary 
variables from the regression analyses in an arbitrary fashion. Instead, collinearity 
tests were run as part of the test to explore whether these inter-correlations are 
potentially problematic. These correlations are, however, referred to when 
interpreting the final regression models.
4.6 PREDICTING CLINICALLY RELEVANT PSYCHOLOGICAL OUTCOMES
In this section, findings will be presented to establish the extent of variance 
explained by potentially modifiable psychological predictor variables. Time-lagged 
analyses will establish whether different predictor variables exert influence over 
outcome at different time-points of the illness adjustment period.
4.6.1 B ivariate analyses of time-lagged variable relationships
Only those predictor variables that significantly correlated with outcome 
variables were entered into regressions, a procedure often used in studies of this 
type and magnitude (Tabachnick & Fidell, 2006). In order to both further 
minimise the number of variables entered into regressions, and to render the 
findings comparable with the literature, computed sub-totals of emotion and 
coping were used rather than the many individual subscales. Highly significantly 
associated predictor variables were not discounted at this stage (see section 4.5.2). 
Instead, statistical tests of collinearity were carried out. None of these 
demonstrated significance, and thus the correlations were not concluded to be 
problematic. As the focus of these analyses was three and six month outcome 
prediction, concurrent associations are not presented. Instead, tables 4.9 to 4.11 
summarise findings from correlation analyses between time one predictors and 
time two outcomes; time one predictors and time three outcomes; and time two 
predictors and time three outcomes, respectively.
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Table 4.9. Associations between predictors at time one, and outcomes at time two.
QoL (T2)_____________ Anxiety (T2]_________Depression (T2)
r P r P r P
Personality
Optimism .30 < . 0 1 -.38 < . 0 1 - . 2 0 . 0 2Neuroticism -.47 < . 0 1 .49 < . 0 1 .39 < . 0 1Extroversion .24 < 0 1 - . 2 0 . 0 2 -.24 < . 0 1Openness .08 .38 - . 1 2 .18 -.07 .46
Agreeableness .33 < . 0 1 -.24 < . 0 1 -.26 < . 0 1
Conscientiousness .08 .38 -.07 .45 - . 1 1 . 2 0
Health Locus o f Control 
Internal LoC .03 .74 .19 .03 . 0 1 .90
Chance LoC -.03 .78 - . 0 0 .93 -.05 .54
General Others LoC . 0 1 . 8 8 -.13 .13 -.06 .50
Doctor LoC .09 .31 -.19 .03 - . 1 0 .25
Other People LoC -.04 .70 -.06 .51 -.03 .96
Mental Adjustment to Cancer
Hopelessness/Helplessness -.40 < 0 1 .39 < . 0 1 .34 < . 0 1
Anxious Preoccupation -.47 < 0 1 .48 < . 0 1 -.39 < . 0 1
Fighting Spirit .06 .47 -.06 .47 -.06 .50
Fatalism - . 0 1 .98 - . 0 1 .92 - . 0 2 .81
Cognitive Avoidance -.03 .72
. 0 1 .93 -.06 .50
Appraisal Components
Motivational Relevance - . 1 0 .23 .07 .43 .13 .13
Motivational Incongruence -.16 .06 .09 .30 .16 .07
Motivational Congruence .18 .04 -.05 .54 -.14 . 1 0
Self-Responsibility -.13 . 1 2 .19 . 0 2 .16 .07
Other Responsibility - . 2 0 . 0 2 .18 .04 . 2 1 . 0 1
Future Expectancy .33 < . 0 1 -.18 .04 -.23 < . 0 1
Problem Focussed Coping . 2 0 . 0 2 - . 1 1 . 2 2 -.14 . 1 1
Emotion Focussed Coping .42 < 0 1 .38 < . 0 1 -.33 < . 0 1
Core-Relational Themes
Self Consciousness -.25 < . 0 1 . 1 0 .25 . 1 2 .16
Relevance -.05 .57 -.03 .75 .06 .48
Unexpectedness .03 .77 - . 0 2 .87 -.03 .70
Irrelevance - . 0 2 .83 . 0 2 .81 .03 .78
Lack of Concern . 2 1 . 0 2 - . 2 0 .03 - . 1 1 . 2 2
Removal of Threat . 1 2 .17 .04 .70 -.06 .51
Other-Blame -.40 < 0 1 .29 < . 0 1 .26 < . 0 1
Self-Blame -.14 . 1 1 . 2 2 . 0 1 .13 .15
Threat -.50 . 1 1 .46 < . 0 1 .33 < . 0 1
Loss/Helplessness -.40 < . 0 1 .38 < . 0 1 .32 < . 0 1
Effortful Optimism .06 .50 -.16 .07 - . 0 2 .79
Success .14 . 1 1 - . 0 0 .97 - . 0 2 .87
Emotion Themes
Total Positive .34 < . 0 1 -.25 < . 0 1 -.28 < . 0 1
Total Negative -.56 < . 0 1 .55 < . 0 1 .53 < . 0 1
Coping
Total Adaptive Coping .07 .41 .06 .50 -.06 .47
Total Maladaptive Coping -.33 < . 0 1 .38 < . 0 1 .25 < . 0 1
Health Status
Physical .26 < . 0 1 - . 1 0 .27 -.24 < . 0 1
Mental .54 < . 0 1 -.50 < . 0 1 -.42 < . 0 1
QoL . 6 8 < . 0 1 -.55 < . 0 1 -.59 < . 0 1
Anxiety -.55 < . 0 1 .73 < . 0 1 .50 < . 0 1
Depression -.56 < . 0 1 .67 < . 0 1 .61 < . 0 1
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Table 4.10. Associations between predictors at time one, and outcomes at time three.
______ QoL (T3)____________ Anxiety fT3)_________ Depression (T3)
 r-___________ £_________ r_________ g_________ r_________ g__
Personality
Optimism .26 <01 .37 <.01 -.14 .14
Neurotictsm -.35 <.01 .54 <.01 .18 .05
Extroversion .19 .05 -.20 .03 -.16 .07
Openness .18 .06 -.15 .12 -.09 .32
Agreeableness .12 .20 -.25 <.01 -.14 .12
Conscientiousness 1 5  n  . n  1 8  , 0 2  8 5
Health Locus o f Control
Internal LoC .01 .91 .15 .12 -.01 .92
Chance LoC .08 .41 .00 .97 -.11 .22
General Others LoC -.08 .39 -.02 .84 .01 .91
Doctor LoC .20 .04 -.15 .12 -.08 .41
Other People LoC -.02 . 8 6  .05 .58 .70 .46
Mental Adjustment to Cancer
Hopelessness/Helplessness -.33 <01 .31 <.01 .22 .01
Anxious Preoccupation -.43 < 01 .46 <.01 .30 <.01
Fighting Spirit .20 .03 -.13 .15 -.17 .06
Fatalism .15 .10 -.02 .82 -.08 .40
Cognitive Avoidance .12 .22 .03 . 7 3  -.14 .12
Appraisal Components
Motivational Relevance -.04 .70 .18 .05 .13 .16
Motivational Incongruence -.12 .20 .20 .03 .16 .08
Motivational Congruence .21 .02 -.17 .07 -.15 .10
Self-Responsibility -.22 .02 .18 .05 .18 .05
Other Responsibility -.31 < 01 .32 .00 .33 <.01
Future Expectancy 3 4  <0, . 2 3  . 2 0  „ 3
Problem Focussed Coping .12 .22 .08 .39 -.01 .95
Emotion Focussed Coping .35 < 01 -.31 < 01 -.21 .02
Core-Relational Themes
Self Consciousness -.14 .15 .17 .07 .13 .16
Relevance *09 .33 .05 .60 .09 .34
Unexpectedness -07 .44 .06 .51 .08 .35
Irrelevance - 10 .92 .07 .44 -.08 .38
Lack of Concern .18 .05 -.01 .31 -.11 23
Removal of Threat .10 .31 .15 .11 - 05 .57
Other-Blame -.38 <.01 .33 <.01 .35 <.01
Self-Blame -15 11 14 .13 .09 .33
Threat -37 <01 .49 <01 .29 <.01
Loss/Helplessness -32 <01 35 <01 .21 .03
Effortful Optimism - 01 .93 -.12 .20 .04 .67
Success .03 .78 .09 .36 .05 .60
Emotion Themes
Total Positive 26 < 01 -15 .12 -.13 .17
Total Negative - 45 < 01 55 < 01 .37 <.01
Coping
Total Adaptive Coping_  .25 02 00 1.00 -.21 .02 
Total Maladaptive Coping - 26 04 .34 < 01 .09 .37
Health Status
Physical
Mental
Outcome ( T l )  
QoL
.33 <01 -25  <01 -.28 <.01
.48 <01 -50  <01 -30  .<01
.65 <01 -60  <01 -.52 <01
..37 <.01 -68 <01 22 .01Anxiety 0 0  ™  ' nl
Depression  :^0_______ S2i-------------42------------------ 12------------ 121
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Table 4.11. Associations between predictors a t time two, and outcomes a t time three.
QoL (T3) Anxiety fT3) Depression (T3)
Personality
Optimism
Neurotic ism
Extroversion
Openness
Agreeableness
Conscientiousness
Health Locus o f Control 
Internal LoC 
Chance LoC 
General Others LoC 
Doctor LoC 
Other People LoC
Mental Adjustment to Cancer 
Hopelessness/Helplessness 
Anxious Preoccupation 
Fighting Spirit 
Fatalism
Cognitive Avoidance
Appraisal Components 
Motivational Relevance 
Motivational Incongruence 
Motivational Congruence 
Self-Responsibility 
Other Responsibility 
Future Expectancy 
Problem Focussed Coping 
Emotion Focussed Coping
Core-Relational Themes
Self Consciousness
Relevance
Unexpectedness
Irrelevance
Lack of Concern
Removal of Threat
Other-Blame
Self-Blame
Threat
Loss/Helplessness 
Effortful Optimism 
Success
Emotion Themes 
Total Positive 
Total Negative
Coping
Total Adaptive Coping 
Total Maladaptive Coping
Health Status
Physical
Mental
.37
-.41
.16
.16
.14
.23
.01
-.06
.06
.03
-.10
-.47
-.56
.15
.08
.03
-.12
-.05
.19
-.15
-.27
.32
.16
.37
-.13
.09
-.21
.01
.12
.16
-.28
-.19
-.23
-.29
.30
.29
.24
-.50
.18
-.24
.44
.33
<01
<.01
.09
.09
.14
.01
.92
.51
.55
.73
.29
<01
<01
.12
•40
.75
.22
.61
.05
.10
<01
<01
.08
<01
.17
.33
.03
.93
.22
.09
<01
.05
.01
<.01
<•01
<.01
.01
<.01
.06
<.10
<.01
<01
-.45
-.56
-.19
-.19
-.20
-.14
.14
.06
.06
.06
.05
.39
.57
-.09
-.02
.16
.21
-.01
.00
.14
.20
-.18
-.12
-.43
-.07
-.02
.09
.05
-.26
-.08
.26
.17
.45
.27
-.08
-.21
-.15
.47
.16
.40
.29
.49
<.01
<.01
.04
.04
.03
.13
.14
.56
.51
.55
.61
<.01
<.01
.32
.84
.09
.02
.95
1.00
.13
.03
.06
.18
<.01
.47
.83
.36
.57
<.01
.39
<.01
.07
<.01
<.01
.41
.03
.19
<.01
.09
<.01
<.01
<.01
-.25
.25
-.13
-.12
-.12
-.05
-.05
-.06
.03
-.04
.06
.33
.39
-.15
-.12
-.09
.02
-.02
-.04
.13
.34
-.25
-.10
-.35
.02
-.14
-.01
-.03
-.01
-.16
.26
.15
.24
.15
-.24
-.30
-.18
.43
-.06
.16
.49
.28
<.01
<.01
.16
.19
.15
.56
.63
.50
.74
.69
.52
<.01
<.01
.10
.21
.34
.86
.84
.75
.26
<.01
.03
.40
<.01
.89
.22
.96
.78
.94
.17
.02
.18
.04
.20
.04
.01
.06
<.01
.54
.09
<.01
<.01
Outcome (T2) 
QoL 
Anxiety 
Depression
.68
-.51
.44
<.01
<01
<.01
-.60
.80
.56
<.01
<.01
<.01
-.58
.38
.66
<.01
<.01
<.01
213
In relation to the outcomes measured, personality was prominent, with a 
number of significant associations between these groups of variables. Although 
openness and conscientiousness rarely feature as significant correlates, 
relationships with optimism, neuroticism and extroversion are more consistently 
associated, particularly for quality of life and anxiety; correlations with depression 
seem far more time-dependent with the six-month time lagged correlations 
dropping substantially in effect size. Where baseline agreeableness scores 
significantly correlated with three month outcomes, this effect was not sustained 
into the remaining correlation analyses.
Correlations between health locus of control and outcome are far less 
important Effect sizes, whilst generally stable across different time-lagged 
analyses, are very low and some even appear inconsistent in direction. Baseline 
scores, for example, are all negatively correlated with three month anxiety, 
however, three month scores are all positively correlated with six month anxiety.
Both hopeless/helplessness and anxious preoccupation subscales of the MAC 
are strongly and consistently significantly correlated with all outcomes, 
independent of time-lag. The effects of fighting spirit, fatalism, and cognitive 
avoidance are less consistent (with regard to statistical significance) and are 
typically reported with much smaller effect sizes.
A high number of appraisal components were significantly correlated with 
outcome in all time-lagged analyses, although comparatively fewer reached 
significance for six month depression from three month predictors. There is a 
tentative indication that secondary appraisals—especially other responsibility and 
emotion focussed coping potential appraisals—are more strongly correlated with 
outcome than are primary appraisals, although some exceptions can be observed, 
for example in the case of correlations with motivational incongruence. Effect 
sizes of correlations between core-relational themes and outcomes are typically 
smaller than for the appraisal components but still around half of these 
correlations reached significance. Again, there is some indication of an outcome 
bias in that these cognitions are more frequently significantly correlated with 
quality of life than anxiety and depression.
Effect sizes of correlations between negative emotion and outcome are far 
higher and more consistently significant than are correlations between positive
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emotion and outcome. Where both subscales are correlated in baseline to three 
month outcome correlations, effect sizes between positive emotion and anxiety 
and depression at six month follow up are much reduced. Similarly, with just one 
exception (baseline predictors and six month depression), maladaptive coping is 
more strongly correlated with outcome than is adaptive coping.
As expected, by far the most consistent and strongest effect sizes are 
reported for correlations using earlier levels of outcome as a predictor variable. 
Both mental and physical subscales of perceived health status are also consistently 
correlated with outcome, although the effect sizes are much higher for correlations 
with mental rather than physical subscale scores.
4.6.2 M ultivariate analyses: predicting anxiety, depression and quality of 
life
The next set of analyses had two purposes. First, to identify which 
psychological predictor variables contributed to the variance in outcome scores 
above and beyond the variance already explained by non-modifiable and/or 
control) demographic, clinical and personality variables. Second, to establish 
whether these significant variables are most predictive when measured at baseline 
or at a later time point. As such, three regression analyses were performed for 
each outcome variable:
• Baseline predictors and three month outcome
• Baseline predictors and six month outcome
• Three month follow up predictors and six month outcome
A detailed consideration of method of data entry into these models has 
previously been provided (section 3.6.3.3). In summary, for each model, a two- 
block design was used. In the first block, all non-modifiable and/or control 
variable were inputted using the enter command. Control variables for this block 
were selected by various means. Demographic variables were selected based on 
the results of the systematic review, just one clinical variable was entered as 
standard: cancer type. Remaining clinical data could not be entered due to data 
limitations (see section s3.4.5 and 3.6.3.2) The remaining clinical data were 
unsuitable for entry into regressions because they either resulted in small sub­
sample groupings (i.e. treatment) or because of too much missing and unavailable 
data (i.e. waiting time to treatment). Previous levels of all outcomes and perceived
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health status variables were selected based on their high level of expected 
contribution to the models; and trait personality variables were selected if they 
had previously been highlighted as significantly correlated (section 4.5.2). Only 
inclusion of personality variables, therefore, distinguished between this block of 
each regression model. The residual level of the outcome not explained by this 
block of variables was then used as the dependent variable for a subsequent block 
of potentially modifiable psychological variables inputted using a stepwise (p in 
=.05, p out = .10) method. Therefore, the R2 output from this block of the 
regression is representative of variance explained in the remaining proportion of 
emotion only; a proportional addition to the true percentage variance explained is 
then calculated. Only those participants with data for all variables (included or 
excluded) in both blocks of the model were included to ensure accurate 
comparison between blocks.
For each model, collinearity diagnostics and plots of residuals were explored. 
No evidence was found that the assumptions of linear regression had been 
violated.
4.6,2.1 Quality of Life
For the three month outcome regression (from time one predictors; table 
4.12) block one—the control variables— accounted for 60.0% of the variance in 
quality of life. Within this block, gender, presence of a significant other, cancer 
type, previous level of quality of life, and anxiety contributed most, however only 
the coefficients for quality of life and anxiety were significant.
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Table 4.12. Regression analysis fo r  quality o f life at three months, from baseline predictors1
Block 1 (Enter)
Unstandardised Model Summary
coefficients
Constant 27.24 21.16
Gender 1.73 2.93
Age -.08 .13
Significant other -.65 2.81
Cancer type 1.26 1.27
Physical health status -.00 .13
Mental health status -.12 .20
Quality of life .66** .15
Depression .32 .63
Anxiety -1.05* .45
Neuroticism -.09 .19
Extroversion .07 .19
Agreeableness .27 .23
Block 2 (Stepwise*)
Constant 3.96 2.21
Negative Emotion -.14 .07*
B SE df R2
12,90 .60 11.34**
1, 101 .04 3.96*
• j k .0 5  • *p < -0 1
•Excluded variables (see appendix 4.1): Optimism; Hope/helplessness; Anxious Preoccupation; 
Motivational congruence; Motivational incongruence; Other responsibility; Future expectancy; 
Problem focussed coping potential; Emotion focussed coping potential; Self-consciousness; Lack o f 
concern; Other-blame; Loss/helplessness; Positive emotion;; Maladaptive coping.
A high number of variables were initially entered into block two, spanning a 
range of appraisals, core-relational themes, emotions, coping, and MAC 
components. However, only negative emotion was included as a significant 
predictor of quality of life; the more negative the emotional reaction to diagnosis, 
the lower the quality of life rating. This block explained 4.0% of the residual level 
of quality of life which equates to an additional 1.6% of the overall variance.
Table 4.13 summarises the findings for the regression analysis predicting six 
month quality of life from baseline predictors. Block one of this model accounted 
for 66.0% of the variance in quality of life. Only baseline level of quality of life was 
a significant contributors to the model (p<.01).
»In all tables that follow in the results section, a total R2 (or percentage equivalent) is not 
provided as to do so required further computation of the R2 for the stepwise block. The 
adjusted percentage variance explained is, therefore, referred to both in text and in the 
summary table (table 4.21) on page 224.
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Table 4.13. Regression analysis fo r quality of life at six months, from baseline predictors.
Unstandardised Model Summary
coefficients
Constant 28.26 17.24
Gender 3.13 2.35
Age .11 .11
Significant other 3.26 2.37
Cancer type -.37 1.09
Physical health status .05 .10
Mental health status -.11 .17
Quality of life .56 ** .13
Depression -.76 .53
Anxiety -.16 .37
Neuroticism -.13 .15
Extroversion -.10 .17
Openness .27 .17
B__________SE___________d f R2
Block 1 (Enter)
1 2 ,8 1  .66 13.00’
Block 2 (S tepw ise')
Constant -2.32 1.38 1 ,9 2  .04 4 .24 ’
Lack of concern .63* . 3 1 ____________________________________
•p< 05 *mp< 0 1
•Excluded variables (see appendix 4.2): Optimism; Anxious Preoccupation; Fighting spirit; Fatalism; 
Motivational congruence; Future Expectancy; Hope/Helplessness; Other responsibility; Emotion 
focussed coping potential; Other-blamc; Threat; Loss/helplessness; Positive emotion; Negative 
emotion; Adaptive coping; Maladaptive coping.
Again, a range of variables was initially entered into block two. Only the core 
relational theme of lack of concern emerged as significant (p<.05). As would be 
expected a higher score (indicative of less concern) and predictive of higher 
quality of life scores. This block explained 4.4% of the residual level of quality of 
life, which equates to an additional contribution of 1.5% of the overall variance.
Finally, table 4.14 summarises the findings for the regression analysis 
predicting six month quality of life from predictor variables measured at three 
month follow up. Block one of this model accounted for 64.0% of the variance in 
quality of life. Once again, both the earlier level of quality of life (p<.01), and also 
age (p<.05) and neuroticism (p<.05), were significant contributors to this model.
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Table 4.14. Regression analysis fo r quality o f life at six months, from three month predictors.
Unstandardised
coefficients
Model Summary
B SE d f R2 F
Block 1 (Enter)
Constant 41.05 16.17 13,75 .64 10.06**
Gender 2.22 2.24
Age .21* .11
Significant other 4.21 2.50
Cancer type -2.08 1.09
Physical health status .23 .13
Mental health status .02 .15
Quality of life .34** .11
Depression -.48 .50
Anxiety -.04 .37
Neuroticism -.28* .12
Extroversion -.19 .17
Openness -.08 .16
Conscientiousness .14 .19
Block 2 (Stepwise-)
Constant -.84 3.35 4, 84 .26 7.45**
Adaptive coping .24* .09
Unexpectedness -.85** .28
Other responsibility -.13** .44
Threat .68* .32
•jx.OS • •p<.0 \
•Excluded variables (see appendix 4.3): Optimism; Hope/helplessness; Anxious Preoccupation; 
Motivational congruence; Self responsibility; Future expectancy; Problem focussed coping potential; 
Emotion focussed coping potential; Effortful Optimism; Threat removal; Other-blame; Self-blame; 
Loss/helplessness; Success; Positive emotion; Negative emotion; Maladaptive coping.
Four variables emerged as significant predictors of the residual level of 
quality of life: adaptive coping, other responsibility appraisals, and the core 
relational themes of unexpectedness and threat. This final block explained 26.0% 
of the residual level of quality of life, an additional 9.4% of the overall variance in 
addition to the 64.0% explained in the first block.
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16.2.2 Anxiety
The three statistical models for anxiety follow. The first (table 4.15) shows 
that the control and non-modifiable variables at baseline account for a total 68.0%  
of the variance in anxiety at three month follow-up. Only previous levels of quality 
of life and anxiety emerged as significant contributors to this model (p=. 04 and 
<01 respectively).
Table 4.15. Regression analysis fo r  three month anxiety from  baseline predictors.
Unstandardised Model Summary
coefficients
Constant 1.59 5.06
Gender 1.24 7.2
Age .04 .03
Significant other -.81 .67
Cancer type .20 .31
Physical health status .03 .03
Mental health status .06 .05
Quality of life
•00o .04
Depression -.09 .15
Anxiety .66** .11
Neuroticism .06 .05
Extroversion -.03 .05
Agreeableness -.05 .06
Block 2 (Stepwise')
Constant -.211 .37
Self-responsibility .28** .10
Other-blame -.26* .13
B_________SE__________d f R2
Block 1 (Enter)
12,91 .68 15.84**
2, 101 .10 5.56 * *
*/K. 05 •*p<01
•Excluded variables (see appendix 4.4): Optimism; Hope/helplessness; Anxious Preoccupation; Other 
responsibility; Future expectancy; Emotion focussed coping potential; Doctor locus o f control; Lack o f  
concern; Self-blame; Threat; Loss/helplessness; Effortful optimism; Positive emotion; Negative 
emotion; Maladaptive coping.
In block two, higher self-responsibility appraisals and lower core-relational 
theme other-blame scores were predictive of 10.0% of the residual level of anxiety. 
This contributes an additional 3.2% to the overall variance.
Of the control variables for the six month time-lagged analysis (table 4.16), 
only age and baseline anxiety were significant contributors to this model. 
Nonetheless, this first block of variables together explain 67.1% of the variance in 
six month follow up anxiety levels.
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Table 4.16. Regression analysis fo r  six month anxiety from  baseline predictors.
Unstandardised Model Summary
coefficients
Constant 8.08 4.29
Gender .09 .59
Age -.02 .03
Significant other -.08 .58
Cancer type .11 .26
Physical health status -.04 .03
Mental health status .01 .04
Quality of life -.05 .03
Depression .06 .13
Anxiety .46** .09
Neuroticism .07 .04
Extroversion .01 .04
Agreeableness -.03 .05
Block 2 (Stepwise*)
B_________ SE___________d f R2
Block 1 (Enter)
12,83 .67 14.08**
•JK.05 * * p <  01
•Excluded variables (see appendix 4.5): Optimism; Hope/helplessness; Anxious Preoccupation; 
Motivational relevance; Motivational incongruence; Motivational congruence; Self responsibility; 
Other responsibility; Emotion focussed coping potential; Self-consciousness; Other-blame; Threat; 
loss/Helplessness; Negative emotion; Maladaptive coping.
None of the additional psychological predictors were found significantly to 
improve upon this model; exploration of alternative stepwise criteria found that 
the p in (for F change) criterion would need increasing to p<.15 for any additional 
variables to enter the model. Conventionally, a p in of p<.05 is preferred in order 
to maintain a low error probability. However, had the criterion been set at this 
higher level, negative emotion, the core-relational theme of loss/helplessness, and 
maladaptive coping would all have entered as significant predictors. In this case 
though, the probability of making a Type I error (wrongly rejecting the null 
hypothesis) would have substantially increased.
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A high 72.4% of variance in six-month anxiety was predicted by the non- 
modifiable and/or control variables (block 1) at three-month follow-up (table
4.17). Of these variables, anxiety and neuroticism were all significant predictors 
(p<.01) with physical health status approaching significance.
Table 4.17. Regression analysis fo r  six month anxiety from  three month predictors.
Block 1 (Enter)
Unstandardised
coefficients
B SE
Constant 7.49 3.46
Gender -.19 .50
Age -.04 .02
Significant other .22 .54
Cancer type .10 .23
Physical health status -.05 .03
Mental health status -.05 .03
Quality of life .01 .02
Depression -.10 .11
Anxiety .50** .08
Neuroticism .10** .03
Extroversion .02 .03
Agreeableness -.00 .05
Openness -.02 .03
Block 2 (Stepwise*)
Constant -.40 .25
Other-blame .29 .13
Model Summary
df R2
13,82 .72 16.51**
1,94 .05 4.94"
•p<.05 m0p < O \
•Excluded variables (see appendix 4 .6): Optimism; Hope/helplessness; Anxious Preoccupation; 
Cognitive avoidance; M o tiva tio n a l relevance; O ther responsibility; Future expectancy; Emotion 
focussed coping potentia l; Lack o f  concern; Self-blam e; Threat; Loss/helplessness; Success; Positive 
emotion; N egative em otion; A daptive coping; M aladap tive  coping.
Only the core-relational theme of other-blame contributed additional 
variance explanation where higher other-blame was predictive of higher anxiety. 
This second regression block explain 5.0% of the residual level of anxiety, thus 
contributing an additional 1.4% to the overall variance.
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4.6,23 Depression
This first block of the baseline— three month time-lagged regression (table
4.18) explained 57.0% of the total variance in depression (at three month follow- 
up). Significant contributors to the model included age (p<.01), mental health 
status (p<.05), baseline quality of life (p<.05), baseline depression (p<.01) and 
neuroticism (p<.05).
Table 4.18. Regression analysis fo r  three month depression from baseline predictors.
Unstandardised Model Summary
coefficients  _________________________
B SE d f  R2 F
Block 1 (Enter)
Constant -2.61 4.82
Gender -.18 .68
Age .06* .03
Significant other .24 .65
Cancer type -.56 .29
Physical health status .03 .03
Mental health status .11* .05
Quality of life -.09* .04
Depression .51** .15
Anxiety .20 .10
Neuroticism .09* .05
Extroversion -.01 .05
Agreeableness .03 .05
Block 2 (Stepwise*)
•p<.05 * ^ <  01
*Excluded variables (see appendix 4 .7): Optim ism ; Hope/helplessness; Anxious Preoccupation; 
M otivational incongruence; M o tiva tio n a l congruence; S e lf responsibility; O ther responsibility; Future  
expectancy; Em otion focussed coping potentia l; O th er-b lam e; Threat; Loss/Helplessness; Positive 
emotion; N egative em otion; M aladap tive  coping.
No further variance could be explained by the potentially modifiable 
psychological predictor variables; none of the variables could be entered until the 
input criterion was increased to p=.10, at which point other-blame, negative 
emotion, threat, emotion focussed coping potential and future expectancy would 
all enter the model as significant predictors. Again, whilst including more 
variables, the statistical accuracy of the model would be questionable given the 
higher probability of making a type I error.
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Baseline control variables explained a total of 57.0% variance in six-month 
follow up depression levels (table 4.19). Only baseline quality of life and 
depression emerged as significant variables (p<.05 and <.01 respectively). Once 
again, no additional variables were entered into this model; exploratory analysis 
revealed that a higher input criterion of p=. 15 would be necessary for any of the 
excluded variables to otherwise contribute. Had this non-conventional alpha level 
been used, emotion focussed coping potential, negative emotion, and fighting spirit 
would have been first to enter the model.
Table 4.19. Regression analysis fo r  six month depression from  baseline predictors.
Unstandardised Model Summary
coefficients  _________________________
B SE d f R2 F
Block 1 (Enter)
Constant 6.70 4.30
Gender -.82 .59
Age .01 .03
Significant other .12 .60
Cancer type -.21 .27
Physical health status .01 .03
Mental health status .05 .04
Quality of life -.08* .03
Depression .56** .13
Anxiety .04 .09
Neuroticism -.00 .04
Extroversion .02 .04
Block 2 (Stepwise*)
•p< 05 "p ^O l
*Excluded variables (see appendix 4.8): Hope/helplessness; Anxious Preoccupation; Fighting Spirit; 
M otivational incongruence; M o tiva tio n a l congruence; S e lf responsibility; O ther responsibility; Future  
expectancy; Em otion focussed coping potentia l; O ther-b lam e; Threat; Loss/Helplessness; Negative 
emotion; M a ladap tive  coping.
Control variables measured at three month follow-up explained 49.0% of 
variance in depression at six month follow-up (table 4.20). Here, only depression 
level (p<.01) and perceived physical health status at three months were significant 
[p<.05). Once again, no additional variables were entered into this model; a much 
higher input criterion of p- .30 would have been necessary for this.
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Table 4.20. Regression analysis fo r six month depression from three month follow-up
predictors.
Unstandardised Model Summary
coefficients  _________________________
B SE d f R2 F
Block 1 (Enter)
Constant 4.31 3.49
Gender .07 .52
Age -.01 .03
Significant other -.18 .55
Cancer type .36 .25
Physical health status -.07* .03
Mental health status .01 .04
Quality of life -.01 .03
Anxiety .38 .12
Depression -.00** .09
Neuroticism .04 .03
Block 2 (Stepwise*)
•pc05 **p<01
*Excluded variables (see appendix 4.9): Hope/helplessness; Anxious Preoccupation; Fighting Spirit; 
Motivational incongruence; M o tiva tio n a l congruence; S e lf responsibility; O ther responsibility; Future 
expectancy; Em otion focussed coping potentia l; O th er-b lam e; Threat; Loss/Helplessness; Negative  
emotion; M aladap tive  coping.
4.S.2.4 Summary and comparison of regression models.
In order to be able to explore similarities and differences between each of the 
regression models, a summary table follows in table 4.21.
Overall model performance for quality of life and anxiety was far better than 
for depression. The lower level explained for depression, however, should not be 
dismissed as their range of 47.0 to 57.0% remains a substantial proportion of 
variance.
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Table 4.21. Summary o f regression models fo r  each set o f analysis (variables in bold indicate 
significant individual predictorsj.
T1-T2 T1-T3 T2-T3
Quality of life
Block 1
Block 2
Total Variance
Gender
Age
Significant other 
Cancer type 
Physical health status 
Mental health status 
Quality of life 
Anxiety 
Depression 
Neuroticism 
Extroversion 
Agreeableness
Negative emotion 
61.6%
Gender
Age
Significant other 
Cancer type 
Physical health status 
Mental health status 
Quality of life 
Anxiety 
Depression 
Neuroticism 
Extroversion 
Openness
Lack of concern 
67.5%
Gender
Age
Significant other
Cancer type
Physical health status
Mental health status
Quality of life
Anxiety
Depression
Neuroticism
Extroversion
Openness
Conscientiousness
Adaptive coping 
Unexpectedness 
Other responsibility 
Threat
73.4%
Anxiety
Block 1 Gender Gender Gender
Age Age Age
Significant other Significant other Significant other
Cancer type Cancer type Cancer type
Physical health status Physical health status Physical health status
Mental health status Mental health status Mental health status
Quality of life Quality of life Quality of life
Anxiety Anxiety Anxiety
Depression Depression Depression
Neuroticism Neuroticism Neuroticism
Extroversion Extroversion Extroversion
Agreeableness Agreeableness Agreeableness
Openness
Block 2 Self-responsibility
Other-blame
Other-blame
Total variance 71.2% 67.0% 73.5%
Depression
Block 1 Gender Gender Gender
Age Age Age
Significant other Significant other Significant other
Cancer type Cancer type Cancer type
Physical health status Physical health status Physical health status
Mental health status Mental health status Mental health status
Quality of life Quality of life Quality of life
Anxiety Anxiety Anxiety
Depression Depression Depression
Neuroticism Neuroticism 
Extroversion Extroversion 
Agreeableness
No additional variables entered in block 2
Neuroticism
Total variance 57.0% 57.0% 47.0%
2 2 6
IP*
h
Depression was most successfully predicted using baseline predictor 
variables. Quality of life models improved with the prediction of later levels of the 
outcome variable (six month rather than three month) and even more so when 
three month predictor variables are used over baseline predictors. Anxiety was 
most poorly predicted when the time-lag between measurement of predictor 
variables and outcome was largest; similar levels of prediction were found for 
models predicting outcome three months later regardless of whether prediction is 
made at baseline or three month follow up.
Earlier timepoints of outcome variable measurement were clearly some of 
the most predictive variables; however, some differences emerge. Where quality 
of life featured as a significant variable in the prediction of later anxiety and 
depression the opposite effect is not so consistent. Although anxiety at baseline 
was predictive of quality of life at three months, depression does not contribute to 
prediction of this outcome at all. Age was the only demographic variable to feature 
at all, and even so, only for the three to six month quality of life regression model. 
Concurrent health status featured only in prediction of depression; for three 
month prediction mental health status is important, however, for six month 
prediction, physical health status takes prominence. Neuroticism featured 
significantly in later quality of life prediction (three to six month), but early 
depression (baseline to three month).
Of the many additional variables initially entered in block two of the 
analyses, few remained in the final models. No additional variance was explained 
by these potentially modifiable variables for depression, however, for both quality 
of life and anxiety, additional variance was explained by variety of components of 
the Transactional Model. Cognitions feature most frequently. Appraisal 
components of other responsibility and self responsibility feature in the prediction 
of quality of life and anxiety (three to six month model and baseline to three month 
models respectively) and the core relational themes of other blame (anxiety 
baseline to three month and tree to six month); lack of concern (quality of life 
baseline to six month); and, unexpectedness and threat (quality of life three to six 
month). The implications and applications of these findings will be discussed in 
the next chapter.
227
47 THEORY TESTING
In contrast to the previous section which presented more clinically oriented 
data, this section presents results related to theoretical tests of the Transactional 
Model. Essentially, the purpose was to test whether or not the defined macro and 
micro cognition combinations which, according to Lazarus (1999), form emotional 
reaction to stressors (see section 1.5) are evident in this patient group. Two 
approaches are taken: exploration of correlation between changes scores across 
the full longitudinal database and regressions using cross sectional baseline data.
47.1 Correlating change in associated components of the Transaction 
Model
47.1.1 Introduction to the statistical approach taken
The first set of analysis (4.7.1) considers longitudinal patterns in the data.
Due to the high level of theoretical association between specific appraisal, core- 
relational themes and emotions, it would be expected that a change over time in 
one component, would be highly correlated with a change in its theoretically 
associated components. Furthermore, because these theoretical associations are 
supposedly unique, it is expected that change would not be correlated with 
theoretically un-associated components. For example, anger is theoretically 
proposed to be associated with three appraisals (motivational relevance, 
motivational incongruence, and other responsibility) and the core relational theme 
of other blame. Therefore, it would be expected that changes on any of these 
specific components would be highly correlated with each other, but less 
correlated with change scores on the numerous other appraisal and core-relational 
themes. This was tested by calculating change scores for each component between 
baseline and six-month follow-up and conducting a series of Spearman's Rho 
correlation tests (selected due to non-Normality of the change scores).
Table 4.22 presents the results of correlations between each emotion and the 
two levels of cognition (appraisal and core-relational theme). Correlations are 
presented for components that theory would lead one to expected to be correlated, 
but also any unexpected correlations that emerged. Note that under the expected 
correlations column, not all emotions have an expected cognition correlate -  this is 
because different emotions are at different levels of theoretical development (see 
section 1.4 and 3.4.1.3) and some emotions are developed such that appraisals and
228
core-relational themes are clearly defined, for others just a core-relational theme, 
or even nothing at all, is hypothesised. For these latter cases, the only correlations 
presented are those listed under the additional correlates column.
Due to the high number of correlations being tested for each emotion, 
Bonferroni adjustment to the significance level was required; this equated to an 
adjusted alpha level of p-.003. Results of expected component correlations are 
listed whether significant or not; inclusion of exact significance levels for each 
correlation can be used to assess whether or not this low level of significance was 
met Results of additional components are only included if the correlation is 
significant at p<.01 in order to also highlight those components which didn't meet 
the adjusted significance level, but approached.
4.7.1.2 Results
Few significant correlations were found between the emotions and their 
expected cognitive correlates. Effect sizes were typically low and few correlations 
even approached significance. Just three core-relational themes reached the 
Bonferroni corrected significance level: Self-consciousness for shame-humiliation; 
threat removal for relief; and, self-blame for guilt. Three further core-relational 
themes approached this significance level: success for happiness; unexpectedness 
for surprise; and, loss/helplessness for sadness. It is important to note that none 
of the appraisal change scores were significantly correlated with changes in 
emotion.
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Table 4-22. C orrelations betw een change on components o f cognition and em otion.
Emotion Expected correlates Additional correlates
r P r P
Anger Appraisal components: 
Motivational Relevance .04 .741
Core-relational theme: 
Self-blame .27 .004
Motivational Incongruence 
Other Responsibility 
Core-relational theme:
- . 0 1
- . 0 1
.936
.924
Loss/helplessness
Success
.24
-.25
. 0 1 1
. 0 1 0
Other-blame . 1 2 .208
Guilt Appraisal components: 
Motivational Relevance .17 .134
Core-relational theme: 
Self-consciousness .25 .008
Motivational Incongruence .03 .793 Threat .34 < . 0 0 1
Self Responsibility 
Core-relational theme:
. 2 1 .023
Self-blame .29 . 0 0 2
Fear/Anxiety Appraisal components: 
Motivational Relevance . 1 1 .344
Appraisal components: 
Self Responsibility .25 .007
Motivational Incongruence . 0 1 .946 Core-relational theme:
Emotion Focussed Coping Potential -.16 .097 Self-blame .24 . 0 1 0
Core-relational theme: Success .25 .007
Threat .13 .167
Sadness Appraisal components: 
Motivational Relevance . 1 0 .356
Core-relational theme: 
Self-consciousness .25 .006
Motivational Incongruence -.04 .687 Other-blame .26 .005
Future Expectancy .09 .363 Threat .26 .005
Problem Focussed Coping Potential . 0 0 .968
Core-relational theme:
Loss/helplessness .28 .008
Hope/Challenge Appraisal components:
Motivational Relevance 
Motivational Congruence 
Problem Focussed Coping Potential 
Core-relational theme:
Effortful optimism
-.04
.16
. 1 1
- . 2 2
.759
.089
.242
.019
Core-relational theme: 
Loss/Helplessness -.30 . 0 0 1
Tmbfm4Jt2. Corrmtationa bmt%¥mmn change on comptmmnt*  o f cognition and am otion (continuad)-
Emotion Expected correlates Additional correlates
r P r P
Happiness Appraisal components: 
Motivational Relevance 
Core-relational theme: 
Success
.13
.25
.260
. 0 1 0
Shame/Humiliation Core-relational theme: 
Self-consciousness .33 < . 0 0 1
Appraisal components:
Emotion Focussed Coping Potential -.29 
Core-relational theme:
Irrelevance .30
. 0 0 2
. 0 0 1
Relief Core-relational theme: 
Removal of threat .43 < . 0 0 1
Core-relational theme:
Success .38 < 0 0 1
Surprise Appraisal components: 
Motivational Relevance 
Motivational Incongruence 
Core-relational theme: 
Unexpectedness
.07
.14
-.24
.526
. 1 1 1
.008
Tranquility Core-relational theme: 
Lack of concern -.03 .736
Resignation Core-relational theme: 
Loss/helplessness -.07 .432
Boredom Core-relational theme: 
Irrelevance .09 .328
Self-directed anger Appraisal components:
Self Responsibility .30 
Core-relational theme:
.007
Self-consciousness
Self-blame
Loss/helplessness
.38 .001
.42 <.001
.35 .003
Table 4.22. Correlations between change on components o f cognition and em otion (continued).
Emotion Expected correlates Additional correlates
r P r P
Frustration Core-relational theme:
Self-consciousness
Loss/helplessness
.34
-.25
<001
.009
Regret Core-relational theme:
Relevance
Threat
Loss/helplessness
.31
.25
.38
.001
.003
<.001
There were four emotions for which no additional components were 
significantly correlated due to the adjusted significance level. Had a standard 
alpha of p<.05 been used, additional components would also have been added for 
surprise, tranquillity, resignation and boredom, the effect sizes for which ranged 
between r=. 19 to 26.
In most cases, additional components found to be significant were comparable, 
if not bigger, in effect size that any significant expected correlates. Contrary to 
theory, for a number of emotions multiple core-relational themes were found to 
highly correlate. There were just three occasions where changes in appraisal 
correlated highly with changes in emotion: emotion focussed coping potential for 
shame/humiliation and self-responsibility for both self-directed anger and 
fear/anxiety. Finally, some unusual patterns in correlations also emerge in terms 
of direction of effect. There are instances where the implications of the direction 
of a correlation are surprising. For example, the negative correlation between 
motivational incongruence and both anger and sadness is opposite to that which 
would be expected; if the situation became more incongruent, anger and sadness 
would be expected to increase, not decrease. Similarly, the negative correlation 
between increased unexpectedness related cognitions and decreased surprise 
seems somewhat contradictory.
4.7.2. Comparing theory versus data driven statistical tests of the 
Transactional model.
4.7.2.1 Introduction to the statistical approach taken
In this approach to theory testing, a number of regression analyses were 
conducted. For each emotion, a theory driven regression was compared with an 
entirely data driven regression. Where the data driven model used a stepwise 
approach, the theory driven analyses were more structured. In the first block, 
theoretically derived appraisals were entered. The residual of the emotion 
variable was then saved and used as the dependent variable for the second block, 
where theoretically derived core-relational themes were entered. Again, the 
residual outcome was saved and used as the dependent variable for a third block 
in which all other variables were entered. Once again, therefore, the R2 stated in 
the subsequent blocks needed to be proportionally adjusted in order to calculate 
the total variance explained (see also p.214 and footnote on p.215); a summary of
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total percentage variance explained for this section is presented in table 4.40 
(p.253-254).
Theory driven regressions indicate how well theoretically associated 
appraisals and core-relational themes contribute to variance in emotion and 
whether the additional contribution of non-theoretically derived components 
contributed additional variance. A comparison with a data driven regression 
established whether these theoretically associated components were indeed the 
best initial predictors of emotion and whether the unique packages of cognitive 
and emotional variables of Lazarus's theory were valid.
Regression models demonstrated a range of overall effect sizes. The lowest 
effect was for boredom where both theory driven and data driven models 
explained just 7% of variance. Relief was best explained with the theory driven 
model explaining 49.9% variance and the data driven model explaining 54%.
4.7.2.2 Results for the 'hot' cognitions
Six cognition-emotion groupings fall into this category: anger, guilt, 
fear/anxiety; sadness; hope/challenge; and happiness (Lazarus, 1999). It is only 
for these six emotions that a clear literature is available to suggest which 
appraisals and core-relational themes are most highly associated. For that reason 
they have been the focus of the majority of theory testing to date.
Analysis of these data revealed high similarity in total variance explained by 
theory and data-driven models, but in two cases (anger and sadness) this 
similarity did not emerge until additional variables were added in block three of 
the theory driven regression. There was just one case where the theory driven 
analysis resulted in a higher effect size than did its comparable data driven model 
(anger: 29.4% versus 23.9%). Fear/anxiety and sadness both resulted in models 
where slightly more variance was explained by the data driven approach. Each of 
these regression models will be presented and discussed in turn.
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For anger (see table 4.23), 10.2% variance was explained in block one 
(theoretically derived appraisals) but of the three appraisals hypothesised, just 
one emerged significant. A further 3.6% was explained by higher other-blame core 
relational theme scores [R2=.04 of the residual emotion). Further variance 
(15.5%) was explained by additional components including higher concern, lower 
emotion focussed coping potential and, perhaps more strangely, increased effortful 
optimism. The data driven model predicted 5.1% less variance than the theory 
driven model (theory, 29.4%: data, 23.0%).
Although there is some overlap with block three of the theory driven model, 
none of the included predictors for anger are the same as those proposed by the 
theory. This model, which included one appraisal component and four core- 
relational themes, demonstrates that whilst not equivalent, similar levels of 
variance can be explained by an entirely different set of cognitive components. 
Most notable differences are in orientation of blame— the theory driven model 
includes other blame but the data driven includes self-blame, both as positive 
coefficients of anger—and the importance of coping related appraisals rather than 
goal related appraisals in both models.
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Table 4.23. Theory and data driven tests o f the cognitive precursors o f anger.
Theory Driven
Unstandardised Model Summary
Coefficients
B SE df Rt F
Block 1 (Enter)
(Constant) -.22 1.31 3,134 .10 5.09**
Motivational Relevance .08 . 1 2
Motivational Incongruence .16 .09
Other Responsibility .2 1 * .07
Block 2 (Enter)
(Constant) -.40 .25 1.136 .04 5.59*
Other Blame .24* . 1 0
Block 3 (Stepwise*)
(Constant) 1 . 6 8 .93 3, 134 .18 9.99**
Lack of Concern -.23** .07
EF Coping Potential -.27** .09
Effortful Optimism .2 2 ** .08
*p<. 05, **p<. 001
* Excluded Variables (see appendix 4.10): Motivational Congruence; Self-Responsibility; 
Future Expectancy' Problem Focussed Coping Potential; Self-Consciousness; Relevance; 
Unexpectedness; Irrelevance; Threat Removal; Self-Blame; Threat; Loss/Helplessness; 
Success.
Data Driven___________________________
Unstandardised Model Summary
Coefficients
B SE df R* F
Stepwise*
(Constant) 2.61* 1.24 5, 132 .24 11.93**
Threat .2 0 ** .08
Unexpectedness .2 1 ** .07
Self-Blame .38** . 1 2
Lack of Concern -.2 1 ** .07
EF Coping Potential -.2 1 * . 1 0
*p< 05. **p<.001
* Excluded Variables (see appendix 4.11): Motivational Relevance; Motivational 
Incongruence; Motivational Congruence; Self-Responsibility; Other-Responsibility; Future 
Expectancy; Problem Focussed Coping Potential; Self-Consciousness; Relevance; 
Irrelevance; Threat Removal; Other-Blame; Loss/Helplessness; Effortful Optimism; 
Success.
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Theory Driven
Unstandardised Model Summary
Coefficients
B SE df R* F
Block 1 (Enter)
(Constant) 2.33** .87 3,136 .12 6.32**
Motivational Relevance .05 .08
Motivational Incongruence -.16** .06
Self Responsibility .13** .05
Block 2 (Enter)
(Constant) -.67* .16 1.138 .07 10.53**
Self Blame .26** .08
Block 3 (Stepwise*)
No variables added
*p<.05, **p<.001
*Excluded Variables (see appendix 4.12): Motivational Congruence; Other-Responsibility; 
Future Expectancy; Problem Focussed Coping Potential; Emotion Focussed Coping 
Potential; Self-Consciousness; Other blame; Relevance; Unexpectedness; Irrelevance; Lack 
of Concern; Threat Removal; Threat; Loss/Helplessness; Effortful Optimism; Success.
Data Driven
Unstandardised Model Summary
Coefficients
_B______ SE________ df R*______ F_
Stepwise*
(Constant) 2.55** .55 3,136 .19 10.43**
Self-Blame .28** .08
Motivational Incongruence -.16** .05
Self Responsibility .09* .05
*p< 0S, **p<.001
* Excluded Variables (see appendix 4.113): Motivational Relevance;; Motivational 
Congruence; Other-Responsibility; Future Expectancy; Problem Focussed Coping 
Potential; Emotion Focussed Coping Potential; Self-Consciousness; Relevance; Irrelevance; 
Unexpectedness; Lack of Concern; Threat Removal; Other-Blame; Threat; 
Loss/Helplessness; Effortful Optimism; Success.
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Regressions of the cognitive precursors of guilt (table 4.24) largely confirmed 
theory. No additional variance was explained in block three of the theory driven 
approach and a comparative data driven approach revealed no different predictors 
than those proposed by theory. Total variance explained for the theory driven 
model was 18.4% and for the data driven model was 18.7%. The absence of 
motivational relevance in the data driven approach, and indeed, the lack of 
significance for inclusion of this in the theory driven approach, suggests that the 
contribution of this component is redundant. There is, once again, a clear focus 
on blame and responsibility cognitions with higher guilt resulting from higher self­
blame and responsibility and lower perceived other-blame. However, compared 
with anger, goal related appraisals emerge as more important than coping related 
appraisals.
For fear/anxiety (table 4.25), the majority of variance in the theory driven 
analysis was explained by two of the three hypothesised cognitive appraisals: 
higher motivational relevance and lower emotion focussed coping potential (33% 
of the 40.8% total variance). Two additional core relational themes, self-blame 
and unexpectedness, added a further 3.8% to the overall variance explained 
(residual R2=.06). Although the theory hypothesised core-relational theme, 
threat, added just a small 4% to the over all variance, in the data driven model, this 
cognition was by far the largest contributor. The data driven model (which 
explained a total of 43.3% variance) also included self-blame and unexpectedness 
core relational themes confirming the importance of these additional variables. 
Whilst proposed by theory as an important predictor of fear/anxiety, motivational 
incongruence did not emerge as significant in either the theory driven, or data 
driven models.
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TmtdmUtS, Thaory and data drivmn tmatm of th* cognitive pracunors of J*ar/arud+&.
Theory Driven______________________
Unstandardised Model Summary
Coefficients
B SE df R* F
Block 1 (Enter)
(Constant) 10.87** 3.29 3,135 .33 22.14**
Motivational Relevance .75** .25
Motivational Incongruence .24 .17
EF Coping Potential -1.26** .19
Block 2 (Enter)
(Constant) -1.58* .62 1.137 .07 9.72**
Threat .42** .13
Block 3 (Stepwise*)
(Constant) -2.65* 1.04 2,136 .06 4.66*
Self-blame .63* .25
Unexpectedness .27** .14
*p<. 05, **p<.001
•Excluded Variablse (see appendix 4.14): Motivational Congruence; Self-Responsibility; 
Other-Responsibility; Future Expectancy; Problem Focussed Coping Potential; Self- 
Consciousness; Relevance; Irrelevance; Lack of Concern; Threat Removal; Other-Blame; 
Loss/Helplessness; Effortful Optimism; Success.
Data Driven_________________________
Unstandardised Model Summary
Coefficients
_B______ SE________df R*______ F
Stepwise•
(Constant) 5.93 3.5
Threat .61** .17
EF Coping Potential 00 o • • . 2 1
Motivational Relevance .54* .23
Self-Blame .63* .25
Unexpectedness .633* .14
*p<.05,**p<.001
•Excluded Variables (see appendix 4.15): Motivational Incongruence; Motivational 
Congruence; Self-Responsibility; Other-Responsibility; Future Expectancy; Problem 
Focussed Coping Potential; Self-Consciousness; Relevance; Irrelevance; Lack of Concern; 
Threat Removal; Other-Blame; Loss/Helplessness; Effortful Optimism; Success
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Table 4.26. Theory and data driven tests o f the cognitive precursors o f sadness.
Theory Driven
Unstandardised
Coefficients
Block 3 (Stepwise')
No variables added
Model Summary
B SE 4f. R- F
Block 1 (Enter)
(Constant) 1 38 1 . 6 6 4, 134 . 1 0 3 59"
Motivational Relevance 2 1 14
Motivational Incongruence .19 . 1 0
Future Expectancy -26* . 1 0
PF Coping Potential .04 . 1 0
Block 2 (Enter)
(Constant) -1.09** .28 1, 137 .18 30.08**
Loss/Helplessness .43** .08
*p<0S,**p<001
*Excluded Variables (see appendix 4.16): Motivational Congruence; Self-Responsibility;
Other-Responsibility; Emotion Focussed Coping Potential; Self-Consciousness; Relevance; 
Unexpectedness; Irrelevance; Lack of Concern; Threat; Threat Removal; Other-Blame; 
Self-Blame; Effortful Optimism; Success.
Data Driven
Unstandardised 
Coefficients 
B SE
Model Summary 
df R-' F
Stepwise'
(Constant) - 29 .83 3, 135 37 25 83**
Threat .30** 09
Loss/Helplessness 35** . 1 0
Motivational Incongruence 18* 08
*p<05.**p<001
•Excluded Variables (see appendix 4.17): Motivational Relevance; Motivational 
Congruence; Self-Responsibility; Other-Responsibility; Future Expectancy; Problem 
Focussed Coping Potential; Emotion Focussed Coping Potential; Self-Consciousness; 
Relevance; Unexpectedness; Irrelevance; Lack of Concern; Threat Removal; Other-Blame; 
Self-Blame; Effortful Optimism; Success
240
The majority of statistical variance in sadness (table 4.26) was explained by 
core-relational themes; higher loss/helplessness in the theory driven model, and 
both higher threat and higher loss/helplessness in the data driven approach. Of 
the four theorised appraisal components, only future expectancy emerged as 
significant in the theory driven model. Inclusion of this variable was not confirmed 
by the data driven model as here, motivational incongruence was included. The 
inclusion of threat in the data driven model seems to have improved overall 
variance explained slightly, though, it's absence from the theory driven model (and 
subsequently equivalent effect size) may indicate, once again, that the predictors of 
emotion are not unique and that varying combinations may be permissible. 
Differences in the appraisal components included may account for the 12% 
difference in overall variance between the theory (total variance explained 25.9%) 
and data (36.5%) driven model. In the data driven model, there is a clear focus on 
concurrent goal related appraisals, however, the theory driven model seems 
otherwise focussed around future oriented appraisals.
Of the theorised appraisal predictors of hope/challenge (table 4.27), only 
problem focussed coping potential emerged as significant in the theory driven 
analysis. Just 3.6% variance was added by the theorised core-relational theme, 
effortful optimism, but the model was strengthened by inclusion of higher emotion 
focussed coping potential and higher relevance scores (total variance explained 
being 22.3%). The data driven model confirms the necessary inclusion of 
additional cognitive predictors and explained 21.6% of the total variance. Just one 
of the four variables included in the model matches theory; two are equivalent to 
those added in block three of the theory driven model; and one additional core- 
relational theme, lower levels of loss/helplessness, was included. As with anger, 
the emphasis here is on coping oriented appraisals rather than goal, responsibility 
or future oriented appraisal.
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Table 4.27. Theory and data driven tests o f the cognitive precursors o f hope/challenge.
Theory Driven 
Unstandardised 
Coefficients
Model Summary
Data Driven 
Unstandardised 
Coefficients
B SE df R- F B SE
Block 1 (Enter) Stepwise’
(Constant) 922" 228 3. 133 1 1 543" (Constant) 5 22* 2 25
Motivational Relevance .06 . 2 1 EF Coping Potential A T 19
Motivational Congruence .18 . 1 2 PF Coping Potential .32* 13
PF Coping Potential .45" .13 Relevance 36* .15
Block 2 (Enter) Loss/Helplessness - 31* 15
(Constant) -2.2T 1.06 1. 135 04 503*
Effortful Optimism 33* .15
Block 3 (Stepwise')
(Constant) -6.95" 1.92 2. 134 .09 678"
EF Coping Potential .53" .16
Relevance .32* .15
Model Summary
df R-______ F_
4. 132 22 909*
*p<.0S,"p<001
•Excluded Variables (see appendix 4.18): Motivational Incongruence; Self-Responsibility; 
Other-Responsibility; Future Expectancy; Self-Consciousness; Unexpectedness; 
Irrelevance; Lack of Concern; Threat Removal; Other-Blame; Self-Blame; Threat; 
Loss/Helplessness; Success
*p< 05, "pc.OOl
*Excluded Vanablesfsee appendix 4.19): Motivational Relevance; Motivational 
Incongruence; Motivational Congruence; Self-Responsibility; Other-Responsibility; Future 
Expectancy; Self-Consciousness; Unexpectedness; Irrelevance; Lack of Concern; Threat 
Removal; Other-Blame; Self-Blame; Threat; Effortful Optimism; Success.
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fe ta .
Tab/e 4-28. Theory and data driven tests o f tha cognitive precursors o f happiness.
Theory Driven__________________________
Unstandardised Model Summary
Coefficients
B SE df R: F
Block 1 (Enter)
(Constant) 3.20* 1.39 2. 136 0 1 39
Motivational Relevance -.06 .13
Motivational Congruence .06 08
Block 2 (Enter)
(Constant) -1 45— .32 1. 137 19 31 77"
Success 34" .06
Block 3 (Stepwise’)
(Constant) -1.38* .61 1. 137 .04 5.58*
Effortful Optimism .2 0 * .08
*p< 05. "p<001
•Excluded Variables (see appendix 4.20): Motivational Incongruence; Self-Responsibility; 
Other-Responsibility; Future Expectancy; Problem Focussed Coping Potential; Emotion 
Focussed Coping Potential; Self-Consciousness; Relevance; Unexpectedness; Irrelevance; 
Lack of Concern; Threat Removal; Other-Blame; Self-Blame; Threat; Loss/Helplessness.
Data Driven
Unstandardised Mode1 Summary
Coefficients 
B SE df R- F
Stepwise’
(Constant) 02 64 2,136 22 18.90"
Success .32" 06
Effortful Optimism 19* 09
•p<.05,"p<001
*Excluded Variables (see appendix 4.21): Motivational Relevance; Motivational 
Incongruence; Motivational Congruence; Self-Responsibility; Other-Responsibility; Future 
Expectancy; Problem Focussed Coping Potential; Emotion Focussed Coping Potential; Self- 
Consciousness; Relevance; Unexpectedness; Irrelevance; Lack of Concern; Threat Removal; 
Other-Blame; Self-Blame; Threat; Loss/Helplessness.
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The analyses for happiness, the final 'hot' cognition, are surprising (table 
4.29). Whilst the theoretically derived appraisals explained virtually none of the 
variance in happiness, more variance was explained by the addition of the 
specified core-relational theme than in any other case (an equivalent addition of 
18.8%). One further core-relational theme, effortful optimism, was added in 
block three. The predictive strength of these two core-relational themes above all 
other cognitions is further evidenced in the data-driven model which produces 
equivalent results and only slightly lower overall predictive ability (data driven 
explained 21.7% of the variance compared to 22.6% in the theory driven model). 
No appraisal components at all added to this model.
4.7.2.3 Results for the less theoretically developed emotions
Literature relating to the remaining ten emotions is less explicit about which 
cognitive components are most strongly related to each specific emotion (Smith & 
Ellsworth, 1985; Smith & Lazarus, 1993; Lazarus, 1999). Unlike for the 'hot' 
cognitions, no explicit appraisal patterns are specified in the literature, in part 
probably explaining the previous lack of empirical theory testing. For seven of 
these emotions, unique core-relational themes and emotion pairings are still 
proposed and results pertaining to these follow.
For these analyses, the theory driven regressions are presented slightly 
differently. As no appraisals are defined in the literature, the first block of the 
regression was unnecessary. Therefore, for the following models, block one 
consisted of a regression based on the uniquely paired core relational theme 
(enter) method (the equivalent of block two in the previous tests). Block two used 
a stepwise method to explore all appraisals, and all remaining core-relational 
themes for the residual emotion dependent variable. The analytic strategy for data 
driven models remains unchanged.
Unlike for the 'hot' cognitions, there was far more similarity between the 
theory driven and data driven models, not only in which predictors contributed to 
the model, but subsequent equivalence in how much overall variance in emotion 
was explained. This is not surprising given the proportion of testing now using 
the same, stepwise, approach as in data driven models.
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Table 4.29. Theory and data driven tests o f the cognitive predictors o f boredom.
Theory Driven______________________
Unstandardised Model Summary
Coefficients
B SE df R-
Block 1 (Enter)
(Constant) 1 65— 19 1, 137 . 0 0
Irrelevance - . 0 0 . 0 1
Block 2 (Stepwise*) 
(Constant) 1.83** .59 1. 137 .07
Motivational Incongruence -.18" .06
*p<.05,"p<001
* Excluded Variables (see appendix 4.22): Motivational Relevance; Motivational 
Congruence; Self Responsibility; Other-Responsibility; Future Expectancy; Problem 
Focussed Coping Potential; Emotion Focussed Coping Potential; Self Consciousness;
Relevance; Unexpectedness; Lack of Concern; Threat Removal; Other-Blame; Self Blame; 
Threat; Loss/Helplessness; Effortful Optimism; Success.
Data Driven
Unstandardised 
Coefficients 
B SE
Model Summary 
df R2 F
Stepwise*
(Constant) 3 45" .59 1. 137 .07 10.09"
Motivational Incongruence -.18" .06
'p<05."p<001
•Excluded Variables (see appendix 4.23): Motivational Relevance; Motivational 
Congruence; Self Responsibility; Other-Responsibility; Future Expectancy; Problem 
Focussed Coping Potential; Emotion Focussed Coping Potential; Self-Consciousness; 
Relevance; Unexpectedness; Lack of Concern; Threat Removal; Other-Blame; Self-Blame; 
Threat; Loss/Helplessness; Effortful Optimism; Success
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The theoretically hypothesised core-relational theme emerged significant in 
six out of seven of the theory driven models (not boredom) but to varying extents 
ranging from R2= .02 to .41. These core-relational themes also significantly 
emerged in five of the seven data driven models (not boredom nor 
shame/humiliation). Consistent with theory, six theory driven models benefitted 
from the addition of one or more appraisal components; only shame/humiliation 
didn't, one of the poorest performing of all models included. However, as with the 
results from analysis reported in the previous section, additional core-relational 
themes were included in five out of seven cases.
Only low variance was explained for boredom (7.0%; table 4.29) and these 
results are incongruent with theory; the hypothesised core-relational theme was 
not an important component. Motivational incongruence appraisals instead 
significantly predicted this emotional outcome.
For five of the remaining emotions within this group (surprise, table 4.30; 
resignation, table 4.32; tranquillity, table 4.33; interest, table 4.34; and, relief, table 
4.35), whilst the theoretically derived core-relational theme was significant in both 
theory driven and data driven analyses, many more variables were necessary for 
optimal prediction. In all cases, cognitive components do not differ between data 
driven and full theory driven regressions (although these do include the final 
stepwise additions). These additions included additional core-relational themes 
and a number of appraisals components (see table 4.30). For a summary of total 
proportioned variance explained, see table 4.40 (p.253).
Table 4.30. Summary o f additional cognitive precursors fo r  surprise, resignation, 
tranquillity, re lie f and interest
Emotion
Additional components Variance
Appraisals Core relational themes added
Surprise Motivational Relevance Lack of Concern 
Self-consciousness
9.5%
Resignation Other Responsibility Threat Removal 7.8%
Tranquility EF Coping Potential . . . 14.0%
Interest EF Coping Potential 
Motivational Incongruence 
Self-Responsibility
Effortful Optimism 
Self-blame
33.3%
Future Expectancy ................................. .. __ ______
Relief Self-Responsibility 
Motivational Congruence
Loss/helplessness 8.9%
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Here, a clear role for responsibility-oriented appraisals emerges, especially 
so for the emotions of resignation and relief. Resignation was further explained by 
higher loss/helplessness cognitions and the core-relational theme of other 
responsibility. These results are in no way counterintuitive and make logical 
sense. Similarly, the three core-relational themes included as significant 
predictors of relief (threat removal, success, and lower loss/helplessness), and the 
one for tranquillity (lack of concern) also seem fitting to the nature of these 
emotional reactions. These associations are not unexpected.
Surprise was associated with goal-related appraisals and unexpectedness. 
The correlation between high surprise and low self-consciousness and lack of 
concern are perhaps not so obvious.
Interest was one of few emotions that required a much higher number of 
cognitive precursors to be included for optimal explanation of variance. Unlike for 
other emotions which seem to have specific subsets of appraisal attached to them, 
the full range of goal oriented, responsibility oriented, coping focused and future 
related appraisals feature.
The final emotion within this section, shame/humiliation (table 4.36), was 
unique in that no appraisal components were included. Furthermore, the theory 
hypothesised core-relational theme of self-consciousness failed to emerge as a 
significant predictor. Instead, one additional core-relational theme (other blame) 
was included in the theory driven model, and two additional core-relational 
themes in the slightly better performing data driven model (other blame and self 
blame). That self-blame didn't emerge in the theory driven model possibly 
indicates covariance with self-consciousness.
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Theory Driven
Unstandardised Model Summary
Coefficients
_B_______ SE_________ df R!________F_
Block 1 (Enter)
(Constant) 2 27" 59 1. 138 2 1 3567"
Unexpectedness .50" 08
Block 2 (Stepwise’)
(Constant) -3.78* 1.44 3. 136 1 2 6 2 "
Motivational Relevance 35" 13
Lack of Concern 2 1 2 " .08
Self-Consciousness -43* 18
•p<05.**P<001
’Excluded Variables (see appendix 4.24): Motivational Incongruence; Motivational 
Congruence; Self-Responsibility; Other-Responsibility; Future Expectancy; Problem 
Focussed Coping Potential; Emotion Focussed Coping Potential; Relevance; Irrelevance; 
Threat Removal; Other-Blame; Self-Blame; Threat; Loss/Helplessness; Effortful Optimism; 
Success.
Data Drtvsn
Unstandardised Model Summary
Coefficients
_B _______ SE_________ df RJ________F_
Stepwise’
(Constant) -1 23 1 49
Unexpectedness 44" 08
Motivational Relevance 36" 13
Lack of Concern 23" 08
Self-Consciousness 44* 18
•p< 05. "p< 001
’Excluded Variables (see appendix 4.2S): Motivational Incongruence; Motivational 
Congruence; Self-Responsibility; Other-Responsibility; Future Expectancy; Problem 
Focussed Coping Potential; Emotion Focussed Coping Potential; Relevance; Irrelevance; 
Threat Removal; Other-Blame; Self-Blame; Threat; Loss/Helplessness; Effortful Optimism; 
Success
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Theory Driven__________________________
Unstandardised Model Summary
Coefficients
B SE _ df R- F
Block 1 (Enter)
(Constant) 1 24** .25 1. 138 2 2 39 17"
Loss/Helplessness 43" .07
Block 2 (Stepwise’)
(Constant) -.91" .29 2. 137 1 0 7 19"
Threat Removal .16* 06
Other Responsibility 14* 06
'p<  OS, ••p c .O O l
*Excluded Variables (see appendix 4.26): Motivational Relevance; Motivational 
Incongruence; Motivational Congruence; Self Responsibility; Future Expectancy; Problem 
Focussed Coping Potential; Emotion Focussed Coping Potential; Self-Consciousness; 
Relevance; Unexpectedness; Irrelevance; Lack of Concern; Other-Blame; Self-Blame; 
Threat; Effortful Optimism; Success.
Data Driven
Unstandardised Model Summary
Coefficients
__________________________ B SE________ df R-______ F
Stepwise’
(Constant) 40 34 3. 136 30 1907"
Loss/Helplessness 40" 07
Threat Removal 16" 06
Other Responsibility IS* 07
> < 05. •><  001
‘Excluded Variables (see appendix 4.27) Motivational Relevance; Motivational 
Incongruence; Motivational Congruence; Self-Responsibility; Future Expectancy; Problem 
Focussed Coping Potential; Emotion Focussed Coping Potential; Self-Consciousness; 
Relevance; Unexpectedness; Irrelevance; Lack of Concern; Other-Blame; Self -Blame; 
Threat; Effortful Optimism; Success.
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Table 4.33. Theory and data driven tests o f the cognitive precursors o f tranquility.
__________________________ Theory Driven________________________
Unstandardised Model Summary
Coefficients
B______ SE________ df R*______ F_
Block 1 (Enter)
(Constant) 3.75** .34 1,137 .07
Lack of Concern .25" .08
Block 2 (Stepwise')
(Constant) -4.10" .85 1.137 .15
EF Coping Potential .46" .09
*p<05, "pc.OOl
'Excluded Variables (see appendix 4.28): Motivational Relevance; Motivational 
Incongruence; Motivational Congruence; Self-Responsibility; Other-Responsibility; Future 
Expectancy; Problem Focussed Coping Potential; Self-Consciousness; Relevance; 
Unexpectedness; Irrelevance; Threat Removal; Other-Blame; Self-Blame; Threat; 
Loss/Helplessness; Effortful Optimism; Success.
Data Driven
Unstandardised 
Coefficients 
B SE
Model Summary 
df Ri F
Stepwise*
(Constant) -25 . 8 6 2,136 .21 18.55"
EF Coping Potential .47" .09
Lack of Concern .2 0 " .07
*p<.05, "p<001
'Excluded Variables (see appendix 4.29): Motivational Relevance; Motivational 
Incongruence; Motivational Congruence; Self-Responsibility; Other-Responsibility; Future 
Expectancy; Problem Focussed Coping Potential; Self-Consciousness; Relevance; 
Unexpectedness; Irrelevance; Threat Removal; Other-Blame; Self-Blame; Threat; 
Loss/Helplessness; Effortful Optimism; Success.
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IF*
Tabla 4 3 4 . Thmory and d ata  drtvan tmsts o fth a  cognitive precursors o f in terest.
Theory Driven______________________
Unstandardised Model Summary
Coefficients
B SE df R- F
Block 1 (Enter)
(Constant) 3.78" .74 1. 137 . 0 2 405*
Relevance .2 1 * . 1 0
Block 2 (Stepwise')
(Constant) -4.48" 1.39 6 . 132 .34 1 1 .1 2 "
EF Coping Potential 29" . 1 1
Effortful Optimism .36" .09
Motivational Incongruence -.2 2 * .08
Self-Blame -.38* .14
Self Responsibility .19* 08
Future Expectancy .19* .09
•p<05."p<001
*Excluded Variables (see appendix 4.30): Motivational Relevance; Motivational 
Congruence; Other-Responsibility; Problem Focussed Coping Potential; Self- 
Consciousness; Unexpectedness; Irrelevance; Lack of Concern; Threat Removal; Other- 
Blame; Threat; Loss/Helplessness; Success.
Data Driven_________________________
Unstandardised Model Summary
Coefficients
JB______ SE________ df R‘______ F_
Stepwise'
(Constant) - 8 8 1.50
Effortful Optimism 36" 09
EF Coping Potential .29" . 1 1
Motivational Incongruence -.2 2 " .09
Self-Blame -.38" .14
Relevance 24" .09
Self-Responsibility .19" .08
Future Expectancy .19* .09
*p< 05. "p< 001
•Excluded Variables (see appendix 4.31): Motivational Relevance; Motivational 
Congruence; Other-Responsibility; Problem Focussed Coping Potential; Self-Consciousness; 
Unexpectedness; Irrelevance; Lack of Concern; Threat Removal; Other-Blame; Threat; 
Loss/Helplessness; Success.
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Table 4.35. Theory and data driven tests o f  the cognitive precursors o f relief.
Theory Driven
Unstandardised Model Summary
Coefficients
B SE df R- F
Block 1 (Enter)
(Constant) 1.35“ .32 1. 137 .41 94.03**
Threat removal .67** .07
Block 2 (Stepwise')
(Constant) -.30 .34 3. 135 .15 805**
Self Responsibility .23“ .07
Loss/Helplessness -.22“ .08
Motivational Congruence .17* .07
*p<.05, ••pc.OOl
*Excluded Variables (see appendix 4.32): Motivational Relevance; Motivational 
Incongruence; Other-Responsibility; Problem Focussed Coping Potential; Emotion 
Focussed Coping Potential; Self-Consciousness; Relevance; Unexpectedness; Irrelevance; 
Lack of Concern; Threat Removal; Other-Blame; Self-Blame; Threat; Effortful Optimism; 
Success.
Data Driven
Unstandardised Model Summary
Coefficients
B SE df V  F
Stepwise'
(Constant) 84* 43
Threat Removal 44** .08
Success .24“ .08
Self-Responsibility .24“ .07
Loss/Helplessness -.22“ .07
Motivational Congruence .15* .06
*p<05.“ p<001
*Excluded Variables (see appendix 4.33): Motivational Relevance; Motivational 
Incongruence; Other-Responsibility; Future Expectancy; Problem Focussed Coping 
Potential; Emotion Focussed Coping Potential; Self-Consciousness; Relevance; 
Unexpectedness; Irrelevance; Lack of Concern; Other-Blame; Self-Blame; Threat; Effortful 
Optimism.
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Theory Driven Data Driven
Unstandardised 
Coefficients 
B SE
Block 1 (Enter)
(Constant) 1.07" .16
Self Consciousness .21 .09
Block 2 (Stepwise')
(Constant) -.22 .14
Other Blame .13* .06
Model Summary
_JL____81 t  _________
Stepwise'
1, 137 .04 5.61* (Constant)
Other Blame 
Self Blame
1. 137 .04 5.33*
Unstandardised Model Summary
Coefficients
_B______ SE________ df R*_______F
8 9 " 16 2. 136 10 7.76"
14* 06
17* .07
*p< 05, "p<001
*Excluded Variables (see appendix 4.34): Motivational Relevance; Motivational 
Incongruence; Motivational Congruence; Self-Responsibility; Other-Responsibility; Future 
Expectancy; Problem Focussed Coping Potential; Emotion Focussed Coping Potential; 
Relevance; Unexpectedness; Irrelevance; Lack of Concern; Threat Removal; Self-Blame; 
Threat; Loss/Helplessness; Effortful Optimism; Success.
•p< 05. "p<001
'Excluded Variables (see appendix 4.35): Motivational Relevance; Motivational 
Incongruence; Motivational Congruence; Self-Responsibility; Other-Responsibility; Future 
Expectancy; Problem Focussed Coping Potential; Emotion Focussed Coping Potential; Self- 
Consciousness; Relevance; Unexpectedness; Irrelevance; Lack of Concern; Threat Removal; 
Threat; Loss/Helplessness; Effortful Optimism; Success.
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4.7'2.4 Exploratory results for regret, frustration and self-directed anger.
For these remaining three emotions, no literature exists to suggest which 
appraisals nor which core-relational themes act as cognitive precursors to these 
specific emotional outcomes. Thus, an entirely data driven approach was used.
Only the model for self-directed anger included both appraisals and core- 
relational themes: higher self-directed anger was predicted by higher self 
responsibility appraisals, and higher scores on the core-relational themes of self- 
blame, loss/helplessness, and unexpectedness. The final model explained 36% of 
variance in the emotion (table 4.37).
Table 4 37 Data d riven  tests o f  the cogn itive  p recu rso rs  o f  se lf-d irected anger.
Theory Driven___________________________
Unstandardised Model Summary
Coefficients
H_______SF_________dj_______R*________F
- 4 6  49 4, 134 .36 1 8 .4 0 "
4 9 "  .12
2 6 "  07
2 1 "  .06
13* 06  _________
•p< OS, *mp< 001
•Fxcluded Variables (see appendix 4 Motivational  Relevance; Motivational 
Incongruence. Motivational Congruence; Other-Responsibility; Future Expectancy; 
Problem Focussed Coping Potential. Emotion Focussed Coping Potential; Self- 
Consctousness. Relevance, Irrelevance; Lack of Concern; Threat Removal; Other-Blame; 
Threat. Fffortful Optimism; Success
The analyses for both frustration and regret resulted in models containing 
core-relational themes only. Higher self-blame and threat were predictive of 
higher frustration (R 2=. 13; see table 4.38); and higher threat and loss/helplessness 
were predictive of higher regret [R 2= .23; see table 4.39).
S t e p w i s e  
(C onstan t)
Self-Blame  
Loss/ Helplessness 
Self-Responsibility  
11nexjsectetlness _
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Table 4.38. Data driven tests of the cognitive precursors o f frustration.
Theory Driven
Unstandardised Model Summary
Coefficients
B SE df R2 F
Stepwise
(Constant) 1.81** .38 2 ,136 .13 9.92**
Threat .27** .08
Self-Blame .30* .14
•p<.05. **p<.001
•Excluded Variables (see appendix 4.37): Motivational Relevance; Motivational 
Incongruence; Motivational Congruence; Self-Responsibility; Other-Responsibility; Future 
Expectancy; Problem Focussed Coping Potential; Emotion Focussed Coping Potential; 
Self-Consciousness; Relevance; Unexpectedness; Irrelevance; Lack of Concern; Threat 
Removal; Other-Blame; Loss/Helplessness; Effortful Optimism; Success.
Table 4.39. Data driven tests o f the cognitive precursors o f  re g re t
Theory Driven
Unstandardised Model Summary
Coefficients 
B SE df R2 F
Stepwise
(Constant) 1.16** .30 2, 136 .23 19.93**
Threat .23** .08
Loss/Helplessness .23** .09
•p<.05. **p<.001
*Excluded Variables (see appendix 4.38): Motivational Relevance; Motivational 
Incongruence; Motivational Congruence; Self-Responsibility; Other-Responsibility; Future 
Expectancy; Problem Focussed Coping Potential; Emotion Focussed Coping Potential; 
Self-Consciousness; Relevance; Unexpectedness; Irrelevance; Lack of Concern; Threat 
Removal; Other-Blame; Self-Blame; Effortful Optimism; Success.
4.7.3 Summary of results of theory testing
Longitudinal theory testing of change scores (section 4.7.1) did not support 
the unique cognition-emotion associations of Lazarus's theory (1999). Correlation 
effect sizes were generally small and a number of supposedly non-associated 
components were found significantly to correlate. A summary table of the results 
of the cross-sectional regression theory tests from section 4.7.2 (including effect 
sizes and significant predictors) is presented in table 4.39.
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Table 4.40. Summary findings from theory testing regressions (negative coefficient Indicated In parentheses).
Summary statistical results Summary models
Emotion Theoretical hypothesis Theory Driven Data Theory Driven Data Driven
Appraisal CRT Extra Driven
Anger A: Motivational Relevance R2=. 10 R2=. 04 R2=. 18 A: Other Responsibility C: Threat
A: Motivational Incongruence 
A: Other Responsibility 
C: Other Blame
(10.2%) (3.6%) 
Total: 29.4%
(15.6%) R2=. 24 
(23.9%)
C: Other Blame 
C: Lack of Concern (-ve)
A: EF Coping Potential (-ve) 
C: Effortful Optimism ( ve)
C: Unexpectedness
C: Self-blame
C: Lack of Concern ( ve)
A: EF Coping Potential ( ve)
Guilt A: Motivational Relevance /?>=. 12 R2=.07 R2=. 00 A: Motivational Incongruence (-ve) C: Self-blame
A: Motivational Congruence 
A: Self Responsibility 
C: Self-blame
(12.2%) (6.2%) 
Total: 18.4%
R2-.\9
(18.7%)
A: Self Responsibility 
C: Self-blame
A: Motivational Incongruence ( ve) 
A: Self Responsibility
Fear / A: Motivational Relevance R2=. 33 R2=. 07 R2=. 06 A: Motivational Relevance C: Threat
Anxiety A: Motivational Incongruence 
A: EF Coping Potential (-ve)
C: Threat
(33.0%) (4.0%) 
Total: 40.8%
(3.8%) R2=A3
(43.3%)
A: EF Coping Potential (-ve) 
C: Threat 
C: Self-blame 
C: Unexpectedness
A: EF Coping Potential (-ve) 
A: Motivational Relevance 
C: Self-blame
Sadness A: Motivational Relevance R*=. 10 R2=. 18 R2=. 00 A: Future Expectancy (-ve) C: Threat
A: Motivational Incongruence 
A: Future Expectancy (-ve)
A: PF Coping Potential (-ve)
C: Loss/Helplessness
(9.7%) (16.2%) 
Total: 25.9%
R2=. 37 
(36.5%)
C: Loss/Helplessness C: Loss/Helplessness 
A: Motivational Incongruence
Hope / A: Motivational Relevance R*=.ll R2=. 04 R2=. 09 A: PF Coping Potential A: PF Coping Potential
Challenge A: Motivational Incongruence 
A: PF Coping Potential 
C: Effortful Optimism
(10.9%) (3.6%) 
Total: 22.3%
(7.8%) R2-.22
(21.6%)
C: Effortful Optimism 
A: EF Coping Potential 
C: Relevance
A: EF Coping Potential 
C: Relevance
C: Loss/Helplessness (-ve)
Happiness A: Motivational Relevance 
A: Motivational Congruence 
C: Success
R2=.01
(0.6%)
R2-.19 
(18.8%) 
Total: 22.6%
R2=. 04 
(3.2%) R2=. 22 (21.7%)
C: Success
C: Effortful Optimism
C: Success
C: Effortful Optimism
Boredom C: Irrelevance R2=. 00 
Total: 6.9%
R2=. 07 
(6.9% ) R2=.07(6.9%)
A: Motivational Incongruence (-ve) A: Motivational Incongruence (-ve)
A: Appraisal components; C: Core-relational theme
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Tabkt 4.40. Summaryfindings prom thmory tasting rsgrmssions (continumd).
Summary statistical results Summary models
Emotion Theoretical hypothesis Theory Driven 
Appraisal CRT Extra
Data
Driven
Theory Driven Data Driven
Surprise C: Unexpectedness R2-.2 \
(20.5%)
R2=. 12 
(9.5%) R2=. 31
C: Unexpectedness 
A: Motivational Relevance
C: Unexpectedness 
A: Motivational Relevance
Total: 30.0% (30.5%) C: Lack of Concern 
C: Self-consciousness (v e )
C: Lack of Concern 
C: Self-consciousness ( ve)
Resignation C: Loss/helplessness R2-.22 
(22.2%) 
Total: 30.0%
R2=
(7.8%)
R2=30
(29.6%)
C: Loss/helplessness 
C: Threat Removal 
A: Other Responsibility
C: Loss/helplessness 
C: Threat Removal
Tranquility C: Lack of Concern R2=. 07 
(7.0%) 
Total: 21.0%
R2=. 15 
(14.0%)
R2-.2 \
(21.4%)
C: Lack of Concern 
A: EF Coping Potential
A: EF Coping Potential 
C: Lack of Concern
Interest C: Relevance R2=. 02 R2=.34 C: Relevance C: Effortful Optimism
(2.9%) 
Total: 36.2%
(33.3%)
R2=. 36 
(36.0%)
A: EF Coping Potential 
C: Effortful Optimism 
A: Motivational Incongruence (-ve) 
C: Self-blame (-ve)
A: Self Responsibility 
A: Future Expectancy
A: EF Coping Potential 
A: Motivational Incongruence (-ve) 
C: Self-blame (-ve)
C: Relevance 
A: Self Responsibility 
A: Future Expectancy
Relief R2= A l R2=. 15 C: Threat Removal C: Threat Removal
(40.7%) 
Total: 49.6%
(8.9%) R2=. 54 
(53.5%)
A: Self Responsibility 
C: Loss/Helplessness (-ve) 
A: Motivational Congruence
C: Success
A: Self Responsibility 
C: Loss/Helplessness (-ve) 
A: Motivational Congruence
Shame /  
Humiliation
C: Self Consciousness R2=. 04 
(3.9%) 
Total: 7.7%
R2=. 04 
(3.8%)
R2=.10
(10.5%)
C: Other-blame C: Other-blame 
C: Self-blame
Self-directed C: Self-blame
Anger /?2=.36
(35.5%)
C: Loss /  Helplessness 
A: Self Responsibility 
C: Unexpectedness
Frustration R2=.13
(12.7%)
C: Threat 
C: Self-blame
Regret R2=. 23 
(22.7%)
C: Threat
C: Loss /  Helplessness
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For the six 'hot' cognitions, relatively equal results were found in the theory 
driven and data driven approach. However, theory in and of itself was insufficient 
to explain all variance in the emotion for four out of these six emotions and the 
additional block using stepwise methods added substantially. In all six cases, some 
of the theoretically hypothesised cognitive components were not significant. 
Additional variables were required. Content of three of the six data driven models 
replicated that found in theory driven models, although the comparative 
coefficient sizes were different. Prominently, for some emotions, equal variance 
could be explained with a largely different set of predictors to that predicted by 
theory. For ail emotions (including the less empirically developed emotions), the 
results largely support the notion that both appraisals and core-relational themes 
are necessary for best variance to be explained (with just three exceptions). 
However, findings do not support unique emotion and core-relational theme 
pairings. There were no occasions where the directional relationship of 
coefficients opposed theory or was not as expected and few occasions where the 
specific cognitive precursors seemed illogical or unanticipated. Whilst a wide 
range of overall effect sizes resulted from the models, there were no occasions 
where cognitions were able to entirely predict variance in emotion.
4.8 ANALYSIS OF QUALITATIVE COMMENTS
At the end of each questionnaire, participants were given the opportunity to 
write freely about their experiences, and/or their participation in the study. 
Analysis of this data allows a rich interpretation of the quantitative results and 
helps to generate further research hypotheses. Furthermore, due to the sensitive 
nature of some of the questions, it seemed reasonable that some participants 
might want an opportunity to express some of their responses to participation. 
Therefore, the qualitative element of the research was anticipated to act similarly 
to a debrief.
As participants were not directly asked to comment, it was not expected that 
enough data would emerge for a sophisticated qualitative analysis, therefore a 
basic content analysis was planned.
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Overall, 92 participants (57.5%) made some level of comment in this 
section of the questionnaires; many commented at more than one time point 
Length of comments varied greatly from just a few words, up to (in 10 cases) one 
to two sides of handwritten notes. Upon transcription of these comments it 
became clear that whilst a simple content analysis may be adequate, a basic level 
thematic analysis may also be possible. This thematic analysis led to the 
construction of 28 separate themes (subordinate themes) which were grouped 
into five independent categories or superordinate themes. A hierarchy of these 
themes is presented in table 4.41. Transcription and primary analysis of this data 
were carried out by the candidate and validated by the supervision team.
Table 4.41. Them atic sum m ary o f  qua lita tive  data.
Superordinate Them e Subordinate Theme
1 Causation & Control 1.1 Life event p rio r to diagnosis
1.2 Life events post diagnosis
1.3 Religious control
1.4 O ther causes
1.5 H ered ito ry  concerns
2 Cancer & Treatm ent 2.1 T rea tm en t
2.2 Cancer sym ptom s
2.3 C om orbid ity
2.4 Preparedness
2.5 Health care interactions
2.6 Diagnosis and trea tm en t delay
2.7 Perceived current health status
3 Psychological 3.1 A djustm ent to diagnosis
Adjustment 3.2 Expected nature o f diagnosis
3.3 D esirab ility  o f diagnosis
3.4 Em otional reaction to illness
3.5 Coping w ith  cancer
3.6 Religious coping
3.7 Social support
3.8 Body image
4 Transition & Return to 4.1 Personal grow th
Norm ality 4.2 Future expectations o f return  to norm ality
4.3 Thoughts o f recurrence and survival
5 Participation Issues 5.1 Presentation o f questionnaire
5.2 Relevance o f study
5.3 Religious enquiry
5.4 Benefits and harm s o f participation
Because the thematic analysis was so varied, and given that fewer than 60% 
of participants made any comment at all, it is not surprising that some themes
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contained only two or three comments, providing too little data to derive any 
theoretical insight. Thus, not all thematic descriptions will be presented here. 
Theme five, however, seemed particularly relevant to understand both why 
participants did (and didn't) answer certain sections of the questionnaire, and also 
to understand their personal experiences and reflections of participation. This 
information is useful in both evaluating the current study, and planning future 
protocols with this patient group and so analysis follows. The chart of transcribed 
comments relevant to this theme is presented in appendix 4.39 and a written 
summary of this theme follows. Very few participants commented on this theme at 
more than one time-point, but where they have, any changes in opinion will be 
highlighted. Accordingly, the remaining comments have not been separated by 
time-point. The appended transcriptions contain this information for reference 
(appendix 4.39).
4.8.1 Subordinate theme 5.1: Presentation of the questionnaire
Quite a complex questionnaire. Have done my best
Participant 005, Tl.
The over-arching message of these comments is that participants found the 
questionnaire very difficult, both in content and how they were asked to provide 
answers. Across the three time points, 19 participants made comments in line 
with this theme. Two participants commented on specific measures within the 
questionnaire pack. Participant 30, for example, did not understand one of the 
measures, and participant 108 found those questions relating to causation 
particularly difficult:
I had difficulty answering the questions relating to 'blame'. As I understand 
my condition it is age related and as a consequence it would have happened 
anyway.
Participant 108, T2.
Seven participants (1, 30, 52,106,112,158) also commented on the way 
that they were asked to answer particular questions. Participant 158 also 
commented on the seeming" ...duplicat[ion]..."through the questionnaire. 
Participant 106 suggested that a "...neutral response..." would have been helpful 
and another participant said the following:
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Respectfully note that I find some of your questions to be rather nebulous and 
not easy to respond to specifically.
Participant 001, T2
Two participants related their difficulty to complete the questionnaire to 
fluctuations in their feelings and emotions over time (11,132). Seven participants 
(18,62,93,101,113,122,141) commented that it was difficult to isolate their 
answers to the cancer from other health problems and specific features of their 
treatment. For example, participant 113 related most his problems to his 
"...ileostomy and kidney failure". One participant (018) felt that his age (more than 
the cancer) would have influenced his answers throughout and participant 122 
commented that more than his health affecting the answers given, it was daily 
appointments at the hospitals for treatment which impact life to a greater extent 
Similarly, another participant found that it was not direct health problems which 
restricted activity and affected life, but the indirect effects of health advice:
/ also found difficulty answering with regard to restricted activities. I was 
told not do any lifting for three months. I have carefully avoided this.
Participant 093, T2
One participant commented that answering the questionnaires got 
increasingly more difficult as she progressed through the study due to the 
uncertainty as here illness progressed:
This questionnaire has been more difficult to answer as I am coming to the end
of the chemo treatment, so do not know what will be the next stage.
Participant 131. T3
Given the length of the questionnaire, it is perhaps surprising that only two 
participants (027,152) commented on this:
It is far too long and too repetitive and requires an "act of will" to 
answer it at all.
Participant 027, T2
4.8.2 Subordinate theme 5.2: Relevance of the study
Two participants raised questions of the general relevance the study to 
cancer patients. For one patient, this ambiguity was resolved after both speaking 
the her GP and being given time:
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I feel tons better about participating, as he explained it's [sic] relevance in the 
light of recent thought relating to a positive attitude...having got my head 
around things now, I found completion of the questionnaire considerably 
easier.
Participant 106, T2
The other participant did not feel that this issue was resolved but related this to 
her previous experience of cancer. She commented that her personal experience 
seemed in contrast to the aims of the study:
I really find it difficult to know how these answers really help in the ongoing 
fight against cancer. My partner was an extremely positive person...he died 
aged 58 from pancreatic cancer. So I am fatalistic about these things.
Participant 084, T3
Similarly, one participant felt that some specific questions were 
inappropriate, especially given the timing:
Spirituality and sexuality are deeply personal issues, and I am not prepared to 
offer an opinion...also felt rather annoyed at being confronted with this at 
such a deeply emotional time
Participant 106, T1
A number of participants commented on the irrelevance of some questions in 
respect to their treatment. Two (101,141) had received only minimal treatment 
due to their diagnosis being made at an early stage:
As I had a non-aggressive malignant tumour some of the questions have been 
irrelevant...therefore I have tried to answer the questions adequately, 
sometimes with difficulyt
Participant 101, T2
A further seven participants (012, 025, 045, 052, 081,122,135) felt that some of 
the questions were irrelevant because they had not yet started treatment:
I have been unable to answer some of the questionnaire, because I think I need 
to have started treatment before I can do so
Participant 012, T1
However, these participants also acknowledge that this is likely to change over the 
course of treatment leading them to feel "...more involved..." (Participant 135, Tl).
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4.8.3 Subordinate theme 5.3: Religious enquiry
One participant felt that the questions in this study were not of relevance to 
medicine:
The questionnaire has many facets in common with the Church of Jesus Christ 
Scientists (Scientology). It has nothing in common with a serious medical 
scientific study.
Participant 027, T2
This opinion was similar to that of seven other participants who commented on 
tfie necessity to include questions about religion and spirituality. Participant 152 
suggested that such questions should be left out as "...not all people believe..."and 
that"there is too much [sic] question on God". Participant 75 wrote simply that she 
has "...found the issue of God difficult", but with no further expansion it is difficult to 
know whether this is because having cancer has made her question her 
spirituality, or if she is simply referring to difficulty in knowing how to answer 
these questions. One participant claimed to be confused at the inclusion of 
spirituality in this study with a further suggestion that to fully understand this, 
research should ask about the "...relevance of a person's faith in the usual 
circumstances... and whether it has helped in the present circumstances."
(Participant 093, T3).
Three participants (001, 93,151) reflected on the wording of these particular 
questions commenting that they provide a biased impression of God:
Your question gives me a feeling of being critical or negative toward God.
Participant 001, T2
The questions imply a draconian God who 'deals out' cancer on a random 
basis. I do not believe that God decides that I get a disease...[I] believe in a 
God who cares and supports me.
Participant 151, T2
This latter extract also further highlights the importance of establishing a 
participant's personal faith in addition to appraisals of religious control; this 
participant felt that questions of spiritual blame were irrelevant because of their 
personal definition of God. This is further expanded by participant 72 who claims 
that "blaming God is stupid...we don't ask to be ill, it just happens."
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4.8.4 Subordinate theme 5.4: Benefits and harms from participation
Only three participants reported harms, or negative effects from the study: 
Participant 106 felt that it:
..focused the mind so strongly on things that are difficult to cope with, when 
[I] would rather 'go with the flow'.
Participant 106, T3
A similar but stronger reaction was written by participant 027, who felt that such 
"...dwelling...is not constructive." This participant further expanded on this 
daiming "I do not approve of this study." (T2). A less critical, but equally negative 
reaction, was reported by another participant:
Filling in this has reduced me to tears, don't understand why.
Participant 28, T2
Despite this emotional reaction, this same participant wrote about the benefits of 
m...hav[ing] written it all down" and in a later follow-up seems to have found 
understanding of why her reaction is so emotional:
This questionnaire has made me confront my condition. I have not accepted 
that I've had cancer...I have had to face reality and my emotions and end up in 
tears...I do not think I am handling my condition in the way that I should.
Participant 23, T3
Participant 117 also commented that participation helped in the process of 
realisation that the "...cancer, although small, was real".
One participant directly commented that participation had helped, but went 
on to claim that:
It would be good to talk to people, including doctors, and be given help in 
adopting a positive attitude.
Participant 057, T1
A further two participants wrote of their gratitude of having had the opportunity
to take part. The first seems thankful for the opportunity to help others:
Many thanks for allowing me the opportunity to take part...I do hope that it 
will benefit others.
Participant 103, T3
For participant 103, it is not benefit to others that is the cause of her gratitude, but 
benefit on a much more personal level. She comments, "Thankyou for listening.
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CHAPTER 5 
EMPIRICAL STUDY: DISCUSSION
5.1 CHAPTER OVERVIEW
The summary of the results will be organised around the four principle 
objectives for this study:
1) To identify the most important psychological predictors of 
anxiety, depression and quality of life at three and six month time- 
points after cancer diagnosis.
2) To identify at what time-period (baseline, three or six month 
follow up) predictor variables best predict each of the outcomes 
at three and six month follow-up.
3) To examine whether theoretically associated components of the 
Transactional model (cognitive appraisal, core-relational themes, 
emotion themes, and coping) vary equivalently over time.
4) To test the hypothesised associations between specific cognitive 
appraisals, core-relational themes, and emotion themes (i.e. the 
'exclusively' linked components) in relation to cancer diagnosis.
These will be grouped by their primary aim: prediction of clinically-relevant 
psychosocial outcomes (objectives 1 and 2; section 5.2) and theory testing 
(objectives 3 and 4; section 5.3). Findings are discussed in the context of the 
psychosocial oncology literature, in particular those studies included in the 
systematic review (Chapter 2). A general study evaluation (section 5.4), and future 
recommendations follow (section 5.5).
5.2 PREDICTING ANXIETY, DEPRESSION AND QUALITY OF LIFE
5.2.1 Overview of score distributions and outcome prevalence
In relation to sample distributions, a full range of scores on optimism were 
obtained, but the mean was relatively high compared to similar research (e.g. 
Scheier et al, 1994). Mean scores of neuroticism were low, although again, a wide 
spread of scores were demonstrated. When compared to normative data 
(Furnham & Bramwell, 2006), mean neuroticism scores were lower than would be 
expected (17.27 as opposed to the normative mean of 24.56). The same is true for 
both extroversion and openness (although to a lesser extent). Conversely, means
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scores on both agreeableness and conscientiousness were higher than normative 
data.
A full range of scores on the Smith and Lazarus (1993) measures was 
observed. Median scores from these indicate, not surprisingly, that motivational 
relevance was high. That is, diagnosis was important in relation to individuals' 
current goals. Furthermore, the data seemed to show that the situation was 
largely incongruent with perceived achievement of those goals. Few patients held 
themselves responsible, but perceptions of other-responsibility were at a higher 
level. Confidence in future expectancy was low but perceived coping expectancies 
high. Most highly reported relational meanings included self-consciousness, 
irrelevance, other blame, and effortful optimism. Loss and helplessness were rated 
very low as was, perhaps surprisingly, perceived threat. The most highly reported 
emotions were guilt, resignation, interest, boredom/detachment and anxiety and 
relief. Low median scores on challenge, hope, anger and fear (all scoring a median 
of 1 out of a possible 9) were surprising given previous literature reporting high 
levels of negative emotions in similar samples (e.g. Longman etal., 1999).
In accordance with findings reported by Lowery etal. (1993), in a 
comparison of each subscale of locus of control, internal control scored lowest, 
other-people oriented control highest, and chance control in the middle. On the 
MiniMac, hopelessness was low but scores on fighting spirit, fatalism and 
avoidance both tended towards the higher ends of the scale. There were no 
significant changes in these variables over the course of the study. In terms of 
coping; acceptance, distraction and seeking social support were most common at 
diagnosis. Grouped adaptive strategies were reported more commonly than 
maladaptive strategies. Concurrent health status was rated fairly highly, and 
although only minor changes were observed over time, these seem to indicate 
worsening physical, but improving mental health over the six months of study.
Quality of life was high, possibly in large part due to the less physically 
demanding nature of early stage illness. This finding confirms that of Kessler 
(2002). Whilst further improvements were observed for all site-specific sub­
scales, for lung cancer patients this was less noticeable and non-significant. 
Although there was a slight depreciation in total mean quality of life at three 
month follow-up (which had returned to earlier levels by six months), emotional
quality of life subscales consistently improved at each time point. This pattern of 
results is congruent with those previously reported in the associated literature 
(e.g. Hee et al, 2005; Schou et al, 2004).
Mean anxiety and depression scores were consistently below clinical cut-off 
scores at each time point and are representative of a comparatively 
psychologically healthy' sample when viewed alongside other literature (e.g. 
Maguire, 2000). Crawford, Henry, Crombie and Taylor (2001) provide normative 
data for a non-clinical adult populations on the HADS and these compare 
favourably with the data from this study. Their anxiety normative mean score is 
reported at 6.14. In this study, mean anxiety scores at each timepoint were 6.62, 
5.78, and 5.29; although slightly higher than the general population at baseline, 
anxiety decreases below general population levels in later stages of illness 
adjustment. Similarly, Crawford et a l ’s depression data suggest a normative mean 
score of 3.68. In this study, mean scores of 3.40, 4.08 and 3.41 were found at each 
timepoint; patients are at most risk from increases in depression at a midpoint of 
adjustment. There were cases above clinical cut off at all timepoints, though 
proportionally more for anxiety, again reflective of trends in the previous 
literature (see systematic review). As with quality of life, depression scores 
increased at three month follow-up, but had returned to baseline levels by six 
month follow up (two cases met clinical cut off at baseline, nine at three months, 
and none at six months). Anxiety scores improved consistently throughout the 
study, with most decrease in the latter three months. Even though only small 
numbers reached clinical cut-offs at diagnosis, by three month follow-up none of 
the participants reached such cut-offs for either psychological disorder.
It is clear that adjustment to diagnosis is not straightforward. Whilst 
consistent improvements in anxiety support the notion of an immediate post­
diagnosis adjustment process (Trask etal., 2003; Yan & Sellick, 2004; Deshields et 
al, 2005), quality of life and depression incidence seem to indicate a more delayed 
process, perhaps, as suggested by other researchers (Bleiker et al, 1995; Nordin & 
Glimelius, 1998; Butow et a l., 1999), not commencing until treatment is underway. 
Low clinical caseness figures do not allow for direct comparison of this data with 
other longitudinal studies such as Bleiker et al. (1995) and Nordin & Glimelius 
(1998).
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5*2.2 Objective one: Identifying the most important predictors of outcome 
$2.2.1 Demographic variables
Age, gender, and the presence of a significant other were entered into 
regression analyses for all outcomes. Of these, only age emerged as a significant 
predictor, and only on one occasion (three-to-six month prediction of quality of 
life). The absence of a gender effect on these outcomes is surprising given 
previous results reported by Hassanein etal. (2001), Lehto etal. (2005), and 
Ranchoretal. (2002).
Considerable evidence indicates that elderly patients adjust better to 
diagnosis than their younger peers (see section 3.7.4), but once again, this variable 
failed to reach significance in multivariate tests. Previous literature also 
emphasises the importance of social support both as a buffer to psychological 
distress and as a primary mechanism in psychological intervention studies 
(Llewelyn et al., 1999; Schou et al., 2004; Bloom, 2007). In the current study, no 
confirmatory data for this relationship were found.
One possible explanation for the lack of effect for demographic variables in 
these analyses may be due to the longitudinal nature of the study. In all cases, 
regressions included previous levels of outcome. It is possible that the effects of 
these demographic variables may act more on initial reaction than later 
adjustment (i.e. anxiety, depression, and quality of life as measured at baseline). 
Therefore, their effect could be encapsulated within the large effect sizes of 
previous outcome included in each model. Alternatively, Osoweicki and Compass
(1998) suggest that demographic variables influence coping processes far more 
than outcome and this might well explain the absence of effect here.
52.2.2 Clinical variables
Previous literature (e.g. Alhama et al. 1996; Gallagher et al. 2002; Kessler et 
aL 2002) reports on the effects of cancer type, cancer stage, treatment differences 
and time since diagnosis as outcome moderators and mediators. Just one of these 
variables (cancer type) was suitable for inclusion in the analysis; other data were 
not usable primarily due to quantities of missing data, and small and unequal sub­
samples sizes for clinical categories of treatment and specific histological 
diagnosis. Although entered into regression analyses, no significant effects of 
cancer site (colorectal, breast, lung or prostate) were found. Again, this could be
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an effect of unequal group sizes. Alternatively, it could be that the individual’s 
perception of illness (i.e. perceived health status) is more predictive than the 
.clinical variables themselves.
£2.2.3 Personality
High intercorrelation was found between personality variables but 
differences emerged regarding their association with outcome. Where optimism 
and neuroticism were both consistently and highly correlated with all outcomes, 
regardless of time-lag, extroversion and agreeableness were correlated less 
frequently. Both were found to be highly significant for all outcomes in baseline- 
to-three month correlation, but only for anxiety in three-to-six month correlation. 
Only extroversion remained correlated in baseline-to-six month correlations, and 
only with quality of life and anxiety. No significant correlations were found for 
openness or conscientiousness, with the one exception of openness in three-to-six 
month anxiety.
Although associations between extroversion and outcome have previously 
been studied (with inconsistent conclusions), few studies have investigated the 
effects of openness, agreeableness and conscientiousness. The current data 
suggest an equally important role of agreeableness as for extroversion, but a lack 
of evidence for the importance of openness and conscientiousness.
Of all personality variables, only neuroticism emerged significantly 
predictive in the regression analyses, although this was affected by time point. For 
quality of life and anxiety, neuroticism emerged significant only for later outcome 
(three-to-six month) whereas for depression, it featured only for early outcome 
(baseline-to-three month). Correlation data provide no explanation for this: 
effect sizes are relatively consistent within each outcome across different 
timepoint. There are suggestions in the general psychology literature that some 
factors of supposed trait personality actually demonstrate moderate instability 
over the life-course (Roberts, Walton & Viechtbauer, 2006). Should this be a valid 
hypothesis, this may explain differences observed in the trait structure here, and 
why some factors, particularly neuroticism and extroversion appear to effect 
outcome more similarly to optimism than their trait counterparts.
The failure of optimism to emerge as a significant predictor in regression 
models is surprising given previous literature (e.g. Carver, 2003) however, this
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y be due to the specificity of the outcome. Effects reported in the literature (see 
ticularly table 2.7 in the systematic review) tended to be for generic outcomes 
mch as distress or well-being, rather than specific disorders such as anxiety and 
depression.
$22.4 Health locus of control.
The systematic review (Chapter 2) highlighted the inconsistency of findings 
relating to associations between locus of control and outcome, hence the 
hypothesis that these would not be found in the current data set. In this study, just 
three significant correlations emerged between the five sub-scales and the three 
outcomes and given the sheer number of correlation tests conducted in this 
section, it is possible that these appeared simply by chance. None of these effects 
emerged as significant in multivariate analysis, confirming the results of Naus etal 
2005) and DeValck & Vink (1996). This hypothesis (hypothesis two) was, 
therefore, supported.
$2.2.5 Cognitions and emotions
Correlations between appraisal components and outcome were frequent. 
Where a range of appraisals correlated with quality of life and anxiety, only 
components of secondary appraisal (coping and responsibility oriented) 
correlated significantly with depression. Whilst the generic influence of cognitive 
appraisal on outcome is consistent with findings reported by Krietler etal. (1996) 
and Burgess and Haaga (1998), the absence of focus on goal-related appraisals is 
somewhat at odds with more recent research (e.g. Lampic etal, 2002; Schroevers 
etal, 2008).
There were also far more correlations between core-relational themes and 
quality of life than for anxiety and depression. Four of the twelve core-relational 
themes (other-blame, threat, threat removal, and loss/helplessness) seem more 
pervasive in effect than the remainder. Threat and loss/helplessness in particular 
were associated throughout all correlation tests. However, where other-blame is 
most highly correlated with early levels (three month follow-up) of the three 
outcomes, threat removal is more highly correlated with later levels (six month 
follow-up). This particular focus is not surprising given the nature of the stressor 
in question and confirms findings reported by Padilla, (1992, Glinder and Compas
(1999) and Green (2003).
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In multivariate analysis just two appraisal components emerged: other 
responsibility for three-to-six month quality of life, and self responsibility for 
baseline-to-three month anxiety. Core-relational themes of lack of concern 
emerged for baseline-to-six month quality of life; unexpectedness and threat for 
three-to-six month quality of life; and, other blame for both baseline to three 
month and three to six month anxiety.
Emotions were highly correlated with all outcomes, a finding also is 
supported by previous research (e.g. Watson etal. 1999; Longman etal. 1999; 
Kessler et al., 2002). Whereas negative emotion was consistently correlated with 
all outcomes, across all time-lagged correlations, an alternative pattern of results 
emerges for positive emotion. For quality of life, correlation with positive emotion 
was found consistently across all regression timepoint, but anxiety and depression 
only significantly correlate for analyses of early adjustment (baseline to three 
month correlations) with effect sizes significantly decreasing where six month 
outcomes are used. Emotions feature in just one regression model, showing the 
importance of negative emotion for baseline-to-three month quality of life.
5.2.2.6 Coping
There were just two occasions where adaptive coping was significantly 
associated with outcome: baseline coping to six month quality of life and 
depression. Maladaptive coping was correlated with poorer adjustment on all 
outcomes at baseline, but only associations with quality of life and anxiety remain 
significantly correlated at three month follow-up. In multivariate analysis, only 
three-month adaptive coping emerged as a significant predictor of six month 
quality of life, a surprising finding given that this was one of the lowest correlation 
effect sizes found.
There is a wide literature reporting the direct and mediating effects of coping 
on anxiety, depression and quality of life (see table 2.11 for a summary). That 
coping was not included in more regression models is unexpected. In this study, 
most cognitive appraisals and core-relational themes correlated with outcome 
measures with equal, if not higher effect sizes, than the small to medium effect 
sizes previously reported for coping to outcome relationships (de Ridder & 
Schreurs, 1996). It is possible, therefore, that coping was rendered unnecessary in
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the regression models because of the larger amount of variance already explained 
by its cognitive precursors.
The choice of coping measure may also be partly responsible for these 
findings. Rather than using individual sub-scales, or more traditional composite 
score dichotomies (see also section 1.5), the BriefCOPE employs an adaptive- 
maladaptive dichotomy (see also section 1.5). Although the use of these composite 
scores is validated (Carver, 1997) there is some question, more broadly, over the 
validity of the nature of grouping coping responses in this way. Some literature 
instead recommends the use of individual strategies in data analysis (Jensen, 
Turner & Romano, 1992). Due to data limitations (power and normality) such 
analysis was not here possible but with larger sample sizes, exploration of each 
individual coping type may yield different results.
5.2.2.7 Mental Adjustment to Cancer Variables
Hopelessness/helplessness and anxious preoccupation were consistently 
correlated with all three outcomes, regardless of time-lag. Whilst fighting spirit 
also emerged significantly correlated with quality of life and depression in 
baseline-to-three month outcome only, correlations between both fatalism and 
cognitive avoidance with outcome were small to negligible. These associations are 
only in part supportive of those in the published literature (e.g. Watson etal.,
1991; Hassannein etal., 2005). The larger effects of anxious preoccupation and 
hopelessness/helplessness on these three outcome measures are particularly 
reflective of the results of the meta-analysis earlier in this thesis (see table 2.7).
That components of the MiniMAC were not included in the regression models 
was unexpected given the previous literature on their effects. This may be due to 
the underlying constructs which are measured by the scale. As previously 
reported (in sections 2.6.3 and 3.4.1.7) there is some debate regarding the specific 
construct measured. Despite this, there is consensus that it is likely to be a 
cognition or coping construct rather than personality or emotion. Correlation data 
from this study between the MAC, BriefCOPE and Smith and Lazarus (1993) 
appraisal and emotion measures confirms strongest relationships between the 
MAC and core-relational themes which may go some way to clarifying this 
conceptual issue in favour of the cognition argument (see also Nelson et al., 1994). 
Collinearity between the MAC and core-relational themes was tested as part of the
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regression procedure and no problematic effects were found. However, it is likely 
that there is some degree of shared variance. Given that the core-relational themes 
were prominent in the regression models, this may explain why MAC components 
did not add further variance.
5.2.2.8 Concurrent health status and earlier measures of the outcome 
variables
Concurrent physical and mental health status were significantly correlated 
with all three outcomes and remained so over the larger time-lagged baseline-to- 
six month correlation tests. By far the most significant and largest correlations are 
those between earlier and concurrent anxiety, depression and quality of life.
These high effect sizes remained significant contributors in the multivariate 
regression analyses.
In regression analyses, concurrent health status emerged significant only for 
depression. For this outcome, a noticeable distinction was observed between 
mental health status which is predictive in baseline-to-three month regressions, 
and physical health status which is predictive in three-to-six month regression.
In all statistical models, earlier levels of the outcome variables were highly 
significant of later levels of these same variables. There was also some cross-over 
effects of baseline levels of outcome with anxiety emerging a significant predictor 
of baseline-to-three month quality of life; and baseline quality of life predictive of 
three month anxiety, and both three and six month depression. The high 
correlation and predictive power between these constructs was expected and is 
congruent with the published literature (e.g. Malcarne etal, 1995; D'Antonio etal, 
1998; Green, 2002; Badger eta l 2004).
5.2.2.9 Summary
Hypothesis one stated that potentially modifiable psychological variables 
would contribute to prediction of psychosocial outcomes. This was confirmed in 
the current study, but the limited number of individual predictors significantly 
entering the regression models was unexpected. Hypothesis two stated that locus 
of control would not be predictive of outcome. This was also supported. The 
implications and application of these findings will be further discussed later in this 
chapter.
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5.2.3 Objective two: Optimal assessment times for best outcome prediction
Three regression models were tested for each of the outcomes variables 
(anxiety, depression and quality of life): baseline predictors and three month 
outcome; baseline predictors and six month outcome; and, three month predictors 
and six month outcome. Across all multivariate analyses, final models produced 
higher effect sizes than expected ranging from R2- A l  to .74. It is unusual to find 
such high levels in the psychosocial oncology literature and this may reflect the 
importance of including multi-component measures.
For quality of life, prediction from baseline measures proved least effective, 
although still explaining 61.6% variance in outcome. Models became more 
efficient when both six month outcomes and three month predictor data were used 
(total variance increasing to 67.5% and 73.4% respectively). A interesting pattern 
of inclusion of modifiable psychological predictors was also evident. In the early 
adjustment model (baseline-to-three months), only negative emotion was 
included. Oriented toward six month outcome, emotion was replaced by lack of 
concern, a core-relational theme. The three-to-six month model included the 
highest number of additional variables within this set of analyses; predictors 
included an appraisal component, two core-relational themes and adaptive coping.
Total variance explained for baseline-to-three month and three-to-six month 
anxiety were relatively equal. Both models included the core-relational theme of 
other blame. Although the early adjustment model also included the appraisal 
component of self-responsibility, the overall variance explained is lower. It is 
likely that, as with quality of life, the addition of neuroticism in block one of the 
three-to-six month regressions improved the predictive ability of the model.
More variance for depression was explained using baseline measures than 
those measured at three month follow-up; whether predicting over a three or six 
month time-lag, overall variance explained was 57.0%.
These differing trajectories of outcome over time do not provide clear 
answers to hypotheses three which had predicted longer time-lagged analyses (i.e. 
baseline-to-six months) to perform worst. Hypothesis four further predicted that 
later models of adjustment would outperform early models of adjustment. Again, 
this was not confirmed by the current data as each outcome demonstrated 
different patterns over time. Quality of life was worst predicted in the early
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adjustment model (baseline-to-three month) and depression was worst predicted 
in the late adjustment model (three-to-six months). Only findings for anxiety 
supported this hypothesis by producing a model for baseline-to-six month 
prediction that was worse performing that other variable and time combinations. 
Although a complex picture of adjustment, these findings are not unique. Bleiker 
etal. (1995), for example, proposed that for quality of life, adjustment processes 
and improvements do not begin until after treatment has finished because the 
situation is simply far too complex and unstable. This may go some way to 
explaining the increased variance predicted in the later models regardless of time 
lag; at this later stage, physical aspects of illness are beginning to settle. Cognitions 
and coping are more likely to stabilise, thus increasing their predictive ability for 
psychological outcome.
5.2.4 Applications to clinical practice and policy
There are two important applications from these data: the identification of 
significantly predictive control, demographic and clinical variables; and, the 
additionally significant modifiable psychological variables.
The primary purpose for including clinical, demographic and control 
variables into the analyses was such that the potential clinical impact of the 
psychological variables (in block two) could be assessed against those variables 
that cannot easily be modified. More will be said on this in due course. A 
secondary outcome, however, was the identification of a group of core predictors 
of anxiety, depression and quality of life. Measurement of these in routine clinical 
assessment may provide an efficient method of clinical screening for the prediction 
of the psychological outcomes and the monitoring of those who may later 
encounter adjustment difficulties.
The majority of variables entered in block one of these regression analyses 
did not reach significance. Nonetheless, their presence did add some level of 
variance and together they provide a comprehensive outline of those patients who 
may be most at risk. Consistent with the previous literature, these included 
younger, female patients, lacking in the support of a significant other. Clinically, 
lung cancer patients were most likely to report poorer quality of life and higher 
anxiety and depression scores than the other cancer groups. Personality risk 
factors were not so easy to identify. So far as the results demonstrated,
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agreeableness consistently correlated with better outcome, as did openness and 
conscientiousness, in the few models into which they were included. Neuroticism 
was clearly associated with poorer outcome and being the most highly and 
significantly associated of all personality traits, this is the primary sub-scale on 
which risk might be best assessed. A direction of risk for extroversion is more 
difficult to establish as at different time points of analysis, even within the same 
outcome, the direction of effect for this variable regularly changed. Extroversion is 
unlikely, therefore, to enable reliable screening assessment.
That early levels of psychosocial outcome are the best predictor of later 
levels was expected. Given trends observed in the current data, it appears that 
where adjustment difficulties are identifiable early on in illness, that these are 
likely to persist throughout the illness experience. Ongoing adjustment difficulties 
can pose a threat to not only psychological health, but also to physical aspects of 
illness including treatment adherence, symptom management and further 
worsening of quality of life (Jacobsen, Donovan, Trask, Fleishman, Zabora, Baker & 
Holland, 2004). Regular and routine assessment of quality of life and psychological 
disorders at early states of illness is suggested to be important to both identify at 
risk patients, and to provide additional psychological support and treatment to 
those in need. Such psychosocial support strategies are likely to reduce longer- 
term adjustment-related complications. The recent development of short 
screening tools, such as the Distress Thermometer (Roth, Kornblith, Batel-Copel, 
Peabody, Scher & Holland, 1998) have enabled early screening to be applied to 
dinical care far more routinely (Mitchell, 2007) and the findings from the current 
study would encourage the continuation of such practices.
Variables entered into block two of the regression models were specifically 
separated from block one variables as they represented psychological constructs 
with most potential for modification through psychological intervention. Once 
again, these results indicate which variables which may be potentially effective 
screening tools, but also to inform interventions targeted at the main study 
outcomes of anxiety, depression and quality of life. The current data demonstrate 
that of all components in the Transactional Model, illness cognitions (whether at 
an appraisal component or core-relational theme level) are more strongly 
correlated with, and predictive of, future outcome. Thoughts and emotions are
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often difficult topics to discuss in clinical practice (Brennan & Moynihan, 2004), 
however, inclusion into clinical consultation may reduce their negative impact. 
Research with clinical staff on communication skills has demonstrated that 
training workshops on the discussion of difficult issues with cancer patients and 
their families can be effective (e.g. Fallowfield & Jenkins, 2004; Baile & Aaronson,
2005). From the findings of this study, it is suggested that such training might 
benefit, at least in part, from training clinicians in how to discuss and respond to 
patients' cognitive and emotional reactions to illness, in addition to training on 
more conventional issues such as breaking bad news.
The individual cognitive predictors that emerged as most significant were 
perceived threat, issues of blame and responsibility, and unexpectedness. These 
hold most promise for effective intervention components. There is some 
limitation here in that different variables are predictive of outcome at different 
time-points though; it is unlikely that a general intervention could be developed to 
target all outcomes, for all patients, at any time-point. This concurs with the 
guidance of the Cancer Reform Strategy (Department of Health, 2007) that 
psychosocial support needs to be tailored to both the individual and to specific 
illness points.
Analyses demonstrated that prediction of six month quality of life was better 
than prediction of three month quality of life. There are two plausible 
mechanisms by which this might occur which would both have implications for 
clinical intervention. First, it may be that there was simply too much intra- 
participant variability in the predictor variables at this earlier timepoint. This 
variability is likely caused by the wide-ranging psychological and physical impact 
of cancer diagnosis and this may affect how amenable these measures might be as 
adjustment screening tools if used at this early timepoint. Second, it could be that 
these predictor variables do not have an immediate impact on quality of life. In 
this case, delay between intervention and impact on quality of life should be 
expected. For anxiety, short time-lagged (three month as opposed to six month 
delay) analyses consistently produced better results. Whilst this is likely 
reflective of the inherent instability of anxiety measurement, those aiming to 
implement psychological interventions into clinical practice for this outcome may 
wish to consider whether more regular interventions are better able to manage
277
this instability. The current data do not provide clear evidence of when 
depression-oriented interventions might be most, or less, effective.
As a final point on the topic of clinical intervention, it was surprising that 
components of the MAC, in particular, fighting spirit, were neither highly 
correlated with outcome, nor featured as significant predictors in the regression 
models. The MAC framework has long been recommended as a basis for 
intervention in psychosocial oncology, with therapists claiming that increased 
fighting spirit provides a sensible target outcome for cognitive behavioural 
therapy (Greer, 2008). What the current study demonstrated was the predictive 
power of more personally reflective appraisal processes over the effects of fighting 
sprit. O'Baugh, Wilkes, Luke and George (2003) also highlight this distinction and 
proposed that whilst high levels of fighting spirit were identified by clinicians as an 
indicator of positive adjustment, for patients themselves, it is the continuation of 
normal life that is key. These authors, and others (e.g. Wilkinson & Kitzinger, 
2000; Hulbert-Williams, Storey & Wilson, in prep), propose that the focus of 
therapeutic intervention might benefit from a shift from encouragement of fighting 
spirit, to management and acceptance (but not necessarily change) of cognitions 
and towards continuation of normality despite cancer. Whilst not providing a 
therapeutic framework, this study clearly supports these theoretical propositions. 
Further work is now required to explore how this information might best be used 
to inform effective interventions for cancer patients and what the longer-term 
clinically-related benefits of such interventions might be.
5.2.5 The contribution of the Transactional Model to understanding the 
cancer adjustment process
Data from this study demonstrated that each component of the Transactional 
Model was associated with one or more of the psychosocial outcomes measured.
It can be concluded, therefore, that the Transactional Model provided a useful 
framework for a more holistic approach to assessment of the potential 
psychological predictors of adjustment and outcome. Cognitive elements of the 
theory in particular, enabled higher variance to be predicted for anxiety and 
quality of life than is reported in much of the previous literature (see Chapter 2: 
Systematic Review). The application of the model for depression was limited as
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significant association was found in bivariate anlaysis only, failing to reach 
significance in the regression models.
From a theoretical perspective, it is intriguing that different components are 
important predictors at different time-points through the first six months of 
illness. The theory assumes that components are in constant dynamic flux and 
implies that changes in each component occurs regularly and affects associated 
components soon thereafter (Lazarus, 1999). In reflection of this dynamic 
processes, it was expected that each outcome model would include a variety of 
components from the Transactional Model. Though the analyses did not fully test 
the process nature of the model (they were simply not sufficiently powered for a 
path analysis) some interesting findings emerge nonetheless, particularly for 
quality of life.
Bivariate and multivariate statistical tests showed that where baseline 
predictor data were used, both cognitions and emotions emerge as highly 
correlated and predictive variables of quality of life at three and six month follow- 
up. Where three month follow-up predictor data are used, cognitions, emotions 
and coping significantly correlate, but only cognitions and coping emerge in 
stepwise regression models. The absence of baseline coping and of three month 
emotions as predictors is noteworthy. One possible explanation for this changing 
importance of different predictor variables might be that variables early in the 
process (e.g. appraisals and emotions) are in too much flux to enable general 
patterns of later processes (e.g. coping) to reliably emerge.
This suggests there is a delay between stressor onset and when coping 
becomes predictive of outcome based upon the extent of disruption to appraisals 
and emotions. Whilst not explicitly described by Lazarus (1999), this seems a 
particularly logical conclusion for this study. At baseline, participants would have 
been dealing with many uncertainties; few had begun treatment, and many had 
only very recently received their confirmed diagnosis. Their prognosis and the 
implications of having the illness would have been largely unknown. Whilst 
cognitions and emotions may be prominent predictors here, the amount of flux and 
change within these variables may prevent the adoption of stable and reliably 
predictive coping strategies. At three month follow-up, however, most would 
have had opportunities to adjusted to a new conception of normality (Taylor,
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2006). Those with early-stage illness would have completed active treatment and 
would by this time be regularly receiving follow-up care. Those with more 
advanced illness would likely still be engaged in active treatment but would still 
have gained the experience to know what to expect and potentially how to cope 
with its associated demands. It may not be until this stage of illness, when enough 
uncertainty has passed, that cognitions and emotions begin to stabilise enough 
such that patients can begin to actively monitor and engage in more stable 
psychological coping strategies to manage the stress of cancer. These then may 
become more predictive of outcome than some of the ealier components. This 
supports the conclusions of related studies, for example Bleiker et al (1995), 
Nordin and Glimelius (1998) and Butow e ta l (1999) which also provide evidence 
that coping with, and adjusting to, being diagnosed with cancer does not begin 
until after treatment has finished and patients begin to re-adapt back to normality.
Previous empirical tests of the Transactional Model have been limited to the 
effects of acute and vicarious stressors, rather than chronic and major life event 
stressors such as receiving a cancer diagnosis. This may also account for some of 
the process differences suggested by the quality of life results. The psychological 
effects of acute and chronic stressors are not thought to be qualitatively different, 
but it is plausible that they may result in different statistically predictive 
frameworks over varying time-frames (Lazarus, 1999). The data from this study 
are not, therefore, opposed to Lazarus's model, nor do they contradict the already 
established evidence base for it which works sufficiently well for acute stressors 
and in laboratory based simulations (Smith & Lazarus, 1993). Instead, these data 
indicate that with higher-impact stressors, coping may not be predictive of 
outcome until some of the initial reactive flux in cognitions and emotions subsides. 
The suggestion of a time delay in the predictability of coping is clearly deserving of 
further research but potentially provides useful extension in understanding of the 
process nature of the Transactional Model.
Caution is required in the interpretation of this conclusion. The purpose of 
these analyses was not to develop, nor even to test this model, but to simply use it 
as a research framework for applied research in a clinical setting. The analyses 
conducted, therefore, may not be entirely appropriate for theory development. 
Nonetheless, the emerging observations are both theoretically and clinically
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relevant and some attempt to interpret them collectively is imperative. The 
conclusion is drawn entirely from the trends in quality of life as data for anxiety 
and depression findings were less consistent. Once again, this may be indicative of 
very different underlying adjustment processes for different types of psychosocial 
outcomes.
53 TESTING THE TRANSACTIONAL MODEL
Two specific objectives were tested in this part of the thesis, each involving a 
separate analytical strategy. Investigation of bivariate associations between 
change scores on theoretically linked Transactional Model over time, and 
multivariate testing of the significant cognitive precursors of each emotional 
response to stress.
53.1 Objective three: Correlations of change between Transactional Model 
components.
Two hypotheses were made: First, that all components of the Transactional 
model would fluctuate over time (hypothesis five), and second, that the extent of 
change between them would be equivalent for each theoretically associated 
component (hypothesis six). The data from the current study showed surprisingly 
litde change over the six months of data collection on any components of the 
Transactional Model. Only one third of the mean scores demonstrated changes 
but even fewer of these reached significance. Just one appraisal component (out of 
eight), two emotions (out of twelve) and seven core-relational themes (also out of 
twelve) reached a significant level of change.
Where previous theory testing research (e.g. Bennett et al, 2003; Bennett et 
al# 2008) has used correlation approaches, this has been restricted to cross- 
sectional correlations of concurrent ratings of each component. These studies 
have reported largely supportive evidence for the theory. Lazarus (1999) claims 
that the model could be used to predict changes in coping and stress outcomes 
overtime, but to test this empirically cross-sectional analyses are limited. There 
has remained a need to test this using a robust longitudinal approach. This study 
aimed to fill this research gap. Cross-sectional data collected at baseline and six 
month follow-up were used to calculate change scores for each appraisal 
component, core-relational theme, and emotion over time. Correlation tests were 
then conducted between change scores. The anticipated advantage for this
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modified approach was to allow for interpretation of whether these components 
do indeed act as part of a dynamic process rather than demonstrating fixed 
concurrent correlations only.
Effect sizes from these tests were typically low; far less correlation was found 
between change scores than has been reported previously for cross-sectional 
correlations. Due to the high number of tests conducted, Bonferroni corrections 
were applied to significance levels to safeguard against Type I error but this 
correction substantially minimised the impact of the findings. No appraisal 
components and just three core-relational themes reached the adjusted 
significance level. Even less anticipated were the results of correlations between 
theoretically unassociated components. For these, higher effect sizes, and more 
significant correlations, were found when compared to the associations hypothesis 
by Lazarus (1999). The current data demonstrated that some emotion change 
scores correlated with no appraisal components whatsoever, and that others were 
significantly correlated with more than one core relational theme. This finding is 
in contradiction to the Transactional Model.
Little has been published to suggest over what time-period these stress 
adjustment processes may operate. For example, there is scarce mention in the 
literature to date which might suggest what length of time delay might be expected 
between a change on the specific appraisal and a subsequent change in emotion 
scores. Early theory (e.g. Lazarus & Folkman, 1984; Lazarus, 1991) implied that 
the process is rapid, dynamic, and continuous involving constant reappraisal and 
feedback. Due to this implication of speed in associated component change, and 
given that concurrent correlations were previously demonstrated to reach 
significance, so too were hypothesised correlations between change scores on 
associated components. It was also assumed from the associated literature that 
change on components which are theoretically associated would be more strongly 
correlated then correlations with their non-associated counterparts. This was 
clearly not the case in the current study. Changes over time for some variables 
were apparent, thus partially supporting hypothesis five. Hypothesis six was 
rejected though as correlations between theoretically aligned components were 
both inconsistent and typically failed to reach significance.
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This study represented a novel attempt to theory test the Transactional Model 
and as such, the findings should be interpreted with caution. The lack of expected 
associations may not necessarily mean that the theory is inaccurate. The 
Transactional Model is an undoubtedly complex theory with clearly predicted 
specific patters of association between components. Within the six months of this 
study it is likely that many other stressful situations and changes in personal 
circumstances will have been encountered by the participants, each potentially 
being accountable to different causes from both within and external to the cancer 
diagnosis. Whilst this does not negate the expectation that association 
components would be correlated, this is mentioned to draw attention to the fact 
that each component would have been under constant flux in both directions of 
effect, and to varying extents. It is possible that the methodological and statistical 
approaches taken were simply not complex enough to test this constantly changing 
model.
A further complication is that whilst core-relational themes and emotions 
theoretically share unique one-to-one associations (unsupported by the current 
data), theory proposes that changes in numerous appraisal components in 
conjunction will lead to changes in emotion components. It may, therefore, be the 
case that changes in each appraisal were too small to significantly correlate with 
change in emotion and that calculation of composite scores of all relevant 
appraisal for each emotion may prove to be more highly correlated.
Bennett et al (2003) claim that when testing the Transactional model, 
participants should be explicitly asked to report on a specific recent stressful 
encounters. In future testing of longitudinal cognition and emotion associations, it 
might be beneficial to take this guidance into account and to ask participants 
directly to report on their own perceptions of how they think their appraisals and 
emotions have change over time with regard to a specific stressor. Compared to a 
statistically computed changes score, these data might be more appropriate for the 
subjective and dynamic nature of this process model. An alternative might be to 
use shorter measures which are more regularly administered, but assessment 
burden must here be considered.
Whilst these data do not provide a clear answer to this specific thesis 
objective, they do represent a sound first approach to testing the longitudinal
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relationships of the Transactional Model in a novel way. Further research is 
clearly needed to verify the findings of this study but some challenges will need 
attention in the design of such studies. Consideration needs to be given to what is 
the most appropriate method of measuring these data: calculation of change scores 
from cross-sectional data or self report of perceived changes on each individual 
component The issue of how often to collect data needs also be considered. It 
may be that the six month time-lag in the current study was simply too long for 
effects to be separately identified from the effects of other concurrent stressors. 
More frequent data collection might valuable. Brevity will, however, be important 
to ensure good participant retention rates given the more demanding nature of 
this type of research.
5.3.2 Objective four: Regression analyses of the emotions and their 
cognitive precursors
Previous attempts to test and validate the Transactional Model have used 
regression analyses to explore the extent to which variance in emotion is explained 
by theoretically derived cognitive appraisals and core-relational themes. Such 
testing, has, however been limited by two primary factors. First, they have 
explored only a small sub-set of six emotions included in the Smith and Lazarus 
(1993) measures: the so-called 'hot' cognitions. The remaining emotions barely 
feature in empirical research and receive only cursory mention in the theoretical 
literature. This study, therefore, aimed to test a much larger range of emotions 
from the measures excluding just two that were considered inappropriate for this 
particular sample and stressor type—affection and sympathy. Second, the 
statistical approach to testing has been limited. With just one exception, these 
published studies conduct regression analyses in which theoretically hypothesised 
components are entered first, and then theoretically non-associated components 
tested on the residual amount of the emotion outcome variable. Whilst this is not a 
statistically inappropriate method of analysis, the extent to which this constitutes 
wholly unbiased theory testing is debateable as early steps of the analysis are 
limited based upon a theoretical assumption. It is possible that non-theoretically 
aligned cognitive precursors may actually explain far more variance in the emotion 
than those drawn from the literature. But structured in this way, these 
components will have little chance to enter the model until much of their share of
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the variance has already been accounted for. In the current study, in addition to 
conducting regressions to replicate this already established method, separate 
regressions using an entirely data-driven, stepwise approach were conducted in 
parallel. The findings were anticipated to demonstrate whether variance is best 
explained by theory-derived components, and which individual component 
combinations are the best predictors of each emotion.
Overall the data did not fit neatly with the specifically prescribed cognition- 
emotion associations of the most developed version the Transactional Model 
(Lazarus, 1999). For the six, fully developed 'hot' cognitions in particular, the fit 
between data and theory was incomplete. For some emotions, very large 
proportions of the variance remained unexplained. In others, theoretically derived 
models were statistically inappropriate for the best modelling of outcome 
variance. Four out of the six hot cognitions benefitted from the inclusion of 
additional, theoretically non-hypothesised variables, which in one case improving 
R2 by .018. Hypothesis seven—that the theoretically unique relationships for the 
hot cognitions would be replicated—was, therefore, not supported.
For the remaining emotions, the data failed to confirm the theoretically 
derived pairings between specific core-relational themes and the emotions. 
Hypothesis eight was, therefore, also rejected.
There were some elements of the results, however, that do support the 
theory. First, variance in each emotion was best explained using a combination of 
both appraisal components and core-relational themes. Second, there were no 
occasions whereby the direction of association between predictor and outcome 
variables was not as expected, and few occasions where individual cognitive 
precursors seemed illogically matched. Third, there were no occasions where 
different emotions were explained by the same set of cognitive predictors; 
consistent with theory, each had a unique combination of cognitive precursors.
In addition to specifying unique pairings between core-relational themes and 
emotions, Lazarus (1999) states that each emotion will also be associated with a 
specific set of appraisal components. He added that this unique combination 
should include both components of primary and secondary appraisal. This 
proposition was not supported by the current data. Data driven models indicated 
that although most emotions required combinations of up to four appraisals for
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optimal variance modelling, four emotions did not benefit from inclusion of 
appraisals at all. All eight appraisal components featured at least once in these 
analyses, however, there were only four occasions where a combination of both 
primary and secondary appraisals were included in the same model. Goal-related 
appraisals featured in seven models; responsibility-related appraisals in five; 
coping-related appraisals in three; and future-expectancy in just one model. These 
findings better replicate a more recent theory testing paper from Bennett and 
Lowe (2008) which also reports a failure of the primary appraisal to emerge as 
consistent predictors of the emotions.
With regard to the unique pairings between core relational themes and 
emotion, the findings of the current study were equally inconsistent. One of the 
emotion models did not include a significant core-relational theme at all and 
thirteen others included more than one core relational theme (up to four in the 
case of anger). Although not theory consistent, this is not necessarily a surprising 
finding given the similarity between overlapping core-relational themes. The relief 
model, for example, included the significant contributions of three core-relational 
themes: threat removal; success; and, reduced loss/helplessness. All of these are 
entirely plausible correlates of relief. This example is not unique in the current 
data but represents a finding not previously reported in the literature. The 
implication being, once again, that the Transactional Model may simply be too 
specific in its hypotheses.
Of the twelve core-relational themes, some were incorporated more 
frequently than others. Some did not feature at all. The most commonly included 
were self-blame which appeared in seven models; loss/helplessness which 
emerged in six; threat which was included in five models; and, unexpectedness in 
four. Lack of concern and threat removal emerged significant in just three models; 
effortful optimism and success in two; and, self-consciousness and other blame 
emerged significant in just one model. No models included the core-relational 
themes of relevance or irrelevance. These findings are difficult to compare with 
the literature as no published research to date has fully investigated associations 
between the full range of variables that were included in this study. More research 
on this wider range of core-relation themes and emotions is clearly required.
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The comparisons between theory and data driven models in this study 
demonstrated that for some emotions, equally high variance can be explained by 
entirely different combinations of cognitive precursors than those hypothesised in 
the literature. None of the six 'hot' cognition data driven models included all of the 
theoretically proposed components: sadness included just two out of five proposed 
cognitions; guilt and fear/anxiety included two our four proposed; hope/challenge 
and happiness, included just one of four; and, anger didn't include any. Once 
again, comparison of these findings with other theory testing literature is difficult 
as no other studies have used a similar comparative design between theory and 
data driven analytic approaches.
The Bennett and Lowe (2008) study also breaks from the traditional method 
of testing these relationships in a theory biased manner. Instead, all potential 
appraisals are entered together, followed by all potential core-relational themes 
also being entered together using forced entry regression. This is less biased 
because all components have an equal opportunity to be included in the models. 
However, this approach still assumes that variance explained by appraisals and 
core-relational themes must be dealt with in separate regression blocks rather 
than using concurrent analysis (as was the case in the current study). Three 
approaches to theory testing now exist A replication study which compares the 
results of all three of these would be an interesting and useful question for further 
research in this field.
In summary, the findings of this study failed to replicate all of those found in 
previous theory testing literature (Smith and Lazarus, 1993; Bennett etal., 2003; 
and Bennett etal., 2008), although some concordant conclusions were reached at 
the general, rather than specific, level of the model. This was probably due to two 
methodological features: the differing extent of stressor under question (as 
outlined in section 5.2.5), and the alternative method of data analysis. Whilst the 
findings did not confirm all aspects of Lazarus's (1999) theory, there are sufficient 
similarities such that they did not seem to deviate from the generic process 
structure of the Model, even if the specifics of it are called into question. The 
complexity of relationships between reactions to stress, cognitions and emotions 
were demonstrated. The findings suggest that that the theory as outlined in
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Lazarus (1999) is perhaps too prematurely specific given the complex and 
dynamic nature of the stress experience.
5.4 STUDY EVALUATION
Having used a validated quality assessment tool in the systematic review 
(Kmet et al, 2004) to evaluate the quality of the previous literature, it seemed 
appropriate to evaluate the current study on similar criteria. This allowed for 
objective evaluation of the comparative strengths and weakness of the current 
study.
5.4.1 Study design, tim ing of recruitm ent and tim ing of follow-up
Clinically-oriented objectives. As suggested in the conclusions of the 
systematic review, this study employed a longitudinal design. Patients were all 
recruited post diagnosis and in many cases, pre-treatment. Although not ideal in 
that there was variance in treatment experiences, this does represent an 
improvement on some of the published literature which recruited many weeks 
into, and after completion of treatment. Timing of recruitment into this study was 
a mean of 116 days post-diagnosis, which although longer than hoped for, 
compares favourably. In a further improvement on previous methodology, the 
range of time between diagnosis and recruitment was substantially decreased: the 
sample recruited formed a more homogenous group.
Follow-up data were collected at three and six month follow-up timepoints in 
effort to ensure that data was comparable with other published literature. Due to 
delays between diagnosis and recruitment into the study, this actually represented 
follow-up data collection at approximately five and eight months post diagnosis.
Theory-testing objectives. The design of this part of the study represented a 
marked improvement on much previous theory testing research. Primarily, the 
design allowed the theory to be tested according to a homogenous chronic stressor 
common to all participants. Additionally, it allowed for statistical testing of the 
longitudinal stress process rather than focussing entirely on cross sectional data.
5.4.2 Sample and recruitm ent
Clinically-oriented objectives. The recruitment target of 160 patients was 
achieved. This is lower than some, but higher than other comparable studies 
included in the systematic review (Chapter 2). The systematically reviewed
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papers ranged in response rates but just five recording a response rate of less than 
30%. The 34.6% response rate in this study was toward the lower end of the 
range.
Participant eligibility rates were a source of concern as far fewer patients 
were deemed suitable by their clinical nurse specialist than expected. Within 
cancer type, eligibility between data collection site were also variable. These 
findings raise some concerns about the nature of the sample, however, the cause is 
not clear. It could be a consequence of very different populations attending clinic 
in each trust, unclear study inclusion criteria, or covert protectionism of patients, 
on the part of the nurses. This is clearly an issue that will need to be clarified and, 
where possible improved upon, in future research.
Three features of the study design may be accountable for the low response 
and eligibility rates: the early timing of recruitment; the length of the 
questionnaire; and, the inclusion of multi-site cancer patients. In recruiting both 
male and female patients, a less gender-biased sample was achieved than in 
comparative studies, but males remained outnumbered at a ratio of approximately 
2:3. This resulted primarily from recruitment of a higher number of breast cancer 
patients into the study. Compared with the literature reviewed in Chapter Two, 
especially that also recruiting mixed cancer samples, the current study sample 
comprised a more equal distribution between the four cancer sites, notably by 
including more lung cancer patients. This study was unique in that it included 
both male and female breast cancer patients, however, only two male patients 
were diagnosed during the recruitment timeframe. To these ends, the current 
study comprised a sample more representative of cancer patients in general. The 
wide variability in treatments and specific histological diagnoses, particularly 
within the breast cancer sub-sample, continue to represent challenges to data 
analysis which this study was unable to reconcile.
It is pertinent to review the justification for recruiting across multiple cancer 
site recruitment. Although prompted by pragmatic necessity to speed up 
recruitment into the study, the rationale was supported by evidence provided in 
the systematic review (see section 2.7.2.5): inclusion of multiple sites typically 
maximises the generalisability of the data. In this study, no between cancer-site 
differences were found for any outcome variable. This should not, however, be
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taken as indication that future studies should focus recruitment on a single cancer 
site only. It is instead recommended that where possible, expansion of 
recruitment to other cancer sites is preferable but efforts to better control for a 
wider range of clinical variables would be welcomed.
Clinically, the sample was relatively healthy, both physically and 
psychologically. This was no doubt a result of focusing recruitment on early stage 
diagnoses only. Nonetheless some patients did progressively worsen at a quicker 
rate. Ten patients died during the six months of this study; deaths were mainly 
from the lung cancer patient subgroup who by the very nature of their illness had 
much poorer prognosis at the time of diagnosis.
Just two participants had been referred to secondary care based specialist 
psychosocial oncology services. There are two plausible explanations for this. 
First, it might indicate that the sample recruited were biased in that they were 
coping well and did not have need for this level of care. Second, it may be 
indicative of either limited service provision or unclear clinical referral pathways 
which prevented patients accessing these specialist psychological services.
From a methodological perspective, future research would benefit from also 
recruiting those at more advanced stages of illness and those who have not 
psychologically adjusted to their diagnosis. Expanding recruitment in this way 
would aid the understanding of how varying disease extent can lead to differences 
in the psychological adjustment process. From an ethical perspective, however, 
recruitment of these samples may prove difficult. Not only might they be less 
physically capable to take part, but also at higher risk of distress of other negative 
responses as a consequence of participation. These issues should not render 
attempts impossible, but it is essential that adequate safeguards be put into place 
to protect participants both physiologically and psychologically.
A mix of demographic cases was achieved in terms of age, gender and 
education level, but the sample was entirely Caucasian in ethnic origin. This was 
largely a byproduct of where participants were recruited from and are actually 
representative of the population in North Wales. Some effects of age on 
psychosocial outcome were reported although these were limited by a bias toward 
older, retired participants. This should be borne in mind when applying the 
findings of this study: at different stages of life, activities, values and priorities are
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likely to change thus affecting the impact that diagnosis may have. Whilst 
representative of the population from which the sample was drawn, these sample 
restrictions limit the extent to which the findings may be generalisable to other 
cancer populations. This also prevented testing of ethnic and cultural differences 
in adjustment, a subject of growing research attention.
The follow-up sample used in longitudinal analysis was smaller than ideal. 
Participant retention was a very high 76.8%, again a comparative improvement on 
other similarly designed research (see table 2.4). But the loss of participants 
through death, and especially through drop out and non-response, limited the data 
available for analysis. One hundred and twenty-three patients provided 
longitudinal data, but due to missing data, particularly on the Smith and Lazarus 
(1993) measures, the regressions were based on samples of approximately 100 
participants. Reflecting back to the original sample size calculation (see section 
3.5.1), to ensure that analyses were sufficiently powered (to p=.80 ; a=.05) to 
detect medium effect sizes, the recruited sample would only have allowed for six 
or seven variables to be entered into the analysis. Whilst block one of the clinical 
outcome regressions contained more variables than this (between 10 and 13 
variables were entered), the combined effect size for this block was higher than 
expected, approaching what would be considered a large effect size. Green (1992) 
suggests that a sample size such as this would sufficiently power analyses to detect 
large effect sizes with up to 30 predictor variables entered and medium effect sizes 
with around nine variables entered. The current study did not fall substantially 
away from this. Whilst effect sizes added in the second block were certainly no 
bigger than medium effect sizes, far fewer variables (between one and four) were 
included in the statistical models. This suggests that the analyses were sufficiently 
powered for the research question. It is always possible that other psychological 
predictor variables didn't enter the model because they influence the outcomes 
with only small effect sizes for which analyses were not able to detect. This is 
usually a risk of conducting multiple linear regression in the human sciences. 
Whilst a larger sample size might have produce models which also included these 
variables, the clinical relevance of such findings is limited. It is unlikely that 
findings based on the identification of small effect sizes would provide a sufficient 
evidence base to justify changes to standard clinical practice, especially given the
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much larger effect sizes exhibited by other demographic, clinical, control and
psychological variables.
Theory testing objectives. From a theory testing perspective, the demographic 
and clinical variety obtained in recruitment was advantageous and ensured for a 
well-representative sample. That the sample was not recruited from student 
populations representing comparative improvement of Transactional Model 
relevant research and continues the trend previously set by Bennett and 
colleagues for designs with increased external validity. Correlation analysis used a 
sample of n-100 participants and regression analysis used a sample of n-145 
participants. This compares favourably with other published literature in which 
sample sizes range between n=104 and n=196. Given the effect sizes reported in 
previous research and those that were resultant from the current analyses, the 
analyses were on the whole sufficiently powered.
5.4.3 Measurement
All data collected for this study were obtained using pre-validated measures. 
The majority of these performed well, although some (such as the God Locus of 
Control Scale and site-specific sub-scales of the FACT) had low Cronbach alphas in 
internal consistency (see section 3.4.5). Such scales were not used in the 
regression analyses and may benefit from further psychometric development.
Where possible, constructs measured were comparable to published 
literature through selection of similar measurement instruments, such as the NEO- 
FFI for personality, the Brief COPE for coping, and the HADS for psychological co­
morbidity. Only those constructs pertaining to the Transactional Model were 
single-item measures; these were avoided elsewhere in order to address the 
criticism of such practices highlighted in the review. Whilst these single-item 
measures have been used and validated in previous research, Smith and Lazarus 
(1993) have also developed an alternative measure whereby each component is 
scored from between two and four items. These were not used in the current 
study to reduce participant burden, but the use of this measure is recommended 
for future research as it is likely to be a more robust and reliable tool increasing 
the likelihood of enabling parametric statistical analysis.
In exploratory analysis, some of the variables measured were found to be 
non-Normally distributed. In most cases, this was not problematic for the
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statistical approaches taken: either adjustments could be made to the data or the 
tests chosen were robust enough to deal with this. However, one subscale of the 
MHLC (God Locus of Control) had to be removed from the analysis due both to its 
abnormal distribution and high number of missing data.
5.4.4 Control of confounding variables.
Potentially confounding demographic and clinical variables were measured, 
and included, where possible, in correlation analyses. Those that were 
significantly associated with outcome were then included in multivariate analyses. 
However, due to variability in the recording and coding of the data, some could not 
be analysed. Primary examples include treatment received and the exact 
histological nature of diagnosis where in both cases sample subgroups were so 
numerous that sub-sample sizes were very small. Treatment waiting time was 
also excluded from the analysis as these data were was only available for patients 
recruited from one hospital; to have included this variable in the analysis would 
have reduced the sample size such that statistical power would have been 
jeopardised.
The inability to control for all confounding variables in the current study was 
largely a result of recruiting using multi-site strategies. In future studies, it may be 
beneficial to recruit more equal numbers of patients in each category of these 
variables. Of course, such a design would either require a very large sample or a 
much more focussed sub-set of clinical cases. As an alternative, future research 
could consider developing methods by which these variables can be grouped for 
equivalence between cancer site. Such improvements would allow for analysis 
using more complex path analysis and multi-level modelling techniques.
5.4.5 Appropriateness of statistical analysis
Clinically oriented objectives. The current study conformed with all statistical 
recommendations made in the systematic review: descriptive, bivariate and 
multivariate analyses were all conducted, each of which being adequately powered 
for confidence in the findings to be maintained. Where possible, effect sizes were 
reported and discussed in addition to statements of statistical significance. No 
composite outcome scores were used in this study. Where composite predictor
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variables were used, these were calculated in accordance with published methods 
for doing so.
Theory testing objectives. Statistical analysis used in the theory testing 
component of the thesis represented an improved, less theoretically biased 
approach to analysis. Although resulting in some rather disappointing findings, 
this more robust and objective method was more statistically rigorous and 
produced some interesting possibilities for further research.
5.4.6 Evaluative insights gained from the qualitative comments
This study had the advantage of collecting qualitative comments regarding 
study participation which can be used in evaluation of the design. Comments were 
only received from 56% of participants and in future, it is recommended that this 
aspect of data collection be a requirement of participation rather than an optional 
extra as was the case in the current study. Few comments made were of a negative 
nature.
The most frequent comment was that the questionnaire and response 
options were complex, and in particular, it was difficult for participants to isolate 
their answers related to the cancer from both other co-morbidities and enforced 
rehabilitation restrictions. The length of the questionnaire was considered an 
issue both by the clinical teams involved in recruitment and the ethics committee, 
and this may have acted as a disincentive to participation. However, with only two 
comments made on the length it seems that for those participants who do commit 
to participation, the length of the questionnaire is of less relevance.
Also to be considered in the planning of future studies are comments made 
by a number of participants that the timing of approach to participate was 
inappropriate. It is important to relate this to comments made about the overall 
relevance of the study. Comments seemed to indicate that the information 
provided did not make the purpose and relevance of the study explicitly clear— 
perhaps had this been clearer, participants may not have felt the timing so 
intrusive and indeed, some non-participators may have more inclined to take part.
Comments made on the inclusion of questions relevant to religion and beliefs 
about God are also important to note; the overarching message here is that 
sensitivity is required and care must be taken to ensure that both the questions are 
worded in an unbiased way, perhaps using more culturally sensitive terms by
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I  referring to spiritual beliefs for example, rather than beliefs specifically about God. 
V  Furthermore, it is important to make the relevance of such questions clear. 
k  Comments made on this theme were useful in understanding the high rate of 
i  missing data on this variable.
| Although some negative emotional impacts from participation were
reported, these were few and judging by the nature of the comments no issues of 
risk or increased distress were aroused.
Just as important for evaluative purposes are the positive comments received 
which demonstrated that participation in this study enabled some participants to 
both confront the reality of their situation and express feelings and emotions that 
they would not otherwise have had opportunity to do so. Indeed, a number of 
participants explicitly expressed gratitude for being given the opportunity to help 
other patients with cancer and to benefit scientific progress through their own 
participation. A number of others were explicitly grateful for an opportunity to 
talk about these psychological issues. There is clearly a need for more 
opportunity for emotional expression within this patient group. It is likely that in 
this region, these needs are not being met by current clinical services. Access to 
clinical debriefing may have been a useful and perhaps more ethical addition to 
this study and is recommended for future research.
5.5 RECOMMENDATIONS AND IMPLICATIONS FOR RESEARCH, POLICY 
AND CLINICAL PRACTICE
To an extent, recommendations from, and implications of, this study have 
already been partially covered elsewhere in this chapter when discussing the 
findings related to each research objective. A summary follows.
Regarding prediction of psychosocial outcome, this study demonstrated the 
multi-faceted nature of adjustment and it is clear that cognitive appraisals are an 
important component of this adjustment process. More research is needed on the 
exact nature of interactions between clinical variables, emotions, coping and these 
cognitive appraisals. The ability of these variables to predict psychosocial 
outcome would also benefit from further research attention in order that clinical 
intervention can be based a sound empirical evidence base. This study seemed to 
indicate that not only would interventions benefit from being tailored to outcome, 
but also to time point through diagnosis and treatment. The study concluded that
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interventions might benefit from increased focus on cognitive aspects of 
adjustment more than other aspects (e.g. coping), but again, confirmatory studies 
would be useful to provide an adequate basis for such intervention programmes to 
be developed. Future research also needs to consider how best to test the 
adjustment process. This study has been useful in highlighting the large number 
of contributing psychological variables. Future studies need to evaluate how best 
to assess these in a succinct and reliable manner to develop accurate clinical 
screening tools. Application of this questionnaire into clinical practice as it 
currently stands would be infeasible. Shorter and easier response assessment is 
essential.
One clear extension of the clinically-oriented research objective is to explore 
survival data. Published literature to date is inconclusive about the ability of 
psychological variables to predict survival (see section 1.4). However, such studies 
also focussed measurement on the ability of personality variables and coping 
responses to predict survival, not cognitive appraisal variables. In the current 
study, there were too few deaths to test this statistically. Indications are that 
those who did die scored lower in emotional quality of life, reported higher levels 
of negative emotion, more other-blame cognitions, higher levels of 
loss/helplessness, and more likelihood of using maladaptive coping strategies.
The results are likely a consequence of worse functional status within this 
subsample due to a poorer underlying clinical presentation of the more advanced 
and aggressive nature of the illness. Although not definitive, the preliminary 
findings established in the current sample are worthy or further investigation. 
Given current drop out rates, it is unlikely that sufficient sample will still be alive 
and responsive at five year follow-up (the standard time-point for survival studies) 
for further data to be collected and tested and so future research should plan in 
advance for this when estimating sample size calculations.
The qualitative component of this study highlighted the importance of giving 
participants the opportunity to express themselves for both personal reasons and 
as a methodological evaluation tool. It is recommended that inclusion of some 
open-ended response questions would be beneficial as a research development 
tool and as a form of additional data collection, particularly for emotionally 
vulnerable participant groups who may wish to express more subjective and
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individual responses beyond the restrictive format of many psychometric 
assessment tools.
Although it has a long theoretical history, the Transactional Model has 
relatively recently been re-developed (Lazarus, 1999). This latest version had not 
previously been sufficiently empirically tested using a wide range of samples and 
stressor types. This study aimed to expand upon this literature by investigating 
the process in a chronically stress samples. The findings from this study do not 
fully support the theory. It is not clear whether these different conclusions are a 
consequence of testing the model with a different stressor type, due to differences 
in statistical approach, or even whether they simply occurred spuriously. Future 
development of the model needs to continue the trend to explore this stress 
adjustment process for a number of other chronic stressor situations including, for 
example, other illness diagnoses, bereavement, divorce and so forth. When using 
the model for research purposes, whether that be to investigate chronic stress, 
acute stress, or even daily hassles, it is recommended that both theory driven and 
data driven approaches be used until a reliable and generalisible theoretical 
framework of cognition-emotion relationships is developed. In a move away from 
research exploring the impact of stressors retrospectively, this study has 
demonstrated that it is possible, and advantageous, to recruit participants who 
were much closer to the time of stress in order to prospectively explore the 
process of adjustment over time.
Further work is clearly required, to build upon this study and to replicate the 
findings. In general, the results indicate that it may be possible to assess which 
patients may need more psychosocial care and support to prevent poor 
adjustment by means of assessing stress-process variables. It is recommended 
that such assessment could usefully be implemented as part of routine clinical 
practice at early time-points in the illness experience to screen those most at risk 
of late psychosocial adjustment problems. The development of methodologically 
sound interventions focussing on these cognitive variables may be beneficial, but 
these would likely require high-level resources for application into clinical 
practice. For those researching adjustment to cancer, the Transactional Model 
provides a thorough research framework, although further empirical development 
of both measurement and conceptual processes are necessary.
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fCHAPTER 6 
THESIS EVALUATION & FUTURE RESEARCH DIRECTIONS
6.1 CHAPTER OVERVIEW
The thesis rationale (section 1.11) concluded with the suggestion that the 
Transactional Model of stress, whilst not fully understood within clinical samples, 
had potential to enable better understanding of the patient adjustment process 
following cancer diagnosis. Strengths of this model over competing theories of 
adjustment included its multi-dimensional nature and a particular emphasis on 
cognitive and emotional processes. Empirically, however, the model was not well 
supported, especially within the context of a major life stressors such that cancer 
represents.
Methodological critiques of the psychosocial oncology literature led to a 
plethora of identified weaknesses, but the absence of a systematic review in the 
field meant that a comprehensive understanding of which particular 
methodological improvements are necessary was unknown. Additionally, meta­
analysis and systematic review of the many disparate studies of cognitions, 
emotions and personality was required to inform the direction of future research
Set against this backdrop, the thesis was designed to answer four principal 
research questions. The first two of these were explored through a systematic 
review of the literature:
1) What evidence is there currently in the literature demonstrating 
predictive associations between personality, cognitive appraisal, 
emotions, and psychosocial outcome?
2) Since early reviews, has research methodology in the field 
improved? If not, what further steps need to be taken?
In response to the findings, an empirical study was then designed in to 
address the third research question. Using a framework defined by the 
Transactional Model of stress, the aim was to assess:
3) What are the most important predictors of psychosocial outcome in 
newly diagnosed cancer patients, and leading from this, at what time 
point (baseline or three month follow-up) are these most predictive 
of longitudinal (three or six month) outcome.
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The final question aimed to develop the Transactional Model through 
extensive testing of the micro-level cognitive processes within this illness-related 
stressful situation:
4) Are the hypothesised associations between cognitive appraisals, 
core-relational themes, and emotions in Lazarus's Transactional 
Model supported in a sample of newly diagnosed cancer patients?
This final chapter will consider the success of the thesis in addressing these 
four research questions. Two primary evaluations will be made. First, whether or 
not the aims and objectives of each individual study have been achieved (section 
6.2); in doing so, a summary of the pertinent points of study critique will be 
highlighted. Second, the overall impact made upon research and clinical practice 
will be evaluated (section 6.3). This will be followed by a short description of 
further research protocols being developed in follow up to the work contained in 
this thesis.
6.2 HAVE THE AIMS AND OBJECTIVES FOR THE THESIS BEEN ACHIEVED?
6.2.1 Systematic review
This study aimed to review published evidence on associations between 
either personality, cognitive appraisal, or emotions and psychosocial outcome 
(either quality of life, anxiety or depression) in cancer patients. The specific 
objectives were to provide a precis of the current literature and a methodological 
critique of this field of research. The purpose was to inform the direction of 
hypothesis setting and methodological approaches used in future research.
Despite a much larger body of literature being included than expected, the studies 
were predictably heterogenous and varied both in quality and content.
A number of demographic and clinical factors were highlighted as potentially 
important variables in cancer adjustment. Primarily, these included age, gender, 
stage of illness, time since diagnosis and treatment received. Personality was 
found to be a consistent predictor of psychosocial outcome, sometimes through 
independent predictive pathways, and other times through mediating effects of 
other psychological variables (such as coping). Incongruence was found for the 
reported associations between cognitive appraisal or emotion and psychosocial 
outcome. In relation to thesis question one, the review highlighted, above all else,
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the lack of evidence to draw confident conclusions about the role of these 
predictor variables in influencing psychosocial outcome.
Methodological quality ranged in excess of 60% with the majority of studies 
scoring within the range of 81-85%. Despite this, a number of methodological 
weaknesses were highlighted. Methodologically poor studies were not just 
restricted to older published literature, indicating that the recent publication of a 
number of critical reviews has not yet led to the adoption of improved research 
designs. In response to thesis question two, the following measures are 
recommended for those planning research into psychosocial adjustment:
• Longitudinal rather than cross-sectional research is preferable.
• Participants should be recruited as close to diagnosis as possible, if not at a 
pre-diagnosis stage. Additionally, for this particular research area, efforts 
should be made to recruit patients within a much smaller range of time 
since diagnosis in order to minimise the effects of potentially confounding 
variables.
• Timing of follow-up in longitudinal research requires some level of 
standardisation to enable effective comparison between the literature. 
Those most commonly used are three, six, nine, twelve, eighteen and 
twenty-four months and it would seem sensible for these to be retained.
• Research needs to expand beyond predominantly breast cancer focussed 
research to reduce both clinical characteristic and demographic biases. 
Lung, colorectal and prostate cancer studies are all highlighted as pertinent 
areas of expansion due to their high clinical incidence, although the use of 
mixed-site recruitment may often be more advantageous.
• Researchers need to be aware of incoherence in definitions and use of 
psychosocial constructs and measures and ensure that only those most 
appropriate are used.
• Improved clarity and transparency in recruitment and the reporting of 
response statistics is desirable in order to better assess the generalisability 
of findings.
• In analysis, researchers are encouraged to use robust parametric and 
multivariate statistical approaches where possibility to ensure that the full
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complexity of intra-variable interactions and relationships can be fully 
explored.
• Finally, the use of composite outcome scores must be discouraged except 
where valid and reliable methods have been developed for the calculation 
of such scores.
Although the aims and objectives for the systematic review were achieved, 
there are some shortcomings of the work which should be considered when 
interpreting the findings. A formal review evaluation based on the Russell etal. 
(1998) quality checklist provided an overall score of 11 out of 14 and highlighted 
two main areas of weakness: first, single reviewer data extraction, and second, 
inadequate search methodology. With regard to data extraction, quality would 
have been improved had sources other than electronic databases been used.
Additionally, the highly sensitive search strings, which although useful in 
exploratory reviews, may have inadvertently caused some research to be omitted 
from inclusion; smaller scope, specific reviews focussed on numerate aspects of 
the current work may prove more reliable. Furthermore, in such cases it would be 
far more feasible to also include non-published literature which was not possible 
in this case.
A lack of concordance in quality assessment between reviewers was also of 
concern; differences in scores may be a consequence of reviewer subjectivity or 
could be indicative of a weakness in Kmet et al's (2002) assessment tool. This 
latter possibility should be borne in mind when planning to use the tool in future 
reviews. Finally, as a result of heterogeneity between included studies, the meta­
analyses were based on very small numbers of studies and, therefore, the findings 
must be regarded as indicative only, and used as evidence with caution.
6.2.2 Empirical study
The aim of this study was to investigate relationships between personality, 
cognitive appraisals, emotional reaction to diagnosis and psychosocial adjustment 
in a cohort of newly diagnosed cancer patients. There were four specific objectives 
pertaining both to theory development and clinical application. First, to identify 
important psychological predictors of three primary psychosocial outcomes for
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newly diagnosed cancer patients. Second to identify at what time-period these are 
most predictive. The third objective was to examine whether associated 
components of the Transactional Model varied equivalently over time. And finally, 
the fourth objective was to test the hypothesised associations between specific 
cognitive appraisals, core-relational themes and emotion in relation to cancer 
diagnosis. All four of these objectives were achieved to an extent.
A longitudinal questionnaire based study was planned in order to accrue 
data. A three centre, multi-centre recruitment strategy was developed and whilst 
both time-consuming and at times challenging, the target sample size of 160 
patients was recruited. Participant retention was high and a follow-up sample of 
between 100 and 140 patients (dependent on analysis and quantity of missing 
data) was available. Although representing a more methodologically rigorous 
design, the study did have a number of weaknesses. Although timing of 
recruitment and follow-up represented a methodological improvement 
(particularly from a clinical perspective), for theory-driven analyses, three 
monthly follow-ups were not ideal as Transactional Model constructs are so 
frequently changing. The difficulty of testing both clinical questions and 
developing this theory in the same study are apparent
The sample, whilst of sufficient size to adequately power the analyses and 
less biased than that of some other published research, was focussed on early- 
stage cancer patients only. This impacts upon both the representativeness of the 
sample and generalisability of the findings. A future challenge will be to include 
patients at all stages of disease but to control for such clinical differences in 
analysis. This will be a challenge from practical (ethical and recruitment) issues 
perhaps moreso than statistically.
Time-lagged correlation and regression analysis demonstrated that a range 
of personality, appraisal, core-relational themes, emotions and coping added to 
variance already explained by control clinical and demographic variables for 
anxiety, depression and quality of life. Locus of control and the mental adjustment 
to cancer were the only measures found not to contribute to outcome prediction. 
Hypotheses one and two were therefore accepted. Across all combinations of 
time-lag, regression effect sizes were larger than expected compared to the
302
previous literature. This in itself may be indicative of the importance of an all- 
inclusive framework such as the Transactional Model.
Comparison of anxiety, depression and quality of life regression models 
highlighted the importance of different predictor variables. Additionally, different 
time-lagged analyses were most predictive for different outcomes. These differing 
trajectories of adjustment do not provide clear answers to either hypothesis three 
or four. Outcomes from these analyses can potentially be applied to the clinical 
setting to inform screening assessments and psychological interventions for 
cancer patients.
The theory testing component of this thesis represented both replication and 
development of statistical testing methods of similar studies. Whilst fluctuation on 
Transactional Model components was observed over time, change score 
correlations were not as expected and did not provide full support for Lazarus's 
theoretical model. Hypothesis five was therefore supported, but hypothesis six 
rejected. Similarly, the results of theory testing regressions only partially 
supported both previous theory and empirical findings. Hypotheses seven and 
eight were, therefore, both rejected. Methodological and statistical issues were 
discussed as primary explanations for the failure of this study to confirm theory.
In conclusion, whilst further research and development of the Transactional 
Model is clearly necessary, even in its current state, the model is able to provide a 
useful framework through which to study adjustment to major life event stressors 
and upon which to develop psychosocial interventions for newly diagnosed cancer 
patients.
6.3 IMPACT, AND FUTURE DIRECTIONS, OF THE RESEARCH
The individual impact of each study in terms of how it might influence 
further work has already been presented. Instead, the direct impact that the 
research has had will be discussed.
Final outcomes of the study are yet to be disseminated to local clinical 
collaborators. A short report outlining the main findings has been produced for 
the study funder (appendix 6.1) and copies of this will shortly be distributed to all 
clinical teams involved with the study. Short presentations and discussions of the
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research will also be offered to cancer management teams and each clinical multi­
disciplinary team involved.
Perhaps of most importance within the clinical setting is the impact upon 
nurses resulting from their role within the study. Although data were not collected 
on this issue, nurses involved with the study reported that they were more 
enthusiastic about research and more understanding of the processes. It is hoped 
that this may contribute to a more research-active ethos within their clinical 
practice. Indeed, in the process of recruiting into this study a recruitment method 
has been developed which is acceptable from research, clinical and ethical 
perspectives and we hope to access more patients using such systems in the future. 
Since the cessation of patient recruitment, mutually beneficial relationships have 
been maintained between the research and clinical teams and it is hoped that more 
collaborative research will be planned in the future. The author has already been 
approached on a number of occasions to provide ad-hoc consultancy-style advice 
to the clinical teams, particularly with respect to routine data collection used for 
monitoring psychosocial adjustment and patient satisfaction with clinical services. 
The study has been disseminated at a number of national and international 
conferences (see appendix 6.2 for a summary list and appendices 6.3-6.9 for 
abstracts). The numerous studies included are also being written up for 
submission to relevant journals. The systematic review and meta-analysis will be 
submitted to Health Psychology within a few weeks of submitting this thesis. The 
clinically oriented outcomes will be written and submitted to Psycho-Oncology and 
the theory testing to Cognition and Emotion, both scheduled for submission later 
this summer. Some secondary analysis to psychometrically develop some of the 
measures used is also underway and will also be submitted for publication.
A number of new protocols are also in development as extensions of this 
programme of research. Given the number of qualitative responses received in the 
questionnaires, it was clear that many participants had far more to say on this 
research question and felt the quantitative format of data collection too restrictive. 
Funding was received from the North Wales Research Committee to conduct a 
qualitative follow-up to this study using Interpretative Phenomenological Analysis 
(IPA). A sub-sample of three breast, three colorectal, and three prostate cancer 
patients have all been interviewed and primary analysis has been completed.
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Secondary validation of the thematic analysis is currently underway and is 
expected to be completed later this year. It is hoped that the results from this can 
be triangulated with some of the thesis data to give a more rounded impression of 
psychosocial adjustment processes to cancer diagnosis.
It is also important to remember that the adjustment process does not 
resolve for many months (or ever in some cases). The end of treatment stage— 
that from being a patient to resuming a normal life once again— is yet another 
period prone to adjustment difficulties. It is possible that the same process may be 
at work here too and that similar psychological predictors may be influential. 
Focussing primarily on future expectancy appraisals and later realisation (or not) 
of such appraisals, work is underway with a number of colleagues to develop 
research into the end of treatment transition period.
Also in the late stage of development is a qualitative study in collaboration 
with NHS collaborators to investigate willingness and confidence of cancer nurse 
specialists to provide psychological support for patients. It is hoped that this 
study, if funded, will additionally highlight any important training and support 
needs for the nurse community.
Last, but by no means least, it is important to reflect on the rationale for this 
thesis; that prior to the implementation of new psychological interventions for 
cancer patients, theory based empirical testing of the adjustment process and 
important predictor variables is necessary. It was recommended in section 5.4 
that in light of these findings, such interventions should focus efforts on cognitive 
appraisals. This also conforms with the findings of psychosocial oncology research 
conducted using a Self-Regulation framework, see for example, Schroevers et ai 
(2008J. The emphasis on goal and value based appraisals is congruent with newly 
developed interventions based on Acceptance and Commitment Therapy (ACT; 
Hayes, Strosahl & Wilson, 1999), one of the third-wave cognitive-behavioural 
therapies. Interventions based on ACT have had great success in the field of 
mental illness, but research emphasis has also expanded to the trialling of the 
therapy for the effects of physical illness. As such, the candidate has led 
authorship (in collaboration with both UK and USA based academics) of a position 
paper proposing the future potential use of ACT within oncology settings. 
Applications for funding for pilot studies using both ACT based psychometric
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constructs in survey research, and intervention development studies, are currently 
in the early stages of preparation.
6.4 CONCLUDING STATEMENT
A number of key objectives and hypotheses were defined for this thesis, 
each of which has been addressed, at least to an extent. In meeting these aims, 
evidence has been produced which provides some clarity into the nature of 
adjustment to cancer diagnosis, but which also which questions the stress-related 
theoretical framework used. Further empirical testing of the three outcomes 
(anxiety, depression and quality of life) is necessary. Despite the criticism lodged 
against psychological interventions for cancer patients, the findings from the thesis 
clearly show that psychological mechanisms are responsible, at least in part, for 
both psychological and quality of life outcomes. With improved methodological 
approaches and consideration of psychological models focussing especially on 
cognitive and affective processes, it seems possible that new interventions can be 
developed which may have greater impact upon clinical oncology (see also 
Schofield et al, 2006). In response to the seemingly important contribution of 
cognitive appraisals in predicting psychological outcome, the use of acceptance- 
based therapies may show particular theoretical promise for an intervention 
framework.
i
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APPENDIX 2.1: PUBLICATION DETAILS AND CAUSE FOR LATER EXCLUSION 
OF THOSE STUDIES FOR WHICH SUFFICIENT INFORMATION WAS NOT 
AVAILABLE TO ASSESS INCLUSION FOR THE REVIEW.
Authors & Date Title Reason for 
exclusion
Aarstad, Aarstad, Birkhaug, The personality and quality of life in Unavailable
Bni&Olofsson (2003) HNSCC patients following treatment. mailbox
Arathuzik (1991) The appraisal of pain and coping in cancer No response
patients. to email 
request.
Beadle, Yates, Najman, Illusions in advanced cancer: The effect of Data not
Clavarino, Thomson, belief systems and attitudes on quality of available.
Williams, et al. (2004) life.
Beckham, Burker, Lytle, Self-efficacy and adjustment in cancer No response
Feldman & Costakis. patients: a preliminary report. to email
(1997) request.
Berckman & Austin. Causal attribution, perceived control, and Corresponding
(1993) adjustment in patients with lung cancer. author
untraceable.
Fehring, Miller & Shaw. Spiritual well-being, religiosity, hope, No response
(1997) depression, and other mood states in to email
elderly people coping with cancer. request.
Fife, Huster, Cornetta, Longitudinal study of adaptation to the No response
Kennedy, Akard & Broun. stress of bone marrow transplantation. to email
(2000) request.
Friedman, Baer, Lewy, Predictors of psychosocial adjustment to Data not
Lane & Smith. (1988) breast cancer. available.
Grassi, Rosti, Albertazzi & Depressive symptoms in autologous bone No response
Marangolo. (1996) marrow transplant (ABMT) patients with to email
cancer: an exploratory study. request.
Jenkins & Paragament. Cognitive appraisals in cancer patients. Unavailable
(1988) mailbox.
Lev, Paul & Owen. (1999) Age, self efficacy, and change in patients' Data not
adjustment to cancer. available.
Montgomery, Pocock, Predicting psychological distress in Data not
Titley & Lloyd. (2003) patients with leukaemia and lymphoma. available.
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Authors Title Reason for
exclusion
Mytko, Knight, Chastain, 
Mumby, Siston & Williams. 
(1996)
Nair. (2000)
Secchi & Strepparava.
(2001)
Schnoll, Mackinnon,
Stolbach & Lorman. (1995)
Tamburini, Filiberti, 
Ventafridda & De Palo. 
(1986)
Wagner & Armstrong. 
(1995)
Coping strategies and psychological 
distress in cancer patients before 
autologous bone marrow transplant.
Quality of life in cancer of the cervix 
patients.
The quality of life in cancer patients: a 
cognitive approach.
The relationship between emotional 
adjustment and two factor structures of the 
mental adjustment to cancer (MAC) scale. 
Quality of life and psychological state after 
radical vulvectomy.
Corresponding
author
untraceable.
No response 
to email 
request. 
Unavailable 
mailbox
Data not 
available.
Data not 
available.
Cognitive determinants of quality of life Corresponding
after onset of cancer. author
untraceable.
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APPENDIX 2.2: LIST OF MEASURES USED BY INDIVIDUAL STUDIES 
AND THEIR ASSIGNED ABBREVIATIONS USED IN TABLE 2.3.
Abbreviation Full Title
ABS Affect Balance Scale
AEI Anger Expression Inventory
AEI Anger Expression Inventory
AS Appraisal Scale
BAI Beck Anxiety Inventory
BDI Beck Depression Inventory
BIS/BAS Behavioural Inhibition System/Behavioural Activation System 
Inventory
CARES Cancer Rehabilitation Evaluation System
CBS Coping Behaviours Scale
CECS Courtauld Emotional Control Scale
CES-D Centre for Epidemiologic Studies Depression Scale
CLoCS Cancer Locus of Control Scale
CLQoL Cantrill Ladder of Quality of Life
COPE COPE Coping Inventory
CRI Coping Responses Inventory
CSC Cancer Specific Control Scale
CSI Coping Strategies Inventory
DASS Depression Anxiety Stress Scales
DCL Dutch Complaints List for Cancer Patients
DS Depression Scale
EES Epstein Emotion Scales
EORTC-QLQ European Organisation for Research and Treatment of Cancer- 
Quality of Life Questionnaire
EPI Eysenck Personality Questionnaire
FQCI Frieburg Questions of Coping with Illness
GBI General Behaviour Inventory
GHQ General Health Questionnaire
GRQLI Global Rating of Quality of Life Inventory
GSES General Self-Efficacy Scale
HADS Hospital Anxiety and Depression Scale
HLCS Health Locus of Control Scale
HRQoL Health Related Quality of Life Scale
HS Hope Scale
IBQ Illness Behaviour Questionnaire
I-E Internal-External Control Scale
IES Impact of Events Scale
IWB Index of Well Being
JGLI Japanese Quality of Life Inventory
LASA Linear Analogue Self Assessment Questionnaire
MAC Mental Adjustment to Cancer Scale
MAS Manifest Anxiety Scale
MCS Moos Coping Scale
MHI Millon Health Inventory
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MHLC Multidimensional Health Locus of Control Scale
MQOLS-CA Multidimensional Quality of Life Scale-Cancer
MUIS Mischel Uncertainty in Illness Scale
NAS Negative Affect Scale
PAC Perceived Adjustment to Cancer
PACIS Perceived Adjustment to Chronic Illness Scale
PAIS Perceived Adjustment to Illness Scale
PANAS Positive And Negative Affect Scale
PCBC Profile of Concerns about Breast Cancer
PCI Prostate Cancer Index
PHQ Perceived Health Questionnaire
PLT Purpose in Life Test
PLT Purpose in Life Test
POMS Profile Of Mood States
PRF Personality Research Form
PSS Perceived Stress Scale
QLS Quality of Life Scale
RAND Dutch MOS Health Survey (36 Item)
RSCL Rotterdam Symptom CheckList
RSE Rosenberg Self-Esteem Inventory
SAQ-N Self-Assessment Questionnaire-Nijmegen
SBI Self-Blame Interview
SCL Symptom Check List
SDS Symptom Distress Scale
SEC Side Effects Checklist
SF36 Short Form MOS Health Survey (36 Item)
SPI Standard Psychiatric Interview
STAI-S/T State-Trait Anxiety Questionnaire
SVQ Svebak Humour Questionnaire
SWBS Spiritual Well Being Scale
UWQOL University of Washington Quality of Life Scales
VASA Visual Analogue Scales for Appraisal
WoC Ways of Coping Scale
ZAS Zung Anxiety Scale
ZDS Zung Depression Scale
APPENDIX 2 .3 : QUALITY ASSESSMENT T O O L  A N D  S fO R IN r , r . Iim F .U N R S
CRITERIA YES/GOOD (2) PARTIAL (1) NO/POOR (0) N/A (X) SCORE
STUDY AIMS
1. Is the
hypothesis/objective 
sufficiently 
described in paper 
introduction?
Specifies: 
(l)purpose; (2) 
population; (3) 
associations 
under
investigation
Vague /  
incomplete /  
not clear.
Incomprehen-sible 
or not reported
DESIGN
2. Is the study design 
well described and 
appropriate?
Clear, well 
described and 
appropriate
Not clearly 
described or 
design only 
partially 
addresses 
question
Poorly described 
or inappropriate 
design for question
3. Are predictor and 
outcome measures 
clearly described in 
the intro/methods 
and appropriate
Defined and 
measured 
according to 
criteria
Definition open 
to subjectivity 
or description 
missing /n o t  
reported
Not mentioned 
until results or 
not/inconsistently 
defined
4. Is follow up data
collected and timing 
between study 
components 
appropriate?
Data collected 
and timing 
appropriate
Data collected 
but timing not 
specified /  
appropriate
No follow up data 
collected
Not
required 
for study 
design
SAMPLE
5. Is
selection/recruitme 
nt well described 
and appropriate so 
as to not introduced 
bias?
Clear and 
appropriate with 
defined inclusion 
criteria
Not fully 
described, but 
appropriate or 
bias not likely 
to influence 
results
Not described or 
inappropriate or 
bias likely to 
influence results
6. Are participant 
characteristics /  
subgroup 
categorisation 
clearly described?
Sufficient 
demographic 
info and 
categorisation 
criteria defined.
Incomplete 
demographics 
or poorly 
defined criteria
No demographics 
or criteria supplied
7. Have patients been 
lost of follow-up 
been described?
Losses reported 
and not likely to 
affect results
Losses not well 
reported but 
not likely to 
affect results
No information or 
large losses likely 
to affect results
Not collect­
ed or no 
losses
8. Is the sample size 
adequate?
Sample size is 
adequate
Sample size 
inadequate but 
justified /  
explained
Sample size too 
small
METHODOLOGY (RCT & INTERVENTION STUDIES MAINLY)
10. Were participants 
randomised to 
intervention /  trial 
groups?
Randomisation 
method clearly 
described
Randomisation 
mentioned but 
method not 
described
Randomisation not 
mentioned 
although feasible 
and appropriate
Not
approp­
riate
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11. Are tr ia l/ 
intervention 
components clearly 
described and 
appropriately 
justified?
12. Was randomisation 
/  allocation 
concealed from 
participants?
14. Were data analysed 
according to 
'intention to treat’ 
principles?
All components 
clearly described 
and appropriate
Evidence of 
method of 
concealment
All data analysed 
regardless of 
adherence to 
protocol
Appropriate 
but not well 
described or 
some
components
inappropriate
Concealment 
reported, but not 
described
Inappropriate 
attempts made 
or some 
participants not 
included
Inappropriately
justified
components
No attempt made
Not
approp­
riate
No Conceal-
randomisation ment not
reported app-
although feasible ropriate 
and appropriate
ITT not 
appropr­
iate for 
design
ANALYSIS & RESULTS
15. Are methods of All described and Not reported, but Methods not
analysis clearly appropriate probably most described
described and analysed
appropriate? appropriately
16. Are estimates of Appropriate Undefined or not Not provided
variance reported estimates provided for all
for the main results? provided 
(SD/SE/Confiden 
ce intervals)
results
17. Are confounding Appropriate Incomplete Not controlled
variables adequately control or control or and likely to
controlled for? participants 
comparable at 
baseline
considered but 
unlikely to affect 
results
affect results
13. Was randomisation Investigators Inadequate: Not attempt
/  allocation blind to investigator made to blind
concealed from participant maybe aware of
investigators? allocation participant
randomisation
Do analyses adjust Different lengths Differences Differences
for different lengths of time adjusted probably ignored
of follow up or time for and adjusted for but
between described not described
intervention and
outcome
18. Are the main Clear reporting Incomplete or No /  inadequate
findings clearly of descriptive inappropriate descriptive
described? data for all major 
findings
descriptive
statistics
statistics
CONCLUSIONS
19. Are the conclusions 
supported by the 
results?
All conclusion 
supported by 
results
Some supported; None/few
others not or 
speculative 
interpretations 
no indicated as 
such
conclusions 
supported by 
data
Blinding 
not approp­
riate.
Same time 
or not coll­
ected
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APPENDIX 2.4; META-ANALYSIS CALCULATIONS
This example of the meta-analysis calculations is based on relationships between 
Self-efficacy and distress. Two studies were entered into the analysis: Ranchor et 
al., 2002, (n =167, r =-.33) and Green et al, 2002 (n =65, r =-.01). Meta-analyses 
were conducted using Hunter and Schimdt's method, following the procedural 
guidance of Field (2001).
1) Mean Effect Size [MES]
Z " ‘r>
r -*J —
I * .I-1
(167 x -.33) +(65 x -.01) 
(167 + 65)
-.240
2) Standard Deviation o f the MES
SD--
Z ^ r . - r f
1= 1-
1
(l67(-.33 -  --24 )2) + (65(-.01 -  --24 )2) | (167 x .0081)+ (65 x .0527)
(167 + 65) V 232
3) Standard Error o f the MES
02
4) Calculation of the z-score
SE-
-.240
.102
-2.365
5) Significance
Minitab was used to generate the observed significance level. The cumulative distribution 
function gives a value ofp(Z<z)=.009 under the standard Normal curve. This value was subtracted 
from 1 and multiplied by 2 to yield a two-tailed p value o f p=.018.
Therefore, r -  -  .240, p < .05.
.144
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an extension must be sought on a timely basis. Extensions to completion dates will usually not 
exceed three months unless sufficient reason is given.
4. Final Report A final report needs to be provided on completion of the research.
5. Acknowledgement of Support Acknowledgement of the support given by the North Wales 
Research Committee is expected in any publication of your research findings and a copy of the 
publication(s) should be provided when this is available.
Should you require any further help or should problems arise then please contact me. Otherwise 
may I wish you all the best with your project.
Yours sincerely
Dr J H P Evans
Executive Secretary
North Wales Research Committee
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Dear Dr Neal
The importance of personality in appraisal and psycho-social outcome prediction for 
colorectal cancer patients
I confirm that Cardiff University agrees in principle to act as Sponsor for the above 
project, as required by the Research Governance Framework for Health and Social Care.
Final confirmation of acceptance of Sponsorship responsibilities will be provided in due 
course by the Joint Cardiff and Vale NHS Trust / University Peer and Risk Review 
Committee (JTUPeRR).
You will have received the Guidance Note and Appendices covering the Research 
Governance Framework and The Medicines for Human Use (Clinical Trials) Regulations 
2004 (MHUR) (formerly the EU Clinical Trials Directive) which sets out the 
responsibilities of the Sponsor and any individual undertaking. You should ensure that 
your responsibilities as Chief/Principal Investigator are fully understood.
You should quote the following unique reference number as evidence of Cardiff 
University accepting, in principle, sponsorship for the above project:
This reference number should be quoted on all documentation associated with this project. 
Yours sincerely
Dr K J Pittard Davies
Head of Research Policy & Management
Direct line: +44 (0) 29208 79274 
Email: DaviesKP2@cf.ac.uk
cc Dr Jane Jones
Trust R & D Manager
SPON CU 121
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Tel: 0207 388 9222
Fax: 0207 388 9229 U • M • A S SO CIATIO N LTD
TO WHOM IT MAY CONCERN 
1* August 2004 
Dear Sir/Madam
CARDIFF UNIVERSITY 
AND ALL ITS SUBSIDIARY COMPANIES
We confirm that the above Institution is a Member of U.M. Association Limited, and that the 
following cover is currently in place:-
EMPLOYERS’ LIABILITY
Certificate No. 42UKA09609/027
Period of Cover 1 August 2004 to 31 July 2005
Limit of Indemnity £10,000,000 any one event unlimited in the aggregate.
Includes Indemnity to Principals
Cover provided by ACE Insurance S.A.-N.V. and Excess Insurers.
PUBLIC AND PRODUCTS LIABILITY
Certificate of Entry No. UM027/95
Period of Cover 1 August 2004 to 31 July 2005
Includes Indemnity to Principals
Limit Of Indemnity £50,000,000 any one event and in the aggregate in respect of
Products Liability and Unlimited in the aggregate in respect of
Pubfic Liability.
Cover provided by U.M. Association Limited and Excess Cover Providers led by ACE
Insurance S.A. - N.V.
If you have any queries in respect of the above details, please do not hesitate to contact us.
Yours faithfully
Peter Watkins
For U.M. Association Limited
Woburn House 
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Tel: 0207 388 9222
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following cover is currently in place:-
PROFESSIONAL INDEMNITY *'
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Period of Cover 1 August 2004 - 31 July 2005
Limit of Indemnity £5,000,000 any one claim and in the aggregate except for Pollution
where cover is limited to £1,000,000 in the aggregate.
Cover provided by U.M. Association Limited and Excess Cover Providers led by ACE
Insurance S A  - N.V.
If you have any queries in respect of the above details, please do not hesitate to contact us. 
Yours faithfully
Peter Watkins
For U.M. Association Limited
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North East Wales Local Research Ethics Committee
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Ethics Co-ordinator
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LL13 7TD
28* April 2005
Mr N HuJbcrt 
PhD Student
Cardiff University, Wales College of Medicine
Gwenfro Unit 5
Wrexham Technology Park
Wrexham
LL13 7YP
Dear Mr Hulbert
Full tide of study: The Importance of Personality In Appraisal And Psycho-Social
Outcome Prediction For Colorectal Cancer Patients?
REC reference number: 05/WNo03/10
Thank you for your letter of IS* April 2005, responding to the Committee’s request for further 
information on the above research and submitting revised documentation.
The further information was considered at the meeting of the Committee held on 27th April 
2005. A list of the members who were present at the meeting is attached.
Confirmation of ethical opinion
On behalf of the Committee, 1 am pleased to confirm a favourable ethical opinion for the above 
research on the basis described in the application form, protocol and supporting documentation 
as revised.
Conditions of approval
The favourable opinion is given provided that you comply with the conditions set out in the 
attached document. You are advised to study the conditions carefully.
Approved documents
The final list of documents reviewed and approved by the Committee is as follows:
Document Type: Version: Dated: Date Received:
Application 08/03/2005 09/03/2005
Investigator CV 08/03/2005 09/03/2005
Protocol 1 07/03/2005 09/03/2005
Covering Letter 08/03/2005 09/03/2005
Covering Letter 09/03/2005
Cont overleaf
Ffon/Tel: (01978) 725368 (lltneU ualongyrchol/direct line) 
Ffact/Fai: (01978) 725368
Lhth-el/E-mail: Eleanor. Thoma»anew-tr. wales.nhs.uk
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Compensation
Arrangements
01/08/2004 09/03/2005
Copy of Questionnaire 09/03/2005
Participant Information 
Sheet
1 08/03/2005 09/03/2005
Participant Consent 
Form
1 08/03/2005 09/03/2005
Response to Request 
for Further Information
13/04/2005 14/04/2005
Summary C.V for 
Cheif Investigator
09/03/2005
Management approval
The study should not commence at any NHS site until the local Principal Investigator has 
obtained final management approval from the R&D Department for the relevant NHS care 
organisation.
Membership of the Committee
The members of the Ethics Committee who were present at the meeting are listed on the 
attached sheet.
Notification of other bodies
The Committee Administrator will notify the research sponsor that the study has a favourable 
ethical opinion.
Statement of compliance
The Committee is constituted in accordance with the Governance Arrangements for Research 
Ethics Committees (July 2001) and complies fully with the Standard Operating Procedures for 
Research Ethics Committees in the UK.
0S/WNo03/10______________________Please quote this number on all correspondence
With the Committee’s best wishes for the success of this project,
Yours sincerely,
Mr P Richards
Associate Specialist -  Surgery, Secretary 
North East Wales LREC
Enclosures List o f names and professions o f members who were present at the
meeting and those who submitted written comments 
Standard approval conditions 
Site approval form  (SFJ)
Cont overleaf
352
Pwyllgor Moeseg Ymchwil Dwyrain Gogleddd Cymru 
North East Wales Local Research Ethics Committee
Cydlynydd Moeseg 
Ethics Co-ordinator
Ysbyty Maelor W n c u n W m b u i Maeior Hospital 
Croesnewydd Rond 
W tta im /W  rtikmm 
LL I3 7TD
28* April 2005
Mr N Hulbcrt 
PhD Student
Cardiff University, Wales College of Medicine
Gwenfro Unit 5
Wrexham Technology Park
Wrexham
LLI3 7YP
Dear Mr Hulbcrt
Full tide of study: The Importance of Personality In Appraisal And Psycho-Social
Outcome Prediction For Colorectal Cancer Patients?
REC reference number: 0S/WNo03/10
The Research Ethics Committee reviewed die above application at die meeting held on 27* April 2005.
We have written to you separately with the outcome of the review. This letter relates specifically to your 
declaration that this is a study with no local investigators.
The Committee agreed that this is a “no local investigator” study and site-specific assessment is net required for 
sites involved in the research. No information about the study needs to be submitted to Local Research Ethics 
Committees. However, you should arrange fix all relevant host organisations to be notified that die research 
will be taking place before the research commences.
All researchers and research collaborators who will be participating in the research must obtain management 
approval from the relevant host organisation before commencing any research procedures. Where a substantive 
contract is not held with the host organisation, it may be necessary fix an honorary contract to be issued before 
approval for the research can be given.
REC reference number:______05/WNo03/10 Please quote this number on all correspondence
Yours sincerely,
Miss E Thomas
Research Ethics Co-ordinator
North East Wales LREC
Ffon/Tcl: (01978) 725368 (llinell uniongyrchol/direct line) 
Ffacs/Fax: (01978) 725368
Liyth-el/E-mall: Eleanor.Tfcomasvrnen-tr.iralei.nhs.uk
353
APPENDIX 3.5: LETTER OF PERMISSION TO CONDUCT RESEARCH FROM TRUST A
North
c .\C
 East Wales NHS Trust 
Internal Review Panel 
Clinical Audit / Research 
Effectiveness Department 
Wrexham Medical Institute 
Croesnewydd Road 
Wrexham LL13 7YP 
Tel: 01978 291100 ext 7453
Our Ref JJ/jh/RP05/06/01
21“ July 2005.
Private & Confidential 
Nick Hulbert
North Wales Clinical School 
Cardiff University Department of General Practice 
Gwenfro Unit 5, Wrexham Technology Park 
Croesnewydd Road, Wrexham, LL13 7YP
Dear Nick
RE: The Importance of personality in appraisal and psvcho-social outcome prediction for colorectal 
cancer patients
Thank you for responding regarding the amendments requested to the above project by the North 
East Wales NHS Trust Internal Review Panel, following review on 9 * June 2005. Following the 
Internal Panel Review meeting on 14m July I would like to inform you on behalf of the Review Panel 
that your project has now received full approval. Attached for your information is a list of the Panel 
members who reviewed your project.
As part of the approval process, 6-monthly progress reports and a final report will be required by 
the panel. These should be sent to the above address.
Any amendments to the research protocol should be notified to the panel.
As you know you are also required to have approval from a Research Ethics Committee before you 
can proceed with your project.
Yours sincerely
Mrs Julie Jones
Research & Audit Manager
Clinical Audit / Research Effectiveness
Ptncv*}* Ymddiriedolactfv flordd Cfoongwydd. Wnaam 1113 7TD. F(6n 01978 291100 
Truat Hoadquartati: Croaanewydd Road. Waxham 111] 710 Tal: 01978 291100 
CadakydcKThainnan' Lloyd FiaHu0\ 08 L. DL. Prif \Mti*ra*«rOwef tuocutiv*: Hllafy ftpiar 
Cont. overleaf
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Panel Members who reviewed your project are as follows:-
Sally Ann Baker, Lecturer Researcher, NEWI, Centre for Health & Community Research, 
Directorate of Medical Education, Health, Sports & Science.
Dr Emma Bedson, Research Officer, All Wales Alliance for Research and Development (AWARD) 
Institute of Medical & Social Care (IMSCar) University of Wales, Bangor
Mr Tony daSilva, Consultant Surgeon, North East Wales Trust
Mr John Day, Consultant Audiological Scientist, * M “
Mrs Julie Jones, Clinical Audit/R & D Manager
Dr David Parker, Associate Medical Director, Lead Clinician: Clinical Audit/Research & 
Development
Ron Iphofen, Senior Lecturer in Sociology of Health.
Mrs Louise Howard Baker,Senior Pharmacist
Dr Jim Turner, Senior Research Fellow, Dept Clinical Audit/Research Effectiveness 
Clive Williams, Consultant Biochemical Pathologist
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APPENDIX 3.6: LETTER OF PERMISSION TO CONDUCT RESEARCH IN CENTRE B
Dear Mr Hulbert
Re : Trust Approval to Proceed
Project Title: The importance of personality in appraisal and psychosocial 
outcome prediction for colorectal cancer patients.
Trust Ref:2005/0nc/240
I am pleased to inform you that following the R&D Internal Review panel meeting held 
on 7 June 2005, the above project has obtained approval to proceed at the Conwy and 
Denbighshire NHS Trust subject to ethical approval.
As part of regular monitoring undertaken by the Trust R&D Committee, you will be 
required to complete a short progress report. This \MII be requested on a six monthly 
basis. However, please contact me sooner should you need to report any particular 
successes or problems concerning your research. Whilst the Trust is keen to reduce the 
burden of paperwork for Researchers failure to produce a progress report may result in 
withdrawal of approval and any allocated funding.
To confirm the details and amount of funding, if any, allocated to your project, please 
contact Shelagh Evans, Management Accounts in the Finance Department, H M 
Stanley Hospital. Ext 3771.
All research conducted at Conwy and Denbighshire NHS Trust must comply with the 
Research Governance Framework for Health and Social Care in Wales (November 
2001). An electronic link to this document is provided on the Trusts R&D webpages. 
Alternatively you may obtain a paper copy of this document via the Trust R&D Office.
Please note the following as Principal investigator ie. the person designated as taking 
overall responsibility within the team of researchers for the design, conduct and reporting 
of the study.
• Controlled trials are registered.
The research proposal has ethical approval.
• The study complies with ethical and legal requirements.
• The research follows the protocol approved by the relevant ethics committee and the 
research sponsor.
Ymddiriedolaeth GIG Siroedd Conwy a Dinbych 
Conwy & Denbighshire NHS Trust
TO:
Mr Nicholas J Hulbert
North Wales Clinical School Cardiff University 
Wales College of Medicine,
Gwenfro Unit 5 
Wrexham Technology Park 
Wrexham LL13 7YP
Bn cyffOtf ret. LTJ/June/2005
Bch cyt/Your ret:
Dydciad/Deto: 27 June 2005
Whh ffonio gotynnwcti am/M telephoning ask tor
Lone Tudor Jones
Line! UntonflyrchoiAXrect Line:
01745 -  589624 
E-Mail Address
Lona.TudorJones@cd-tr.wales.nhs.uk
occr«dlud by th« 
H to llh  Quality 5«r*k»
MOS Ysbyty H. M. Stanley, Uanelwy, Sir Ddinbych LLI7 ORS. Ff6n: 01745 583910 Ffacs: 01745 589600 
H. M. Stanley Hospital, St. Asaph, Denbighshire LLI7 ORS. Phone: 01745 583910 Fax: 01745 589600 
Website: www.conwy-denblghshire-nhs.org.uk
Cont. overleaf
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- Any proposed changes or amendment to or deviations from the protocol and 
submitted for approval to the ethics committee, the research sponsor and any other 
appropriate body.
- The research proposal is worthwhile, of high scientific quality and value for money
- The arrangements, resources proposed and procedures are in place to ensure the 
collection of high quality, accurate data and the integrity and confidentiality of data 
during processing and storage.
- The research team are suitably qualified and have the necessary skills and 
experience. Students and new researchers have adequate supervision, support and 
training.
- Care staff are suitably informed about their patients raking part in research.
- Assistance will be provided to any potential enquiry audit or investigation related to 
the funded work. All data associated with the study are available for audit
- The principal investigator plays a key role in detecting and preventing scientific 
misconduct by adopting the role of guarantor on published outputs.
- Unless participants or the relevant ethics committee request otherwise, participants' 
care professionals are given information specifically relevant to their care which 
arises in the research.
- The findings from the work are open to critical review.
I trust this is in order. If you would like further information on any of the points covered by
this letter, please do not hesitate to contact me. On behalf of the R&D Committee, may I
wish you every success with your research.
Yours sincerely
Lona Tudor Jones 
R&D Manager
Cc
Julie Whitmore, Ethics Gian Clwyd Hospital 
Shelagh Evans, Finance, H M Stanley Hospital
APPENDIX 3.7: LETTER OF PERMISSION TO CONDUCT RESEARCH IN CENTRE C
■ ■ ■ ■ ■
B D H g
Ymddiriedolacth CIC 
Gogledd Orllewin Cymru
North West Wales 
NHS Trust
Trust Research Governance Committee 
Internal Review Panel
3 June 2005 
Mr. N. Hulbert
Cardiff University, Wales College of Medicine 
Gwenfro Unit 5, Wrexham Technology Park 
Wrexham LL13 7YP
Dear Mr. Hulbert,
Re: 05/WNo03/10 ‘ The importance of personality in appraisal and psycho 
social outcome prediction for colorectal cancer patients’
The above research project was reviewed at the meeting of the Internal Review 
Panel held on 2 June 2005
I have pleasure In confirming that the Trust Research Governance 
Committee /  Internal Review Panel is pleased to grant Trust approval for 
the conduct of this research at the North West Wales NHS Trust sites.
As part of the regular monitoring undertaken by the Trust’s Research 
Governance Committee you will be required to complete a short progress 
report. This will be requested on an annual basis. However, please contact me 
sooner should you need to report any particular successes or problems 
concerning your research. Whilst the Trust is keen to reduce the burden of 
paperwork for researchers failure to produce a report may result in withdrawal 
of approval.
All research conducted at the North West Wales NHS Trust sites must comply 
with the Research Governance Framework for Health and Social Care in Wales 
(November 2001). An electronic link to this document is provided on the Trust's 
R&D WebPages. Alternatively, you may obtain a paper copy of this document 
via the R&D Office.
If you would like further information on any other points covered by this letter 
please do not hesitate to contact me. On behalf of the Committee, may I take 
this opportunity to wish you every success with your research.
Yours sincerely,
f f  Dr. K.D. Griffiths
Consultant Biochemist - Assistant to the Medical Director 
Chairman, Trust Research Governance Committee 
Acting Chairman, Internal Review Panel
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APPENDIX 3.8: DEMOGRAPHIC QUESTIONNAIRE
Demographic Questionnaire
Please complete the following questions about yourself by ticking the appropriate box:
1. Are you Male
Female
2. What is your date of birth? .............
3. Which best describes you (please tick one box only):
Employed full-time Employed part-time
Self-employed In full-time education
Retired Other (please specify below)
Not employed (seeking work) Not employed (ill health)
Not employed (not seeking work for other reason)
4. Would you describe yourself as having a 'significant other' (e.g. wife, husband, partner,
etc.)?
Yes 
No
5. Do you live with your 'significant other'?
B
Yes
No
N/A
Do you care for any dependants (tick and indicate number as appropriate)?
7.
Under 18 
18-65 
Over 65
Are you-
White
Black-Caribbean
Asian-Pakistani
Chinese
Black-African 
Asian-Indian 
Asian-Bangladeshi 
Other (please specify)
8. What is your highest level of qualification?
None 
'A' Level
Degree (or equivalent)
GCSE '0' Level
Diploma (or equivalent)
Other (please specify)
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9. What is your GP's name and address?
10. What hospital are you being treated at?
11. What is your consultant's name?
12. Who is your assigned nurse specialist?
13. What treatment have you had so far/are you having for your illness?
APPENDIX 3.9: LIFE ORIENTATION TEST
LOT-R
This next set questions asks about your feelings. Answer according to your own feelings, rather than 
how you think "most people" would answer. Please use the following key and answer by circling the 
most appropriate number.
1
3
5
1.
1 disagree a lot 2 
I neither agree nor disagree 4 
1 strongly agree
In uncertain times, I usually expect the best
I disagree a little 
I agree a little
1 2 3 4
2. It's easy for me to relax. 1 2 3 4
3. If something can go wrong for me, it will. 1 2 3 4
4. I’m always optimistic about my future. 1 2 3 4
5. I enjoy my friends a lo t 1 2 3 4
6. It's important for me to keep busy. 1 2 3 4
7. 1 hardly ever expect things to go my way. 1 2 3 4
8. I don’t get upset easily. 1 2 3 4
9. I rarely count on good things happening to me. 1 2 3 4
10. Overall, I expect more good things to happen to me than bad. 1 2 3 4
5
5
5
5
5
5
5
5
5
5
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APPENDIX 3.10: NEQ-FFI INVENTORY
This section contains 60 statements. Read each one carefully. For each statement, circle the response 
that best represents your opinion. Please use the following key and answer by circling the most 
appropriate number.
1 Strongly Disagree
2 Disagree
3 Neither Agree nor Disagree
4 Agree
5 Strongly Agree
1. 1 am not a worrier.
2. I like to have a lot of people around me.
3. 1 don't like to waste my time daydreaming.
4. 1 try to be courteous to everyone I meet.
5. I keep my belongings neat and clean.
6. 1 often feel inferior to others.
7. I laugh easily.
8. Once I find the right way to do something, I stick to i t
9. 1 often get into arguments with my family and co-workers.
10. I’m pretty good about pacing myself so as to get things done on time.
11. When I'm under a great deal of stress, sometimes I feel like I'm going
to pieces.
12. I don’t consider myself especially "light-hearted".
13. I am intrigued by the patterns I find in art and nature.
14. Some people think I'm selfish and egotistical.
15. I am not a very methodical person.
16. I rarely feel lonely or blue.
17. I really enjoy talking to people.
18. I believe letting students hear controversial speakers can only confuse 
and mislead them.
19. I would rather cooperate with others than compete with them.
20. I try to perform all the tasks assigned to me conscientiously.
21. I often feel tense and jittery.
22. I like to be where the action is.
23. Poetry has little or no effect on me.
24. I tend to be cynical and sceptical or others' intentions.
25. 1 have a clear set of goals and work toward them in an orderly fashion.
26. Sometimes I feel completely worthless.
27. I usually prefer to do things alone.
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
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28. I often try new and foreign foods. 1 2 3 4
29. I believe most people will take advantage of you if you let them. 1 2 3 4
30. 1 waste a lot of time before settling down to work. 1 2 3 4
31. I rarely feel fearful or anxious. 1 2 3 4
32. I often feel as if I'm bursting with energy. 1 2 3 4
33. 1 seldom notice the moods or feelings that different environments 
produce.
1 2 3 4
34. Most people 1 know like me. 1 2 3 4
35. I work hard to accomplish my goals. 1 2 3 4
36. I often get angry at the way people treat me. 1 2 3 4
37. 1 am a cheerful, high-spirited person. 1 2 3 4
38. 1 believe we should look to our religious authorities for decisions on 
moral issues.
1 2 3 4
39. Some people think of me as cold and calculating. 1 2 3 4
40. When I make a commitment, I can always be counted on to follow 
through.
1 2 3 4
41. Too often, when things go wrong, I get discouraged and feel like giving 
up.
1 2 3 4
42. 1 am not a cheerful optimist. 1 2 3 4
43. Sometimes when I am reading poetry or looking at a work of art, I feel 
a chill or wave of excitement
1 2 3 4
44. I’m hard-headed and tough-minded in my attitudes 1 2 3 4
45. Sometimes I'm not as dependable or reliable as I should be. 1 2 3 4
46. 1 am seldom sad or depressed. 1 2 3 4
47. My life is fast-paced. 1 2 3 4
48. 1 have little interest in speculating on the nature of the universe or the 
human condition.
1 2 3 4
49. I generally try to be thoughtful and considerate. 1 2 3 4
50. I am a productive person who always gets the job done. 1 2 3 4
51. I often feel helpless and want someone else to solve my problems 1 2 3 4
52. I am a very active person. 1 2 3 4
53. I have a lot of intellectual curiosity. 1 2 3 4
54. If  I don't like people, I let them know i t 1 2 3 4
55. I never seem to be able to get organized. 1 2 3 4
56. At times I have been so ashamed I just wanted to hide. 1 2 3 4
57. 1 would rather go my own way than be a leader of others. 1 2 3 4
58. I often enjoy playing with theories or abstract ideas. 1 2 3 4
59. If necessary, I am willing to manipulate people to get what I want. 1 2 3 4
60. I strive for excellence in everything I do. 1 2 3 4
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5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
APEEMD1X 3.11: APPRAISAL COMPONENTS QUESTIONNAIRE
Below are a number o f questions concerning your thoughts about your diagnosis. For each question please circle 
the relevant number (from 1 to 11) to indicate what you now think about the time o f your diagnosis. For each 
question, specific endpoints are provided to help you define the scale fo r  that question.
1. How important or significant to you was your illness diagnosis?
2 .
3.
4.
5.
8 10Not at all 1 2 3 4 5 6 7
To what extent was this an undesirable event?
Not at all 1 2 3 4 5 6 7
To what extent was this a desirable event?
Not at all 1 2 3 4 5 6 7
Did you consider yourself responsible for your illness?
Not at all 1 2 3 4 5 6 7
Did you consider someone or something else responsible for your illness?
Not at all 1 2 3 4 5 6 7 8 9  10
When you think about how you want this situation to turn out, are you confident that this will happen?
Not  at  al l  1 2 3 4 5 6 7 8 9  10 11 Extremely
How much do you think you can influence things to make sure you get what you want (and don't want) 
out of your illness?
8
8
8
10
10 11
10 11
11 Extremely 
11 Extremely 
Extremely 
Extremely 
Extremely11
Certain would 
not be able to
8 10 11
How well do you think you will be able to deal emotionally with this illness?
Certain would 1 2 3 4 5 6 7 8 9  10 11
not be able to
Certain would 
be able to
Certain would 
be able to
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APPENDIX 3.12: CORE RELATIONAL THEMES QUESTIONNAIRE
Below are a number o f clusters o f statements that describe thoughts that people often have about various 
situations. Please indicate the extent to which each characterises your current thoughts about your illness 
diagnosis.
Please use the nine-point scale depicted below. Indicate your ratings by writing the appropriate number (1 to 9) in 
the box provided next to each cluster o f statements.
1 2 3 4 5 6 7 8 9  
Does not characterise my Characterises my Characterises my feelings extremely
feelings at all feelings somewhat well
1. I have made a fool of myself in this situation.
People disapprove of what I’ve done in this situation.
People think I’m stupid in this situation.
2. Something important to me is happening in this situation. 
This situation touches upon my personal concerns.
There are important things to think about here.
3. I didn't expect this at all.
I never thought this would happen.
What happened here was totally unpredictable.
4. This situation is totally irrelevant to my concerns. 
I don't care at all about what is happening here. 
What's happening here is a total waste of time.
5. There's nothing I need to be doing right now.
Everything is fine for now.
For the moment there's nothing I need to be concerned about
6. A burden has been lifted from my mind.
Things have worked out after all.
A threat or harm has been removed from the situation.
7. Someone is interfering with my goals.
I’ve been cheated or wronged.
Someone else is to blame for the situation I'm in.
I’ve been dealt with shabbily
8. I have done something bad.
Things are bad because of me.
1 am to blame for this bad situation.
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APPENDIX 3.13: EMOTION THEMES QUESTIONNAIRE
Below are a number o f clusters o f adjectives that describe emotions and feelings. Each group o f adjectives is 
meant to get a t a single basic feeling or emotion. Please indicate the extent to which each cluster o f adjectives 
characterises your current feelings and emotions about your illness diagnosis.
Please use the nine-point scale depicted below. Indicate your ratings by writing the appropriate number (1 to 9) 
in the box provided next to each cluster o f statements.
1 2 3 4 5 6 7 8 9
Characterises my Characterises my feelings extremelyDoes not characterise my 
feelings at all
1. Surprised 
Amazed 
Astonished
2. Guilty 
Remorseful 
Ashamed
3. Defeated 
Resigned 
Beaten
4. Tranquil
Calm
Serene
5. Frustrated 
Thwarted 
Exasperated
6. Annoyed with myself 
Mad at myself
7. Challenged 
Determined 
Eager
8. Regretful 
Dissatisfied
Disappointed in myself
9. Sad 
Downhearted 
Sorrowful
feelings somewhat well
10. Embarrassed 
Humiliated 
Disgraced
11. Interested 
Involved 
Intrigued
12. Joyful 
Happy
Light-hearted
13. Bored 
Indifferent 
Apathetic
14. Nervous 
Anxious 
Tense
15. Hopeful 
Optimistic
16. Angry 
Annoyed 
Resentful
17. Afraid 
Frightened 
Scared
18. Relieved
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APPENDIX 3.14: MULTIDIMENSIONAL HEALTH LOCUS OF CONTROL SCALE
Each item below is a belief statement about your medical condition with which you may agree or disagree. Please 
use the following key in answering the follow ing questions, by circling the most appropriate answer.
1 Strongly Disagree 2 Moderately Disagree
3 Slightly Disagree 4 Slightly Agree
5 Moderately Agree 6 Strongly Agree
1. If my condition worsens, it is my own behaviour which determines how 
soon I will feel better again.
1 2 3 4 5
2. As to my condition, what will be, will be. 1 2 3 4 5
3. If I see my doctor regularly, I am less likely to have problems with my 
condition.
1 2 3 4 5
4. If my condition worsens, it is up to God to determine whether I will feel 
better again.
1 2 3 4 5
5. Most things that affect my condition happen to me by chance. 1 2 3 4 5
6. Whenever my condition worsens, I should consult a medically trained 
professional.
1 2 3 4 5
7. I am directly responsible for my condition getting better or worse. 1 2 3 4 5
8. Most things that affect my condition happen because of God. 1 2 3 4 5
9. Other people play a big role in whether my condition improves, stays the 
same, or gets worse.
1 2 3 4 5
10. Whatever goes wrong with my condition is my own fault 1 2 3 4 5
11. Luck plays a bit part in determining how my condition improves. 1 2 3 4 5
12. God is directly responsible for my condition getting better or worse. 1 2 3 4 5
13. In order for my condition to improve, it is up to other people to see that 
the right things happen.
1 2 3 4 5
14. Whatever improvement occurs with my condition is largely a matter of 
good fortune.
1 2 3 4 5
15. The main thing which affects my condition is what I myself do. 1 2 3 4 5
16. Whatever happens to my condition is God's will. 1 2 3 4 5
17. I deserve the credit when my condition improves and the blame when it 
gets worse.
1 2 3 4 5
18. Following doctor's orders to the letter is the best way to keep my 
condition from getting any worse.
1 2 3 4 5
19. If  my condition worsens, it's a matter of fate. 1 2 3 4 5
20. Whether or not my condition improves is up to God. 1 2 3 4 5
21. If I am lucky, my condition will get better. 1 2 3 4 5
22. If  my condition takes a turn for the worse, it is because I have not been 
taking proper care of myself.
1 2 3 4 5
23. The type of help I receive from other people determines how soon my 
condition improves.
1 2 3 4 5
24. God is in control of my condition. 1 2 3 4 5
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APPENDIX 3.15: BRIEFCQPE INVENTORY
These items deal with way's you've been coping with the stress in your life since you found out 
about your diagnosis. Use the follow ing key to indicate what extent you've been doing what the
item says—not i f  they are working o r not, jus t whether or not you're doing it8
1 I haven't been doing this at all
2 I've been doing this a little bit
3 I've been doing this a medium amount
4 I've been doing this a lot
1. I’ve been turning to work or other activities to take my mind off things. 1
2. I've been concentrating my efforts on doing something about the situation 1
I'm in.
3. I've been saying to myself "this isn’t real". 1
4. I’ve been using alcohol or other drugs to make myself feel better. 1
5. I've been getting emotional support from others. 1
6. I've been giving up trying to deal with i t  1
7. I've been taking action to try to make the situation better. 1
8. I’ve been refusing to believe that it has happened. 1
9. I’ve been saying things to let my unpleasant feelings escape. 1
10. I've been getting help and advice from other people. 1
11. I’ve been using alcohol or other drugs to help me get through i t  1
12. I’ve been trying to see it in a different light, to make it seem more positive. 1
13. I’ve been criticizing myself. 1
14. I've been trying to come up with a strategy about what to do. 1
15. I've been getting comfort and understanding from someone. 1
16. I’ve been giving up the attempt to cope. 1
17. I've been looking for something good in what is happening. 1
18. I've been making jokes about it. 1
19. I've been doing something to think about it less, such as going to movies, 1
watching TV, reading, daydreaming, sleeping, or shopping.
20. I've been accepting the reality of the fact that it has happened.
21. I've been expressing my negative feelings.
22. I’ve been trying to find comfort in my religion or spiritual beliefs.
23. I’ve been trying to get advice or help from other people about what to do.
24. I've been learning to live with it
25. I've been thinking hard about what steps to take.
26. I've been blaming myself for things that happened.
27. I've been praying or meditating.
28. I've been making fun of the situation.
ABPENDIX 3,16; SF-12 INVENTORY
These questions ask about your views about your health, how you feel and how well you are able to do 
your usual activities. Please answer each by marking the box which most fits  how you feel.
1. In general, would you say your health is:d □ □ □ □
Excellent Very Good Good Fair Poor
The following items are about activities you might do during a typical day. Does your health now 
limit vou in these activities? If so, how much?
Yes, Limited Yes, Limited No, Not
A Lot A Little Limited
2. Moderate activities, such as moving a □ □ □table, pushing a vacuum cleaner, bowling, or
playing golf. □ □ □3. Climbing several flights of stairs.
During the past 4 weeks, have you had any of the following problems with your work or other 
regular daily activities as a result of vour physical health?
Yes No
4. Accomplished less than you would like.
5. Were limited in the kind of work or other activities.
During the past 4 weeks, have you had any of the following problems with your work or other 
regular daily activities as a result of anv emotional problems (such as feeling depressed or 
anxious)?
Yes No
6. Accomplished less than you would like
7. Didn't do work or other activities as carefully as 
usual
8. During the past 4 weeks, how much did pain interfere with your normal work (including 
both work outside the home and housework)?□ □ □ □ □
Not at all A little bit Moderately Quite a bit Extremely
These questions are about how you feel and how things have been for you during the past 4 weeks. 
For each question, please give the one answer that comes closest to the way you have been feeling. 
How much of the time during the past 4 weeks:
9. Have you felt calm and 
peaceful?
10. Did you have a lot of energy?
11. Have you felt downhearted 
and blue?
All of 
the 
Time□
Most 
of the 
Time□
A Good 
Bit of the 
Time□
Some of 
the 
Time□
□ □ □ □
tC H h  as ynl L vsirall 1th or en12. During the past 4 weeks, how mud Ithe
problems interfered with your social activities (visiting friends, re atives, etc.)?□ □ □ □
All of the Time Most of the Time Some of the Time A little of the
Time
A Little 
of the 
Time□□
CL
None 
of the 
Time□ □
nal I— 1
□
None of the Time
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APPENDIX 3.17: MINI MENTAL ADIUSTMKNT TO CANCER SCALE
A number o f statements are given below which describe people's reactions to having cancer. Please 
use the following key and circle the response that indicates how fa r  i t  applies to you at present
1.
1. Definitely does not apply to me
2. Does not apply to me
3. Applies to me
4. Definitely applies to me
At the moment I take one day at a time. 1 2 3
2. I see my illness as a challenge. 1 2 3
3. I've put myself in the hands of God. 1 2 3
4. I feel like giving up. 1 2 3
5. 1 feel very angry about what has happened to me. 1 2 3
6. 1 feel completely at a loss about what to do. 1 2 3
7. It is a devastating feeling. 1 2 3
8. I count my blessings. 1 2 3
9. I worry about the cancer returning or getting worse. 1 2 3
10. I try to fight the illness. 1 2 3
11. I distract myself when thoughts about my illness come into my 1 2 3
12.
head.
1 can’t handle i t 1 2 3
13. I am apprehensive. 1 2 3
14. I am not very hopeful about the future. 1 2 3
15. I feel there is nothing 1 can do to help myself. 1 2 3
16. I think it is the end of the world. 1 2 3
17. Not thinking about it helps me cope. 1 2 3
18. I am very optimistic. 1 2 3
19. I've had a good life what's left is a bonus. 1 2 3
20. I feel that life is hopeless. 1 2 3
21. I can't cope. 1 2 3
22. I am upset about having cancer. 1 2 3
23. 1 am determined to beat this disease. 1 2 3
24. Since my diagnosis of cancer I now realise how precious life is 1 2 3
25.
and I'm making the most of i t
I have difficulty in believing that this happened to me. 1 2 3
26. I make a positive effort not to think about my illness. 1 2 3
27. I deliberately push all thoughts of cancer out of my mind. 1 2 3
28. I suffer great anxiety about i t 1 2 3
29. I am a little frightened. 1 2 3
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
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APPENDIX 3.18: FACT-G INVENTORY
Below is a list o f statements that other people with your illness have said are important By circling 
one number fo r  each, please indicate how true each statement has been fo r you during the past 7 
days. Please use the following scale when selecting your answer:
0 Not at all
1 A little bit
2 Somewhat
3 Quite A Bit
4 Very Much
Physical Well Being
1. I have a lack of energy 0 1 2 3
2. I have nausea. 0 1 2 3
3. Because of my physical condition, I have trouble meeting the 
needs of my family.
0 1 2 3
4. I have pain. 0 1 2 3
5. 1 am bothered by side effects of treatment 0 1 2 3
6. I feel ill. 0 1 2 3
7. I am forced to spend time in bed. 
Social/Family Well Being
0 1 2 3
8. I feel close to my friends. 0 1 2 3
9. 1 get emotional support from my family. 0 1 2 3
10. I get support from my friends. 0 1 2 3
11. My family has accepted by illness. 0 1 2 3
12. I am satisfied with family communication about my illness. 0 1 2 3
13.
14.
I feel close to my partner (or the person who is my main support). 
Regardless o f your current level o f sexual activity, please answer the 
following question. I f  you prefer not to answer it, please tick this 
box and go to the next section.
0
□
1 2 3
15. I am satisfied with my sex life. 
Emotional Well Being
0 1 2 3
16. I feel sad. 0 1 2 3
17. I am satisfied with how 1 am coping with my illness. 0 1 2 3
18. 1 am losing hope in the fight against my illness. 0 1 2 3
19. I feel nervous. 0 1 2 3
20. 1 worry about dying. 0 1 2 3
21. I worry that my condition will get worse. 0 1 2 3
Functional Well Being
22. I am able to work (include work at home). 0 1 2 3
23. My work (including work at home) is fulfilling. 0 1 2 3
24. I am able to enjoy life. 0 1 2 3
25. 1 have accepted my illness. 0 1 2 3
26. 1 am sleeping well. 0 1 2 3
27. I am enjoying the things I usually do for fun. 0 1 2 3
28. I am content with the quality of my life right now. 0 1 2 3
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
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APPENDIX 3.19: FACT-C INVENTORY
Additional Concerns
29. I have swelling or cramps in my stomach area. 0
30. I am losing weight 0
31. I have control of my bowels. 0
32. I can digest my food well. 0
33. I have diarrhoea 0
34. 1 have a good appetite. 0
35. I like the appearance of my body. 0
36. Do you have an ostomy appliance? (Tick one box)
If yes, please answer the next two items:
37. I am embarrassed by my ostomy appliance.
38. Caring for my ostomy appliance is difficult.
1 2  3 4
1 2  3 4
1 2  3 4
1 2  3 4
1 2  3 4
1 2  3 4
1 2  3 4
YesQ
1 2  3 4
1 2  3 4
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APPENDIX 3.20; FACT-P INVENTORY
Additional Concerns
29. I am losing weight 0 1 2 3
30. I have a good appetite. 0 1 2 3
31. 1 have aches and pains that bother me. 0 1 2 3
32. 1 have certain parts of my body where I experience significant 0 1 2 3
33.
pain.
My pain keeps me from doing things I want to do. 0 1 2 3
34. 1 am satisfied with my present comfort level. 0 1 2 3
35. I am able to feel like a man. 0 1 2 3
37. I have trouble moving my bowels. 0 1 2 3
38. I have difficulty urinating. 0 1 2 3
39. I urinate more frequently than usual. 0 1 2 3
40. My problems with urinating limit my activities. 0 1 2 3
41. I am able to have and maintain an erection. 0 1 2 3
4
4
4
4
4
4
4
4
4
4
4
4
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APPENDIX 3.21: FACT-B INVENTORY
Additional Concerns
29. I have been short of breath. 0 1 2 3 4
30. I am self-conscious about the way I dress. 0 1 2 3 4
31. One or both of my arms are swollen or tender. 0 1 2 3 4
32. I feel sexually attractive. 0 1 2 3 4
33. I am bothered by hair loss. 0 1 2 3 4
34. 1 worry that other members of my family might someday get the 0 1 2 3 4
same illness I have.
35. I worry about the effect of stress on my illness. 0 1 2 3 4
36. 1 am bothered by a change in weight. 0 1 2 3 4
37. I am able to feel like a woman. 0 1 2 3 4
38. 1 have certain parts of my body where I experience significant 0 1 2 3 4
pain.
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APPENDIX 3.22: FACT-L INVENTORY
Additional Concerns
29. I have been short of breath. 0 1 2 3 4
30. I am losing weight 0 1 2 3 4
31. My thinking is clear. 0 1 2 3 4
32. I have been coughing. 0 1 2 3 4
33. 1 am bothered by hair loss. 0 1 2 3 4
34. I have a good appetite. 0 1 2 3 4
35. I feel tightness in my chest 0 1 2 3 4
36. Breathing is easy for me.
37. Have you ever smoked? ___
No □  Yes | |
If yes:
38. I regret my smoking. 0 1 2  3 4
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APPENDIX 3.23: HOSPITAL ANXIETY & DEPRESSION SCALE fHADSI
This section w ill tell us more about how you fee l and y o u r illness-related emotions. Read each item and tick the box 
nest to the reply which comes closest to how you have been feeling  in the past week. Don't take too long over your 
replies;you im m ediate reaction w ill probably be more accurate than a long thought out response.
1. I feel tense or wound up:   8. 1 feel as if I am slowed down:
Most of the time Nearly all the time
A lot of the time Very often
From time to time, occasionally Sometimes
Not at all Not at all
2. I still enjoy the things I used to enjoy:
Definitely as much ___
Not quite as much ___
Only a little ___
Hardly at all______________________________________
3. I get a sort of frightened feeling as if something 
awful is about to happen:
Very definitely and quite badly ___
Yes, but not too badly ___
A little, but it doesn't worry me ___
Not at all
4. I can laugh and see the funny side of things:
As much as I always could 
Not quite as much now 
Definitely not so much now 
Not at all
5. Worrying thoughts go through my head:
A great deal of the time 
A lot of the time
From time to time, but not too often 
Only occasionally
6. 1 feel cheerful:
Not at all 
Not often 
Sometimes 
Most of the time
7. I can sit at ease and feel relaxed:
Definitely 
Usually 
Not often 
Not at all
9. I get a sort of frightened feeling like 
'butterflies' in the stomach:
Not at all _
Occasionally _
Quite often _
Very often _
10. I have lost interest in my appearance:
Definitely _
I don't take so much care as I should _
I may not take quite as much care _
I take just as much care as ever _
11. 1 feel restless as if I have to be on the move:
Very much indeed _
Quite a lot _
Not very much _
Not at all _
12. I look forward with enjoyment to things:
As much as I ever did _
Rather less than I used to _
Definitely less than I used to _
Hardly at all _
13. I get sudden feelings of panic:
Very often indeed _
Quite often _
Not very often _
Not at all _
14. I can enjoy a good book or radio/TV  
programme:
Often
Sometimes 
Not often 
Very seldom
376
APPENDIX 3.24; INCLUSION CRITERIA MATRIX
Personality Differences in Cancer Patients 
Inclusion Criteria Matrix
Is the diagnosis recurrent or of a very YES
advanced (terminal) Stage?
NO
EXCLUDE
YES
♦ EXCLUDE
NO
YES
EXCLUDE
NO
YES
♦ EXCLUDE
NO
YES
♦ EXCLUDE
Does the patient struggle to 
understand English?
Does the patient have any serious 
psychiatric conditions?
Does the patient demonstrate a clear 
understanding of their diagnosis?
Does the patient have any serious 
developmental or learning difficulties? *
NO
Has the diagnosis been made in 
the last six weeks?
YES
EXCLUDE
NO
In your opinion, are there any other reasons why 
this patient should not be invited to participate?
YES
EXCLUDE
NO
INCLUDE
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APPENDIX 3.25: PATIENT INVITATION LETTERS
Research Study - Personality Differences in Cancer Patients.
I am writing to you on behalf of a team of researchers at the Cardiff 
University School of Medicine. They would like to invite you to take part in 
a new research study. This will investigate how different personalities cope 
with a cancer diagnosis and the implications that this may have on their 
physical and emotional adjustment throughout illness, treatment, the 
future. If  you agree to take part the research team will contact you directly.
To take part, you will be asked to complete a questionnaire at three times 
over the next six months. Each will take approximately 30 minutes to 
complete. The researchers hope that this study will help to improve care 
delivery to people diagnosed with cancer. For more information please see 
the enclosed ‘Information Sheet'.
If you wish to take part, please read the information carefully, sign the 
consent forms and complete the questionnaire. Please then return two 
copies of the consent form and the questionnaire in the enclosed FREEPOST 
envelope (please retain the information sheet and the third consent form 
for your records). If you do not wish to take part, please return all of the 
enclosed documents in the enclosed FREEPOST envelope. Your decision 
whether or not to participate in this study in no way will affect your 
treatment
Astudiaeth Ymchwil -  Gwahaniaethau Personoliaeth mewn Cleifion 
Canser
Ysgrifennaf atoch ar ran tim o ymchwilwyr, Ysgol Meddygaeth Prifysgol 
Caerdydd. Hoffen nhw eich gwahodd i gymryd rhan mewn astudiaeth 
ymchwil newydd. Bydd hyn yn ymchwilio i sut mae gwahanol 
bersonoliaethau'n ymdopi gyda diagnosis canser a'r goblygiadau posibl ar 
eu haddasiad corfforol ac emosiynol trwy'r salwch, y driniaeth ac ar 61 
hynny. Ni fydd yr astudiaeth yn effeithio'r ffordd y byddwch yn derbyn 
triniaeth am eich salwch ac unwaith byddwch wedi cytuno i gymryd rhan, 
bydd y tim ymchwil yn cysylltu 6 chi'n uniongyrchol.
Er mwyn cymryd rhan, byddwch angen cwblhau holiadur tair gwaith dros y 
chwe mis nesaf. Bydd pob un yn cymryd oddeutu 30 munud i'w gwblhau. 
Tra ein bod yn sylweddoli bod hyn yn gofyn Hawer, gobeithiwn y byddwch 
yn manteisio ar y cyfle i'n helpu yn ein hymdrechion i wella gofal i gleifion 6 
chanser. I gael gwybodaeth bellach, gweler y 'Daflen Wybodaeth' 
amgaeedig.
Os byddwch yn dymuno cymryd rhan, darllenwch yr wybodaeth yn ofalus, 
arwyddwch y ffurflenni caniatcld a chwblhewch yr holiadur. Yna, 
dychwelwch 2 gopi o'r ffurflen ganiat6d a'r holiadur yn yr amlen 
RHADBOST (cadwch y daflen wybodaeth a'r 3ydd ffurflen ganiatSd ar gyfer 
eich cofnodion). Os na fyddwch yn dymuno cymryd rhan, dychwelwch yr 
holl ddogfennau amgaeedig yn yr amlen RHADBOST amgaeedig. Ni fydd 
eich penderfyniad i gymryd rhan yn yr astudiaeth ai peidio yn effeithio ar 
eich triniaeth o gwbl.
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APPENDIX 3.26: PATIENT INFORMATION SHEET
Personality Differences In Cancer Patients
Invitation
You are being invited to take part in a research study. Before you decide it is 
important for you to understand why the research is being done. Please take time to 
read the following information carefully and discuss it with friends, relatives or 
those in your medical care team. Ask us if there is anything that is not clear or if you 
would like more information.
Background and study purpose
This study is investigating how individual differences can affect how newly 
diagnosed cancer patients adjust to being diagnosed, and whether this can be used 
to predict their longer-term psycho-social outcomes, such as their quality of life, 
mental adjustment, and vulnerability to psychological illnesses such as depression.
We are approaching all patients with a new cancer diagnosis within three North 
Wales NHS hospitals. We will be asking about 150 people to take part. The study 
will take approximately two years and will be written up for Mr Hulbert's PhD 
thesis.
Why have I been chosen?
You have been approached for this study because you have recently received a 
cancer diagnosis. You have been contacted by your appointed Clinical Nurse 
Specialist on behalf of Mr Hulbert
Do I have to take part? What happens if I don't take part?
No -  you do not have to take part at all and you need not give a reason for this 
decision. You are also free to withdraw at any time during the study period. This 
will not affect the standard of care you receive for your illness.
If you decide not to take part, we would appreciate the return of the blank 
questionnaire and consent form in the FREEPOST envelope. You may take as long as 
you need in making this decision.
What will happen to me if I take part? What do I have to do?
If you agree to take part, you are required to sign the enclosed consent form. You 
will also need to complete the questionnaire [this should take you no longer than 30 
minutes) and return both the questionnaire and consent form in the enclosed 
FREEPOST envelope. The questionnaire consists of three sections (About you;
About your illness and how you are dealing with it; and, About your reaction to 
diagnosis) which must all be completed if you wish to participate. You will receive 
acknowledgement that we have received your response and then, in three month's 
time, you will receive a second questionnaire. This should be completed in the same 
way. The final questionnaire will be posted to you a further three months later. This 
type of questionnaire repetition is important to allow us to study how you have 
changed over time as a result of your illness. Please do not allow anyone to 
complete the questionnaire on your behalf; it is your personal thoughts and feelings 
that we are interested in learning about Additionally, you will be asked to consent 
for our research team to record some details from your medical notes so that we can 
accurately understand your illness. Your GP and Consultant will be informed that 
you are taking part in this research, however this will not affect your care in any 
way.
Is there any potential harm from taking part in the study?
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There are no harmful effects from taking part At what may be a difficult time for 
you, we realise that some of the questions may be upsetting for you, but we hope 
this is balanced out by the potential gains from studies of this type.
How will I benefit from the study?
There are no direct benefits to you as a patient The results will be used to inform 
the development of new, holistic treatment programmes to help and support 
patients through their illnesses. You may, however, indirectly benefit from the 
opportunity to express some of your feelings, thoughts, and emotions at this very 
difficult time.
What if something goes wrong?
If you wish to make a complaint about any aspect of this research, or how you have 
been treated as a participant, please make to the Head of Department, Department of 
General Practice, Cardiff University, Wales College of Medicine. If at any time you 
have a question or concern regarding your medical condition, please refer these to 
your own care team [GP, Nurse etc.)
Confidentiality
The data provided by you, or obtained from your medical notes, will be used only for 
the purposes of this research. Information will be kept confidentially and securely, 
and you will remain entirely anonymous in any written reports, scientific papers, or 
study summaries. Data will be stored in accordance with the Data Protection Act 
and Cardiff University Research Policies and destroyed after three years from 
submission of Mr Hulbert's PhD thesis.
What will happen to the results of the study?
The main documentation of the study is for Mr. Hulbert's PhD thesis. From this, 
academic papers will be written and submitted to health psychology- and cancer- 
related scientific journals. Some results may also be presented at scientific meetings 
and conferences. In all results, all participants will remain anonymous. If you would 
like a summary of the results, please contact Mr Hulbert to arrange this.
Who is organizing and funding this research study?
The study is being organized, sponsored, and funded by Cardiff University, Wales 
College of Medicine. Mr Hulbert is being supervised by Dr Richard Neal [Wrexham 
GP), Prof. Clare Wilkinson [Director of Research, North Wales Clinical School, 
Wrexham), and Dr Val Morrison [Health Psychologist, University of Wales, Bangor).
Where can I get further information?
Please fe e l fre e  to contact M r  N  Hulbert, Departm ent o f General Practice, North Wales 
Clinical School, C ard iff University, Gwenfro Unit 5, Wrexham Technology Park, 
W rexham, LL13 7YP. Tel: 01978  727859; email: hulbertpi&cf.ac.uk. Please note that 
M r H ulbert is not qualified to comment on any aspect o f y o u r condition or treatm ent
Please keep this Inform ation Sheet fo r  y o u r fu tu re  reference, and, i f  you decide to take 
part, also keep one copy o f  the Patient Consent Sheet Thankyoufor taking p a rt in this
research.
GWYBODAETHIGLEIFION
Canser a Gwahaniaeth mewn Personoliaethau
Gwahoddiad
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Gwahoddir chi i gymryd rhan mewn astudiaeth ymchwil. Cyn penderfynu, mae'n 
bwysig eich bod yn deall pam y cynhelir yr ymchwil. Cymerwch amser i ddarllen yr 
wybodaeth ganlynol yn ofalus a thrafodwch gyda ffrindiau, perthnasau neu rhai yn y 
tim gofal meddygol. Gofynnwch os bydd rhywbeth yn aneglur neu os hoffech 
dderbyn mwy o wybodaeth.
Cefndir a phwrpas yr astudiaeth
Mae'r astudiaeth hon yn ymchwilio sut y gall gwahaniaeth rhwng unigolion effeithio 
ar sut mae cleifion sydd wedi derbyn diagnosis o ganser yn addasu i dderbyn 
diagnosis a pha un a ellir defnyddio hyn i ragweld eu deilliannau seico-gymdeithasol 
tymor hir, fel ansawdd eu bywyd, addasiad meddwl a bregusrwydd i salwch 
seicolegol fel iselder.
Rydym yn cysylltu £ phob claf gyda diagnosis o ganser newydd mewn pum ysbyty 
GIG gwahanol yng Nghymru. Byddwn yn gofyn i oddeutu 150 o bobl i gymryd rhan. 
Bydd yr astudiaeth yn cymryd oddeutu dwy flynedd a pharatoir ar gyfer traethawd 
PhD Mr Hulbert
Pam cefais fy newis?
Cysylltwyd 3 chi ar gyfer yr astudiaeth hon gan eich bod wedi derbyn diagnosis o 
ganser colorectaidd yn ddiweddar. Darparwyd eich manylion gan yr Arbenigydd 
Nyrsio a fydd wedi derbyn caniatdd gennych ar lafar i wneud hynny.
A oes yn rhaid i mi gymryd rhan? Beth fydd yn digwydd os na fyddaf yn 
cymryd rhan?
Na -  nid oes yn rhaid i chi gymryd rhan o gwbl ac ni fydd yn rhaid i chi roi rheswm 
dros y penderfyniad hwn. Hefyd, gallwch dynnu allan ar unrhyw adeg yn ystod 
cyfnod yr astudiaeth. Ni fydd hyn yn effeithio ar safon y gofal y byddwch yn ei 
dderbyn ar gyfer y salwch.
Os byddwch yn penderfynu peidio 3 chymryd rhan, byddem yn gwerthfawrogi 
petaech yn dychwelyd yr holiadur a'r ffurflen ganiat3d yn wag yn yr amlen 
RHADBOST. Gallwch gymryd gymaint o amser ag y dymunwch i wneud y 
penderfyniad hwn. Ar 61 mis, os na fyddwn wedi derbyn ymateb gennych, efallai y 
byddwch yn derbyn galwad fF6n i gadamhau eich bod wedi derbyn pecyn yr 
holiadur.
Beth fydd yn digwydd i mi os byddaf yn cymryd rhan? Beth sy*n rhaid i mi ei 
wneud?
Os byddwch yn cytuno i gymryd rhan, byddwch angen arwyddo'r ffurflen ganiat3d 
amgaeedig. Hefyd, byddwch angen cwblhau'r holiadur (ni ddylai hyn gymryd mwy 
na 45 munud) a dychwelyd yr holiadur a'r ffurflen ganiat3d yn yr amlen RHADBOST 
amgaeedig. Mae'r holiadur yn cynnwys tair adran (Amdanoch chi; Am eich salwch a 
sut rydych yn delio ag ef; ac am eich ymateb i'r diagnosis) y dylid eu cwblhau i gyd os 
byddwch yn dymuno cymryd rhan. Byddwch yn derbyn cydnabyddiaeth ein bod 
wedi derbyn eich ymateb, ac yna ymhen tri mis, byddwch yn derbyn ail holiadur. 
Dylid cwblhau hwn yn yr un modd. Anfonir yr holiadur terfynol atoch 3 mis yn 
ddiweddarach. Mae'r math yma o ailadrodd holiadur yn bwysig i'n galluogi i astudio 
sut rydych wedi newid dros amser o ganlyniad i'ch salwch. Peidiwch 6 gadael i 
unrhyw un gwblhau'r holiadur ar eich rhan; mae gennym ddiddordeb mewn dysgu 
am eich meddwl a'ch teimladau personol chi. Yn ogystal, gofynnir i chi roi caniat3d 
i'r tim ymchwil i gofnodi manylion o'ch cofnodion meddygol fel y gallwn ddeall eich 
salwch yn iawn. Hysbysir eich meddyg teulu a'r ymgynghorydd eich bod yn cymryd 
rhan yn yr ymchwil hwn, fodd bynnag, ni fydd hyn yn effeithio ar eich gofal mewn 
unrhyw ffordd.
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A oes unrhyw niwed posibl mewn cymryd rhan yn yr astudiaeth?
Nid oes unrhyw effeithiau niweidiol mewn cymryd rhan. Ar adeg anodd i chi, sylweddolwn y gall 
rhai o’r cwestiynau fod yn anodd ond gobeithio y bydd manteision posibl o astudiaethau o'r fath yn 
cydbwyso hyn.
Sut byddaf yn manteisio o'r astudiaeth?
Nid oes unrhyw fudd uniongyrchol i chi fel claf. Defnyddir y canlyniadau i ddatblygu rhaglenni 
triniaeth gyfannol newydd i helpu a chefnogi cleifion trwy eu salwch. Fodd bynnag, efallai y 
byddwch yn manteisio'n anuniongyrchol ar y cyfle i fynegi rhai o'ch teimladau, meddyliau ac 
emosiynau ar yr adeg hynod anodd hwn.
Beth os bydd rhywbeth yn mynd o'i le?
Os dymunwch gwyno am unrhyw agwedd o’r ymchwil hwn, neu sut rydych wedi cael eich trin fel 
cyfranogydd, cyflwynwch y gwyn i’r Pennaeth Adran, Adran Meddygaeth Gyffredinol, Prifysgol 
Caerdydd, Coleg Meddygaeth Cymru. Os bydd gennych gwestiwn neu bryder ynglyn 6’ch cyflwr 
meddygol ar unrhyw adeg, cyfeiriwch y rhain i'ch tfm gofal eich hun (meddyg teulu, nyrs ayyb).
Cyfrinachedd
Defnyddir y data a ddarperir gennych chi neu trwy eich cofnodion meddygol ar gyfer yr ymchwil 
hwn yn unig. Cedwir gwybodaeth yn gyfrinachol ac yn ddiogel a byddwch yn parhau'n gwbl 
ddienw mewn unrhyw adroddiadau ysgrifenedig, papurau gwyddonol neu grynodeb o 
astudiaethau. Bydd data yn cael ei storio yn unol i ’r Ddeddf Amddiffyn Data a Pholisiau Ymchwil 
Prifysgol Caerdydd ac yn cael ei dymchwel tair blynedd ar 61 ei chyflwyno ar gyfer traethawd PhD 
Mr Hulbert
Beth fydd yn digwydd i ganlyniadau'r astudiaeth?
Mae prif ddogfennau'r astudiaeth ar gyfer traethawd PhD Mr. Hulbert 0 hyn, paratoir papurau 
academaidd a chyflwynir i'r seicolegydd iechyd a chylchgronau gwyddonol sy’n gysylltiedig 6 
chanser. Bydd rhai canlyniadau'n cael eu cyflwyno mewn cyfarfodydd a chynadleddau gwyddonol 
hefyd. Bydd yr holl ganlyniadau a'r holl gyfranogwyr yn parhau’n ddienw. Os hoffech grynodeb o'r 
canlyniadau, cysylltwch 6 Mr Hulbert i drefnu hyn.
Pwy sy*n trefnu ac yn ariannu'r astudiaeth ymchwil?
Mae’r astudiaeth hon yn cael ei threfnu, ei noddi a’i hariannu gan Goleg Meddygaeth Cymru, 
Prifysgol Caerdydd. Mae Mr Hulbert yn cael ei oruchwylio gan Dr Richard Neal (MT Wrecsam), Yr 
Athro. Clare Wilkinson (Cyfarwyddwr Ymchwil, Ysgol Glinigol Gogledd Cymru, Wrecsam) a Dr Val 
Morrison (Seicolegydd Iechyd, Prifysgol Cymru, Bangor).
Ble gallaf gael gwybodaeth bellach?
Gallwch gysylltu 6 M r  N  Hulbert, Adran Meddygaeth Gyffredinol, Ysgol Glinigol Gogledd Cymru, 
Prifysgol Caerdydd, Uned 5  Gwenfro, Parc Technoleg Wrecsam, Wrecsam, LL13 7YP. Ffdn: 01978  
727859; e-bost: hulbertni@>cf. ac.uk. Sylwer n a d y w  M r  H ulbert yn  gymwys i wneud sylw a r  unrhyw  
agwedd o'ch cyflw r n a ’ch triniaeth.
Cadwchy Daflen Wybodaeth hon i gyfeirio a t iy n y  dyfodol ac os byddwch yn penderfynu cymryd rhan, 
cadwch un copi o 'r Daflen C aniat&dy C laf hefyd. Diolch i chi am gym ryd rhan yn y r  ym chwil hwn.
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APPENDIX 3.27: PATIENT CONSENT SHEETS
Centre Number:
Study Number:
Patient Identification Number:
CONSENT FORM 
Title  of Project: Personality Differences in Cancer Patients
Name of Researcher: Mr Nick Hulbert
Please initial box, sign you name, and complete your address so that we can contact you with your 
follow up questionnaires:
1) I confirm that I have read and understood the information sheet for
the above study and have had the opportunity to ask questions. |----- 1
2) 1 understand that my participation is voluntary and that I am free to
withdraw at any time without giving any reason, without my medical 
care or legal rights being affected.
3) I understand that sections of any of my medical notes may be looked 
at by responsible individuals from the North Wales Clinical School, 
Cardiff University, or from regulatory authorities where it is relevant 
to my taking part in research. I give permission for these individuals 
to have access to my records.
5) I consent to my name and address being held on record by Mr Nick 
Hulbert so that he may contact me with an invitation to participate in 
other future studies (please not that you can agree to this even if you 
do not wish to take part in the current study).
Name of Patient Date Signature
Patient address
□
4) I agree to take part in the above study. □
□
Name of Researcher Date Signature
Please complete all three copies o f this form and keep one copy fo r yourself One w ill be 
retained by the researcher and the other kept with your medical records
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Rhif y Ganolfan:
Rhif Astudio:
Rhif Adnabod y Claf:
FFURFLEN GANIATAD 
Teitl y Project: Gwahaniaeth Personoliaethau mewn Cleifion Canser
Enw'r Ymchwilydd: Mr Nick Hulbert
Llofnodwch y blwch os gwelwch yn dda, llofnodwch eich enw, a chwblhewch eich cyfeiriad fel y 
gallwn gysylltu a chi gyda'r holiaduron dilynol:
1) Cadamhaf fy mod wedi darllen a deall y daflen wybodaeth ar gyfer yr 
astudiaeth uchod ac wedi cael cyfle i ofyn cwestiynau.
2) Deallaf y byddaf yn cymryd rhan yn wirfoddol ac y gallaf dynnu allan 
ar unrhyw adeg heb roi rheswm, heb effeithio ar fy ngofal meddygol 
na hawliau cyfreithiol.
□
□
3) Deallaf efallai y bydd unigolion cyfrifol o Ysgol Glinigol Gogledd
Cymru, Prifysgol Caerdydd neu awdurdodau rheoleiddio yn edrych ar |-----.
adrannau o fy nghofnodion meddygol ble bydd hynny'n berthnasol i |___|
mi gymryd rhan yn yr ymchwil. Rhoddaf ganiat^d i'r unigolion hyn 
weld fy nghofnodion.
4) Cytunaf i gymryd rhan yn yr astudiaeth uchod. □
5) Rwyn cytuno i Mr Nick Hulbert gadw cofnod o fy enw a nghyfeiriad 
fel y gall gysylltu & mi gyda gwahoddiad i gymryd rhan mewn
astudiaethau eraill yn y dyfodol (nodwch os gwelwch yn dda y .----- .
gallwch gytuno i hyn hyd yn oed os nad ydych yn dymuno cymryd |___|
rhan yn yr astudiaeth gyfredol).
Enw'r claf Dyddiad Llofhod
Cyfeiriad y claf
Enw'r Ymchwilydd Dyddiad Llofhod
Cwblhewch dri chopi o’r  ffurflen hon a chadwch un copi i chi. Bydd y r  ymchwilydd yn cadw un
a'r Uallgyda’ch cofhodion meddygol
384
APPENDIX 3.28: PATIENT THANK-YOU LETTER
February 2006 
Dear,
Research Study - Personality Differences in Cancer Patients.
Many thanks for completing the questionnaire for the above named study. The 
information that you have provided will be a great help in this research study. In 
approximately 3 months time you will receive a further questionnaire (the same will 
also happen in 6 months time). The questionnaires are all similar, however, it is very 
important that you fill them all in carefully so that we can assess how you have 
changed throughout your illness. These follow-up questionnaires will be posted to you 
nearer the time.
If you have any further questions about your participation in this study, please do not 
hesitate to contact me.
On behalf of all involved in the research, I would like to wish you the very best for your 
treatment
Chwefror 2006 
Annwyl,
Astudiaeth Ymchwil -  Gwahaniaethau Personoliaeth mewn Cleifion Canser
Llawer o ddiolch am gwblhau'r holiadur ar gyfer yr astudiaeth uchod. Bydd yr 
wybodaeth a ddarparwyd gennych o gymorth mawr i'r astudiaeth ymchwil hwn. 
Ymhen oddeutu 3 mis byddwch yn derbyn holiadur arall (bydd yr un peth yn digwydd 
ymhen 6 mis). Mae'r holiaduron i gyd yn debyg, fodd bynnag, mae’n bwysig eich bod 
yn eu cwblhau'n ofalus fel y gallwn asesu sut rydych wedi newid yn ystod eich salwch. 
Anfonir yr holiadur dilynol hwn atoch nes at yr amser.
Os bydd gennych unrhyw gwestiynau pellach ynglyn S chyfrannu atyr astudiaeth hon, 
gallwch gysylltu & mi.
Ar ran pawb sy'n rhan o'r ymchwil, hoffwn ddymuno'n dda i chi gyda'r driniaeth.
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AEPEND1X 3.29: GP INFORMATION LETTER
February 2006
Dear Dr — ,
The importance of personality in appraisal and psycho-social outcome prediction 
for cancer patients.
As Principal Investigator in the above named study, I am required to inform you that 
your patient,, has consented to participate in this research. As a participant, they will 
complete three questionnaires (on initial recruitment, and at a three- and six- month 
follow up). You do not need to do anything about this and it will not affect the way that 
they are cared for or treated.
If you have any questions regarding your patient's participation, please do not hesitate 
to contact me on 01978 727859, or by email at hulbertni@cf.ac.uk.
Yours sincerely,
Nick Hulbert
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AEPENDIX 3.30: GP FOLLOW-UP LETTER
DATE
Dear Dr
The importance of personality in appraisal and psycho*social outcome prediction 
for cancer patients.
As Principle Investigator in the above named study, I wrote to you approximately 2
participate in this research. The patient is shortly due their three-month follow up 
questionnaire. Before sending this questionnaire out, we are contacting all of our 
participants’ GPs to ensure that the patient hasn’t died, or is close to death, because 
sending out a follow-up questionnaire in these cases would be both unnecessary and 
quite distressing for the patient and their families.
If this patient has died or is close to death, we would very much appreciate you 
letting us know as soon as possible by ticking the appropriate box below and 
returning this letter to us (at the above address) or by fax on 01978 727431. 
Alternatively, you can contact me by telephone on 01978 727859, or email at 
hulbertni@cf.ac.uk. If the patient is still alive, you do not need to do anything.
Many thanks,
Nick Hulbert.
Please complete in the event that sending a follow-up questionnaire is not suitable:
months ago informing you that your patien t, (DOB ) has consented to
Patient ID:
This patient died on
This patient is close to death
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APPENDIX 3.31; PATIENT DEBRIEF SHEET
Research study - Personality differences in cancer patients.
On behalf of the research team, I would like to thank you for taking the time to 
participate in our research study.
We won’t send you any more questionnaires for this study. All data that you’ve 
provided will be used for our final report. If you agreed on your consent form, you 
may hear from us in the future with invitations to take part in further related 
research, but there is no obligation to do so.
We are unable to provide individual feedback about your questionnaires, however, if 
you wuld like a written summary of our results, please do let us know. Please feel 
free to contact us if you have any further questions about this study. If you have any 
queries about your medical condition or the illness, we suggest that you refer these 
back to your GP or cancer team at the hospital where you are being treated.
Once again, many thanks for participating in this research. We all wish you the very 
best for any treatment that you may still be receiving.
Nick Hulbert-Williams, Chief Investigator
Astudiaeth ymchwil - Gwahaniaethau ym mhersonoliaeth cleiflon canser
Ar ran y tim ymchwil, hoffwn ddiolch i chi am gymryd amser i gyfrannu at yr 
astudiaeth ymchwil.
Ni fyddwn yn anfon mwy holiaduron atoch ar gyfer yr astudiaeth hon. Os bydd hyn 
yn eich synnu gan nad ydych wedi cwblhau’r holl holiaduron dilynol. Defnyddir yr 
holl ddata a ddararwyd gennych ar gyfer yr adroddiad terfynol. Os byddwch wedi 
cytuno ar eich ffurflen ganiatad, efallai y byddwch yn clywed gennym yn y dyfodol 
gyda gwahoddiad i gymryd rhan mewn ymchwil cysylltiol arall, ond nid oes rhaid i chi 
wneud hynny.
Ni allwn ddarparu adborth unigol am eich holiaduron, fodd bynnag, os hoffe dderbyn 
crynodeb ysgrifenedig o’n canlyniadau, gadeqch I ni wybod. Croeso i chi gysylltu a ni 
os bydd gennych unrhyw gwestiynau eraill am yr astudiaeth hon. Os bydd gennych 
unrhyw ymholidadau am eich cyflwr meddygol neu’r salwch, awgrymwn eich bod yn 
cyferirio’r rhain at eich meddyg teulu neu’r tim canser yn yr ysbyty ble rydych yn 
derbyn triniaeth.
Unweaith eto, diolch yn fawr iawn i chi am gyfrannu at yr ymchwil hwn. Rydym i gud 
un dymuno’n dda i chi gydag unrhyw driniaeth rydych yn parhaw I’w derbyn.
Nick Hulbert-Williams, Prif Ymchwilydd.
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APPENDIX 4.1: SUMMARY TABLE OF EXCLUDED VARIABLES FOR REGRESSION
OF THREE MONTH QUALITY OF LIFE FROM BASELINE PREDICTORS.
Variable Unstandardised ResidualsBeta In t Significance
Optimism .000 -.006 .995
Hopeless/helplessness .209 1.901 .060
Anxious preoccupation .109 .789 .432
Motivational congruence -.002 -.020 .984
Motivational incongruence .182 1.887 .062
Other Responsibility .060 .580 .563
Future Expectancy .097 .911 .364
PF Coping Potential .092 .932 .354
EF Coping Potential -.119 -1.024 .308
Self-consciousness -.023 -.227 .821
Lack of concern .117 1.164 .247
Other-blame .011 .103 .918
Loss/Helplessness .117 .959 .340
Positive emotion -.003 -.026 .980
Maladaptive coping .182 1.548 .125
389
AEPEND1X 4.2: SUMMARY TABLE OF EXCLUDED VARIABLES FOR REGRESSION
QF SIX MONTH QUALITY OF LIFE FROM BASELINE PREDICTORS.
Variable Unstandardised ResidualsBeta In t Significance
Optimism -.018 -.179 .858
Hopeless/helplessness .145 1.430 .156
Anxious Preoccupation .012 .107 .915
Fighting Spirit .194 1.901 .060
Fatalism .046 .440 .661
Doctor Locus of Control .093 .909 .366
Motivational Congruence .102 1.002 .319
Self Responsibility -.038 -.365 .716
Other Responsibility -.068 -.664 .508
Future Expectancy .121 1.189 .238
EF Coping Potential -.135 -1.290 .200
Other-blame .035 .341 .734
Self-blame .031 .287 .775
Loss/Helplessness -.018 -.172 .864
Positive Emotion -.036 -.333 .740
Negative Emotion -.084 -.793 .430
Adaptive Coping .168 1.657 .101
Maladaptive Coping .130 1.256 .212
I
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APPENDIX 4.3: SUMMARY TABLE OF EXCLUDED VARIABLES FOR REGRESSION
OF SIX MONTH QUALITY OF LIFE FROM THREE MONTH PREDICTORS.
Variable Unstandardised ResidualsBeta In t Significance
Optimism -.111 -1.038 .302
Hopeless/helplessness -.042 -.384 .702
Anxious preoccupation -.054 -.428 .670
Motivational congruence .008 .081 .935
Self Responsibility -.100 -.980 .330
Future Expectancy -.023 -.209 .835
FF Coping Potential -.058 -.061 .549
EF Coping Potential .027 .247 .806
Removal of threat .106 1.039 .302
Other blame -.134 -1.366 .176
Self-blame -.048 -.483 .631
Loss/helplessness -.037 -.274 .784
Effortful optimism .094 .942 .349
Success .005 .052 .959
Positive emotion -.040 -.379 .706
Negative emotion -.124 -.979 .330
Maladaptive coping .148 1.253 .214
i
391
APPENDIX 4.4: SUMMARY TABLE OF EXCLUDED VARIABLES FOR REGRESSION
OF THREE MONTH DEPRESSION FROM BASELINE PREDICTORS.
Variable Unstandardised ResidualsBeta In t Significance
Optimism .017 .167 .868
Doctor Locus of Control -.132 -1.376 .172
Hopeless/helplessness .059 .523 .602
Anxious preoccupation -.046 -.433 .666
Other Responsibility -.021 -.196 .845
Future Expectancy -.027 -.237 .813
PF Coping Potential .067 .670 .504
Lack of concern -.057 -.596 .552
Self-blame-blame .080 .771 .443
Threat -.002 -.016 .987
Loss/Helplessness -.029 -.199 .843
Effortful optimism -.130 -1.358 .177
Positive emotion .013 .131 .868
Negative emotion .105 .941 .349
Maladaptive coping -.046 -.441 .660
i
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APPENDIX 4.5: SUMMARY TABLE OF EXCLUDED VARIABLES FOR REGRESSION
OF SIX MONTH DEPRESSION FROM BASELINE PREDICTORS.
Variable Unstandardised ResidualsBeta In t Significance
Optimism .106 .945 .347
Hopeless/helplessness -.082 -.647 .519
Anxious preoccupation -.147 - 1.000 .320
Motivational Relevance .123 1.214 .228
Motivational Incongruence .069 .696 .488
Motivational Congruence -.067 -.662 .509
Self Responsibility -.024 -.231 .818
Other Responsibility .020 .186 .853
EF Coping Potential .167 1.359 .178
Self- consiousness .106 .072 .943
Other-blame .008 -.965 .337
Threat -.149 .091 .928
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APPENDIX 4.6: SUMMARY TABLE OF EXCLUDED VARIABI.F.S FOR REGRESSION
QF SIX MONTH DEPRESSION FORM THREE MONTH PREDICTORS.
Variable Unstandardised ResidualsBeta In t Significance
Optimism .057 .556 .580
Hopeless/helplessness -.106 -1.037 .302
Anxious preoccupation .021 .206 .837
Cognitive avoidance .047 .466 .643
Motivational Relevance .112 1.114 .268
Other Responsibility -.174 -1.741 .085
Future Expectancy .084 .794 .429
EF Coping Potential .131 1.299 .197
Lack of concern .088 .871 .386
Self-blame -.048 -.428 .670
Threat -.103 -.982 .329
Loss/Helplessness -.191 -1.685 .095
Success -.064 -.638 .525
Negative emotion -.113 -1.055 .294
Adaptive coping .045 .449 .654
Maladaptive coping -.098 -.955 .342
APPENDIX 4.7: SUMMARY TABLE OF EXCLUDED VARIABLES FOR REGRESSION
OF THREE MONTH ANXIETY FROM BASELINE PREDICTORS.
Variable Unstandardised ResidualsBeta In t Significance
Optimism .009 086 .932
Hopeless/helplessness .038 .333 .740
Anxious preoccupation -.018 -.169 .866
Motivational incongruence .028 .283 .778
Motivational congruence -.080 -.823 .413
Self Responsibility .121 1.236 .219
Other Responsibility .076 .694 .489
Future Expectancy -.248 .111 -.257
EF Coping Potential .302 .133 .264
Other-blame -.397 .159 -.304
Threat -.222 .116 -.265
Loss/Helplessness -.087 -.583 .561
Positive emotion .005 .049 .961
Negative emotion .075 .023 .436
Maladaptive coping .006 .062 .951
395
rAEPEND1X 4.8: SUMMARY TABLE OF EXCLUDED VARIABLES FOR REGRESSION
OF SIX MONTH ANXIETY FROM BASRLINE PREDICTORS.
Variable Unstandardised ResidualsBeta In t Significance
Hopeless/helplessness .108 .956 .341
Anxious preoccupation .228 1.791 .077
Fighting spirit -.192 -1.882 .063
Motivational congruence .125 1.229 .222
Motivational incongruence -.052 -.507 .613
Self Responsibility .035 .345 .731
Other Responsibility .180 1.782 .078
Future Expectancy -.154 -1.373 .173
EF Coping Potential .190 1.845 .068
Other-blame .086 .810 .420
Threat .231 1.900 .061
Loss/Helplessness .134 1.135 .259
Negative emotion .381 3.296 .001
Adaptive coping -.133 -1.315 .192
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rAPPENDIX 4.9: SUMMARY TABLE OF EXCLUDED VARIABLES FOR REGRESSION
OF SIX MONTH ANXIETY FROM THREE MONTH PREDICTORS.
Variable Unstandardised ResidualsBeta In t Significance
Optimism .156 1.423 .158
Hopeless/helplessness -.085 -.691 .491
Anxious preoccupation .042 1.081 .282
Fighting Spirit .083 .817 .416
Other Responsibility .008 .080 .936
Future Expectancy .094 .897 .372
EF Coping Potential .182 1.584 .117
Other-blame .094 .926 .357
Threat -.235 -1.957 .053
Loss/helplessness -.099 -.912 .364
Effortful optimism -.076 -.741 .461
Success -.020 -.188 .851
Positive emotion .066 .647 .519
Negative emotion -.109 -.817 .416
Maladaptive coping -.125 -1.133 .260
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APPENDIX 4.10; SUMMARY TABLE OF EXCLUDED VARIABLES FROM THEORY
DRIVEN TESTS OF ANGER.
Variable Unstandardised ResidualsBeta In t Significance
M otivational Congruence .042 .527 .599
Self Responsibility -.015 -.192 .848
Future Expectancy .084 .949 .344
PF Coping Potential .088 1.035 .302
Self-consciousness -.029 -.345 .731
Unexpectedness .144 1.812 .072
Relevance .073 .909 .365
Threat rem oval -.084 -.953 .342
Irrelevance -.044 -.531 .597
Self-blame .116 1.462 .146
Threat .088 .932 .353
Loss/helplessness .087 1.012 .313
Success .044 .522 .602
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AEPENDIX 4.11: SUMMARY TABLE OF EXCLUDED VARIABLES FROM DATA
DRIVEN TESTS OF ANGER.
Variable Unstandardised ResidualsBeta In t Significance
M otivational Relevance .018 .234 .815
M otivational Incongruence .132 1.829 .070
M otivational Congruence -.039 -.531 .596
Self Responsibility -.029 -.381 .7104
Other Responsibility .134 1.744 .084
Future Expectancy .089 1.103 .272
PF Coping Potential .117 1.535 .127
Self-consciousness -.046 -.567 .571
Relevance .112 1.445 .151
Irrelevance -.064 -.834 .406
Threat removal -.038 -.457 .649
Other-blam e .126 1.416 .159
Loss/helplessness .071 .696 .487
Effortful optimism .112 1.506 .134
Success .057 .721 .472
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APPENDIX 4.12; SUMMARY TABLE OF EXCLUDED VARIABLES FROM THEORY
DRIVEN TESTS OF GUILT.
Variable Unstandardised ResidualsBeta In t Significance
Motivational Congruence -.067 -.799 .425
Self Responsibility -.075 -.894 .373
Other Responsibility -.052 -.616 .539
Future Expectancy .078 .867 .387
PF Coping Potential .027 .309 .758
EF Coping Potential -.111 -1.294 .198
Self-consciousness -.080 -.945 .346
Relevance .037 .430 .668
Irrelevance .031 .359 .720
Lack of concern -.070 -.791 .431
Threat removal .071 .629 .530
Other-blame -.124 -1.481 .141
Threat .078 .892 .374
Loss/helplessness .017 .199 .842
Effortful optimism -.017 -.202 .840
Success .063 1.737 .085
400
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APPENDIX 4,13; SUMMARY TABLE OF EXCLUDED VARIABLES FROM DATA
DRIVEN TESTS OF GUILT.
V a ria b le U nstandard ised  Residuals
Beta In t Significance
M otivational Relevance .045 .557 .578
M otivational Congruence -.063 -.740 .460
Other Responsibility -.031 -.390 .697
Future Expectancy .105 1.327 .187
PF Coping Potential 059 .761 .448
EF Coping Potential -.074 -.947 .345
Self-consciousness -.072 -.862 .39
Relevance .008 .101 .920
Unexpectedness .146 1.884 .062
Irrelevance .032 .406 .685
Lack of concern -.024 -.309 .758
Threat removal .130 1.679 .095
Other-blam e -.120 -1.481 .141
Threat .047 .603 .547
Loss/helplessness .016 .199 .843
Effortful optimism .002 .024 .981
Success .137 1.768 .079
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APPENDIX 4.14: SUMMARY TABLE OF EXCLUDED VARIABLES FROM THEORY
DRIVEN TESTS OF FEAR/ANXIETY.
Variable Unstandardised ResidualsBeta In t Significance
Motivational Congruence .098 1.181 .240
Self Responsibility -.013 -.152 .879
Other Responsibility -.084 -.985 .327
Future Expectancy .005 .054 .957
PF Coping Potential .137 1.655 .100
Self-consciousness -.005 -.058 .954
Relevance .078 .929 .355
Irrelevance -.067 -.792 .430
Lack of concern -.087 -1.026 .306
Other-blame -.046 -.524 .601
Loss/helplessness -.001 -.015 .988
Effortful optimism -.084 -.984 .327
Success -.003 -.034 .973
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APPENDIX 4.15: SUMMARY TABLE OF EXCLUDED VARIABLES FROM DATA
DRIVEN TESTS OF FEAR/ANXIETY.
Variable Unstandardised ResidualsBeta In t Significance
Motivational Incongruence .118 1.733 .085
Motivational Congruence .030 .459 .647
Self Responsibility -.028 -.404 .687
Other Responsibility -.066 -.936 .351
Future Expectancy -.014 -.188 .852
PF Coping Potential .078 1.088 .278
Self-consciousness .035 .479 .633
Relevance .066 .958 .340
Irrelevance -.054 -.791 .431
Lack of concern -.073 -1.058 .292
Threat removal -.073 -1.076 .284
Other-blame -.019 -.242 .809
Loss/helplessness .051 .543 .588
Effortful optimism -.079 -1.173 .243
Success -.029 -.423 .673
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APPENDIX 4,16; SUMMARY TABLE OF EXCLUDED VARIABLES FROM THEORY
DRIVEN TESTS OF SADNESS.
Unstandardised ResidualsVariable Beta In t Significance
Motivational Congruence -.111 -1.290 .199
Self Responsibility .022 .263 .793
Other Responsibility .014 .164 .870
EF Coping Potential -.120 -1.422 .157
Self-consciousness .000 -.011 .991
Relevance .171 1.972 .051
Unexpectedness .122 1.452 .149
Irrelevance .024 .281 .779
Lack of concern -.055 -.643 .521
Threat removal .110 1.314 .191
Other-blame .011 .132 .898
Self-blame .046 .542 .589
Loss/helplessness .128 1.469 .144
Effortful optimism -.012 -.146 .884
Success -.022 -.251 .802
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rAPPENDIX 4.17: SUMMARY TABLE OF EXCLUDED VARIABLES FROM DATA
DRIVEN TESTS OF SADNESS.
Variable Unstandardised ResidualsBeta In t Significance
Motivational Relevance -.022 -.294 .769
Motivational Congruence -.104 -1.364 .175
Self Responsibility .048 .680 .497
Other Responsibility .055 .747 .456
Future Expectancy .071 .905 .367
PF Coping Potential .117 1.621 .107
EF Coping Potential -.116 -1.384 .169
Self-consciousness .006 .083 .934
Relevance .102 1.438 .153
Unexpectedness .112 1.622 .107
Irrelevance .014 .199 .843
Lack of concern .000 -.010 .992
Threat removal .095 1.331 .185
Other-blame .103 1.119 .265
Self-blame .081 1.113 .268
Threat -.037 -.534 .594
Success -.048 -.666 .507
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APPENDIX 4.18: SUMMARY TABLE OF EXCLUDED VAR1ABI.ES FROM THEORY
DRIVEN TESTS OF HOPE/CHALLENGE.
Variable Unstandardised ResidualsBeta In t Significance
Motivational Incongruence .095 1.149 .253
Self Responsibility .065 .788 .432
Other Responsibility -.073 -.892 .390
Future Expectancy .057 .629 .530
Self-consciousness .001 .010 .992
Unexpectedness .067 .923 .358
Lack of concern .038 .450 .653
Threat removal .010 .123 .902
Other-blame -.073 -.824 .412
Irrelevance -.095 -1.148 .253
Self-blame -.047 -.559 .577
Threat -.018 -.171 .864
Effortful optimism -.164 -1.805 .073
Success .081 .938 .350
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APPENDIX 4.19:. SUMMARY TABLE OF EXCLUDED VARIABLES FROM DATA
DRIVEN TESTS OF HOPE/CHALLENGE.
Variable Unstandardised ResidualsBeta In t Significance
Motivational Relevance .059 .737 .462
Motivational Incongruence .033 .415 .679
Motivational Congruence .131 1.663 .099
Self Responsibility .091 1.174 .243
Other Responsibility -.040 - A l l .634
Future Expectancy .096 .999 .320
Self-consciousness .082 .955 .342
Unexpectedness .113 1.456 .148
Irrelevance -.043 -.546 .586
Lack of concern .046 .586 .559
Threat removal .030 .369 .713
Other-blame .025 .235 .815
Self-blame .047 .557 .578
Threat .105 .934 .352
Effortful optimism .135 1.678 .096
Success .127 1.559 .121
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APPENDIX 4.20: SUMMARY TABLE OF EXCLUDED VARIABLES FROM THEORY
DRIVEN TESTS OF HAPPINESS.
Variable Unstandardised ResidualsBeta In t Significance
M otivational Incongruence -.068 -.812 .418
Self Responsibility .014 .161 .872
Other Responsibility -.082 -.970 .334
Future Expectancy -.019 -.217 .829
PF Coping Potential -.048 -.555 .580
EF Coping Potential .049 .581 .562
Self-consciousness .042 .500 .618
Unexpectedness .064 .753 .453
Irrelevance .088 1.041 .299
Lack of concern .142 1.689 .094
Threat rem oval .039 .459 .647
Other-blam e .047 .550 .583
Self-blame -.144 -1.714 .089
Threat -.042 -.500 .618
Loss/Helplessness -.007 -.086 .932
Relevance .140 1.666 .098
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fAPPENDIX 4.21: SUMMARY TABLE OF EXCLUDED VARIABLES FROM DATA
DRIVEN TESTS OF HAPPINESS.
Variable Unstandardised ResidualsBeta In t Significance
Motivational Relevance -.033 -.431 .667
Motivational Congruence -.104 -1.370 .173
Motivational Incongruence .088 1.142 .255
Self Responsibility .021 .272 .786
Other Responsibility -.083 -1.083 .281
Future Expectancy -.012 -.141 .888
PF Coping Potential -.031 -.390 .697
EF Coping Potential .063 .798 .426
Self-consciousness .033 .433 .666
Relevance .108 1.375 .172
Unexpectedness .053 .684 .495
Irrelevance .092 1.196 .234
Lack of concern .147 1.862 .065
Threat removal .103 1.021 .309
Other-blame .029 .381 .704
Self-blame -.130 -1.707 .090
Threat -.069 -.869 .387
Loss/Helplessness -.025 -.328 .744
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APPENDIX 4.22: SUMMARY TABLE OF EXCLUDED VARIABLES FROM THEORY
DRIVEN TESTS OF BOREDOM.
Variable Unstandardised ResidualsBeta In t Significance
Motivational Relevance .112 1.304 .194
Motivational Incongruence .064 .699 .486
Self Responsibility .021 .248 .805
Other Responsibility .068 .821 .413
Future Expectancy .066 .795 .428
PF Coping Potential .107 1.294 .198
EF Coping Potential -.067 -.808 .420
Self-consciousness -.030 -.359 .720
Unexpectedness .088 1.067 .288
Relevance -.002 -.021 .984
Lack of concern -.094 -1.136 .258
Threat removal .005 .055 .956
Other-blame .076 .916 .361
Self-blame .016 .190 .850
Threat .089 1.072 .286
Loss/Helplessness .119 1.452 .149
Effortful optimism .004 .051 .959
Success .014 .168 .867
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APPENDIX 4.23: SUMMARY TABLE OF EXCLUDED VARIABLES FROM DATA
DRIVEN TESTS OF BOREDOM.
Variable Unstandardised ResidualsBeta In t Significance
Motivational Relevance .112 1.300 .196
Motivational Incongruence .064 .700 .485
Self Responsibility .021 .249 .804
Other Responsibility .068 .820 .414
Future Expectancy .066 .795 .428
PF Coping Potential .107 1.294 .198
EF Coping Potential -.067 -.810 .420
Self-consciousness -.029 -.351 .726
Unexpectedness -.002 -.018 .986
Relevance .088 1.068 .287
Lack of concern -.093 .130 .897
Threat removal .005 -1.129 .261
Other-blame .076 .063 .950
Self-blame .016 .919 .360
Threat .089 .194 .846
Loss/Helplessness .120 1.073 .285
Effortful optimism .005 1.455 .148
Success .014 .055 .956
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APPENDIX 4.24: SUMMARY TABLE OF EXCLUDED VARIABLES FROM THEORY
DRIVEN TESTS OF SURPRISE.
Variable Unstandardised ResidualsBeta In t Significance
Motivational Incongruence .061 .716 .475
Motivational Congruence .085 1.044 .298
Self Responsibility .122 1.491 .138
Other Responsibility .116 1.424 .157
Future Expectancy .026 .310 .757
PF Coping Potential .036 .440 .660
EF Coping Potential .031 .365 .715
Relevance -.032 -.397 .692
Irrelevance -.075 -.835 .405
Threat removal .037 .400 .690
Other-blame .044 .500 .618
Self-blame .016 .179 .858
Threat .022 .251 .802
Loss/Helplessness -.042 -.473 .637
Effortful optimism -.147 -1.819 .071
Success .006 .069 .945
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APPENDIX 4.25: SUMMARY TABLE OF EXCLUDED VARIABLES FROM DATA
DRIVEN TESTS OF SURPRISE.
Variable Unstandardised ResidualsBeta In t Significance
Motivational Incongruence .056 .744 .458
Motivational Congruence .072 .986 .326
Self Responsibility .106 1.453 .149
Other Responsibility .105 1.442 .152
Future Expectancy 020 .265 .792
PF Coping Potential .028 .377 .707
EF Coping Potential .019 .250 .803
Relevance -.037 -.510 .611
Irrelevance -.065 -.806 .422
Threat removal .029 .359 .720
Other-blame .048 .612 .542
Self-blame .004 .050 .960
Threat .024 .307 .760
Loss/Helplessness -.026 -.325 .746
Effortful optimism -.125 -1.718 .088
Success .009 .115 .908
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APPENDIX 4.26: SUMMARY TABLE OF EXCLUDED VARIABLES FROM THEORY
DRIVEN TESTS OF RESIGNATION.
Variable Unstandardised ResidualsBeta In t Significance
Motivational Relevance .000 -.011 .991
Motivational Incongruence -.031 -.383 .702
Motivational Congruence .068 .836 .405
Self Responsibility -.038 -.457 .648
Future Expectancy .114 1.237 .218
PF Coping Potential .015 .182 .856
EF Coping Potential .068 .818 .415
Self-consciousness -.137 -1.697 .092
Relevance -.020 -.245 .807
Unexpectedness -.007 -.089 .929
Irrelevance -.159 -1.880 .062
Lack of concern -.095 -1.036 .302
Other-blame -.100 -1.037 .302
Self-blame -.088 -1.050 .295
Threat -.010 -.115 .908
Effortful optimism 008 .103 .918
Success -.012 -.114 .910
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APPENDIX 4.27; SUMMARY TABLE OF EXCLUDED VARIABLES FROM DATA
DRIVEN TESTS OF RESIGNATION.
Variable Unstandardised ResidualsBeta In t Significance
M otivational Relevance .004 .052 .959
M otivational Incongruence -.029 -.396 .693
M otivational Congruence .058 .791 .430
Self Responsibility -.031 - A l l .670
Future Expectancy .100 1.18 .253
PF Coping Potential .003 .040 .968
EF Coping Potential .057 .686 .494
Self-consciousness -.132 -1.660 .099
Relevance -.018 -.245 .807
Unexpectedness -.002 -.021 .983
Irrelevance -.139 -1.822 .071
Lack o f concern -.082 -1.007 .316
Other-blam e -.099 -.948 .345
Self-blame -.074 -.960 .339
Threat .019 .196 .845
Effortful optim ism .006 .079 .937
Success -.011 -.114 .909
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APPENDIX 4.28: SUMMARY TABLE OF EXCLUDED VARIABLES FROM THEORY
DRIVEN TESTS OF TRANQUILITY.
Variable Unstandardised ResidualsBeta In t Significance
Motivational Relevance -.113 -1.438 .153
Motivational Incongruence -.069 -.865 .389
Motivational Congruence -.009 -.113 .911
Self Responsibility .085 1.074 .285
Other Responsibility -.038 -.483 .630
Future Expectancy -.082 -.930 .354
PF Coping Potential -.139 -1.670 .097
EF Coping Potential -.013 -.156 .876
Self-consciousness .080 1.018 .310
Relevance -.151 -1.935 .055
Unexpectedness .060 .765 .445
Irrelevance .034 .429 .669
Threat removal -.031 -.367 .714
Other-blame -.052 -.657 .513
Self-blame .017 .174 .862
Threat .005 .060 .952
Effortful optimism -.016 -.197 .844
Success -.035 -.423 .673
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pAPPENDIX 4.29: SUMMARY TABI.E OF EXCLUDED VARIABLES FROM DATA
DRIVEN TESTS OF TRANQUILITY.
Variable Unstandardised ResidualsBeta In t Significance
Motivational Relevance -.114 -1.493 .138
Motivational Incongruence -.065 -.841 .402
Motivational Congruence -.013 -.169 .866
Self Responsibility .081 1.067 .288
Other Responsibility -.033 -.429 .668
Future Expectancy -.076 -.900 .370
PF Coping Potential -.135 -1.676 .096
EF Coping Potential -.005 -.062 .951
Self-consciousness .085 1.109 .269
Relevance -.141 -1.839 .068
Unexpectedness .060 1.007 .316
Irrelevance .070 .818 .415
Threat removal -.022 -.268 .789
Other-blame -.043 -.556 .579
Self-blame .005 .059 .953
Threat .007 .081 .936
Effortful optimism -.009 -.118 .906
Success -.020 -.236 .813
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APPENDIX 4.30: SUMMARY TABLE OF EXCLUDED VARIABLES FROM THEORY
DRIVEN TESTS OF INTEREST.
Variable Unstandardised ResidualsBeta In t Significance
Motivational Relevance -.067 -.895 .372
Motivational Congruence .054 .672 .503
Other Responsibility .035 .462 .645
PF Coping Potential .069 .799 .426
Self-consciousness -.023 -.286 .775
Unexpectedness .036 .489 .626
Irrelevance .081 1.103 .272
Lack of concern .038 .521 .603
Threat removal -.053 -.680 .498
Other-blame .137 1.606 .111
Threat .137 1.561 .121
Loss/helplessness -.014 -.160 .873
Success -.096 -1.228 .222
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IAPPENDIX 4.31: SUMMARY TABLE OF EXCLUDED VARIABLES FROM DATA
DRIVEN TESTS OF INTEREST.
Variable Unstandardised ResidualsBeta In t Significance
Motivational Relevance -.070 -.937 .351
Motivational Congruence .059 .741 .460
Other Responsibility .031 .407 .685
PF Coping Potential .070 .822 .412
Self-consciousness -.022 -.283 .778
Unexpectedness .039 .530 .597
Irrelevance .078 1.082 .281
Lack of concern .036 .491 .625
Threat removal -.054 -.691 .491
Other-blame .134 1.576 .117
Threat .137 1.519 .131
Loss/helplessness -.016 -.183 .855
Success -.093 -1.178 .241
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fAPPENDIX 4.32: SUMMARY TABLE OF EXCLUDED VARIABLES FROM THEORY
DRIVEN TESTS OF RELIEF.
Unstandardised ResidualsVariable Beta In t Significance
Motivational Relevance .041 -.499 .618
Motivational Incongruence .025 .280 .780
Other Responsibility .049 .571 .569
Future Expectancy -.041 -.454 .651
PF Coping Potential -.014 -.165 .869
EF Coping Potential .026 .297 .767
Self-consciousness .108 1.234 .219
Relevance .072 .886 .377
Unexpectedness -.088 -1.097 .274
Irrelevance -.118 -1.489 .139
Lack of concern .021 .269 .789
Other-blame .065 .609 .544
Self-blame -.042 -.486 .628
Threat .106 1.026 .307
Effortful optimism .067 .827 .410
Success .142 1.782 .077
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rAPPENDIX 4.33: SUMMARY TABLE OF EXCLUDED VARIABLES FROM DATA
DRIVEN TESTS OF RRI.1EF.
Variable Unstandardised ResidualsBeta In t Significance
Motivational Relevance -.028 -.456 .649
Motivational Incongruence .042 .625 .533
Other Responsibility .066 1.021 .309
Future Expectancy -.047 -.631 .529
PF Coping Potential -.009 -.143 .886
EF Coping Potential -.017 -.245 .807
Self-consciousness .087 1.309 .193
Relevance .116 1.863 .065
Unexpectedness -.087 -1.442 .152
Irrelevance -.061 -.968 .335
Lack of concern .050 .748 .456
Other-blame .060 .752 .453
Self-blame -.038 -.593 .554
Threat .116 1.451 .149
Effortful optimism .015 .250 .803
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rARPENDIX 4.34: SUMMARY TABLE OF EXCLUDED VARIABLES FROM THEORY
DRIVEN TESTS OF SHAME/HUMILIATION.
Variable Unstandardised ResidualsBeta In t Significance
Motivational Relevance .046 .543 .588
Motivational Congruence -.074 -.876 .383
Motivational Incongruence .105 1.257 .211
Self Responsibility .156 1.854 .066
Other Responsibility .116 1.177 .241
Future Expectancy .090 .933 .352
PF Coping Potential .053 .618 .537
EF Coping Potential .005 .053 .958
Relevance .069 .817 .416
Unexpectedness .081 .955 .341
Irrelevance -.087 -1.031 .304
Lack of concern .064 .755 .452
.Threat removal .114 1.366 .174
Self-blame .145 1.666 .098
Threat -.031 -.323 .747
Loss/helplessness .004 .036 .971
Effortful optimism -.053 -.631 .529
Success .144 1.724 .087
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rAPPENDIX 4.35: SUMMARY TABLE OF EXCLUDED VARIABLES FROM DATA
DRIVEN TESTS OF SHAME/HUMILIATION.
Variable Unstandardised ResidualsBeta In t Significance
Motivational Relevance .029 .355 .723
Motivational Congruence -.060 -.739 .461
Motivational Incongruence .084 1.037 .302
Self Responsibility .144 1.729 .086
Other Responsibility .037 .389 .698
Future Expectancy .086 .921 .359
PF Coping Potential .025 .305 .761
EF Coping Potential -.039 -.458 .648
Self-consciousness .073 .802 .424
Relevance .054 .653 .515
Unexpectedness .097 1.165 .246
Irrelevance -.053 -.639 .524
Lack of concern .052 .634 .527
Threat removal .113 1.384 .169
Threat -.023 -.245 .807
Loss/helplessness .016 .142 .887
Effortful optimism -.053 -.634 .527
Success .139 1.706 .090
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rAPPENDIX 4.36: SUMMARY TABLE OF EXCLUDED VARIABLES FROM DATA
DRIVEN TESTS OF SELF-DIRECTED ANGER.
Variable Unstandardised ResidualsBeta In t Significance
Motivational Relevance .035 .496 .621
Motivational Congruence -.053 -.750 .454
Motivational Incongruence .010 .141 .888
Other Responsibility .081 1.078 .283
Future Expectancy .021 .258 .797
PF Coping Potential .126 1.715 .089
EF Coping Potential .094 1.196 .234
Self-consciousness -.113 -1.439 .153
Relevance .039 .543 .588
Irrelevance -.111 -1.573 .118
Lack of concern -.097 -1.359 .177
Other-blame .018 .252 .801
Threat removal -.084 -.896 .372
Threat -.011 -.116 .908
Effortful optimism -.090 -1.250 .214
Success -.017 -.243 .808
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APPENDIX 4.37: SUMMARY TABLE OF EXCLUDED VARIABLES FROM DATA
DRIVEN TESTS OF FRUSTRATION.
Variable Unstandardised ResidualsBeta In t Significance
Motivational Relevance .102 1.226 .222
Motivational Incongruence -.009 -.113 .910
Motivational Congruence .072 .889 .376
Self Responsibility -.054 -.651 .516
Other Responsibility .132 1.560 .121
Future Expectancy -.105 -1.204 .231
PF Coping Potential .148 1.802 .074
EF Coping Potential .122 1.258 .211
Self-consciousness -.097 -1.124 .263
Relevance .015 .177 .859
Unexpectedness .111 1.370 .173
Irrelevance -.045 -.551 .583
Lack of concern -.007 -.081 .936
Threat removal -.016 -.192 .848
Other-blame .114 1.197 .233
Loss/Helplessness .079 .715 .476
Effortful optimism -.080 -.989 .325
Success .000 -.011 .992
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APPENDIX 4.38: SUMMARY TABLE OF EXCLUDED VARIABLES FROM DATA
DRIVEN TESTS OF REGRET.
Variable Unstandardised ResidualsBeta In t Significance
Motivational Relevance .066 .838 .404
Motivational Incongruence -.131 -1.738 .085
Motivational Congruence .107 1.413 .160
Self responsibility .093 1.221 .224
Other Responsibility .072 .894 .373
Future Expectancy -.110 -1.277 .204
PF Coping Potential .076 .957 .340
EF Coping Potential .176 1.929 .056
Self-consciousness -.116 -1.408 .161
Relevance .028 .359 .720
Unexpectedness .058 .758 .449
Irrelevance -.078 -1.023 .308
Lack of concern -.025 -.323 .748
Threat removal -.021 -.268 .789
Other-blame .113 1.120 .265
Self-blame .100 1.253 .212
Effortful optimism .000 -.001 .999
Success .079 1.004 .317
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APPENDIX 4.39: TRANSCRIPTS OF ALL COMMENTS RELEVANT TO THEME 5 OF
THE QUALITATIVE ANALYSIS
Superordinate Theme 5: Participation Issues
5.1 Presentation of questionnaire
5.2 Relevance given timing
5.3 Relevance of study in general/specific items
5.4 Benefit and harms from participation 
SUPERORPINATE THEME 5: PARTICIPATION ISSUES
EMERGENT THEME 5.1: PRESENTATION OF THE QUESTIONNAIRE 
TIME 1
005: Quite a complex questionnaire. Have done my best.
018: 1 feel that the combination of prostate cancer with my age (90 in Oct 2006) is 
considerably less devastating than many other cancer diagnoses may be. For this 
reason I think it unlikely that my experience would be particularly relevant to the 
experience of others.
030: Cannot understand this page.
062: The last 4 weeks have been post-operative so energy levels have obviously been 
lower than normal. Ordinarily answers would have been very different.
106: Some questions have no neutral response option where I needed one...
112: “ I am sorry I can’t answer the questions I will put them my way.”
113: Most of my problems to date have been because of complications with my 
ileostomy and kidney failure, not my bowel cancer. Your questionnaire seems 
specific to the cancer.
132: If I was to fill this form in about another couple of hours the answers would 
probably be different as my mood is up and down all of the time.
152: I have filled in your questionnaire and I have to say it is a bit too long
158: Some of the questions are duplicated and are similar apart from the actual 
wording.
TIME 2
001: Respectfully not that I find some of your questions to be rather nebulous and 
not easy to respond to specifically.
027: It is far too long and too repetitive and requires an “act of will” to answer it at 
all.
427
030: “Difficult to understand. Do not know if I have filled in right”
052: I found the questions I have not relied to difficult to decide an answer.
083: I’m sorry I can’t finish this because I can’t see where you are going with some of 
the questions.
088: I have tried to answer these questions as honestly as possible but did find some 
of them very difficult to answer.
093: I also found difficulty answering with regard to restricted activities. I was told 
not to do any lifting for three months. I have carefully avoided this, since I normally 
do a Ito of garden maintenance involving muscular exertion. I continue to restrict 
this activity, but otherwise I am quite active leading services of Christian worship 
regularly, which involves careful preparation and some amount of exertion.
101: As I had a non-aggressive malignant tumour some of the question have been 
irrelevant the conclusion which I experienced therefore I have tried to answer the 
questions adequately, sometimes with difficulty.
106: Having told my GP about this project, I feel tons better about participating, as 
he explained it’s relevance in the light of recent thought relating to a positive 
attitude (so I’m much less grumpy this time)... Having got my head around things now, 
I found completion of the questionnaire considerably easier
108: When completing this questionnaire I had difficulty answering the questions 
relating to “blame”. As I understand my condition it is age related and as a 
consequence it would have happened anyway.
122: Some of the questions are ambiguous. My health is not affecting my normal 
activities, but having to attend hospital daily for radiotherapy obviously does.
152: I think to ask someone how they felt when told they had cancer what would you 
think you feel you don’t go out and a party so that is a soft question to ask any one.
TIME 3
011: The questionnaire is difficult to complete because one can feel different as the 
days go by
018: I feel that my age (90 on 12/10/06) may be of necessisty affect my answers - 
particularly with respect to energy and pain which may be more justifiably described 
to old age than to cancer diagnosis. I have tried to ignore the old-age effects, but 
have probably not always been sucessful.
093: I must apologise for misinterpreting the nature and purpose of the 
questionnaire. Seeing a reference to Wrecsam in the address, I believed it to be a 
continuation of a similar study to which I have responded (although participation was 
interrupted some moths ago when I failed to keep an appointment). That study is in 
connection with my condiiton of Epilepsy and the possibility of cancer causing effects 
of medications.The last part of this questionnaire makes it clear that its reference is 
the agreement I made to participate on the occasion of diagnosis and treatment for
cancer, which came about a t ...................................................  I am willing to fill in a
repeat questionnaire if required.
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084: I suppose I felt this questionnaire a little intrusive as I do try not to dwell on all 
that has happened and I really find it difficult to know how these answers really help 
in the ongoing fight against cancer. My partner was an extremely positive person, a 
high flyer and a great achiever in all aspects of life and he died - aged 58 from 
pancreatic cancer. So I am fatalistic about these things. What will be will be. 
However, leading a balanced healthy life definitely helps us all to keep well and 
happy
106: Initially, receiving the questinnaire felt like the last straw, but after talking to 
my GP about it, I could see the relevance and didn’t mind so much.
124: Some of the questions were hard to answer.
EMERGENT THEME 5.2: RELEVANCE OF THE STUDY 
TIME 1
0 1 2 : I have been unable to answer some of the questionnaire, because I think I need 
to have started treatment before I can do so.
025:1 have answered the questions to the best of my ability but please note I have 
not as yet started radiotherapy
052:1 find it difficult to answer these questions as they rather refer to after my 
operation
045: I haven’t yet had the results from the operation—as to whether there has been 
any spread to the lymph nodes. That, inevitably will make me feel differently (but I 
guess, that is something you want to find outl).
081: I have only known for about 8 weeks that I have cancer so there are some 
questions that I have not answered as I feel they are irrelevant.
101: As I am in the very fortunate position to have been diagnosed very early through 
routine mamogramme, I feel some of these questions don’t really relate to me.
106: Spirituality and sexuality are deeply personal issues, and I am not prepared to 
offer an opinion on these options, so have skipped a few. Also felt rather annoyed at 
being confronted with this at such a deeply emotional time... I also have a few doubts 
about the relevance of the study, as everyone is an individual and should be treated 
as such.
122: As I have only recently been diagnosed and only commenced treatment it is 
likely that some of my answers could change as treatment progresses.
141: I found some of the questions a little difficult to answer because having had a 
mastectomy and having very good results I feel able to continue with my life as 
before
135: As I have not experienced any pain since my diagnosis, indeed, feel just as 
healthy as I have been for some time, I found it difficult to answer some of the 
question - they seemed to be aimed at those who were/are already undergoing 
treatment. No doubt I will feel ‘more involved’ after my operation when I answer 
the second questionnaire.
TIME 2
429
TIME 3
EMERGENT THEME 5.3: RELIGIOUS ENQUIRY 
TIME 1
093: My personal faith is important to me and relevant at all times, particularly so in 
the present situation. I did not feel the questionnaire allowed expression of this 
importance. References to the place of God seemed to suggest hopeless resignation 
rather than expression of active faith.
075: I have found the issue of God difficult.
151:1 had difficulty answering questions about God’s part in the development of my 
cancer. The questions imply a draconian God who ‘deals out’ cancer on a random 
basis. I do not believe that God decides that I get a disease any more than that 
ford’s decides that my mondeo gets a damaged suspension 6 years from the factory I I 
do, however, believe in a God who cares and supports me, through my curch friends 
and the medical teams who have been looking after me, in the same way that a 
parent will look after their child when it becomes ill.
152: all the questions about God I think you should leave them out not all people 
believe and you ask the same question a few times and some of the questions about 
how you feel about when you found out that you had cancer I don’t think that a lot of 
people would feel responsible for getting cancer.
TIME 2
001: Questions related to god. Your question gives me a feeling of being critical or 
negative towards God.
027: The questionnaire has many facets in common with the Church of Jesus Christ 
Scientists (Scientology). It has nothing in common with a serious medical scientific 
study.
093: The place of faith and its essential contribution to life is of great importance to 
me (and I believe to be relevant to everyone). I consequently found questions 
referring to God’s place in my present situation to be a little confusing. Since all 
that happens is within His will, I believe this event to be in that will, but I’m no way 
***\ I think the study might gain from asking the relevance of a person’s faith in 
usual circumstances and whether it has helped in the present circumstances. 
Consequently I found references to fat, luck, and fortune to be irrelevant.
152: There is too much question on god.
TIME 3
072: A few questions I have crossed out (blaming God is stupid). As I’ve said on 
another page, we don’t ask to be ill, it just happens.
EMERGENT THEME 5.4: BENEFIT f t  HARMS FROM PARTICIPATION 
TIME 1
028: I feel better now that I have written it all down.
057: It has helped to fill in this questionnaire (a bit) but it would be good to talk to 
people, including doctors, and be given help in adopting a positive attitude.
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103: Taking part in this research has given me the opportunity to make the comment 
that through a great deal of internal analyzing of all the facets of life, has enable me 
to come to a balanced conclusion. Obviously there are still questions, but a positive 
attitude and a belief that anything can be achieved through believing it can - will be.
I do hope this will help others.
117: Answering this questionnaire has made me realise that my cancer, although 
small, was real.
TIME 2
027: I do not approve of this study, it has necessitated dwelling on my medical 
condition in a way that is not constructive.
028: Filling in this has reduced me to tears, don’t understand why
103: Thankyou for listening.
TIME 3
028: Answering this questionnaire has made me confront my condition. I have not 
accepted that I’ve had cancer, I push all thoughts away and pretend nothing has 
happened... I have filled the questionnaire in, I have had to face reality and my 
emotions and end up in tears...l do not think I am handling my condition in the way 
that I should.
103: Many thanks for allowing me the opportunity to take part in this research 
project. I do hope that it will benefit others.
106: I have found it a little difficult to fill these in, as it focuses the mind so strongly 
on things that are difficult to cope with, when I would rather ‘go with the flow’.
431
APPENDIX 6.1; END OF PROTECT REPORT
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Background
Cancer is one of the leading causes of death in the UK accounting for 26% of 
all deaths (Department of Health, 2007). There were 152,491 cancer-related 
deaths in the UK in 2005, of which, 47% resulted from a diagnosis of lung, 
colorectal, breast or prostate cancer (Cancer Research UK, 2008). These remain 
the most common cancer diagnoses made. The Cancer Reform Strategy (2007) 
highlights the need for improved integration of psychological services into routine 
cancer care. Previous research into psychosocial aspects of adjustment is, 
however, inconsistent.
Distress levels following diagnoses are reported in excess of 30% (Zabora, 
Brintzenhofezoc, Curbow, Hooker & Piantadosi, 2001; Mitchell, Kaar, Coggan & 
Herdman, 2008); in some cases being as high as 75% (Galway, Black, Cantwell, 
Cardwell, Mills & Connelly, 2008). Maguire (2000) reports that, furthermore, 
around one third of all patients will develop one or more psychological co­
morbidities at clinical level. Anxiety incidence rates at diagnosis range from 10% 
(Ratcliffe, Dawson & Walker, 1995) to 41% (Glinder & Compas, 1999) and 
depression from 2% (Ratcliff et al., 1995) to 34% (Epping-Jordan, Compas, 
Oxoweicki, Oppedisano, Gerardt, Primo et al., 1999).
Numerous psychological factors have been empirically investigated as 
possible predictors of these psychological outcomes. These include personality, 
cognitions, health control beliefs, emotions, and coping. Our earlier systematic 
review (Hulbert-Williams, Dudley, Neal, Morrison & Wilkinson, in prep) 
highlighted vast inconsistency of these findings both in clinical and statistical size 
and significance of these effects. Furthermore, the review highlighted a lack of 
good quality longitudinal studies exploring multiple of these potential predictors 
together.
Lazarus's Transactional Model of Stress (1984,1987,1993,1999) provides 
a sound theoretical basis in which to do so. The model states that on encountering 
a stressful situation, and individual will make a cognitive appraisal of the expected 
impact and their perceived coping ability to deal with it. In addition to the 
standard factors which influence these appraisals (personality, demographics, 
environment), clinical variables are also likely to be an influential factors following 
diagnosis. The theory proposes that these appraisals then influence emotional
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reaction which in turn shapes the coping response, consequently mediating the 
stress outcome (in this case anxiety, depression and quality of life). The model, 
whilst theoretically developed, lacks empirical support, particularly with regards 
the nature of relationships between specific appraisals and emotional reactions. 
The primary aim of this study was to apply the Transactional Model in an 
investigation of psychosocial adjustment to cancer. Longitudinal data was tested 
such that the predictive value of appraisals, emotions, and coping, on later levels 
of anxiety, depression and quality of life could be assessed. A secondary aim of the 
study was to empirically test the complex relationships between appraisals and 
emotions in the Transactional Model.
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Method
Design
A longitudinal cohort study was designed in which patients would complete 
self-report questionnaires at baseline (diagnosis) and three and six month follow 
up. Predictor variables included personality, appraisals, health control beliefs, 
emotions, and coping. Outcome variables were anxiety, depression and quality of 
life. Demographic and clinical data were also collected at baseline in order to 
control for their potentially confounding effects.
Measures
A number of previously validated and reliable psychological measures were 
used in this study:
• The Life-Orientation Test (Scheier, Carver & Bridges, 1994) for optimism
• The NE0-FF1 (Costa & McCrae, 1992) for trait personality
• The Appraisal Components, Core-Relational Theme, and Emotion Themes 
questionnaires (Smith & Lazarus, 1993) for Transactional Model 
components
• The Multidimensional Health Locus of Control (MHLC) Scale (Wallston, 
Wallston & DeVellis, 1978) for health control beliefs
• The BriefCOPE (Carver, 1997) for coping
• The Mini Mental Adjustment to Cancer (MAC) Scale (Watson, Greer & Bliss, 
1989) for cancer adjustment
• The SF-12 (Ware, Kosinski & Keller, 1996) for perceived helath status
• The FACT (Celia, Tulsky, Gray, Sarafian, Linn, Bonomi et al, 1993) for quality 
of life
• And The HADS (Zigmond & Snaith, 1983) for anxiety and depression.
Data was also collected on participants, age, gender, ethnicity, marital status and a 
number of other demographic variables. Clinical data collected from hospital 
records included: specific cancer cell type, tumour stage at diagnosis, treatment 
planned, type of referral, date of diagnosis, and waiting time to treatment
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Sample
160 patients were recruited into this study representing a low, but not 
unexpected, response rate of 34.6% from the 462 patients initially approached. A 
further 440 patients were diagnosed during this time who were assessed to be 
unsuitable for inclusion by their cancer nurse specialist The most common 
reasons for exclusion included: advanced illness at diagnosis; recurrent disease; 
other physical or mental co-morbidity; or too distressed.
Sixty-three male and 97 female participants were recruited into the study, 
84% of which were from the North East Wales NHS Trust. Their mean age was 64 
years and although a range of other demographics were found (marital status, 
employment status etc.), the sample was 100% Caucasian in ethnicity.
Four different cancer types were recruited: Colorectal (27.5%), breast (43.1%), 
lung (17.5%), and prostate (11.9%). All were contacted within six weeks of 
diagnosis but response delays meant that time between diagnosis and consent 
ranged from 1 to 116 days. Sixty percent of the sample had entered secondary 
care through an urgent referral pathway and consistent with the inclusion criteria, 
most were at an early stage of illness. A wide range of specific cell type and 
treatments were reported for the sample.
Procedure
Ethical and research governance approval was sought from all three North 
Wales NHS Trusts. On a fortnightly basis, NHW met with each nurse specialist to 
discuss new diagnoses from the previous multi-disciplinary team meeting. 
Inclusion criteria were assessed by the nurse specialist. Study information and 
invitation, consent sheet, and questionnaires were posted to all suitable patients 
with a freepost reply envelope. Reminders were sent one month later in the case 
of non-response.
For patients wishing to participate, questionnaires took approximately 45 
minutes to complete. These were self-report questionnaires. On completion, 
patients were instructed to return the questionnaire to NHW in the freepost 
envelope. On receipt, patients were allocated a unique participant identification 
number. Confirmation of receipt was sent to the participant, and a letter of 
information sent to their GP. Prior to follow-up (at three and six months), NHW
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contacted each participant's GP to ensure that the patient hadn't died or become 
too ill to participate. The same questionnaire pack was sent for completion at each 
follow-up stage. Once all three had been returned, the participant was sent a study 
debrief sheet.
Each patient was asked to give consent for the research team to consult 
their secondary care medical records. This was collated by NHW, local cancer 
services, and nurse specialists.
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Results
Non-responders and patient deaths
Thirty-eight patients failed to return questionnaires at all three timepoints. 
Analysis of differences between those retained in the study and the 28 drop-outs 
revealed few significant difference except a tendency towards more negative 
appraisal and emotional reactions at diagnosis. The ten patients who died during 
the study were found to have been lower on psychological subscales of quality of 
life (p<.05) and again to report more negative appraisals, emotions and 
maladaptive coping strategies at baseline. Anxiety and depression were also 
higher at baseline in those who died (t= 3.27, p<.01; t= 2.38, p=.02 respectively).
Prevalence of outcome
Whilst overall levels of quality of life did not significantly change through 
the study, social quality of life was found to significantly decrease (Z(106)=.47, 
p<.01) and emotional quality of life to significantly improve (Z(116)=-4.65, pc.Ol). 
Cancer specific subscales all demonstrated improvement over time except for the 
lung cancer patients' scores which improved slightly at three months, but then 
decreased back to original levels by six month follow-up (see fig. 1)
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QoL Subscale
Fig 1. Graphical display o f trends over time fo r  a ll QoL subscales.
As would be expected given the trend towards improvement for quality of 
life, anxiety and depression were both found to significantly decrease over time 
(Z=-3.49), p<.012; Z=-2.45, p=.01). Few patients scored above cut-off scores for
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clinical levels of anxiety (n=18,14, and 7 respectively for the three time points) 
and depression (n=4,10 and 4).
Prediction of clinically relevant outcomes
High co-variance was expected between the multiple predictor variables; 
they are, after all, variations of psychological responses to the same stressor. 
Pearson's and Spearman's Rho correlation analyses confirmed this.
Regression analyses were used to test the predictability of psychological 
variables for anxiety, depression and quality of life at later time-points. 
Preliminary time-lagged correlation analyses identified those variables which 
significantly correlated (at p<.10) with outcome. A wide range of significant 
correlations were found with personality, appraisal, emotion and coping variables 
emerging over both three month and six-month time lag.
In the first block of the regression analysis, control and potentially 
confounding variables were entered (age, gender, marital status, cancer type, 
treatment delay, health status, previous outcomes, trait personality). The residual 
level of outcome was then saved for use as the dependent variable for block two. 
In this second block, all significantly correlated predictor variables were entered 
using a stepwise method. The results are summarised in table 1.
Table 1. Summary o f regression models fo r  prediction o f psychosocial outcome.
T1-T2 T1-T3 T2-T3
Quality o f Life
Block 1 Variance 61% 67% 71%
Block 2 Predictors Congruence Future Expectancy Effortful Optimism
Add. Variance 5%
Hope/Hopelessness
14% 9%
Anxiety
Block 1 Variance 69% 6 6% 72%
Block 2 Predictors Self Responsibility None significant Other-blame
Add. Variance
Other-Blame 
Dr Locus of Control 
2 1 % 0 % 9%
Depression
Block 1 Variance 61% 59% 51%
Block 2 Predictors 
Add. Variance 0 %
None significant 
0 % 0 %
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Far higher levels of variance were explained for quality of life and anxiety than for 
depression; these lower scores should not, however, be dismissed as their range of 
51-61% remains a substantial proportion of variance. Depression was most 
successfully predicted using baseline psychological predictors than three-month 
follow up predictors. Quality of life was at six-month was better predicted than 
three-month levels, irrespective of which time-point of predictor variables were 
used. Anxiety was best predicted when time-lag between predictor and outcome 
measure was smallest.
From block one, earlier level of outcome was the most predictive variable. 
Age, marital status, cancer type, and health status all featured, but not consistently 
in all models. Few psychological variables significantly contributed to block two of 
the regressions. None emerged as significantly additive for any depression model. 
For quality of life and anxiety, only illness cognitions contributed further variance: 
appraisal of motivational congruence, self-responsibility, and future expectancy; 
core-relational themes of effortful optimism and other blame; doctor oriented 
locus of control; and hopelessness/helplessness subscale from the MAC. The 
absence of emotion and coping here is noteworthy given previous literature.
Theory Testing
Extensive theory tests were conducted; a summary only will be provided. 
First, change scores were calculated for each appraisal and emotion variable 
between baseline and six-month follow-up scores. Correlations between 
components were then explored and compared with theory-driven hypotheses. 
Few of these tests revealed significant results between the emotions and their 
expected cognitive correlates; none of the effect sizes for appraisals were 
significant, and just a small amount of core-relational themes fitted patterns 
proposed in Lazarus' theory. A number of non-expected components 
demonstrated significant correlations. Contrary to theory, multiple core-relational 
themes emerged as correlates of single emotions. These effect sizes were far 
higher than between appraisals and emotions.
Using baseline data only, regression models were constructed to test 
whether non-expected cognition variables contributed additional variance in 
emotion, above and beyond that already explained by theoretically expected
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variables. The results demonstrated that just one out of twelve models failed to 
benefit from the addition of non-expected variables. Not only did the remainder 
include additional variables, but some of the expected variables failed to reach 
significance for inclusion.
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Conclusions
The results from the clinically-oriented regression analyses demonstrated 
far higher effect sizes than the comparable literature (for a review see Hulbert- 
Williams et al, in prep). As hypothesised, cognitive appraisals emerged as far more 
predictive of psychosocial outcome than did emotional reaction or coping. This 
strengthens the current trend within the empirical literature to be focussing upon 
the effects of cognitions rather than coping (e.g. Folkman & Greer, 2000; Schneider, 
2008).
The failure of the cognitions to add to models of depression was surprising 
and is worthy of further research attention. Those appraisals emerging as 
significant for both quality of life and anxiety may provide an important focus for 
future psychological interventions for this patient group. Results indicate that for 
anxiety, appraisals have a time-limited effect on outcome, therefore intervention 
may need tailoring to different illness time-points. For quality of life, results 
indicated that intervention may be most effective at a later-time point (e.g three 
months). The identification of a small set of control variables which reliably 
predict high levels of psychosocial outcome may have potential application within 
the clinical setting to allow prediction and monitoring of those who may encounter 
future adjustment difficulties. Results from this data set indicated that those at 
most risk may be those patients who are younger, unmarried and perceive 
themselves to have a poorer physical health status.
Results from theory tests demonstrated little consistency with Lazarus's 
proposed theory. Not only were different cognitive predictors of emotion 
identified than would be expected, but the specific nature of the unique pairings 
between core-relational themes and emotions was not supported. This was one of 
just a few large scale empirical tests of this model using a homogenously stressed 
sample. The results indicate that further empirical work is necessary to develop 
the model further.
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The Importance of Personality in Appraisal and 
Prediction of Psychosocial Outcome in Cancer 
Patients: A Systematic Review
Hulbert NJa, Dudley HCa, Nel RDa, Wilkinson 
CEa, Morrison VLb
aDepartment of General Practice, Cardiff Univer­
sity, Centre for Health Sciences I North Wales 
Clinical School Wrexham, Wales, UK; bSchool of 
Psychology, University of Wales Bangor, Bangor,
Wales, UK
PURPOSE: Few studies have rigorously ad­
dressed the role of personality in appraisal of 
cancer diagnosis and it ’s relation to psychosocial 
outcome. Findings are often inconsistent, contra­
dictory, and criticised for quality and methodol­
ogy. A comprehensive systematic review of the 
literature is, therefore, required. METHOD:
Search strategies were designed for ten key 
psychological-and medically based electronic da­
tabases. Three questions were explored: the 
importance of personality in cognitive appraisal 
of diagnosis (13 731 hits); the importance of 
personality on psychosocial outcome (21 679 hits); 
and, the relationship between appraisal and 
psychosocial outcome in cancer patients (23 985 
hits). References are being independently assessed 
by two reviewers against pre-defined inclusion 
criteria; approximately 1.8% of retrieved hits have 
been highlighted for possible inclusion. All re­
search (experimental or observational) relevant to 
any of the three research questions in a sample of 
adult cancer patients will be included. Commen­
tary articles and opinion-based sources will be 
excluded. Data extraction and quality assessment 
will be carried out on included papers in accor­
dance with recommendations from the Centre for 
Reviews and Dissemination Guidance (2001), the 
Cochrane Handbook for Systematic Review of 
Interventions (2005) and other key sources of 
review methodology literature. RESULTS/CON­
CLUSION: The review will critically assess 
published literature in order to synthesise key 
findings and highlight core methodological 
issues where research quality is questionable.
Implications shall be drawn for the development 
and improvement of personality-based psycho­
social oncology research and intervention. The 
review will be completed by early autumn and the 
results presented.
Psycho-Oncology 15: S1-S478 (2006) 
DOI: 10.1002/pon
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APPENDIX 6.4: BPOS NEWSLETTER ARTICLE (2006)
THE IMPORTANCE OF PERSONALITY AND APPRAISAL IN PREDICTION OF 
PSYCHOSOCIAL OUTCOME FOR CANCER PATIENTS: A SYSTEMATIC REVIEW. 
PRELIMINARY FINDINGS FOR ANXIETY AND DEPRESSION.
The work that I presented at the IPOS conference was based on a systematic review  
being conducted w ith my colleagues, Helen Dudley, Richard Neal, Clare Wilkinson 
and, Val Morrison. The work will form the first part of my PhD. The review focuses 
on published studies which measure either a personality, cognition or emotion 
predictor variable; and, anxiety, depression or quality of life as an outcome variable. 
The poster presentation given in Venice gave preliminary results for anxiety and 
depression.
Cancer diagnosis often represents personal threat, challenge, and loss to patients; further, 
the illness course is unpredictable, usually interfering with personal goals (see Lazarus et 
al. 1987,1999). This can result in anxiety, stress and distress for many years after 
diagnosis. Research findings pertaining to the influence of psychological variables are 
inconsistent, particularly relating to individual variation in appraisal (Watson et al. 1991; 
Millar et al. 2005), and personality which Eysenck (1993) claims to carry equal weight to 
the stressor itself in determining outcome.
Three search strings were developed for key psychological and medical electronic 
databases. Inclusion criteria stipulated that only published empirical evidence written 
using the English language could be included. Any study of adult cancer patients was 
included provided that samples were recruited within five years of diagnosis. Studies 
were required to measure either a personality, cognition or emotion variable, in addition 
to a measure of either psychological co-morbidity or quality of life.
Literature searching revealed over 50,000 published reports. After de-duplication and 
relevance screening (based on titles and abstracts) by two independent reviewers, the 
searches were combined. 255 articles were ordered for full-article inclusion assessment. 
Of these, 174 were excluded. Main reasons for exclusion included foreign language papers 
(47), inadequate selection of measures for this review (53), or that original study aims 
were not relevant to this review (31). 19 did not provide adequate information to assess 
inclusion; lead authors were contacted by email but all were later excluded due to lack of 
response, or not available information. Three papers were combined with others within 
the inclusion list as they used the same sample, but reported on different analyses. 
Therefore, 74 studies were included: 18 measuring quality of life as the outcome variable, 
32 measuring anxiety or depression as the outcome variable, and 24 measuring both types 
of outcome.
Study quality was assessed using a tool based on that of Kmet, Lee and Cook (2004). 
Overall quality scores take account of clarity of hypotheses, appropriateness of design and 
sampling, appropriateness and clarity of statistical analysis, and validity of conclusions 
based on data provided. No studies scored a quality assessment of less than 50%: 60 
studies scored 75% or higher.
Thirty-two of the included studies used a cross-sectional design, three were baseline 
surveys conducted as part of RCTs or intervention studies, and 39 were longitudinal 
studies with follow-up data collection points ranging between two days and five years. In 
most cases, sample size was appropriate for individual study designs with a mean n of 127 
(ranging from 16-480). Percentage response rates from the originally approached study 
population were variable, ranging from 28% to 99% (M=77%); this variability is most
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likely explained by differences in timing of recruitment and clinical characteristics of the 
study population.
Psychological co-morbidity was grouped into two categories: anxiety and depression. 
Based on measures included, 59 of the included studies were potentially relevant to the 
current analysis. Of these 22 failed to conduct tests beyond simple inferential statistical 
procedures, leaving 37 reporting findings of association or prediction.
Preliminary results showed that personality, cognition and emotion-related variables are 
significantly associated to anxiety and depression in cancer patients, however associations 
based on control beliefs were non-significant. Although not a main focus of this review, 
there was evidence for a mediating role of coping between some of the predictor and 
outcome variables. However, optimum coping styles (for better adjustment) are variable 
both over time and between study.
It was hoped that meta-analysis could be conducted on these 37 studies, however this was 
not possible in most cases. Over 20 different predictor variables were used, and adequate 
statistical information was not provided to enable these statistical procedures to be used. 
In a number of studies, authors chose not to report findings for validated sub-scales of 
depression or anxiety, but rather merged them into one single outcome variable. This is 
not always helpful when trying to understand the complexity of results at a more detailed 
level. Some researchers used factor analysis as the justification for combining results in 
this way, though the failure of a factor structure to emerge in their data is unsurprising 
given the small sample sizes used in these particular studies.
Despite the large number of predictor variables highlighted by this preliminary analysis, 
most of these are illness appraisal or emotion related; only a small number of personality 
variables have been investigated in relation to psychosocial outcome. Future research 
should expand on this.
Additionally, several of the measures used in studies in this review have been purported to 
measure different underlying psychosocial constructs by different researchers. Our 
preliminary findings raise concerns about the coherence and definition of psychosocial 
constructs and measurement, and the theoretical basis underlying study rationales.
Theoretical models of adjustment to cancer describe a complex interaction between many 
psychosocial and clinical factors. The implications (both theoretical and clinically applied) 
of studies that fail to measure, or report statistical findings of, potentially important 
tertiary variables is unclear. It is possible that studies have been intentionally limited to 
avoid over-burdening patients, however in doing so, researchers in this field are 
inadvertently limiting the applicability of their findings to a subject so heavily based in 
theory and the application of that theory to clinical practice.
The fu ll review is now in the fina l stages o f data synthesis (including findings related to 
quality o f life] and w ill be written up fo r publication shortly. For further details on the 
project, please contact the review team at hulbertnj@cfac.uk.
Nick Hulbert-Williams.
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important to determine the relative contribution of 
certain types of beliefs to adjustment. Moreover, it 
would also be important to discern the role 
religious beliefs play in various aspects or stages 
of the stress-appraisal-coping process. For exam­
ple, do certain types of beliefs render some cancer- 
related stressors non-threatening? CLINICAL  
IMPLICATIONS: Interventions with an emphasis 
on enhancing self-efficacy might also include some 
remediating the precursors of efficacy such as social 
support and fostering religious beliefs if the patient 
endorses those beliefs as a coping resource. 
ACKNOW LEDGEMENT OF RESEARCH 
FUNDING : National Cancer Institute (CA88603 
and CA94914).
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Anxiety, Depression, and Quality of Life in the First 
Six Months after Cancer Diagnosis: the Contribu­
tion of Personality, Appraisals, and Emotions
♦Hulbert-Williams N J \ Neal R D \ Wilkinson C1, 
Morrison VL2
1C ard iff University, North Wales Clinical School, 
United Kingdom, School o f  Psychology, University 
o f  Wales, United Kingdom
PURPOSE: Early identification of those failing to 
adjust to a cancer diagnosis is imperative to enable 
optimized provision of psychosocial care. Psycho­
logical variables are undoubtedly important for 
this purpose; however, research findings to date 
have found inconsistent results. This is perhaps a 
methodological issue: many studies use cross- 
sectional designs, recruiting long after treatments 
are completed; and, few studies are truly theory 
based, thus failing to explore all potentially 
relevant predictors. We addressed these methodo­
logical issues in a theory-driven study (using 
Lazarus’s Transactional Model) exploring the 
contribution of personality, illness beliefs, apprai­
sals, emotions, and coping to reported anxiety, 
depression, and quality of life in newly diagnosed 
cancer patients. METHODS: 154 participants from 
three NHS Trusts were recruited shortly after 
diagnosis of a primary breast, prostate, lung, or 
colorectal cancer. Participants were approached 
within 2-8 weeks of diagnosis and completed 
questionnaires at baseline, three months, and six 
months. Questionnaires at all time points assessed 
a range of personality variables (LOT-R, NEO- 
FFI); health control beliefs (MHLC); coping 
(BriefCOPE); cognitive appraisals and emotions 
(Smith & Lazarus’s Appraisal Components Ques­
tionnaire); adjustment (MiniMAC); quality of life 
(SF-12; FACT); anxiety and depression (HADS). 
Clinical data (stage of illness, treatment plan and 
intention at diagnosis, secondary care psychologi­
cal services referral and treatment, waiting time, 
and performance status at diagnosis) were
Copyright ©  2007 John Wiley & Sons, Ltd.
extracted from hospital records. RESULT: Data 
are currently being inputted for analysis using 
teleform technology. Repetition of all psychologi­
cal predictors at each data collection stage will not 
only allow for tests of association and prediction, 
but also stability over time, under the increased 
stress and uncertainty during the first few months 
after diagnosis. T-tests and/or ANOVAs will be 
used to explore differences based on clinical and 
demographic data. Standard and cross-lagged 
correlations will be carried out between all 
predictor (e.g. personality, control beliefs, apprai­
sals etc.) and outcome (e.g. anxiety, depression, 
quality of life etc.) variables. Theory-informed 
regression models (based on Lazarus’s Transac­
tional Model) will be conducted to determine the 
predictive validity of specific variables above and 
beyond that offered by illness specific variables. All 
results will be analyzed and presented at the 
conference. CONCLUSIONS: RESEARCH IM ­
PLICATIONS: This will be one of the first truly 
theory-driven studies within psychosocial oncology 
research to explore, using improved methodologi­
cal approaches, the role of clinical data, individual 
differences, cognitions, emotions, and coping in 
response to cancer diagnosis. The findings will be 
useful in informing future research hypotheses and 
in further development and understanding of 
Lazarus’s Transactional Model. CLINICAL IM ­
PLICATIONS: Findings from this study will be 
useful for the identification of which psychological 
variables are most predictive of distress and quality 
of life, at which time points after cancer diagnosis. 
This information can be used by clinicians to 
identify those at risk of poorer adjustment and 
increased distress at an earlier stage, thus enabling 
better provision of psychosocial care and optimiz­
ing patient well-being through treatment and 
remission. ACKNOWLEDGEMENT OF RE­
SEARCH FUNDING: We are grateful to the 
North Wales Research Committee for a small grant 
to support this work.
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Studying of Depressive Disorders in Patients with 
Acute Leukemia
♦Ibragimova SZ, Makhmudova MR,
Eshimbetova SZ
Institute o f Hematology, Uzbekistan
PURPOSE: The treatment of the patients with 
cancer is often complicated by the development of 
psychopathological frustration. Modem protocol 
of chemotherapy allows achieving a good out­
comes, however such therapy entails occurrence 
of the stressful situation, leading to serious 
complications in mental sphere and behavioral 
ramifications. Depressive infringements cause of 
slow recovery, refuse of treatment, increases the
Psycho-Oncology 16: SI-S287 (2007) 
DOI: 10.1002/pon
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Abstracts 229
Exercise declined from Timel-Time3 (p <.001;eta2 «.075). Baseline exercise accounted for 20% 
of the variance in exercise at two-year follow-up. Intentions and E-SE added 6.2% (Timel) and 9% 
(Time2,ps c.001). Controlled for these measures, neither SABC nor specific self-efficacy 
(Block3b) added to the prediction. Block3c added 5.4% when baseline predictors were used 
(R2adjusted =•.28; Coping Planning: Beta =.23,p <.01; E-SE:Beta =.20,p <.05; Action Control: 
Beta -=.17,p —.065) and 2.6% for Time2 predictors (Action Control: Beta *=.24,p <.05;E-SE: 
Beta». 18,p a .054).
Sustained self-efficacy, coping planning and action control play an important role in foe 
maintenance of behaviour change.
Keywords: Action control, behaviour change, maintenance
Reference
*Sniehotta, F. F., Scholz, U., & Schwarzer, R. (2005). Bridging the intention-behaviour gap. 
Psychology &  Health, 20, 143-160.
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Personality, appraisal, emotional reaction, and adjustment following cancer diagnosis
N. Hulbert-Williams1, R. Neal1, C. Wilkinson1, V. Morrison2; Cardiff University, Nwcs, 
Wrexham, United Kingdom; 2University of Wales, Bangor, United Kingdom
Research Question Early identification of those failing to adjust to cancer is imperative for targeted 
provision of psychosocial care. Psychological variables are undoubtedly important for this purpose, 
however, research findings demonstrate inconsistent results. This is perhaps a methodological issue: 
many studies use cross-sectional designs, recruiting long after treatments are completed; and, few 
are truly theory-based, thus failing to explore all potentially relevant predictors. In particular, 
Folkman and Greer (2000), state the need for more emphasis on cognitive variables. We addressed 
these methodological issues in a theory-driven study (Lazarus's Transactional Model) in cancer.
Method Used 154 participants from three NHS Trusts were recruited shortly after diagnosis of a 
primary breast, prostate, lung or colorectal cancer. Participants completed questionnaires at 
baseline, three months, and six months. Questionnaires assessed personality, health control beliefs, 
coping, appraisals, emotions, quality of life, anxiety, and depression. Clinical data were extracted 
from hospital records.
Results Data are currently being inputted for analysis. Analysis will be conducted using t-tests and/ 
or ANOVA for group comparisons; standard and cross-lagged correlations between all predictor 
and outcome variables; and, theory-informed regression models to determine die predictive validity 
of specific predictor variables.
Conclusions This will be one of few truly theory-driven studies within psycho-sodal oncology 
research to explore, using improved methodological approaches, the role of clinical data, individual 
differences, cognitions, emotions and coping in response to cancer diagnosis.
Keywords: Adjustment, appraisals, cancer
Reference
Folkman, S., & Greer, S. (2000). Promoting psychological well-being in the face of serious illness: 
When theory, research and practice inform each other. Psycho-Oncology, 9, 11-19.
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38L-2
Understanding Patient Perceptions of 
Participation in Psychosocial Oncology Research.
Nicholas Hulbert-Williams1, Richard Neal2, Clare 
Wilkinson2, Val Morrison3
'University o f  Wolverhampton, Wolverhampton, 
England, United Kingdom, 2C a rd iff University, North 
Wales C lin ica l School, Wrexham, Wales, United 
Kingdom, JBangor University, Bangor, Wales, United 
Kingdom
PURPOSE: Most methodological papers investigating 
particpation rates into psychosocial oncology research 
are centred around recruitment into clinical trials. 
Recruitment rates into studies are low but a 
substantial proportion of patients report a desire to 
participate. Few studies explore perceptions of 
participation in non-clinical trial research studies. This 
paper analyses some of the comments made by 
patients during participation in a questionnaire-based 
study of cancer adjustment. METHODS: As an 
adjunct to a larger quantitative study, 160 participants 
were given the opportunity to write freely about any 
aspect of their illness or participation in the study. 
Lung, breast, prostate and colorectal cancer patients 
were recruited, with sixty percent of these sample 
providing comments which were thematically 
analysed. RESULTS: Five super-ordinate themes 
emerged: causation and control; physical aspects of 
illness; psychological adjustment; transition and 
return to normality; and, participation issues. The 
latter theme will be the focus of this presentation. 
CONCLUSION: Some participants found the
questionnaire presentation format difficult. Comments 
centred around question ambiguity, limited response 
formats, and the fluctuating nature of their illness- 
related thoughts and emotions over time. Many 
commented on study timing, predominantly, the 
incongruency between time of recruitment and 
treatment start dates. Many felt that questions related 
to the role of religion were innappropriate and worded 
so as to imply negative perceptions of God. The 
importance of religion as a source of support and 
coping was discussed. Few participants reported 
harms from participation and these were grounded in 
increased attention on their condition. Several 
participants reported benefits of participation, 
expressing gratitude and often suggesting the 
questionnaire as a framework for clinical discussion. 
RESEARCH IMPLICATIONS: The results from this 
paper will be of interest to those designing and 
evalutating new research studies. By analysing patient 
experiences of recruitment, their feedback can be used 
to potentially improve recruitment into, and increase 
perceived benefit from, participation in psychosocial 
oncology research. CLINICAL IMPLICATIONS: 
This analysis highlights patient desire to be included 
in psychosocial oncology research and will help
Copyright ©  2008 John Wiley & Sons, Ltd.
clinicians with decisions within practice relating to the 
introduction of new studies to patients at this complex 
time. ACKNOWLEDGEMENT OF FUNDING: This 
study was part-funded by a small grant from the North 
Wales Research Committee.
38L-3
Towards an Evidence Based Guideline ‘Detection 
of and Referral for Psychosocial Distress’
J. Nogossek3, J.C.J.M. de Haes1, M. Bannink2, M. A. 
van der Pol4
'Amsterdam Medical Center/University o f Amsterdam, 
Amsterdam, Netherlands, 2Erasmus Medical Center- 
Daniel den Hoed, Rotterdam, Netherlands,
3Comprehensive Cancer Center South, Eindhoven, 
Netherlands, 4 Comprehensive Cancer Center 
Rotterdam, Rotterdam, Netherlands
PURPOSE: The guideline will offer healthcare 
providers evidence based recommendations for 
systematic screening of psychosocial distress and 
referral. METHODS: A multidisciplinary expert 
group of representatives from professional 
associations in (psycho-)oncology and from patient 
associations will develop the guideline according to 
the Dutch method of evidence based guideline 
development: Investigate obstacles and their priority 
encountered in the field, by online survey Define 
distinct questions based on obstacles given high 
priority Search for highest levels of evidence and for 
best practices for each question Define 
recommendations based on findings Obtain approval 
from professionals in the field of (psycho-joncology 
Publicate the guideline on www.oncoline.nl Develop 
indicators to monitor implementation The process of 
development and implementation of the guideline is 
facilitated by the Dutch Comprehensive Cancer 
Centers and the Dutch Cancer Society. RESULTS: 
340 respondents - professionals of all disciplines in 
(psycho-)oncology and cancer survivors - of an online 
questionnaire prioritized obstacles from a list of 19 
items considered prominent total group and subgroup 
analyses yielded a balanced set of obstacles with high 
priority as subject for the guideline the obstacles were 
reformulated into five distinct questions, which in turn 
were the starting point for a systematic literature 
search and search for best practice. Thus, 
recommendations will be made for: instrument(s) for 
psychosocial screening frequency and timing of 
screening communication about distress and the 
screening results with the patient rules for referral 
conditions for implementation. CONCLUSION: The 
identification by online survey of the most important 
obstacles in psychosocial screening and referral as 
encountered by health care providers led to a clear 
outline of the subject of the guideline. RESEARCH 
IMPLICATIONS: Based on the literature searches, 
what evidence is missing will become clear. Thus,
Psycho-Oncology 17: SI-S348 (2008) 
DOI: 10 .1002/pon
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STRESS IN CANCER DIAGNOSIS: IS LAZARUS'S TRANSACTIONAL MODEL SUFFICIENT? 
Hulbert-Williams NJ, Neal RD, Wilkinson C & Morrison V.
Lazarus's Transactional Model is one of the most cited socio-cognitive models of stress in 
the literature, yet few validation studies have included samples undergoing major life 
event stress. Instead, studies use real-life daily hassles or hypothetical life events. This 
model was used as the theoretical underpinning for exploring stress after cancer 
diagnosis.
This paper explores whether the data supported the hypothesised relationships between 
different components in the model. Sixty three males, and 97 females were recruited.
The sample included recent diagnoses of breast, colorectal, lung and prostate cancer 
(mean time since diagnosis =46 days). Participants completed a questionnaire including 
Smtih & Lazarus's (1993) measure of appraisal components, core-relational themes, and 
emotion themes.
For each emotion, two sets of regression analysis were performed. The first used the 
unique predictor combinations suggested in the literature in a forced-entry analysis.
These were compared to the second set which used a stepwise approach. These were 
compared to assess comparative contributions of theory-driven and data-driven 
approaches.
In all but two analyses, both appraisal components and core-relationsal themes were 
required to best explain emotion. In 11 out of 12, data-driven analyses (R2 range = 14.9 to 
52.0) outperformed theory-driven analyses (R2 range = 0 to 38.3). Concurrent analysis 
demonstrated the utility of all components in predicting of anxiety, depresison and quality 
of life. However, these analyses question the unique patterns of cognitive antecedents for 
each emotion. Further work, both longitudinal, and in other stressful situations, is 
required to enable refinement of this theory.
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Table 4.21. Summary o f regression models fo r  each set o f analysis (variables in bold indicate 
significant individual predictors).
Quality of life
Block 1
Block 2
Total Variance
Andety
Block 1
Block 2
 Total variance
Depression
Block 1
T1-T2 T1-T3 T2-T3
Gender Gender Gender
Age Age Age
Significant other Significant other Significant other
Cancer type Cancer type Cancer type
Physical health status Physical health status Physical health status
Mental health status Mental health status Mental health status
Quality of life Quality o f life Quality of life
Anxiety Anxiety Anxiety
Depression Depression Depression
Neuroticism Neuroticism Neuroticism
Extroversion Extroversion Extroversion
Agreeableness Openness Openness
Conscientiousness
Negative em otion Lack o f concern Adaptive coping 
Unexpectedness 
Other responsibility 
Threat
61.6% 67.5% 73.4%
Gender Gender Gender
Age Age Age
Significant other Significant other Significant other
Cancer type Cancer type Cancer type
Physical health status Physical health status Physical health status
Mental health status Mental health status Mental health status
Quality of life Quality of life Quality of life
Anxiety Anxiety Anxiety
Depression Depression Depression
Neuroticism Neuroticism Neuroticism
Extroversion Extroversion Extroversion
Agreeableness Agreeableness Agreeableness
Openness
Self-responsibility Other-blame
Other-blame
71.2% 67.0% 73.5%
Gender Gender Gender
Age Age Age
Significant other Significant other Significant other
Cancer type Cancer type Cancer type
Physical health status Physical health status Physical health status
Mental health status Mental health status Mental health status
Quality o f life Quality of life Quality of life
Anxiety Anxiety Anxiety
Depression Depression Depression
Neuroticism Neuroticism Neuroticism
Extroversion Extroversion
Agreeableness
No additional variables entered in block 2
Total variance 57.0% 57.0% 47.0%
